#version 2.4
## Oncotator v1.5.1.0 | Flat File Reference hg19 | GENCODE v19 EFFECT | UniProt_AAxform 2014_12 | ESP 6500SI-V2 | COSMIC v62_291112 | ESP 6500SI-V2 | dbNSFP v2.4 | dbSNP build 142 | 1000gp3 20130502 | ClinVar 12.03.20 | UniProt_AA 2014_12 | ORegAnno UCSC Track | CCLE_By_GP 09292010 | Ensembl ICGC MUCOPA | HumanDNARepairGenes 20110905 | COSMIC_Tissue 291112 | TUMORScape 20100104 | UniProt 2014_12 | HGNC Sept172014 | Familial_Cancer_Genes 20110905 | CGC full_2012-03-15 | MutSig Published Results 20110905 | COSMIC_FusionGenes v62_291112 | gencode_xref_refseq metadata_v19 | TCGAScape 110405 | ACHILLES_Lineage_Results 110303 | CCLE_By_Gene 09292010 
Hugo_Symbol	Entrez_Gene_Id	Center	NCBI_Build	Chromosome	Start_position	End_position	Strand	Variant_Classification	Variant_Type	Reference_Allele	Tumor_Seq_Allele1	Tumor_Seq_Allele2	dbSNP_RS	dbSNP_Val_Status	Tumor_Sample_Barcode	Matched_Norm_Sample_Barcode	Match_Norm_Seq_Allele1	Match_Norm_Seq_Allele2	Tumor_Validation_Allele1	Tumor_Validation_Allele2	Match_Norm_Validation_Allele1	Match_Norm_Validation_Allele2	Verification_Status	Validation_Status	Mutation_Status	Sequencing_Phase	Sequence_Source	Validation_Method	Score	BAM_file	Sequencer	Tumor_Sample_UUID	Matched_Norm_Sample_UUID	Genome_Change	Annotation_Transcript	Transcript_Strand	Transcript_Exon	Transcript_Position	cDNA_Change	Codon_Change	Protein_Change	Other_Transcripts	Refseq_mRNA_Id	Refseq_prot_Id	SwissProt_acc_Id	SwissProt_entry_Id	Description	UniProt_AApos	UniProt_Region	UniProt_Site	UniProt_Natural_Variations	UniProt_Experimental_Info	GO_Biological_Process	GO_Cellular_Component	GO_Molecular_Function	COSMIC_overlapping_mutations	COSMIC_fusion_genes	COSMIC_tissue_types_affected	COSMIC_total_alterations_in_gene	Tumorscape_Amplification_Peaks	Tumorscape_Deletion_Peaks	TCGAscape_Amplification_Peaks	TCGAscape_Deletion_Peaks	DrugBank	ref_context	gc_content	CCLE_ONCOMAP_overlapping_mutations	CCLE_ONCOMAP_total_mutations_in_gene	CGC_Mutation_Type	CGC_Translocation_Partner	CGC_Tumor_Types_Somatic	CGC_Tumor_Types_Germline	CGC_Other_Diseases	DNARepairGenes_Role	FamilialCancerDatabase_Syndromes	MUTSIG_Published_Results	OREGANNO_ID	OREGANNO_Values	1000gp3_AA	1000gp3_AC	1000gp3_AF	1000gp3_AFR_AF	1000gp3_AMR_AF	1000gp3_AN	1000gp3_CIEND	1000gp3_CIPOS	1000gp3_CS	1000gp3_DP	1000gp3_EAS_AF	1000gp3_END	1000gp3_EUR_AF	1000gp3_IMPRECISE	1000gp3_MC	1000gp3_MEINFO	1000gp3_MEND	1000gp3_MLEN	1000gp3_MSTART	1000gp3_NS	1000gp3_SAS_AF	1000gp3_SVLEN	1000gp3_SVTYPE	1000gp3_TSD	ACHILLES_Lineage_Results_Top_Genes	CGC_Cancer Germline Mut	CGC_Cancer Molecular Genetics	CGC_Cancer Somatic Mut	CGC_Cancer Syndrome	CGC_Chr	CGC_Chr Band	CGC_GeneID	CGC_Name	CGC_Other Germline Mut	CGC_Tissue Type	COSMIC_n_overlapping_mutations	COSMIC_overlapping_mutation_descriptions	COSMIC_overlapping_primary_sites	ClinVar_ASSEMBLY	ClinVar_HGMD_ID	ClinVar_SYM	ClinVar_TYPE	ClinVar_rs	ESP_AA	ESP_AAC	ESP_AA_AC	ESP_AA_AGE	ESP_AA_GTC	ESP_AvgAAsampleReadDepth	ESP_AvgEAsampleReadDepth	ESP_AvgSampleReadDepth	ESP_CA	ESP_CDP	ESP_CG	ESP_CP	ESP_Chromosome	ESP_DBSNP	ESP_DP	ESP_EA_AC	ESP_EA_AGE	ESP_EA_GTC	ESP_EXOME_CHIP	ESP_FG	ESP_GL	ESP_GM	ESP_GS	ESP_GTC	ESP_GTS	ESP_GWAS_PUBMED	ESP_MAF	ESP_PH	ESP_PP	ESP_Position	ESP_TAC	ESP_TotalAAsamplesCovered	ESP_TotalEAsamplesCovered	ESP_TotalSamplesCovered	Ensembl_so_accession	Ensembl_so_term	Familial_Cancer_Genes_Reference	Familial_Cancer_Genes_Synonym	HGNC_Accession Numbers	HGNC_CCDS IDs	HGNC_Chromosome	HGNC_Date Modified	HGNC_Date Name Changed	HGNC_Date Symbol Changed	HGNC_Ensembl Gene ID	HGNC_Ensembl ID(supplied by Ensembl)	HGNC_Entrez Gene ID(supplied by NCBI)	HGNC_Enzyme IDs	HGNC_Gene family description	HGNC_HGNC ID	HGNC_Locus Group	HGNC_Locus Type	HGNC_Name Synonyms	HGNC_OMIM ID(supplied by NCBI)	HGNC_Previous Names	HGNC_Previous Symbols	HGNC_Primary IDs	HGNC_Pubmed IDs	HGNC_Record Type	HGNC_RefSeq IDs	HGNC_RefSeq(supplied by NCBI)	HGNC_Secondary IDs	HGNC_Status	HGNC_Synonyms	HGNC_UCSC ID(supplied by UCSC)	HGNC_UniProt ID(supplied by UniProt)	HGNC_VEGA IDs	HGVS_coding_DNA_change	HGVS_genomic_change	HGVS_protein_change	ORegAnno_bin	UniProt_alt_uniprot_accessions	alt_allele_seen	build	ccds_id	dbNSFP_1000Gp1_AC	dbNSFP_1000Gp1_AF	dbNSFP_1000Gp1_AFR_AC	dbNSFP_1000Gp1_AFR_AF	dbNSFP_1000Gp1_AMR_AC	dbNSFP_1000Gp1_AMR_AF	dbNSFP_1000Gp1_ASN_AC	dbNSFP_1000Gp1_ASN_AF	dbNSFP_1000Gp1_EUR_AC	dbNSFP_1000Gp1_EUR_AF	dbNSFP_Ancestral_allele	dbNSFP_CADD_phred	dbNSFP_CADD_raw	dbNSFP_CADD_raw_rankscore	dbNSFP_ESP6500_AA_AF	dbNSFP_ESP6500_EA_AF	dbNSFP_Ensembl_geneid	dbNSFP_Ensembl_transcriptid	dbNSFP_FATHMM_pred	dbNSFP_FATHMM_rankscore	dbNSFP_FATHMM_score	dbNSFP_GERP++_NR	dbNSFP_GERP++_RS	dbNSFP_GERP++_RS_rankscore	dbNSFP_Interpro_domain	dbNSFP_LRT_Omega	dbNSFP_LRT_converted_rankscore	dbNSFP_LRT_pred	dbNSFP_LRT_score	dbNSFP_LR_pred	dbNSFP_LR_rankscore	dbNSFP_LR_score	dbNSFP_MutationAssessor_pred	dbNSFP_MutationAssessor_rankscore	dbNSFP_MutationAssessor_score	dbNSFP_MutationTaster_converted_rankscore	dbNSFP_MutationTaster_pred	dbNSFP_MutationTaster_score	dbNSFP_Polyphen2_HDIV_pred	dbNSFP_Polyphen2_HDIV_rankscore	dbNSFP_Polyphen2_HDIV_score	dbNSFP_Polyphen2_HVAR_pred	dbNSFP_Polyphen2_HVAR_rankscore	dbNSFP_Polyphen2_HVAR_score	dbNSFP_RadialSVM_pred	dbNSFP_RadialSVM_rankscore	dbNSFP_RadialSVM_score	dbNSFP_Reliability_index	dbNSFP_SIFT_converted_rankscore	dbNSFP_SIFT_pred	dbNSFP_SIFT_score	dbNSFP_SLR_test_statistic	dbNSFP_SiPhy_29way_logOdds	dbNSFP_SiPhy_29way_logOdds_rankscore	dbNSFP_SiPhy_29way_pi	dbNSFP_UniSNP_ids	dbNSFP_Uniprot_aapos	dbNSFP_Uniprot_acc	dbNSFP_Uniprot_id	dbNSFP_aaalt	dbNSFP_aapos	dbNSFP_aapos_FATHMM	dbNSFP_aapos_SIFT	dbNSFP_aaref	dbNSFP_cds_strand	dbNSFP_codonpos	dbNSFP_fold-degenerate	dbNSFP_genename	dbNSFP_hg18_pos(1-coor)	dbNSFP_phastCons100way_vertebrate	dbNSFP_phastCons100way_vertebrate_rankscore	dbNSFP_phastCons46way_placental	dbNSFP_phastCons46way_placental_rankscore	dbNSFP_phastCons46way_primate	dbNSFP_phastCons46way_primate_rankscore	dbNSFP_phyloP100way_vertebrate	dbNSFP_phyloP100way_vertebrate_rankscore	dbNSFP_phyloP46way_placental	dbNSFP_phyloP46way_placental_rankscore	dbNSFP_phyloP46way_primate	dbNSFP_phyloP46way_primate_rankscore	dbNSFP_refcodon	gencode_transcript_name	gencode_transcript_status	gencode_transcript_tags	gencode_transcript_type	gene_id	gene_type	havana_transcript	id	qual	secondary_variant_classification	strand	transcript_id
PAX7	5081	__UNKNOWN__	__UNKNOWN__	1	19027615	19027615	__UNKNOWN__	Intron	SNP	C	C	A	rs527816148	byFrequency	__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr1:19027615C>A	ENST00000420770.2	+	6	1035				PAX7_ENST00000375375.3_Intron|PAX7_ENST00000400661.3_Intron	NM_001135254.1	NP_001128726.1	P23759	PAX7_HUMAN	paired box 7						anatomical structure morphogenesis (GO:0009653)|cartilage development (GO:0051216)|chromatin remodeling (GO:0006338)|dorsal/ventral neural tube patterning (GO:0021904)|embryonic skeletal system development (GO:0048706)|muscle tissue morphogenesis (GO:0060415)|negative regulation of apoptotic process (GO:0043066)|neuron fate commitment (GO:0048663)|positive regulation of histone methylation (GO:0031062)|positive regulation of myoblast proliferation (GO:2000288)|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|regulation of cell fate commitment (GO:0010453)|regulation of protein binding (GO:0043393)|skeletal muscle satellite cell commitment (GO:0014813)|skeletal muscle tissue regeneration (GO:0043403)|spinal cord association neuron differentiation (GO:0021527)	nucleus (GO:0005634)	RNA polymerase II core promoter sequence-specific DNA binding transcription factor activity (GO:0000983)|sequence-specific DNA binding (GO:0043565)|sequence-specific DNA binding transcription factor activity (GO:0003700)		PAX7/FOXO1(197)	breast(2)|haematopoietic_and_lymphoid_tissue(1)|large_intestine(7)|lung(17)|ovary(1)|prostate(1)|skin(2)	31		Colorectal(325;3.46e-05)|all_lung(284;0.000439)|Renal(390;0.000518)|Lung NSC(340;0.000543)|Breast(348;0.00093)|Ovarian(437;0.00768)|Myeloproliferative disorder(586;0.0255)		UCEC - Uterine corpus endometrioid carcinoma (279;0.00609)|BRCA - Breast invasive adenocarcinoma(304;4.71e-05)|Kidney(64;0.000279)|KIRC - Kidney renal clear cell carcinoma(64;0.00371)|STAD - Stomach adenocarcinoma(196;0.00658)|READ - Rectum adenocarcinoma(331;0.0576)		ttctgcacttctaaaaatccc	0.527			T	FOXO1A	alveolar rhabdomyosarcoma																																		Dom	yes		1	1p36.2-p36.12	5081	paired box gene 7		M	0																																										SO:0001627	intron_variant			X96743	CCDS186.1, CCDS44074.1, CCDS44075.1	1p36.13	2011-06-20	2007-07-12		ENSG00000009709	ENSG00000009709	5081		"""Paired boxes"", ""Homeoboxes / PRD class"""	8621	protein-coding gene	gene with protein product		167410	"""paired box gene 7"""			7981748, 8431641	Standard	NM_002584	NM_001135254		Approved	Hup1	uc001bay.3	P23759	OTTHUMG00000002433	ENST00000420770.2:c.952+303C>A	chr1.hg19:g.19027615C>A			E9PFV9|Q0VA99|Q2PJS5	True	hg19	CCDS44074.1																																																																																			PAX7-002	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000372482.1		100.0		+	ENST00000420770.2
PAX7	5081	__UNKNOWN__	__UNKNOWN__	1	19027622	19027622	__UNKNOWN__	Intron	SNP	T	T	A			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr1:19027622T>A	ENST00000420770.2	+	6	1035				PAX7_ENST00000375375.3_Intron|PAX7_ENST00000400661.3_Intron	NM_001135254.1	NP_001128726.1	P23759	PAX7_HUMAN	paired box 7						anatomical structure morphogenesis (GO:0009653)|cartilage development (GO:0051216)|chromatin remodeling (GO:0006338)|dorsal/ventral neural tube patterning (GO:0021904)|embryonic skeletal system development (GO:0048706)|muscle tissue morphogenesis (GO:0060415)|negative regulation of apoptotic process (GO:0043066)|neuron fate commitment (GO:0048663)|positive regulation of histone methylation (GO:0031062)|positive regulation of myoblast proliferation (GO:2000288)|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|regulation of cell fate commitment (GO:0010453)|regulation of protein binding (GO:0043393)|skeletal muscle satellite cell commitment (GO:0014813)|skeletal muscle tissue regeneration (GO:0043403)|spinal cord association neuron differentiation (GO:0021527)	nucleus (GO:0005634)	RNA polymerase II core promoter sequence-specific DNA binding transcription factor activity (GO:0000983)|sequence-specific DNA binding (GO:0043565)|sequence-specific DNA binding transcription factor activity (GO:0003700)		PAX7/FOXO1(197)	breast(2)|haematopoietic_and_lymphoid_tissue(1)|large_intestine(7)|lung(17)|ovary(1)|prostate(1)|skin(2)	31		Colorectal(325;3.46e-05)|all_lung(284;0.000439)|Renal(390;0.000518)|Lung NSC(340;0.000543)|Breast(348;0.00093)|Ovarian(437;0.00768)|Myeloproliferative disorder(586;0.0255)		UCEC - Uterine corpus endometrioid carcinoma (279;0.00609)|BRCA - Breast invasive adenocarcinoma(304;4.71e-05)|Kidney(64;0.000279)|KIRC - Kidney renal clear cell carcinoma(64;0.00371)|STAD - Stomach adenocarcinoma(196;0.00658)|READ - Rectum adenocarcinoma(331;0.0576)		cttctaaaaatccccctggga	0.522			T	FOXO1A	alveolar rhabdomyosarcoma																																		Dom	yes		1	1p36.2-p36.12	5081	paired box gene 7		M	0																																										SO:0001627	intron_variant			X96743	CCDS186.1, CCDS44074.1, CCDS44075.1	1p36.13	2011-06-20	2007-07-12		ENSG00000009709	ENSG00000009709	5081		"""Paired boxes"", ""Homeoboxes / PRD class"""	8621	protein-coding gene	gene with protein product		167410	"""paired box gene 7"""			7981748, 8431641	Standard	NM_002584	NM_001135254		Approved	Hup1	uc001bay.3	P23759	OTTHUMG00000002433	ENST00000420770.2:c.952+310T>A	chr1.hg19:g.19027622T>A			E9PFV9|Q0VA99|Q2PJS5	True	hg19	CCDS44074.1																																																																																			PAX7-002	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000372482.1		56.0		+	ENST00000420770.2
PAX7	5081	__UNKNOWN__	__UNKNOWN__	1	19027623	19027623	__UNKNOWN__	Intron	SNP	C	C	A	rs539060971		__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr1:19027623C>A	ENST00000420770.2	+	6	1035				PAX7_ENST00000375375.3_Intron|PAX7_ENST00000400661.3_Intron	NM_001135254.1	NP_001128726.1	P23759	PAX7_HUMAN	paired box 7						anatomical structure morphogenesis (GO:0009653)|cartilage development (GO:0051216)|chromatin remodeling (GO:0006338)|dorsal/ventral neural tube patterning (GO:0021904)|embryonic skeletal system development (GO:0048706)|muscle tissue morphogenesis (GO:0060415)|negative regulation of apoptotic process (GO:0043066)|neuron fate commitment (GO:0048663)|positive regulation of histone methylation (GO:0031062)|positive regulation of myoblast proliferation (GO:2000288)|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|regulation of cell fate commitment (GO:0010453)|regulation of protein binding (GO:0043393)|skeletal muscle satellite cell commitment (GO:0014813)|skeletal muscle tissue regeneration (GO:0043403)|spinal cord association neuron differentiation (GO:0021527)	nucleus (GO:0005634)	RNA polymerase II core promoter sequence-specific DNA binding transcription factor activity (GO:0000983)|sequence-specific DNA binding (GO:0043565)|sequence-specific DNA binding transcription factor activity (GO:0003700)		PAX7/FOXO1(197)	breast(2)|haematopoietic_and_lymphoid_tissue(1)|large_intestine(7)|lung(17)|ovary(1)|prostate(1)|skin(2)	31		Colorectal(325;3.46e-05)|all_lung(284;0.000439)|Renal(390;0.000518)|Lung NSC(340;0.000543)|Breast(348;0.00093)|Ovarian(437;0.00768)|Myeloproliferative disorder(586;0.0255)		UCEC - Uterine corpus endometrioid carcinoma (279;0.00609)|BRCA - Breast invasive adenocarcinoma(304;4.71e-05)|Kidney(64;0.000279)|KIRC - Kidney renal clear cell carcinoma(64;0.00371)|STAD - Stomach adenocarcinoma(196;0.00658)|READ - Rectum adenocarcinoma(331;0.0576)		ttctaaaaatccccctgggaa	0.517			T	FOXO1A	alveolar rhabdomyosarcoma																																		Dom	yes		1	1p36.2-p36.12	5081	paired box gene 7		M	0																																										SO:0001627	intron_variant			X96743	CCDS186.1, CCDS44074.1, CCDS44075.1	1p36.13	2011-06-20	2007-07-12		ENSG00000009709	ENSG00000009709	5081		"""Paired boxes"", ""Homeoboxes / PRD class"""	8621	protein-coding gene	gene with protein product		167410	"""paired box gene 7"""			7981748, 8431641	Standard	NM_002584	NM_001135254		Approved	Hup1	uc001bay.3	P23759	OTTHUMG00000002433	ENST00000420770.2:c.952+311C>A	chr1.hg19:g.19027623C>A			E9PFV9|Q0VA99|Q2PJS5	True	hg19	CCDS44074.1																																																																																			PAX7-002	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000372482.1		36.0		+	ENST00000420770.2
ARID1A	8289	__UNKNOWN__	__UNKNOWN__	1	27023050	27023050	__UNKNOWN__	Silent	SNP	A	A	G			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr1:27023050A>G	ENST00000457599.2	+	1	156	c.156A>G	c.(154-156)gcA>gcG	p.A52A	ARID1A_ENST00000324856.7_Silent_p.A52A	NM_139135.2	NP_624361.1	O14497	ARI1A_HUMAN	AT rich interactive domain 1A (SWI-like)	52					androgen receptor signaling pathway (GO:0030521)|ATP-dependent chromatin remodeling (GO:0043044)|cardiac chamber development (GO:0003205)|chromatin remodeling (GO:0006338)|chromatin-mediated maintenance of transcription (GO:0048096)|forebrain development (GO:0030900)|glucocorticoid receptor signaling pathway (GO:0042921)|intracellular estrogen receptor signaling pathway (GO:0030520)|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|neural tube closure (GO:0001843)|nucleosome disassembly (GO:0006337)|nucleosome mobilization (GO:0042766)|optic cup formation involved in camera-type eye development (GO:0003408)|placenta blood vessel development (GO:0060674)|positive regulation of transcription, DNA-templated (GO:0045893)|regulation of transcription from RNA polymerase II promoter (GO:0006357)|transcription, DNA-templated (GO:0006351)	nBAF complex (GO:0071565)|npBAF complex (GO:0071564)|nuclear chromatin (GO:0000790)|nucleus (GO:0005634)|SWI/SNF complex (GO:0016514)	DNA binding (GO:0003677)|ligand-dependent nuclear receptor binding (GO:0016922)|transcription coactivator activity (GO:0003713)		ARID1A/MAST2_ENST00000361297(2)	NS(1)|autonomic_ganglia(1)|biliary_tract(1)|breast(13)|central_nervous_system(6)|cervix(2)|endometrium(56)|haematopoietic_and_lymphoid_tissue(8)|kidney(10)|large_intestine(41)|liver(31)|lung(34)|ovary(130)|pancreas(18)|prostate(8)|skin(9)|stomach(14)|upper_aerodigestive_tract(4)|urinary_tract(24)	411		all_cancers(24;6.36e-27)|all_epithelial(13;5.93e-24)|Colorectal(325;3.46e-05)|all_lung(284;4.76e-05)|Lung NSC(340;5.83e-05)|Breast(348;9.7e-05)|Renal(390;0.0007)|Ovarian(437;0.00473)|Myeloproliferative disorder(586;0.0255)|all_neural(195;0.0381)		UCEC - Uterine corpus endometrioid carcinoma (279;0.0178)|all cancers(4;2.61e-56)|Epithelial(14;7.53e-55)|OV - Ovarian serous cystadenocarcinoma(117;4.5e-30)|Colorectal(126;2.07e-09)|COAD - Colon adenocarcinoma(152;4.29e-07)|BRCA - Breast invasive adenocarcinoma(304;4.13e-05)|STAD - Stomach adenocarcinoma(196;0.000279)|KIRC - Kidney renal clear cell carcinoma(1967;0.000794)|GBM - Glioblastoma multiforme(114;0.0132)|READ - Rectum adenocarcinoma(331;0.0469)|Lung(427;0.167)|LUSC - Lung squamous cell carcinoma(448;0.242)		AAATGAAGGCAGCCGCCGGGC	0.776			"""Mis, N, F, S, D"""		"""clear cell ovarian carcinoma, RCC"""																																		Rec	yes		1	1p35.3	8289	AT rich interactive domain 1A (SWI-like)		E	0																																										SO:0001819	synonymous_variant			AB001895	CCDS285.1, CCDS44091.1	1p36.1-p35	2014-09-17	2006-11-08	2004-01-30	ENSG00000117713	ENSG00000117713	8289		"""-"""	11110	protein-coding gene	gene with protein product		603024	"""SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily f, member 1"", ""AT rich interactive domain 1A (SWI- like)"""	C1orf4, SMARCF1		9630625, 9434167	Standard	NM_139135	NM_139135		Approved	B120, P270, C10rf4, BAF250, BAF250a	uc001bmv.1	O14497	OTTHUMG00000004004	ENST00000457599.2:c.156A>G	chr1.hg19:g.27023050A>G			D3DPL1|Q53FK9|Q5T0W1|Q5T0W2|Q5T0W3|Q8NFD6|Q96T89|Q9BY33|Q9HBJ5|Q9UPZ1	True	hg19	CCDS44091.1																																																																																			ARID1A-002	NOVEL	basic|appris_candidate|exp_conf|CCDS	protein_coding		protein_coding	OTTHUMT00000011438.2		20.0		+	ENST00000457599.2
ARID1A	8289	__UNKNOWN__	__UNKNOWN__	1	27023244	27023244	__UNKNOWN__	Missense_Mutation	SNP	T	T	C			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr1:27023244T>C	ENST00000457599.2	+	1	350	c.350T>C	c.(349-351)cTc>cCc	p.L117P	ARID1A_ENST00000324856.7_Missense_Mutation_p.L117P	NM_139135.2	NP_624361.1	O14497	ARI1A_HUMAN	AT rich interactive domain 1A (SWI-like)	117					androgen receptor signaling pathway (GO:0030521)|ATP-dependent chromatin remodeling (GO:0043044)|cardiac chamber development (GO:0003205)|chromatin remodeling (GO:0006338)|chromatin-mediated maintenance of transcription (GO:0048096)|forebrain development (GO:0030900)|glucocorticoid receptor signaling pathway (GO:0042921)|intracellular estrogen receptor signaling pathway (GO:0030520)|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|neural tube closure (GO:0001843)|nucleosome disassembly (GO:0006337)|nucleosome mobilization (GO:0042766)|optic cup formation involved in camera-type eye development (GO:0003408)|placenta blood vessel development (GO:0060674)|positive regulation of transcription, DNA-templated (GO:0045893)|regulation of transcription from RNA polymerase II promoter (GO:0006357)|transcription, DNA-templated (GO:0006351)	nBAF complex (GO:0071565)|npBAF complex (GO:0071564)|nuclear chromatin (GO:0000790)|nucleus (GO:0005634)|SWI/SNF complex (GO:0016514)	DNA binding (GO:0003677)|ligand-dependent nuclear receptor binding (GO:0016922)|transcription coactivator activity (GO:0003713)		ARID1A/MAST2_ENST00000361297(2)	NS(1)|autonomic_ganglia(1)|biliary_tract(1)|breast(13)|central_nervous_system(6)|cervix(2)|endometrium(56)|haematopoietic_and_lymphoid_tissue(8)|kidney(10)|large_intestine(41)|liver(31)|lung(34)|ovary(130)|pancreas(18)|prostate(8)|skin(9)|stomach(14)|upper_aerodigestive_tract(4)|urinary_tract(24)	411		all_cancers(24;6.36e-27)|all_epithelial(13;5.93e-24)|Colorectal(325;3.46e-05)|all_lung(284;4.76e-05)|Lung NSC(340;5.83e-05)|Breast(348;9.7e-05)|Renal(390;0.0007)|Ovarian(437;0.00473)|Myeloproliferative disorder(586;0.0255)|all_neural(195;0.0381)		UCEC - Uterine corpus endometrioid carcinoma (279;0.0178)|all cancers(4;2.61e-56)|Epithelial(14;7.53e-55)|OV - Ovarian serous cystadenocarcinoma(117;4.5e-30)|Colorectal(126;2.07e-09)|COAD - Colon adenocarcinoma(152;4.29e-07)|BRCA - Breast invasive adenocarcinoma(304;4.13e-05)|STAD - Stomach adenocarcinoma(196;0.000279)|KIRC - Kidney renal clear cell carcinoma(1967;0.000794)|GBM - Glioblastoma multiforme(114;0.0132)|READ - Rectum adenocarcinoma(331;0.0469)|Lung(427;0.167)|LUSC - Lung squamous cell carcinoma(448;0.242)		AACAATAACCTCACGGAGCCG	0.776			"""Mis, N, F, S, D"""		"""clear cell ovarian carcinoma, RCC"""																																		Rec	yes		1	1p35.3	8289	AT rich interactive domain 1A (SWI-like)		E	0													1.0	1.0	1.0					1																	27023244		332	734	1066	SO:0001583	missense			AB001895	CCDS285.1, CCDS44091.1	1p36.1-p35	2014-09-17	2006-11-08	2004-01-30	ENSG00000117713	ENSG00000117713	8289		"""-"""	11110	protein-coding gene	gene with protein product		603024	"""SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily f, member 1"", ""AT rich interactive domain 1A (SWI- like)"""	C1orf4, SMARCF1		9630625, 9434167	Standard	NM_139135	NM_139135		Approved	B120, P270, C10rf4, BAF250, BAF250a	uc001bmv.1	O14497	OTTHUMG00000004004	ENST00000457599.2:c.350T>C	chr1.hg19:g.27023244T>C	ENSP00000387636:p.Leu117Pro		D3DPL1|Q53FK9|Q5T0W1|Q5T0W2|Q5T0W3|Q8NFD6|Q96T89|Q9BY33|Q9HBJ5|Q9UPZ1	True	hg19	CCDS44091.1	.	.	.	.	.	.	.	.	.	.	T	12.70	2.018021	0.35606	.	.	ENSG00000117713	ENST00000324856;ENST00000457599	T;T	0.02446	4.49;4.29	3.07	3.07	0.35406	.	0.582693	0.14859	U	0.294220	T	0.01320	0.0043	N	0.08118	0	0.80722	D	1	P;D	0.53885	0.939;0.963	B;B	0.36534	0.114;0.227	T	0.67783	-0.5581	10	0.24483	T	0.36	-4.5435	5.5761	0.17225	0.2452:0.0:0.0:0.7547	.	117;117	O14497;O14497-2	ARI1A_HUMAN;.	P	117	ENSP00000320485:L117P;ENSP00000387636:L117P	ENSP00000320485:L117P	L	+	2	0	ARID1A	26895831	1.000000	0.71417	0.999000	0.59377	0.988000	0.76386	3.115000	0.50391	1.400000	0.46741	0.317000	0.21355	CTC	ARID1A-002	NOVEL	basic|appris_candidate|exp_conf|CCDS	protein_coding		protein_coding	OTTHUMT00000011438.2		43.0		+	ENST00000457599.2
ARID1A	8289	__UNKNOWN__	__UNKNOWN__	1	27023778	27023778	__UNKNOWN__	Missense_Mutation	SNP	T	T	C			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr1:27023778T>C	ENST00000457599.2	+	1	884	c.884T>C	c.(883-885)cTc>cCc	p.L295P	ARID1A_ENST00000324856.7_Missense_Mutation_p.L295P	NM_139135.2	NP_624361.1	O14497	ARI1A_HUMAN	AT rich interactive domain 1A (SWI-like)	295					androgen receptor signaling pathway (GO:0030521)|ATP-dependent chromatin remodeling (GO:0043044)|cardiac chamber development (GO:0003205)|chromatin remodeling (GO:0006338)|chromatin-mediated maintenance of transcription (GO:0048096)|forebrain development (GO:0030900)|glucocorticoid receptor signaling pathway (GO:0042921)|intracellular estrogen receptor signaling pathway (GO:0030520)|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|neural tube closure (GO:0001843)|nucleosome disassembly (GO:0006337)|nucleosome mobilization (GO:0042766)|optic cup formation involved in camera-type eye development (GO:0003408)|placenta blood vessel development (GO:0060674)|positive regulation of transcription, DNA-templated (GO:0045893)|regulation of transcription from RNA polymerase II promoter (GO:0006357)|transcription, DNA-templated (GO:0006351)	nBAF complex (GO:0071565)|npBAF complex (GO:0071564)|nuclear chromatin (GO:0000790)|nucleus (GO:0005634)|SWI/SNF complex (GO:0016514)	DNA binding (GO:0003677)|ligand-dependent nuclear receptor binding (GO:0016922)|transcription coactivator activity (GO:0003713)	p.L295fs*105(1)	ARID1A/MAST2_ENST00000361297(2)	NS(1)|autonomic_ganglia(1)|biliary_tract(1)|breast(13)|central_nervous_system(6)|cervix(2)|endometrium(56)|haematopoietic_and_lymphoid_tissue(8)|kidney(10)|large_intestine(41)|liver(31)|lung(34)|ovary(130)|pancreas(18)|prostate(8)|skin(9)|stomach(14)|upper_aerodigestive_tract(4)|urinary_tract(24)	411		all_cancers(24;6.36e-27)|all_epithelial(13;5.93e-24)|Colorectal(325;3.46e-05)|all_lung(284;4.76e-05)|Lung NSC(340;5.83e-05)|Breast(348;9.7e-05)|Renal(390;0.0007)|Ovarian(437;0.00473)|Myeloproliferative disorder(586;0.0255)|all_neural(195;0.0381)		UCEC - Uterine corpus endometrioid carcinoma (279;0.0178)|all cancers(4;2.61e-56)|Epithelial(14;7.53e-55)|OV - Ovarian serous cystadenocarcinoma(117;4.5e-30)|Colorectal(126;2.07e-09)|COAD - Colon adenocarcinoma(152;4.29e-07)|BRCA - Breast invasive adenocarcinoma(304;4.13e-05)|STAD - Stomach adenocarcinoma(196;0.000279)|KIRC - Kidney renal clear cell carcinoma(1967;0.000794)|GBM - Glioblastoma multiforme(114;0.0132)|READ - Rectum adenocarcinoma(331;0.0469)|Lung(427;0.167)|LUSC - Lung squamous cell carcinoma(448;0.242)		ACCCCCACCCTCAACCAACTG	0.761			"""Mis, N, F, S, D"""		"""clear cell ovarian carcinoma, RCC"""																																		Rec	yes		1	1p35.3	8289	AT rich interactive domain 1A (SWI-like)		E	1	Insertion - Frameshift(1)	ovary(1)											2.0	3.0	3.0					1																	27023778		1599	3467	5066	SO:0001583	missense			AB001895	CCDS285.1, CCDS44091.1	1p36.1-p35	2014-09-17	2006-11-08	2004-01-30	ENSG00000117713	ENSG00000117713	8289		"""-"""	11110	protein-coding gene	gene with protein product		603024	"""SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily f, member 1"", ""AT rich interactive domain 1A (SWI- like)"""	C1orf4, SMARCF1		9630625, 9434167	Standard	NM_139135	NM_139135		Approved	B120, P270, C10rf4, BAF250, BAF250a	uc001bmv.1	O14497	OTTHUMG00000004004	ENST00000457599.2:c.884T>C	chr1.hg19:g.27023778T>C	ENSP00000387636:p.Leu295Pro		D3DPL1|Q53FK9|Q5T0W1|Q5T0W2|Q5T0W3|Q8NFD6|Q96T89|Q9BY33|Q9HBJ5|Q9UPZ1	True	hg19	CCDS44091.1	.	.	.	.	.	.	.	.	.	.	T	12.59	1.985106	0.35036	.	.	ENSG00000117713	ENST00000324856;ENST00000457599	T;T	0.09817	3.29;2.94	3.77	2.62	0.31277	.	0.086078	0.44285	D	0.000467	T	0.14141	0.0342	L	0.32530	0.975	0.80722	D	1	D;D	0.64830	0.971;0.994	P;P	0.57776	0.543;0.827	T	0.03852	-1.0998	10	0.34782	T	0.22	-5.5501	7.7348	0.28808	0.0:0.1078:0.0:0.8922	.	295;295	O14497;O14497-2	ARI1A_HUMAN;.	P	295	ENSP00000320485:L295P;ENSP00000387636:L295P	ENSP00000320485:L295P	L	+	2	0	ARID1A	26896365	1.000000	0.71417	1.000000	0.80357	0.995000	0.86356	3.910000	0.56371	1.475000	0.48197	0.334000	0.21626	CTC	ARID1A-002	NOVEL	basic|appris_candidate|exp_conf|CCDS	protein_coding		protein_coding	OTTHUMT00000011438.2		34.0		+	ENST00000457599.2
ARID1A	8289	__UNKNOWN__	__UNKNOWN__	1	27023856	27023856	__UNKNOWN__	Missense_Mutation	SNP	A	A	C			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr1:27023856A>C	ENST00000457599.2	+	1	962	c.962A>C	c.(961-963)cAg>cCg	p.Q321P	ARID1A_ENST00000324856.7_Missense_Mutation_p.Q321P	NM_139135.2	NP_624361.1	O14497	ARI1A_HUMAN	AT rich interactive domain 1A (SWI-like)	321					androgen receptor signaling pathway (GO:0030521)|ATP-dependent chromatin remodeling (GO:0043044)|cardiac chamber development (GO:0003205)|chromatin remodeling (GO:0006338)|chromatin-mediated maintenance of transcription (GO:0048096)|forebrain development (GO:0030900)|glucocorticoid receptor signaling pathway (GO:0042921)|intracellular estrogen receptor signaling pathway (GO:0030520)|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|neural tube closure (GO:0001843)|nucleosome disassembly (GO:0006337)|nucleosome mobilization (GO:0042766)|optic cup formation involved in camera-type eye development (GO:0003408)|placenta blood vessel development (GO:0060674)|positive regulation of transcription, DNA-templated (GO:0045893)|regulation of transcription from RNA polymerase II promoter (GO:0006357)|transcription, DNA-templated (GO:0006351)	nBAF complex (GO:0071565)|npBAF complex (GO:0071564)|nuclear chromatin (GO:0000790)|nucleus (GO:0005634)|SWI/SNF complex (GO:0016514)	DNA binding (GO:0003677)|ligand-dependent nuclear receptor binding (GO:0016922)|transcription coactivator activity (GO:0003713)		ARID1A/MAST2_ENST00000361297(2)	NS(1)|autonomic_ganglia(1)|biliary_tract(1)|breast(13)|central_nervous_system(6)|cervix(2)|endometrium(56)|haematopoietic_and_lymphoid_tissue(8)|kidney(10)|large_intestine(41)|liver(31)|lung(34)|ovary(130)|pancreas(18)|prostate(8)|skin(9)|stomach(14)|upper_aerodigestive_tract(4)|urinary_tract(24)	411		all_cancers(24;6.36e-27)|all_epithelial(13;5.93e-24)|Colorectal(325;3.46e-05)|all_lung(284;4.76e-05)|Lung NSC(340;5.83e-05)|Breast(348;9.7e-05)|Renal(390;0.0007)|Ovarian(437;0.00473)|Myeloproliferative disorder(586;0.0255)|all_neural(195;0.0381)		UCEC - Uterine corpus endometrioid carcinoma (279;0.0178)|all cancers(4;2.61e-56)|Epithelial(14;7.53e-55)|OV - Ovarian serous cystadenocarcinoma(117;4.5e-30)|Colorectal(126;2.07e-09)|COAD - Colon adenocarcinoma(152;4.29e-07)|BRCA - Breast invasive adenocarcinoma(304;4.13e-05)|STAD - Stomach adenocarcinoma(196;0.000279)|KIRC - Kidney renal clear cell carcinoma(1967;0.000794)|GBM - Glioblastoma multiforme(114;0.0132)|READ - Rectum adenocarcinoma(331;0.0469)|Lung(427;0.167)|LUSC - Lung squamous cell carcinoma(448;0.242)		GGCGGGCCCCAGGACGGGGGC	0.781			"""Mis, N, F, S, D"""		"""clear cell ovarian carcinoma, RCC"""																																		Rec	yes		1	1p35.3	8289	AT rich interactive domain 1A (SWI-like)		E	0													1.0	2.0	2.0					1																	27023856		971	2389	3360	SO:0001583	missense			AB001895	CCDS285.1, CCDS44091.1	1p36.1-p35	2014-09-17	2006-11-08	2004-01-30	ENSG00000117713	ENSG00000117713	8289		"""-"""	11110	protein-coding gene	gene with protein product		603024	"""SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily f, member 1"", ""AT rich interactive domain 1A (SWI- like)"""	C1orf4, SMARCF1		9630625, 9434167	Standard	NM_139135	NM_139135		Approved	B120, P270, C10rf4, BAF250, BAF250a	uc001bmv.1	O14497	OTTHUMG00000004004	ENST00000457599.2:c.962A>C	chr1.hg19:g.27023856A>C	ENSP00000387636:p.Gln321Pro		D3DPL1|Q53FK9|Q5T0W1|Q5T0W2|Q5T0W3|Q8NFD6|Q96T89|Q9BY33|Q9HBJ5|Q9UPZ1	True	hg19	CCDS44091.1	.	.	.	.	.	.	.	.	.	.	A	12.53	1.965667	0.34659	.	.	ENSG00000117713	ENST00000324856;ENST00000457599	T;T	0.03920	4.04;3.76	3.15	3.15	0.36227	.	0.396081	0.22666	N	0.057132	T	0.05273	0.0140	N	0.14661	0.345	0.80722	D	1	P;D	0.53745	0.937;0.962	P;P	0.51866	0.483;0.682	T	0.56691	-0.7937	10	0.26408	T	0.33	-1.0E-4	10.779	0.46367	1.0:0.0:0.0:0.0	.	321;321	O14497;O14497-2	ARI1A_HUMAN;.	P	321	ENSP00000320485:Q321P;ENSP00000387636:Q321P	ENSP00000320485:Q321P	Q	+	2	0	ARID1A	26896443	1.000000	0.71417	1.000000	0.80357	0.992000	0.81027	3.755000	0.55197	1.440000	0.47531	0.379000	0.24179	CAG	ARID1A-002	NOVEL	basic|appris_candidate|exp_conf|CCDS	protein_coding		protein_coding	OTTHUMT00000011438.2		22.0		+	ENST00000457599.2
ARID1A	8289	__UNKNOWN__	__UNKNOWN__	1	27023858	27023858	__UNKNOWN__	Missense_Mutation	SNP	G	G	T			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr1:27023858G>T	ENST00000457599.2	+	1	964	c.964G>T	c.(964-966)Gac>Tac	p.D322Y	ARID1A_ENST00000324856.7_Missense_Mutation_p.D322Y	NM_139135.2	NP_624361.1	O14497	ARI1A_HUMAN	AT rich interactive domain 1A (SWI-like)	322					androgen receptor signaling pathway (GO:0030521)|ATP-dependent chromatin remodeling (GO:0043044)|cardiac chamber development (GO:0003205)|chromatin remodeling (GO:0006338)|chromatin-mediated maintenance of transcription (GO:0048096)|forebrain development (GO:0030900)|glucocorticoid receptor signaling pathway (GO:0042921)|intracellular estrogen receptor signaling pathway (GO:0030520)|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|neural tube closure (GO:0001843)|nucleosome disassembly (GO:0006337)|nucleosome mobilization (GO:0042766)|optic cup formation involved in camera-type eye development (GO:0003408)|placenta blood vessel development (GO:0060674)|positive regulation of transcription, DNA-templated (GO:0045893)|regulation of transcription from RNA polymerase II promoter (GO:0006357)|transcription, DNA-templated (GO:0006351)	nBAF complex (GO:0071565)|npBAF complex (GO:0071564)|nuclear chromatin (GO:0000790)|nucleus (GO:0005634)|SWI/SNF complex (GO:0016514)	DNA binding (GO:0003677)|ligand-dependent nuclear receptor binding (GO:0016922)|transcription coactivator activity (GO:0003713)		ARID1A/MAST2_ENST00000361297(2)	NS(1)|autonomic_ganglia(1)|biliary_tract(1)|breast(13)|central_nervous_system(6)|cervix(2)|endometrium(56)|haematopoietic_and_lymphoid_tissue(8)|kidney(10)|large_intestine(41)|liver(31)|lung(34)|ovary(130)|pancreas(18)|prostate(8)|skin(9)|stomach(14)|upper_aerodigestive_tract(4)|urinary_tract(24)	411		all_cancers(24;6.36e-27)|all_epithelial(13;5.93e-24)|Colorectal(325;3.46e-05)|all_lung(284;4.76e-05)|Lung NSC(340;5.83e-05)|Breast(348;9.7e-05)|Renal(390;0.0007)|Ovarian(437;0.00473)|Myeloproliferative disorder(586;0.0255)|all_neural(195;0.0381)		UCEC - Uterine corpus endometrioid carcinoma (279;0.0178)|all cancers(4;2.61e-56)|Epithelial(14;7.53e-55)|OV - Ovarian serous cystadenocarcinoma(117;4.5e-30)|Colorectal(126;2.07e-09)|COAD - Colon adenocarcinoma(152;4.29e-07)|BRCA - Breast invasive adenocarcinoma(304;4.13e-05)|STAD - Stomach adenocarcinoma(196;0.000279)|KIRC - Kidney renal clear cell carcinoma(1967;0.000794)|GBM - Glioblastoma multiforme(114;0.0132)|READ - Rectum adenocarcinoma(331;0.0469)|Lung(427;0.167)|LUSC - Lung squamous cell carcinoma(448;0.242)		CGGGCCCCAGGACGGGGGCGC	0.781			"""Mis, N, F, S, D"""		"""clear cell ovarian carcinoma, RCC"""																																		Rec	yes		1	1p35.3	8289	AT rich interactive domain 1A (SWI-like)		E	0													1.0	2.0	2.0					1																	27023858		962	2376	3338	SO:0001583	missense			AB001895	CCDS285.1, CCDS44091.1	1p36.1-p35	2014-09-17	2006-11-08	2004-01-30	ENSG00000117713	ENSG00000117713	8289		"""-"""	11110	protein-coding gene	gene with protein product		603024	"""SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily f, member 1"", ""AT rich interactive domain 1A (SWI- like)"""	C1orf4, SMARCF1		9630625, 9434167	Standard	NM_139135	NM_139135		Approved	B120, P270, C10rf4, BAF250, BAF250a	uc001bmv.1	O14497	OTTHUMG00000004004	ENST00000457599.2:c.964G>T	chr1.hg19:g.27023858G>T	ENSP00000387636:p.Asp322Tyr		D3DPL1|Q53FK9|Q5T0W1|Q5T0W2|Q5T0W3|Q8NFD6|Q96T89|Q9BY33|Q9HBJ5|Q9UPZ1	True	hg19	CCDS44091.1	.	.	.	.	.	.	.	.	.	.	G	11.93	1.785335	0.31593	.	.	ENSG00000117713	ENST00000324856;ENST00000457599	T;T	0.02525	4.46;4.26	3.15	2.22	0.28083	.	0.334262	0.26931	N	0.021765	T	0.02304	0.0071	N	0.08118	0	0.80722	D	1	P;D	0.54207	0.94;0.965	B;P	0.47981	0.36;0.563	T	0.63319	-0.6664	10	0.59425	D	0.04	-4.0059	7.8481	0.29437	0.1258:0.0:0.8742:0.0	.	322;322	O14497;O14497-2	ARI1A_HUMAN;.	Y	322	ENSP00000320485:D322Y;ENSP00000387636:D322Y	ENSP00000320485:D322Y	D	+	1	0	ARID1A	26896445	1.000000	0.71417	1.000000	0.80357	0.990000	0.78478	6.233000	0.72320	0.651000	0.30788	0.462000	0.41574	GAC	ARID1A-002	NOVEL	basic|appris_candidate|exp_conf|CCDS	protein_coding		protein_coding	OTTHUMT00000011438.2		22.0		+	ENST00000457599.2
ARID1A	8289	__UNKNOWN__	__UNKNOWN__	1	27023859	27023859	__UNKNOWN__	Missense_Mutation	SNP	A	A	C			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr1:27023859A>C	ENST00000457599.2	+	1	965	c.965A>C	c.(964-966)gAc>gCc	p.D322A	ARID1A_ENST00000324856.7_Missense_Mutation_p.D322A	NM_139135.2	NP_624361.1	O14497	ARI1A_HUMAN	AT rich interactive domain 1A (SWI-like)	322					androgen receptor signaling pathway (GO:0030521)|ATP-dependent chromatin remodeling (GO:0043044)|cardiac chamber development (GO:0003205)|chromatin remodeling (GO:0006338)|chromatin-mediated maintenance of transcription (GO:0048096)|forebrain development (GO:0030900)|glucocorticoid receptor signaling pathway (GO:0042921)|intracellular estrogen receptor signaling pathway (GO:0030520)|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|neural tube closure (GO:0001843)|nucleosome disassembly (GO:0006337)|nucleosome mobilization (GO:0042766)|optic cup formation involved in camera-type eye development (GO:0003408)|placenta blood vessel development (GO:0060674)|positive regulation of transcription, DNA-templated (GO:0045893)|regulation of transcription from RNA polymerase II promoter (GO:0006357)|transcription, DNA-templated (GO:0006351)	nBAF complex (GO:0071565)|npBAF complex (GO:0071564)|nuclear chromatin (GO:0000790)|nucleus (GO:0005634)|SWI/SNF complex (GO:0016514)	DNA binding (GO:0003677)|ligand-dependent nuclear receptor binding (GO:0016922)|transcription coactivator activity (GO:0003713)		ARID1A/MAST2_ENST00000361297(2)	NS(1)|autonomic_ganglia(1)|biliary_tract(1)|breast(13)|central_nervous_system(6)|cervix(2)|endometrium(56)|haematopoietic_and_lymphoid_tissue(8)|kidney(10)|large_intestine(41)|liver(31)|lung(34)|ovary(130)|pancreas(18)|prostate(8)|skin(9)|stomach(14)|upper_aerodigestive_tract(4)|urinary_tract(24)	411		all_cancers(24;6.36e-27)|all_epithelial(13;5.93e-24)|Colorectal(325;3.46e-05)|all_lung(284;4.76e-05)|Lung NSC(340;5.83e-05)|Breast(348;9.7e-05)|Renal(390;0.0007)|Ovarian(437;0.00473)|Myeloproliferative disorder(586;0.0255)|all_neural(195;0.0381)		UCEC - Uterine corpus endometrioid carcinoma (279;0.0178)|all cancers(4;2.61e-56)|Epithelial(14;7.53e-55)|OV - Ovarian serous cystadenocarcinoma(117;4.5e-30)|Colorectal(126;2.07e-09)|COAD - Colon adenocarcinoma(152;4.29e-07)|BRCA - Breast invasive adenocarcinoma(304;4.13e-05)|STAD - Stomach adenocarcinoma(196;0.000279)|KIRC - Kidney renal clear cell carcinoma(1967;0.000794)|GBM - Glioblastoma multiforme(114;0.0132)|READ - Rectum adenocarcinoma(331;0.0469)|Lung(427;0.167)|LUSC - Lung squamous cell carcinoma(448;0.242)		GGGCCCCAGGACGGGGGCGCC	0.776			"""Mis, N, F, S, D"""		"""clear cell ovarian carcinoma, RCC"""																																		Rec	yes		1	1p35.3	8289	AT rich interactive domain 1A (SWI-like)		E	0													1.0	2.0	2.0					1																	27023859		951	2364	3315	SO:0001583	missense			AB001895	CCDS285.1, CCDS44091.1	1p36.1-p35	2014-09-17	2006-11-08	2004-01-30	ENSG00000117713	ENSG00000117713	8289		"""-"""	11110	protein-coding gene	gene with protein product		603024	"""SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily f, member 1"", ""AT rich interactive domain 1A (SWI- like)"""	C1orf4, SMARCF1		9630625, 9434167	Standard	NM_139135	NM_139135		Approved	B120, P270, C10rf4, BAF250, BAF250a	uc001bmv.1	O14497	OTTHUMG00000004004	ENST00000457599.2:c.965A>C	chr1.hg19:g.27023859A>C	ENSP00000387636:p.Asp322Ala		D3DPL1|Q53FK9|Q5T0W1|Q5T0W2|Q5T0W3|Q8NFD6|Q96T89|Q9BY33|Q9HBJ5|Q9UPZ1	True	hg19	CCDS44091.1	.	.	.	.	.	.	.	.	.	.	A	12.55	1.972185	0.34754	.	.	ENSG00000117713	ENST00000324856;ENST00000457599	T;T	0.02280	4.56;4.36	3.15	1.97	0.26223	.	0.334262	0.26931	N	0.021765	T	0.00906	0.0030	N	0.03608	-0.345	0.80722	D	1	B;B	0.31817	0.231;0.341	B;B	0.25140	0.026;0.058	T	0.59139	-0.7510	10	0.09843	T	0.71	-4.0059	6.6103	0.22747	0.787:0.0:0.0:0.213	.	322;322	O14497;O14497-2	ARI1A_HUMAN;.	A	322	ENSP00000320485:D322A;ENSP00000387636:D322A	ENSP00000320485:D322A	D	+	2	0	ARID1A	26896446	1.000000	0.71417	1.000000	0.80357	0.989000	0.77384	3.813000	0.55636	0.392000	0.25172	0.379000	0.24179	GAC	ARID1A-002	NOVEL	basic|appris_candidate|exp_conf|CCDS	protein_coding		protein_coding	OTTHUMT00000011438.2		22.0		+	ENST00000457599.2
ARID1A	8289	__UNKNOWN__	__UNKNOWN__	1	27023861	27023861	__UNKNOWN__	Missense_Mutation	SNP	G	G	T			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr1:27023861G>T	ENST00000457599.2	+	1	967	c.967G>T	c.(967-969)Ggg>Tgg	p.G323W	ARID1A_ENST00000324856.7_Missense_Mutation_p.G323W	NM_139135.2	NP_624361.1	O14497	ARI1A_HUMAN	AT rich interactive domain 1A (SWI-like)	323					androgen receptor signaling pathway (GO:0030521)|ATP-dependent chromatin remodeling (GO:0043044)|cardiac chamber development (GO:0003205)|chromatin remodeling (GO:0006338)|chromatin-mediated maintenance of transcription (GO:0048096)|forebrain development (GO:0030900)|glucocorticoid receptor signaling pathway (GO:0042921)|intracellular estrogen receptor signaling pathway (GO:0030520)|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|neural tube closure (GO:0001843)|nucleosome disassembly (GO:0006337)|nucleosome mobilization (GO:0042766)|optic cup formation involved in camera-type eye development (GO:0003408)|placenta blood vessel development (GO:0060674)|positive regulation of transcription, DNA-templated (GO:0045893)|regulation of transcription from RNA polymerase II promoter (GO:0006357)|transcription, DNA-templated (GO:0006351)	nBAF complex (GO:0071565)|npBAF complex (GO:0071564)|nuclear chromatin (GO:0000790)|nucleus (GO:0005634)|SWI/SNF complex (GO:0016514)	DNA binding (GO:0003677)|ligand-dependent nuclear receptor binding (GO:0016922)|transcription coactivator activity (GO:0003713)		ARID1A/MAST2_ENST00000361297(2)	NS(1)|autonomic_ganglia(1)|biliary_tract(1)|breast(13)|central_nervous_system(6)|cervix(2)|endometrium(56)|haematopoietic_and_lymphoid_tissue(8)|kidney(10)|large_intestine(41)|liver(31)|lung(34)|ovary(130)|pancreas(18)|prostate(8)|skin(9)|stomach(14)|upper_aerodigestive_tract(4)|urinary_tract(24)	411		all_cancers(24;6.36e-27)|all_epithelial(13;5.93e-24)|Colorectal(325;3.46e-05)|all_lung(284;4.76e-05)|Lung NSC(340;5.83e-05)|Breast(348;9.7e-05)|Renal(390;0.0007)|Ovarian(437;0.00473)|Myeloproliferative disorder(586;0.0255)|all_neural(195;0.0381)		UCEC - Uterine corpus endometrioid carcinoma (279;0.0178)|all cancers(4;2.61e-56)|Epithelial(14;7.53e-55)|OV - Ovarian serous cystadenocarcinoma(117;4.5e-30)|Colorectal(126;2.07e-09)|COAD - Colon adenocarcinoma(152;4.29e-07)|BRCA - Breast invasive adenocarcinoma(304;4.13e-05)|STAD - Stomach adenocarcinoma(196;0.000279)|KIRC - Kidney renal clear cell carcinoma(1967;0.000794)|GBM - Glioblastoma multiforme(114;0.0132)|READ - Rectum adenocarcinoma(331;0.0469)|Lung(427;0.167)|LUSC - Lung squamous cell carcinoma(448;0.242)		GCCCCAGGACGGGGGCGCCGG	0.771			"""Mis, N, F, S, D"""		"""clear cell ovarian carcinoma, RCC"""																																		Rec	yes		1	1p35.3	8289	AT rich interactive domain 1A (SWI-like)		E	0													1.0	2.0	2.0					1																	27023861		926	2310	3236	SO:0001583	missense			AB001895	CCDS285.1, CCDS44091.1	1p36.1-p35	2014-09-17	2006-11-08	2004-01-30	ENSG00000117713	ENSG00000117713	8289		"""-"""	11110	protein-coding gene	gene with protein product		603024	"""SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily f, member 1"", ""AT rich interactive domain 1A (SWI- like)"""	C1orf4, SMARCF1		9630625, 9434167	Standard	NM_139135	NM_139135		Approved	B120, P270, C10rf4, BAF250, BAF250a	uc001bmv.1	O14497	OTTHUMG00000004004	ENST00000457599.2:c.967G>T	chr1.hg19:g.27023861G>T	ENSP00000387636:p.Gly323Trp		D3DPL1|Q53FK9|Q5T0W1|Q5T0W2|Q5T0W3|Q8NFD6|Q96T89|Q9BY33|Q9HBJ5|Q9UPZ1	True	hg19	CCDS44091.1	.	.	.	.	.	.	.	.	.	.	G	12.75	2.031332	0.35797	.	.	ENSG00000117713	ENST00000324856;ENST00000457599	T;T	0.02525	4.46;4.26	3.15	3.15	0.36227	.	0.082565	0.47852	D	0.000213	T	0.04815	0.0130	N	0.08118	0	0.80722	D	1	D;D	0.76494	0.998;0.999	D;D	0.69824	0.924;0.966	T	0.57888	-0.7733	10	0.54805	T	0.06	-0.9337	11.6021	0.51008	0.0:0.0:1.0:0.0	.	323;323	O14497;O14497-2	ARI1A_HUMAN;.	W	323	ENSP00000320485:G323W;ENSP00000387636:G323W	ENSP00000320485:G323W	G	+	1	0	ARID1A	26896448	1.000000	0.71417	1.000000	0.80357	0.984000	0.73092	4.186000	0.58337	1.763000	0.52060	0.462000	0.41574	GGG	ARID1A-002	NOVEL	basic|appris_candidate|exp_conf|CCDS	protein_coding		protein_coding	OTTHUMT00000011438.2		23.0		+	ENST00000457599.2
ARID1A	8289	__UNKNOWN__	__UNKNOWN__	1	27023867	27023867	__UNKNOWN__	Frame_Shift_Del	DEL	G	G	-			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr1:27023867delG	ENST00000457599.2	+	1	973	c.973delG	c.(973-975)gccfs	p.A325fs	ARID1A_ENST00000324856.7_Frame_Shift_Del_p.A325fs	NM_139135.2	NP_624361.1	O14497	ARI1A_HUMAN	AT rich interactive domain 1A (SWI-like)	325					androgen receptor signaling pathway (GO:0030521)|ATP-dependent chromatin remodeling (GO:0043044)|cardiac chamber development (GO:0003205)|chromatin remodeling (GO:0006338)|chromatin-mediated maintenance of transcription (GO:0048096)|forebrain development (GO:0030900)|glucocorticoid receptor signaling pathway (GO:0042921)|intracellular estrogen receptor signaling pathway (GO:0030520)|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|neural tube closure (GO:0001843)|nucleosome disassembly (GO:0006337)|nucleosome mobilization (GO:0042766)|optic cup formation involved in camera-type eye development (GO:0003408)|placenta blood vessel development (GO:0060674)|positive regulation of transcription, DNA-templated (GO:0045893)|regulation of transcription from RNA polymerase II promoter (GO:0006357)|transcription, DNA-templated (GO:0006351)	nBAF complex (GO:0071565)|npBAF complex (GO:0071564)|nuclear chromatin (GO:0000790)|nucleus (GO:0005634)|SWI/SNF complex (GO:0016514)	DNA binding (GO:0003677)|ligand-dependent nuclear receptor binding (GO:0016922)|transcription coactivator activity (GO:0003713)	p.G324fs*37(1)	ARID1A/MAST2_ENST00000361297(2)	NS(1)|autonomic_ganglia(1)|biliary_tract(1)|breast(13)|central_nervous_system(6)|cervix(2)|endometrium(56)|haematopoietic_and_lymphoid_tissue(8)|kidney(10)|large_intestine(41)|liver(31)|lung(34)|ovary(130)|pancreas(18)|prostate(8)|skin(9)|stomach(14)|upper_aerodigestive_tract(4)|urinary_tract(24)	411		all_cancers(24;6.36e-27)|all_epithelial(13;5.93e-24)|Colorectal(325;3.46e-05)|all_lung(284;4.76e-05)|Lung NSC(340;5.83e-05)|Breast(348;9.7e-05)|Renal(390;0.0007)|Ovarian(437;0.00473)|Myeloproliferative disorder(586;0.0255)|all_neural(195;0.0381)		UCEC - Uterine corpus endometrioid carcinoma (279;0.0178)|all cancers(4;2.61e-56)|Epithelial(14;7.53e-55)|OV - Ovarian serous cystadenocarcinoma(117;4.5e-30)|Colorectal(126;2.07e-09)|COAD - Colon adenocarcinoma(152;4.29e-07)|BRCA - Breast invasive adenocarcinoma(304;4.13e-05)|STAD - Stomach adenocarcinoma(196;0.000279)|KIRC - Kidney renal clear cell carcinoma(1967;0.000794)|GBM - Glioblastoma multiforme(114;0.0132)|READ - Rectum adenocarcinoma(331;0.0469)|Lung(427;0.167)|LUSC - Lung squamous cell carcinoma(448;0.242)		GGACGGGGGCGCCGGCAAGGG	0.766			"""Mis, N, F, S, D"""		"""clear cell ovarian carcinoma, RCC"""																																		Rec	yes		1	1p35.3	8289	AT rich interactive domain 1A (SWI-like)		E	1	Deletion - Frameshift(1)	stomach(1)																																								SO:0001589	frameshift_variant			AB001895	CCDS285.1, CCDS44091.1	1p36.1-p35	2014-09-17	2006-11-08	2004-01-30	ENSG00000117713	ENSG00000117713	8289		"""-"""	11110	protein-coding gene	gene with protein product		603024	"""SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily f, member 1"", ""AT rich interactive domain 1A (SWI- like)"""	C1orf4, SMARCF1		9630625, 9434167	Standard	NM_139135	NM_139135		Approved	B120, P270, C10rf4, BAF250, BAF250a	uc001bmv.1	O14497	OTTHUMG00000004004	ENST00000457599.2:c.973delG	chr1.hg19:g.27023867delG	ENSP00000387636:p.Ala325fs		D3DPL1|Q53FK9|Q5T0W1|Q5T0W2|Q5T0W3|Q8NFD6|Q96T89|Q9BY33|Q9HBJ5|Q9UPZ1	True	hg19	CCDS44091.1																																																																																			ARID1A-002	NOVEL	basic|appris_candidate|exp_conf|CCDS	protein_coding		protein_coding	OTTHUMT00000011438.2		23.0		+	ENST00000457599.2
ARID1A	8289	__UNKNOWN__	__UNKNOWN__	1	27023871	27023871	__UNKNOWN__	Missense_Mutation	SNP	G	G	C			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr1:27023871G>C	ENST00000457599.2	+	1	977	c.977G>C	c.(976-978)gGc>gCc	p.G326A	ARID1A_ENST00000324856.7_Missense_Mutation_p.G326A	NM_139135.2	NP_624361.1	O14497	ARI1A_HUMAN	AT rich interactive domain 1A (SWI-like)	326					androgen receptor signaling pathway (GO:0030521)|ATP-dependent chromatin remodeling (GO:0043044)|cardiac chamber development (GO:0003205)|chromatin remodeling (GO:0006338)|chromatin-mediated maintenance of transcription (GO:0048096)|forebrain development (GO:0030900)|glucocorticoid receptor signaling pathway (GO:0042921)|intracellular estrogen receptor signaling pathway (GO:0030520)|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|neural tube closure (GO:0001843)|nucleosome disassembly (GO:0006337)|nucleosome mobilization (GO:0042766)|optic cup formation involved in camera-type eye development (GO:0003408)|placenta blood vessel development (GO:0060674)|positive regulation of transcription, DNA-templated (GO:0045893)|regulation of transcription from RNA polymerase II promoter (GO:0006357)|transcription, DNA-templated (GO:0006351)	nBAF complex (GO:0071565)|npBAF complex (GO:0071564)|nuclear chromatin (GO:0000790)|nucleus (GO:0005634)|SWI/SNF complex (GO:0016514)	DNA binding (GO:0003677)|ligand-dependent nuclear receptor binding (GO:0016922)|transcription coactivator activity (GO:0003713)		ARID1A/MAST2_ENST00000361297(2)	NS(1)|autonomic_ganglia(1)|biliary_tract(1)|breast(13)|central_nervous_system(6)|cervix(2)|endometrium(56)|haematopoietic_and_lymphoid_tissue(8)|kidney(10)|large_intestine(41)|liver(31)|lung(34)|ovary(130)|pancreas(18)|prostate(8)|skin(9)|stomach(14)|upper_aerodigestive_tract(4)|urinary_tract(24)	411		all_cancers(24;6.36e-27)|all_epithelial(13;5.93e-24)|Colorectal(325;3.46e-05)|all_lung(284;4.76e-05)|Lung NSC(340;5.83e-05)|Breast(348;9.7e-05)|Renal(390;0.0007)|Ovarian(437;0.00473)|Myeloproliferative disorder(586;0.0255)|all_neural(195;0.0381)		UCEC - Uterine corpus endometrioid carcinoma (279;0.0178)|all cancers(4;2.61e-56)|Epithelial(14;7.53e-55)|OV - Ovarian serous cystadenocarcinoma(117;4.5e-30)|Colorectal(126;2.07e-09)|COAD - Colon adenocarcinoma(152;4.29e-07)|BRCA - Breast invasive adenocarcinoma(304;4.13e-05)|STAD - Stomach adenocarcinoma(196;0.000279)|KIRC - Kidney renal clear cell carcinoma(1967;0.000794)|GBM - Glioblastoma multiforme(114;0.0132)|READ - Rectum adenocarcinoma(331;0.0469)|Lung(427;0.167)|LUSC - Lung squamous cell carcinoma(448;0.242)		GGGGGCGCCGGCAAGGGCCCG	0.766			"""Mis, N, F, S, D"""		"""clear cell ovarian carcinoma, RCC"""																																		Rec	yes		1	1p35.3	8289	AT rich interactive domain 1A (SWI-like)		E	0													1.0	2.0	1.0					1																	27023871		818	2157	2975	SO:0001583	missense			AB001895	CCDS285.1, CCDS44091.1	1p36.1-p35	2014-09-17	2006-11-08	2004-01-30	ENSG00000117713	ENSG00000117713	8289		"""-"""	11110	protein-coding gene	gene with protein product		603024	"""SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily f, member 1"", ""AT rich interactive domain 1A (SWI- like)"""	C1orf4, SMARCF1		9630625, 9434167	Standard	NM_139135	NM_139135		Approved	B120, P270, C10rf4, BAF250, BAF250a	uc001bmv.1	O14497	OTTHUMG00000004004	ENST00000457599.2:c.977G>C	chr1.hg19:g.27023871G>C	ENSP00000387636:p.Gly326Ala		D3DPL1|Q53FK9|Q5T0W1|Q5T0W2|Q5T0W3|Q8NFD6|Q96T89|Q9BY33|Q9HBJ5|Q9UPZ1	True	hg19	CCDS44091.1	.	.	.	.	.	.	.	.	.	.	G	4.469	0.086988	0.08583	.	.	ENSG00000117713	ENST00000324856;ENST00000457599	T;T	0.02067	4.67;4.47	3.26	1.08	0.20341	.	0.474827	0.19272	N	0.118384	T	0.01222	0.0040	N	0.08118	0	0.80722	D	1	B;B	0.02656	0.0;0.0	B;B	0.04013	0.0;0.001	T	0.55879	-0.8071	10	0.25751	T	0.34	-0.2022	6.4253	0.21766	0.1097:0.3555:0.5348:0.0	.	326;326	O14497;O14497-2	ARI1A_HUMAN;.	A	326	ENSP00000320485:G326A;ENSP00000387636:G326A	ENSP00000320485:G326A	G	+	2	0	ARID1A	26896458	1.000000	0.71417	1.000000	0.80357	0.789000	0.44602	1.352000	0.34033	0.687000	0.31509	-0.502000	0.04539	GGC	ARID1A-002	NOVEL	basic|appris_candidate|exp_conf|CCDS	protein_coding		protein_coding	OTTHUMT00000011438.2		24.0		+	ENST00000457599.2
ARID1A	8289	__UNKNOWN__	__UNKNOWN__	1	27087901	27087901	__UNKNOWN__	Missense_Mutation	SNP	A	A	G			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr1:27087901A>G	ENST00000457599.2	+	6	2188	c.2188A>G	c.(2188-2190)Agt>Ggt	p.S730G	ARID1A_ENST00000374152.2_Missense_Mutation_p.S347G|ARID1A_ENST00000324856.7_Missense_Mutation_p.S730G	NM_139135.2	NP_624361.1	O14497	ARI1A_HUMAN	AT rich interactive domain 1A (SWI-like)	730					androgen receptor signaling pathway (GO:0030521)|ATP-dependent chromatin remodeling (GO:0043044)|cardiac chamber development (GO:0003205)|chromatin remodeling (GO:0006338)|chromatin-mediated maintenance of transcription (GO:0048096)|forebrain development (GO:0030900)|glucocorticoid receptor signaling pathway (GO:0042921)|intracellular estrogen receptor signaling pathway (GO:0030520)|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|neural tube closure (GO:0001843)|nucleosome disassembly (GO:0006337)|nucleosome mobilization (GO:0042766)|optic cup formation involved in camera-type eye development (GO:0003408)|placenta blood vessel development (GO:0060674)|positive regulation of transcription, DNA-templated (GO:0045893)|regulation of transcription from RNA polymerase II promoter (GO:0006357)|transcription, DNA-templated (GO:0006351)	nBAF complex (GO:0071565)|npBAF complex (GO:0071564)|nuclear chromatin (GO:0000790)|nucleus (GO:0005634)|SWI/SNF complex (GO:0016514)	DNA binding (GO:0003677)|ligand-dependent nuclear receptor binding (GO:0016922)|transcription coactivator activity (GO:0003713)	p.R727fs*12(1)|p.P728fs(1)	ARID1A/MAST2_ENST00000361297(2)	NS(1)|autonomic_ganglia(1)|biliary_tract(1)|breast(13)|central_nervous_system(6)|cervix(2)|endometrium(56)|haematopoietic_and_lymphoid_tissue(8)|kidney(10)|large_intestine(41)|liver(31)|lung(34)|ovary(130)|pancreas(18)|prostate(8)|skin(9)|stomach(14)|upper_aerodigestive_tract(4)|urinary_tract(24)	411		all_cancers(24;6.36e-27)|all_epithelial(13;5.93e-24)|Colorectal(325;3.46e-05)|all_lung(284;4.76e-05)|Lung NSC(340;5.83e-05)|Breast(348;9.7e-05)|Renal(390;0.0007)|Ovarian(437;0.00473)|Myeloproliferative disorder(586;0.0255)|all_neural(195;0.0381)		UCEC - Uterine corpus endometrioid carcinoma (279;0.0178)|all cancers(4;2.61e-56)|Epithelial(14;7.53e-55)|OV - Ovarian serous cystadenocarcinoma(117;4.5e-30)|Colorectal(126;2.07e-09)|COAD - Colon adenocarcinoma(152;4.29e-07)|BRCA - Breast invasive adenocarcinoma(304;4.13e-05)|STAD - Stomach adenocarcinoma(196;0.000279)|KIRC - Kidney renal clear cell carcinoma(1967;0.000794)|GBM - Glioblastoma multiforme(114;0.0132)|READ - Rectum adenocarcinoma(331;0.0469)|Lung(427;0.167)|LUSC - Lung squamous cell carcinoma(448;0.242)		TCGGCCACCCAGTGGCCAGTC	0.527			"""Mis, N, F, S, D"""		"""clear cell ovarian carcinoma, RCC"""																																		Rec	yes		1	1p35.3	8289	AT rich interactive domain 1A (SWI-like)		E	2	Deletion - Frameshift(1)|Complex(1)	ovary(1)|liver(1)											78.0	74.0	75.0					1																	27087901		2203	4300	6503	SO:0001583	missense			AB001895	CCDS285.1, CCDS44091.1	1p36.1-p35	2014-09-17	2006-11-08	2004-01-30	ENSG00000117713	ENSG00000117713	8289		"""-"""	11110	protein-coding gene	gene with protein product		603024	"""SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily f, member 1"", ""AT rich interactive domain 1A (SWI- like)"""	C1orf4, SMARCF1		9630625, 9434167	Standard	NM_139135	NM_139135		Approved	B120, P270, C10rf4, BAF250, BAF250a	uc001bmv.1	O14497	OTTHUMG00000004004	ENST00000457599.2:c.2188A>G	chr1.hg19:g.27087901A>G	ENSP00000387636:p.Ser730Gly		D3DPL1|Q53FK9|Q5T0W1|Q5T0W2|Q5T0W3|Q8NFD6|Q96T89|Q9BY33|Q9HBJ5|Q9UPZ1	True	hg19	CCDS44091.1	.	.	.	.	.	.	.	.	.	.	A	19.05	3.751215	0.69533	.	.	ENSG00000117713	ENST00000324856;ENST00000457599;ENST00000374152	T;T;T	0.25414	1.8;1.8;4.19	5.33	5.33	0.75918	.	0.042207	0.85682	D	0.000000	T	0.37571	0.1008	L	0.42245	1.32	0.80722	D	1	D;D;D	0.61697	0.982;0.99;0.982	D;D;D	0.72982	0.952;0.979;0.952	T	0.11012	-1.0605	10	0.02654	T	1	-6.8891	15.4598	0.75346	1.0:0.0:0.0:0.0	.	730;730;384	O14497;O14497-2;Q4LE49	ARI1A_HUMAN;.;.	G	730;730;347	ENSP00000320485:S730G;ENSP00000387636:S730G;ENSP00000363267:S347G	ENSP00000320485:S730G	S	+	1	0	ARID1A	26960488	1.000000	0.71417	1.000000	0.80357	0.999000	0.98932	5.754000	0.68743	2.234000	0.73211	0.533000	0.62120	AGT	ARID1A-002	NOVEL	basic|appris_candidate|exp_conf|CCDS	protein_coding		protein_coding	OTTHUMT00000011438.2		20.0		+	ENST00000457599.2
ARID1A	8289	__UNKNOWN__	__UNKNOWN__	1	27100199	27100199	__UNKNOWN__	Missense_Mutation	SNP	A	A	T			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr1:27100199A>T	ENST00000457599.2	+	16	3995	c.3995A>T	c.(3994-3996)cAg>cTg	p.Q1332L	ARID1A_ENST00000374152.2_Missense_Mutation_p.Q949L|ARID1A_ENST00000324856.7_Missense_Mutation_p.Q1332L|ARID1A_ENST00000540690.1_5'UTR	NM_139135.2	NP_624361.1	O14497	ARI1A_HUMAN	AT rich interactive domain 1A (SWI-like)	1332	Gln-rich.				androgen receptor signaling pathway (GO:0030521)|ATP-dependent chromatin remodeling (GO:0043044)|cardiac chamber development (GO:0003205)|chromatin remodeling (GO:0006338)|chromatin-mediated maintenance of transcription (GO:0048096)|forebrain development (GO:0030900)|glucocorticoid receptor signaling pathway (GO:0042921)|intracellular estrogen receptor signaling pathway (GO:0030520)|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|neural tube closure (GO:0001843)|nucleosome disassembly (GO:0006337)|nucleosome mobilization (GO:0042766)|optic cup formation involved in camera-type eye development (GO:0003408)|placenta blood vessel development (GO:0060674)|positive regulation of transcription, DNA-templated (GO:0045893)|regulation of transcription from RNA polymerase II promoter (GO:0006357)|transcription, DNA-templated (GO:0006351)	nBAF complex (GO:0071565)|npBAF complex (GO:0071564)|nuclear chromatin (GO:0000790)|nucleus (GO:0005634)|SWI/SNF complex (GO:0016514)	DNA binding (GO:0003677)|ligand-dependent nuclear receptor binding (GO:0016922)|transcription coactivator activity (GO:0003713)		ARID1A/MAST2_ENST00000361297(2)	NS(1)|autonomic_ganglia(1)|biliary_tract(1)|breast(13)|central_nervous_system(6)|cervix(2)|endometrium(56)|haematopoietic_and_lymphoid_tissue(8)|kidney(10)|large_intestine(41)|liver(31)|lung(34)|ovary(130)|pancreas(18)|prostate(8)|skin(9)|stomach(14)|upper_aerodigestive_tract(4)|urinary_tract(24)	411		all_cancers(24;6.36e-27)|all_epithelial(13;5.93e-24)|Colorectal(325;3.46e-05)|all_lung(284;4.76e-05)|Lung NSC(340;5.83e-05)|Breast(348;9.7e-05)|Renal(390;0.0007)|Ovarian(437;0.00473)|Myeloproliferative disorder(586;0.0255)|all_neural(195;0.0381)		UCEC - Uterine corpus endometrioid carcinoma (279;0.0178)|all cancers(4;2.61e-56)|Epithelial(14;7.53e-55)|OV - Ovarian serous cystadenocarcinoma(117;4.5e-30)|Colorectal(126;2.07e-09)|COAD - Colon adenocarcinoma(152;4.29e-07)|BRCA - Breast invasive adenocarcinoma(304;4.13e-05)|STAD - Stomach adenocarcinoma(196;0.000279)|KIRC - Kidney renal clear cell carcinoma(1967;0.000794)|GBM - Glioblastoma multiforme(114;0.0132)|READ - Rectum adenocarcinoma(331;0.0469)|Lung(427;0.167)|LUSC - Lung squamous cell carcinoma(448;0.242)		cagcagcagcagcagcaACGG	0.572			"""Mis, N, F, S, D"""		"""clear cell ovarian carcinoma, RCC"""																																		Rec	yes		1	1p35.3	8289	AT rich interactive domain 1A (SWI-like)		E	0													70.0	72.0	72.0					1																	27100199		2203	4300	6503	SO:0001583	missense			AB001895	CCDS285.1, CCDS44091.1	1p36.1-p35	2014-09-17	2006-11-08	2004-01-30	ENSG00000117713	ENSG00000117713	8289		"""-"""	11110	protein-coding gene	gene with protein product		603024	"""SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily f, member 1"", ""AT rich interactive domain 1A (SWI- like)"""	C1orf4, SMARCF1		9630625, 9434167	Standard	NM_139135	NM_139135		Approved	B120, P270, C10rf4, BAF250, BAF250a	uc001bmv.1	O14497	OTTHUMG00000004004	ENST00000457599.2:c.3995A>T	chr1.hg19:g.27100199A>T	ENSP00000387636:p.Gln1332Leu		D3DPL1|Q53FK9|Q5T0W1|Q5T0W2|Q5T0W3|Q8NFD6|Q96T89|Q9BY33|Q9HBJ5|Q9UPZ1	True	hg19	CCDS44091.1	.	.	.	.	.	.	.	.	.	.	A	12.71	2.019094	0.35606	.	.	ENSG00000117713	ENST00000324856;ENST00000457599;ENST00000374152	T;T;T	0.02579	4.43;4.25;4.24	5.67	4.47	0.54385	.	0.551296	0.20086	N	0.099554	T	0.01661	0.0053	N	0.08118	0	0.80722	D	1	B;B;B;B	0.27732	0.0;0.118;0.187;0.118	B;B;B;B	0.24155	0.002;0.023;0.051;0.023	T	0.60229	-0.7304	10	0.27785	T	0.31	-0.8447	7.4902	0.27458	0.7804:0.1445:0.075:0.0	.	949;1332;1332;985	O14497-3;O14497;O14497-2;Q4LE49	.;ARI1A_HUMAN;.;.	L	1332;1332;949	ENSP00000320485:Q1332L;ENSP00000387636:Q1332L;ENSP00000363267:Q949L	ENSP00000320485:Q1332L	Q	+	2	0	ARID1A	26972786	1.000000	0.71417	1.000000	0.80357	0.993000	0.82548	2.292000	0.43549	2.169000	0.68431	0.533000	0.62120	CAG	ARID1A-002	NOVEL	basic|appris_candidate|exp_conf|CCDS	protein_coding		protein_coding	OTTHUMT00000011438.2		40.0		+	ENST00000457599.2
ARID1A	8289	__UNKNOWN__	__UNKNOWN__	1	27101409	27101409	__UNKNOWN__	Missense_Mutation	SNP	T	T	C			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr1:27101409T>C	ENST00000324856.7	+	18	5062	c.4691T>C	c.(4690-4692)aTg>aCg	p.M1564T	ARID1A_ENST00000457599.2_Intron|ARID1A_ENST00000374152.2_Missense_Mutation_p.M1181T|ARID1A_ENST00000540690.1_Intron	NM_006015.4	NP_006006.3	O14497	ARI1A_HUMAN	AT rich interactive domain 1A (SWI-like)	1564					androgen receptor signaling pathway (GO:0030521)|ATP-dependent chromatin remodeling (GO:0043044)|cardiac chamber development (GO:0003205)|chromatin remodeling (GO:0006338)|chromatin-mediated maintenance of transcription (GO:0048096)|forebrain development (GO:0030900)|glucocorticoid receptor signaling pathway (GO:0042921)|intracellular estrogen receptor signaling pathway (GO:0030520)|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|neural tube closure (GO:0001843)|nucleosome disassembly (GO:0006337)|nucleosome mobilization (GO:0042766)|optic cup formation involved in camera-type eye development (GO:0003408)|placenta blood vessel development (GO:0060674)|positive regulation of transcription, DNA-templated (GO:0045893)|regulation of transcription from RNA polymerase II promoter (GO:0006357)|transcription, DNA-templated (GO:0006351)	nBAF complex (GO:0071565)|npBAF complex (GO:0071564)|nuclear chromatin (GO:0000790)|nucleus (GO:0005634)|SWI/SNF complex (GO:0016514)	DNA binding (GO:0003677)|ligand-dependent nuclear receptor binding (GO:0016922)|transcription coactivator activity (GO:0003713)		ARID1A/MAST2_ENST00000361297(2)	NS(1)|autonomic_ganglia(1)|biliary_tract(1)|breast(13)|central_nervous_system(6)|cervix(2)|endometrium(56)|haematopoietic_and_lymphoid_tissue(8)|kidney(10)|large_intestine(41)|liver(31)|lung(34)|ovary(130)|pancreas(18)|prostate(8)|skin(9)|stomach(14)|upper_aerodigestive_tract(4)|urinary_tract(24)	411		all_cancers(24;6.36e-27)|all_epithelial(13;5.93e-24)|Colorectal(325;3.46e-05)|all_lung(284;4.76e-05)|Lung NSC(340;5.83e-05)|Breast(348;9.7e-05)|Renal(390;0.0007)|Ovarian(437;0.00473)|Myeloproliferative disorder(586;0.0255)|all_neural(195;0.0381)		UCEC - Uterine corpus endometrioid carcinoma (279;0.0178)|all cancers(4;2.61e-56)|Epithelial(14;7.53e-55)|OV - Ovarian serous cystadenocarcinoma(117;4.5e-30)|Colorectal(126;2.07e-09)|COAD - Colon adenocarcinoma(152;4.29e-07)|BRCA - Breast invasive adenocarcinoma(304;4.13e-05)|STAD - Stomach adenocarcinoma(196;0.000279)|KIRC - Kidney renal clear cell carcinoma(1967;0.000794)|GBM - Glioblastoma multiforme(114;0.0132)|READ - Rectum adenocarcinoma(331;0.0469)|Lung(427;0.167)|LUSC - Lung squamous cell carcinoma(448;0.242)		GTGCCCCCCATGACAAGGCCC	0.617			"""Mis, N, F, S, D"""		"""clear cell ovarian carcinoma, RCC"""																																		Rec	yes		1	1p35.3	8289	AT rich interactive domain 1A (SWI-like)		E	0													42.0	42.0	42.0					1																	27101409		2203	4300	6503	SO:0001583	missense			AB001895	CCDS285.1, CCDS44091.1	1p36.1-p35	2014-09-17	2006-11-08	2004-01-30	ENSG00000117713	ENSG00000117713	8289		"""-"""	11110	protein-coding gene	gene with protein product		603024	"""SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily f, member 1"", ""AT rich interactive domain 1A (SWI- like)"""	C1orf4, SMARCF1		9630625, 9434167	Standard	NM_139135	NM_139135		Approved	B120, P270, C10rf4, BAF250, BAF250a	uc001bmv.1	O14497	OTTHUMG00000004004	ENST00000324856.7:c.4691T>C	chr1.hg19:g.27101409T>C	ENSP00000320485:p.Met1564Thr		D3DPL1|Q53FK9|Q5T0W1|Q5T0W2|Q5T0W3|Q8NFD6|Q96T89|Q9BY33|Q9HBJ5|Q9UPZ1	True	hg19	CCDS285.1	.	.	.	.	.	.	.	.	.	.	T	14.04	2.415932	0.42817	.	.	ENSG00000117713	ENST00000324856;ENST00000374152	T;T	0.02472	4.44;4.28	5.31	5.31	0.75309	.	0.000000	0.85682	D	0.000000	T	0.03651	0.0104	L	0.50333	1.59	0.80722	D	1	B;B;P	0.44195	0.023;0.073;0.828	B;B;B	0.36244	0.012;0.018;0.22	T	0.59830	-0.7380	10	0.19590	T	0.45	-6.7419	15.4336	0.75125	0.0:0.0:0.0:1.0	.	1181;1564;1217	O14497-3;O14497;Q4LE49	.;ARI1A_HUMAN;.	T	1564;1181	ENSP00000320485:M1564T;ENSP00000363267:M1181T	ENSP00000320485:M1564T	M	+	2	0	ARID1A	26973996	1.000000	0.71417	1.000000	0.80357	0.981000	0.71138	7.430000	0.80321	2.243000	0.73865	0.533000	0.62120	ATG	ARID1A-001	KNOWN	basic|appris_candidate_longest|CCDS	protein_coding		protein_coding	OTTHUMT00000011437.2		63.0		+	ENST00000324856.7
MYCN	4613	__UNKNOWN__	__UNKNOWN__	2	16082646	16082646	__UNKNOWN__	Missense_Mutation	SNP	G	G	C			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr2:16082646G>C	ENST00000281043.3	+	2	757	c.460G>C	c.(460-462)Gcc>Ccc	p.A154P		NM_005378.4	NP_005369.2	P04198	MYCN_HUMAN	v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog	154					branching morphogenesis of an epithelial tube (GO:0048754)|cartilage condensation (GO:0001502)|embryonic digit morphogenesis (GO:0042733)|embryonic skeletal system morphogenesis (GO:0048704)|lung development (GO:0030324)|negative regulation of astrocyte differentiation (GO:0048712)|negative regulation of reactive oxygen species metabolic process (GO:2000378)|positive regulation of cell death (GO:0010942)|positive regulation of mesenchymal cell proliferation (GO:0002053)|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|regulation of transcription from RNA polymerase II promoter (GO:0006357)	chromatin (GO:0000785)|nucleus (GO:0005634)	DNA binding (GO:0003677)|sequence-specific DNA binding transcription factor activity (GO:0003700)			NS(2)|autonomic_ganglia(1)|breast(1)|central_nervous_system(4)|endometrium(5)|haematopoietic_and_lymphoid_tissue(1)|kidney(1)|large_intestine(3)|lung(7)|ovary(1)|pancreas(1)|prostate(1)|skin(2)|urinary_tract(1)	31	all_cancers(1;1.35e-08)|all_neural(1;2.92e-24)|Lung SC(1;3.26e-07)|Medulloblastoma(1;6.9e-06)|all_lung(1;1.26e-05)|Glioma(3;0.135)|Acute lymphoblastic leukemia(172;0.155)|all_epithelial(1;0.169)|all_hematologic(175;0.197)		GBM - Glioblastoma multiforme(3;0.000332)			gggagccggcgccgccagccc	0.826			A		neuroblastoma																																		Dom	yes		2	2p24.1	4613	"""v-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian)"""		O	0													2.0	2.0	2.0					2																	16082646		622	1531	2153	SO:0001583	missense			BC002712	CCDS1687.1	2p24.3	2013-08-14	2013-07-09		ENSG00000134323	ENSG00000134323	4613		"""Basic helix-loop-helix proteins"""	7559	protein-coding gene	gene with protein product		164840		NMYC			Standard	NM_005378	XM_006711886		Approved	bHLHe37, N-myc, MYCNOT	uc002rci.3	P04198	OTTHUMG00000039579	ENST00000281043.3:c.460G>C	chr2.hg19:g.16082646G>C	ENSP00000281043:p.Ala154Pro		Q53XS5|Q6LDT9	True	hg19	CCDS1687.1	.	.	.	.	.	.	.	.	.	.	G	4.138	0.023884	0.08006	.	.	ENSG00000134323	ENST00000281043	T	0.68331	-0.32	2.23	1.33	0.21861	Transcription regulator Myc, N-terminal (1);	0.112569	0.33161	U	0.005219	T	0.54255	0.1847	N	0.25789	0.76	0.09310	N	1	P	0.47106	0.89	P	0.50082	0.63	T	0.43343	-0.9397	10	0.25106	T	0.35	-7.6311	5.8835	0.18868	0.3569:0.0:0.6431:0.0	.	154	P04198	MYCN_HUMAN	P	154	ENSP00000281043:A154P	ENSP00000281043:A154P	A	+	1	0	MYCN	16000097	0.030000	0.19436	0.005000	0.12908	0.027000	0.11550	0.718000	0.25866	0.493000	0.27837	-0.379000	0.06801	GCC	MYCN-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000095469.2		21.0		+	ENST00000281043.3
MYCN	4613	__UNKNOWN__	__UNKNOWN__	2	16082807	16082807	__UNKNOWN__	Silent	SNP	A	A	C			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr2:16082807A>C	ENST00000281043.3	+	2	918	c.621A>C	c.(619-621)gcA>gcC	p.A207A		NM_005378.4	NP_005369.2	P04198	MYCN_HUMAN	v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog	207					branching morphogenesis of an epithelial tube (GO:0048754)|cartilage condensation (GO:0001502)|embryonic digit morphogenesis (GO:0042733)|embryonic skeletal system morphogenesis (GO:0048704)|lung development (GO:0030324)|negative regulation of astrocyte differentiation (GO:0048712)|negative regulation of reactive oxygen species metabolic process (GO:2000378)|positive regulation of cell death (GO:0010942)|positive regulation of mesenchymal cell proliferation (GO:0002053)|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|regulation of transcription from RNA polymerase II promoter (GO:0006357)	chromatin (GO:0000785)|nucleus (GO:0005634)	DNA binding (GO:0003677)|sequence-specific DNA binding transcription factor activity (GO:0003700)			NS(2)|autonomic_ganglia(1)|breast(1)|central_nervous_system(4)|endometrium(5)|haematopoietic_and_lymphoid_tissue(1)|kidney(1)|large_intestine(3)|lung(7)|ovary(1)|pancreas(1)|prostate(1)|skin(2)|urinary_tract(1)	31	all_cancers(1;1.35e-08)|all_neural(1;2.92e-24)|Lung SC(1;3.26e-07)|Medulloblastoma(1;6.9e-06)|all_lung(1;1.26e-05)|Glioma(3;0.135)|Acute lymphoblastic leukemia(172;0.155)|all_epithelial(1;0.169)|all_hematologic(175;0.197)		GBM - Glioblastoma multiforme(3;0.000332)			CCGTGCCCGCAGCCCCGGCCA	0.811			A		neuroblastoma																																		Dom	yes		2	2p24.1	4613	"""v-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian)"""		O	0													3.0	4.0	4.0					2																	16082807		990	2455	3445	SO:0001819	synonymous_variant			BC002712	CCDS1687.1	2p24.3	2013-08-14	2013-07-09		ENSG00000134323	ENSG00000134323	4613		"""Basic helix-loop-helix proteins"""	7559	protein-coding gene	gene with protein product		164840		NMYC			Standard	NM_005378	XM_006711886		Approved	bHLHe37, N-myc, MYCNOT	uc002rci.3	P04198	OTTHUMG00000039579	ENST00000281043.3:c.621A>C	chr2.hg19:g.16082807A>C			Q53XS5|Q6LDT9	True	hg19	CCDS1687.1																																																																																			MYCN-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000095469.2		28.0		+	ENST00000281043.3
MYCN	4613	__UNKNOWN__	__UNKNOWN__	2	16082857	16082857	__UNKNOWN__	Missense_Mutation	SNP	G	G	C			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr2:16082857G>C	ENST00000281043.3	+	2	968	c.671G>C	c.(670-672)gGt>gCt	p.G224A		NM_005378.4	NP_005369.2	P04198	MYCN_HUMAN	v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog	224					branching morphogenesis of an epithelial tube (GO:0048754)|cartilage condensation (GO:0001502)|embryonic digit morphogenesis (GO:0042733)|embryonic skeletal system morphogenesis (GO:0048704)|lung development (GO:0030324)|negative regulation of astrocyte differentiation (GO:0048712)|negative regulation of reactive oxygen species metabolic process (GO:2000378)|positive regulation of cell death (GO:0010942)|positive regulation of mesenchymal cell proliferation (GO:0002053)|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|regulation of transcription from RNA polymerase II promoter (GO:0006357)	chromatin (GO:0000785)|nucleus (GO:0005634)	DNA binding (GO:0003677)|sequence-specific DNA binding transcription factor activity (GO:0003700)			NS(2)|autonomic_ganglia(1)|breast(1)|central_nervous_system(4)|endometrium(5)|haematopoietic_and_lymphoid_tissue(1)|kidney(1)|large_intestine(3)|lung(7)|ovary(1)|pancreas(1)|prostate(1)|skin(2)|urinary_tract(1)	31	all_cancers(1;1.35e-08)|all_neural(1;2.92e-24)|Lung SC(1;3.26e-07)|Medulloblastoma(1;6.9e-06)|all_lung(1;1.26e-05)|Glioma(3;0.135)|Acute lymphoblastic leukemia(172;0.155)|all_epithelial(1;0.169)|all_hematologic(175;0.197)		GBM - Glioblastoma multiforme(3;0.000332)			TCGGGGGCGGGTATTgccgcc	0.786			A		neuroblastoma																																		Dom	yes		2	2p24.1	4613	"""v-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian)"""		O	0													2.0	3.0	3.0					2																	16082857		492	1186	1678	SO:0001583	missense			BC002712	CCDS1687.1	2p24.3	2013-08-14	2013-07-09		ENSG00000134323	ENSG00000134323	4613		"""Basic helix-loop-helix proteins"""	7559	protein-coding gene	gene with protein product		164840		NMYC			Standard	NM_005378	XM_006711886		Approved	bHLHe37, N-myc, MYCNOT	uc002rci.3	P04198	OTTHUMG00000039579	ENST00000281043.3:c.671G>C	chr2.hg19:g.16082857G>C	ENSP00000281043:p.Gly224Ala		Q53XS5|Q6LDT9	True	hg19	CCDS1687.1	.	.	.	.	.	.	.	.	.	.	G	1.838	-0.468203	0.04445	.	.	ENSG00000134323	ENST00000281043	T	0.48836	0.8	2.52	2.52	0.30459	Transcription regulator Myc, N-terminal (1);	6.799810	0.01555	U	0.019861	T	0.28499	0.0705	N	0.08118	0	0.09310	N	1	B	0.06786	0.001	B	0.06405	0.002	T	0.20042	-1.0287	10	0.07030	T	0.85	-2.121	10.1587	0.42838	0.0:0.2053:0.7947:0.0	.	224	P04198	MYCN_HUMAN	A	224	ENSP00000281043:G224A	ENSP00000281043:G224A	G	+	2	0	MYCN	16000308	.	.	0.002000	0.10522	0.238000	0.25445	.	.	1.727000	0.51537	0.306000	0.20318	GGT	MYCN-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000095469.2		35.0		+	ENST00000281043.3
MYCN	4613	__UNKNOWN__	__UNKNOWN__	2	16082858	16082858	__UNKNOWN__	Silent	SNP	T	T	A			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr2:16082858T>A	ENST00000281043.3	+	2	969	c.672T>A	c.(670-672)ggT>ggA	p.G224G		NM_005378.4	NP_005369.2	P04198	MYCN_HUMAN	v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog	224					branching morphogenesis of an epithelial tube (GO:0048754)|cartilage condensation (GO:0001502)|embryonic digit morphogenesis (GO:0042733)|embryonic skeletal system morphogenesis (GO:0048704)|lung development (GO:0030324)|negative regulation of astrocyte differentiation (GO:0048712)|negative regulation of reactive oxygen species metabolic process (GO:2000378)|positive regulation of cell death (GO:0010942)|positive regulation of mesenchymal cell proliferation (GO:0002053)|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|regulation of transcription from RNA polymerase II promoter (GO:0006357)	chromatin (GO:0000785)|nucleus (GO:0005634)	DNA binding (GO:0003677)|sequence-specific DNA binding transcription factor activity (GO:0003700)			NS(2)|autonomic_ganglia(1)|breast(1)|central_nervous_system(4)|endometrium(5)|haematopoietic_and_lymphoid_tissue(1)|kidney(1)|large_intestine(3)|lung(7)|ovary(1)|pancreas(1)|prostate(1)|skin(2)|urinary_tract(1)	31	all_cancers(1;1.35e-08)|all_neural(1;2.92e-24)|Lung SC(1;3.26e-07)|Medulloblastoma(1;6.9e-06)|all_lung(1;1.26e-05)|Glioma(3;0.135)|Acute lymphoblastic leukemia(172;0.155)|all_epithelial(1;0.169)|all_hematologic(175;0.197)		GBM - Glioblastoma multiforme(3;0.000332)			CGGGGGCGGGTATTgccgccc	0.786			A		neuroblastoma																																		Dom	yes		2	2p24.1	4613	"""v-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian)"""		O	0													2.0	3.0	3.0					2																	16082858		496	1206	1702	SO:0001819	synonymous_variant			BC002712	CCDS1687.1	2p24.3	2013-08-14	2013-07-09		ENSG00000134323	ENSG00000134323	4613		"""Basic helix-loop-helix proteins"""	7559	protein-coding gene	gene with protein product		164840		NMYC			Standard	NM_005378	XM_006711886		Approved	bHLHe37, N-myc, MYCNOT	uc002rci.3	P04198	OTTHUMG00000039579	ENST00000281043.3:c.672T>A	chr2.hg19:g.16082858T>A			Q53XS5|Q6LDT9	True	hg19	CCDS1687.1																																																																																			MYCN-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000095469.2		35.0		+	ENST00000281043.3
MYCN	4613	__UNKNOWN__	__UNKNOWN__	2	16082861	16082861	__UNKNOWN__	Silent	SNP	T	T	A			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr2:16082861T>A	ENST00000281043.3	+	2	972	c.675T>A	c.(673-675)atT>atA	p.I225I		NM_005378.4	NP_005369.2	P04198	MYCN_HUMAN	v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog	225					branching morphogenesis of an epithelial tube (GO:0048754)|cartilage condensation (GO:0001502)|embryonic digit morphogenesis (GO:0042733)|embryonic skeletal system morphogenesis (GO:0048704)|lung development (GO:0030324)|negative regulation of astrocyte differentiation (GO:0048712)|negative regulation of reactive oxygen species metabolic process (GO:2000378)|positive regulation of cell death (GO:0010942)|positive regulation of mesenchymal cell proliferation (GO:0002053)|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|regulation of transcription from RNA polymerase II promoter (GO:0006357)	chromatin (GO:0000785)|nucleus (GO:0005634)	DNA binding (GO:0003677)|sequence-specific DNA binding transcription factor activity (GO:0003700)			NS(2)|autonomic_ganglia(1)|breast(1)|central_nervous_system(4)|endometrium(5)|haematopoietic_and_lymphoid_tissue(1)|kidney(1)|large_intestine(3)|lung(7)|ovary(1)|pancreas(1)|prostate(1)|skin(2)|urinary_tract(1)	31	all_cancers(1;1.35e-08)|all_neural(1;2.92e-24)|Lung SC(1;3.26e-07)|Medulloblastoma(1;6.9e-06)|all_lung(1;1.26e-05)|Glioma(3;0.135)|Acute lymphoblastic leukemia(172;0.155)|all_epithelial(1;0.169)|all_hematologic(175;0.197)		GBM - Glioblastoma multiforme(3;0.000332)			GGGCGGGTATTgccgccccag	0.781			A		neuroblastoma																																		Dom	yes		2	2p24.1	4613	"""v-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian)"""		O	0													2.0	3.0	3.0					2																	16082861		505	1248	1753	SO:0001819	synonymous_variant			BC002712	CCDS1687.1	2p24.3	2013-08-14	2013-07-09		ENSG00000134323	ENSG00000134323	4613		"""Basic helix-loop-helix proteins"""	7559	protein-coding gene	gene with protein product		164840		NMYC			Standard	NM_005378	XM_006711886		Approved	bHLHe37, N-myc, MYCNOT	uc002rci.3	P04198	OTTHUMG00000039579	ENST00000281043.3:c.675T>A	chr2.hg19:g.16082861T>A			Q53XS5|Q6LDT9	True	hg19	CCDS1687.1																																																																																			MYCN-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000095469.2		32.0		+	ENST00000281043.3
MYCN	4613	__UNKNOWN__	__UNKNOWN__	2	16082862	16082862	__UNKNOWN__	Missense_Mutation	SNP	G	G	C			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr2:16082862G>C	ENST00000281043.3	+	2	973	c.676G>C	c.(676-678)Gcc>Ccc	p.A226P		NM_005378.4	NP_005369.2	P04198	MYCN_HUMAN	v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog	226					branching morphogenesis of an epithelial tube (GO:0048754)|cartilage condensation (GO:0001502)|embryonic digit morphogenesis (GO:0042733)|embryonic skeletal system morphogenesis (GO:0048704)|lung development (GO:0030324)|negative regulation of astrocyte differentiation (GO:0048712)|negative regulation of reactive oxygen species metabolic process (GO:2000378)|positive regulation of cell death (GO:0010942)|positive regulation of mesenchymal cell proliferation (GO:0002053)|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|regulation of transcription from RNA polymerase II promoter (GO:0006357)	chromatin (GO:0000785)|nucleus (GO:0005634)	DNA binding (GO:0003677)|sequence-specific DNA binding transcription factor activity (GO:0003700)			NS(2)|autonomic_ganglia(1)|breast(1)|central_nervous_system(4)|endometrium(5)|haematopoietic_and_lymphoid_tissue(1)|kidney(1)|large_intestine(3)|lung(7)|ovary(1)|pancreas(1)|prostate(1)|skin(2)|urinary_tract(1)	31	all_cancers(1;1.35e-08)|all_neural(1;2.92e-24)|Lung SC(1;3.26e-07)|Medulloblastoma(1;6.9e-06)|all_lung(1;1.26e-05)|Glioma(3;0.135)|Acute lymphoblastic leukemia(172;0.155)|all_epithelial(1;0.169)|all_hematologic(175;0.197)		GBM - Glioblastoma multiforme(3;0.000332)			GGCGGGTATTgccgccccagc	0.786			A		neuroblastoma																																		Dom	yes		2	2p24.1	4613	"""v-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian)"""		O	0													2.0	3.0	3.0					2																	16082862		504	1247	1751	SO:0001583	missense			BC002712	CCDS1687.1	2p24.3	2013-08-14	2013-07-09		ENSG00000134323	ENSG00000134323	4613		"""Basic helix-loop-helix proteins"""	7559	protein-coding gene	gene with protein product		164840		NMYC			Standard	NM_005378	XM_006711886		Approved	bHLHe37, N-myc, MYCNOT	uc002rci.3	P04198	OTTHUMG00000039579	ENST00000281043.3:c.676G>C	chr2.hg19:g.16082862G>C	ENSP00000281043:p.Ala226Pro		Q53XS5|Q6LDT9	True	hg19	CCDS1687.1	.	.	.	.	.	.	.	.	.	.	G	8.139	0.784842	0.16189	.	.	ENSG00000134323	ENST00000281043	T	0.52526	0.66	2.52	0.521	0.17046	Transcription regulator Myc, N-terminal (1);	1.498460	0.05365	U	0.534538	T	0.30448	0.0765	N	0.08118	0	0.09310	N	1	P	0.46457	0.878	P	0.46253	0.509	T	0.14896	-1.0456	10	0.30854	T	0.27	-8.0873	4.0719	0.09885	0.1542:0.0:0.4527:0.3931	.	226	P04198	MYCN_HUMAN	P	226	ENSP00000281043:A226P	ENSP00000281043:A226P	A	+	1	0	MYCN	16000313	0.002000	0.14202	0.001000	0.08648	0.125000	0.20455	1.051000	0.30417	0.115000	0.18071	-1.231000	0.01572	GCC	MYCN-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000095469.2		29.0		+	ENST00000281043.3
MYCN	4613	__UNKNOWN__	__UNKNOWN__	2	16082870	16082870	__UNKNOWN__	Silent	SNP	A	A	C			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr2:16082870A>C	ENST00000281043.3	+	2	981	c.684A>C	c.(682-684)ccA>ccC	p.P228P		NM_005378.4	NP_005369.2	P04198	MYCN_HUMAN	v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog	228					branching morphogenesis of an epithelial tube (GO:0048754)|cartilage condensation (GO:0001502)|embryonic digit morphogenesis (GO:0042733)|embryonic skeletal system morphogenesis (GO:0048704)|lung development (GO:0030324)|negative regulation of astrocyte differentiation (GO:0048712)|negative regulation of reactive oxygen species metabolic process (GO:2000378)|positive regulation of cell death (GO:0010942)|positive regulation of mesenchymal cell proliferation (GO:0002053)|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|regulation of transcription from RNA polymerase II promoter (GO:0006357)	chromatin (GO:0000785)|nucleus (GO:0005634)	DNA binding (GO:0003677)|sequence-specific DNA binding transcription factor activity (GO:0003700)			NS(2)|autonomic_ganglia(1)|breast(1)|central_nervous_system(4)|endometrium(5)|haematopoietic_and_lymphoid_tissue(1)|kidney(1)|large_intestine(3)|lung(7)|ovary(1)|pancreas(1)|prostate(1)|skin(2)|urinary_tract(1)	31	all_cancers(1;1.35e-08)|all_neural(1;2.92e-24)|Lung SC(1;3.26e-07)|Medulloblastoma(1;6.9e-06)|all_lung(1;1.26e-05)|Glioma(3;0.135)|Acute lymphoblastic leukemia(172;0.155)|all_epithelial(1;0.169)|all_hematologic(175;0.197)		GBM - Glioblastoma multiforme(3;0.000332)			TTgccgccccagccggggccc	0.791			A		neuroblastoma																																		Dom	yes		2	2p24.1	4613	"""v-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian)"""		O	0													3.0	3.0	3.0					2																	16082870		653	1527	2180	SO:0001819	synonymous_variant			BC002712	CCDS1687.1	2p24.3	2013-08-14	2013-07-09		ENSG00000134323	ENSG00000134323	4613		"""Basic helix-loop-helix proteins"""	7559	protein-coding gene	gene with protein product		164840		NMYC			Standard	NM_005378	XM_006711886		Approved	bHLHe37, N-myc, MYCNOT	uc002rci.3	P04198	OTTHUMG00000039579	ENST00000281043.3:c.684A>C	chr2.hg19:g.16082870A>C			Q53XS5|Q6LDT9	True	hg19	CCDS1687.1																																																																																			MYCN-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000095469.2		22.0		+	ENST00000281043.3
MYCN	4613	__UNKNOWN__	__UNKNOWN__	2	16084631	16084632	__UNKNOWN__	Intron	INS	-	-	T			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr2:16084631_16084632insT	ENST00000281043.3	+	3	1087					NM_005378.4	NP_005369.2	P04198	MYCN_HUMAN	v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog						branching morphogenesis of an epithelial tube (GO:0048754)|cartilage condensation (GO:0001502)|embryonic digit morphogenesis (GO:0042733)|embryonic skeletal system morphogenesis (GO:0048704)|lung development (GO:0030324)|negative regulation of astrocyte differentiation (GO:0048712)|negative regulation of reactive oxygen species metabolic process (GO:2000378)|positive regulation of cell death (GO:0010942)|positive regulation of mesenchymal cell proliferation (GO:0002053)|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|regulation of transcription from RNA polymerase II promoter (GO:0006357)	chromatin (GO:0000785)|nucleus (GO:0005634)	DNA binding (GO:0003677)|sequence-specific DNA binding transcription factor activity (GO:0003700)			NS(2)|autonomic_ganglia(1)|breast(1)|central_nervous_system(4)|endometrium(5)|haematopoietic_and_lymphoid_tissue(1)|kidney(1)|large_intestine(3)|lung(7)|ovary(1)|pancreas(1)|prostate(1)|skin(2)|urinary_tract(1)	31	all_cancers(1;1.35e-08)|all_neural(1;2.92e-24)|Lung SC(1;3.26e-07)|Medulloblastoma(1;6.9e-06)|all_lung(1;1.26e-05)|Glioma(3;0.135)|Acute lymphoblastic leukemia(172;0.155)|all_epithelial(1;0.169)|all_hematologic(175;0.197)		GBM - Glioblastoma multiforme(3;0.000332)			ACGAAAAGTTGTTTTTTTTCTT	0.297			A		neuroblastoma																																		Dom	yes		2	2p24.1	4613	"""v-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian)"""		O	0																																										SO:0001627	intron_variant			BC002712	CCDS1687.1	2p24.3	2013-08-14	2013-07-09		ENSG00000134323	ENSG00000134323	4613		"""Basic helix-loop-helix proteins"""	7559	protein-coding gene	gene with protein product		164840		NMYC			Standard	NM_005378	XM_006711886		Approved	bHLHe37, N-myc, MYCNOT	uc002rci.3	P04198	OTTHUMG00000039579	ENST00000281043.3:c.791-983->T	chr2.hg19:g.16084639_16084639dupT			Q53XS5|Q6LDT9	True	hg19	CCDS1687.1																																																																																			MYCN-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000095469.2		28.0		+	ENST00000281043.3
SETD2	29072	__UNKNOWN__	__UNKNOWN__	3	47162723	47162723	__UNKNOWN__	Missense_Mutation	SNP	T	T	C			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr3:47162723T>C	ENST00000409792.3	-	3	3445	c.3403A>G	c.(3403-3405)Aaa>Gaa	p.K1135E		NM_014159.6	NP_054878.5	Q9BYW2	SETD2_HUMAN	SET domain containing 2	1135					angiogenesis (GO:0001525)|cell migration involved in vasculogenesis (GO:0035441)|coronary vasculature morphogenesis (GO:0060977)|embryonic cranial skeleton morphogenesis (GO:0048701)|embryonic placenta morphogenesis (GO:0060669)|forebrain development (GO:0030900)|histone H3-K36 trimethylation (GO:0097198)|mesoderm morphogenesis (GO:0048332)|mismatch repair (GO:0006298)|morphogenesis of a branching structure (GO:0001763)|neural tube closure (GO:0001843)|nucleosome organization (GO:0034728)|pericardium development (GO:0060039)|regulation of mRNA export from nucleus (GO:0010793)|regulation of transcription, DNA-templated (GO:0006355)|stem cell development (GO:0048864)|transcription elongation from RNA polymerase II promoter (GO:0006368)	chromosome (GO:0005694)|nucleus (GO:0005634)	histone-lysine N-methyltransferase activity (GO:0018024)			breast(6)|central_nervous_system(5)|endometrium(4)|kidney(63)|large_intestine(18)|lung(26)|ovary(6)|prostate(2)|skin(3)|soft_tissue(1)|stomach(2)|urinary_tract(5)	141		Acute lymphoblastic leukemia(5;0.0169)		BRCA - Breast invasive adenocarcinoma(193;0.000302)|KIRC - Kidney renal clear cell carcinoma(197;0.00732)|Kidney(197;0.00844)		TCTGTTCCTTTATGAAGGAAA	0.383			"""N, F, S, Mis"""		clear cell renal carcinoma																																		Rec	yes		3	3p21.31	29072	SET domain containing 2		E	0													122.0	131.0	128.0					3																	47162723		2203	4300	6503	SO:0001583	missense			AJ238403	CCDS2749.2	3p21.31	2014-09-17			ENSG00000181555	ENSG00000181555	29072		"""Chromatin-modifying enzymes / K-methyltransferases"""	18420	protein-coding gene	gene with protein product		612778				16118227, 11461154	Standard	NM_014159	NM_014159		Approved	HYPB, HIF-1, KIAA1732, FLJ23184, KMT3A	uc003cqs.3	Q9BYW2	OTTHUMG00000133514	ENST00000409792.3:c.3403A>G	chr3.hg19:g.47162723T>C	ENSP00000386759:p.Lys1135Glu		O75397|O75405|Q17RW8|Q5BKS9|Q5QGN2|Q69YI5|Q6IN64|Q6ZN53|Q6ZS25|Q8N3R0|Q8TCN0|Q9C0D1|Q9H696|Q9NZW9	True	hg19	CCDS2749.2	.	.	.	.	.	.	.	.	.	.	T	12.74	2.027230	0.35797	.	.	ENSG00000181555	ENST00000451092;ENST00000543224;ENST00000409792;ENST00000412450	D;T	0.90004	-2.6;1.25	5.55	5.55	0.83447	.	0.091355	0.47852	D	0.000204	D	0.85401	0.5688	N	0.19112	0.55	0.29841	N	0.829185	P;P	0.49185	0.92;0.842	P;B	0.48454	0.578;0.257	D	0.84520	0.0627	10	0.72032	D	0.01	.	14.4191	0.67171	0.0:0.0:0.0:1.0	.	1135;1135	F2Z317;Q9BYW2	.;SETD2_HUMAN	E	1135;1135;1135;1091	ENSP00000386759:K1135E;ENSP00000416401:K1091E	ENSP00000386759:K1135E	K	-	1	0	SETD2	47137727	0.990000	0.36364	1.000000	0.80357	0.959000	0.62525	1.054000	0.30455	2.326000	0.78906	0.533000	0.62120	AAA	SETD2-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000257479.2		37.0		-	ENST00000409792.3
SETD2	29072	__UNKNOWN__	__UNKNOWN__	3	47162726	47162726	__UNKNOWN__	Missense_Mutation	SNP	G	G	A			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr3:47162726G>A	ENST00000409792.3	-	3	3442	c.3400C>T	c.(3400-3402)Cat>Tat	p.H1134Y		NM_014159.6	NP_054878.5	Q9BYW2	SETD2_HUMAN	SET domain containing 2	1134					angiogenesis (GO:0001525)|cell migration involved in vasculogenesis (GO:0035441)|coronary vasculature morphogenesis (GO:0060977)|embryonic cranial skeleton morphogenesis (GO:0048701)|embryonic placenta morphogenesis (GO:0060669)|forebrain development (GO:0030900)|histone H3-K36 trimethylation (GO:0097198)|mesoderm morphogenesis (GO:0048332)|mismatch repair (GO:0006298)|morphogenesis of a branching structure (GO:0001763)|neural tube closure (GO:0001843)|nucleosome organization (GO:0034728)|pericardium development (GO:0060039)|regulation of mRNA export from nucleus (GO:0010793)|regulation of transcription, DNA-templated (GO:0006355)|stem cell development (GO:0048864)|transcription elongation from RNA polymerase II promoter (GO:0006368)	chromosome (GO:0005694)|nucleus (GO:0005634)	histone-lysine N-methyltransferase activity (GO:0018024)			breast(6)|central_nervous_system(5)|endometrium(4)|kidney(63)|large_intestine(18)|lung(26)|ovary(6)|prostate(2)|skin(3)|soft_tissue(1)|stomach(2)|urinary_tract(5)	141		Acute lymphoblastic leukemia(5;0.0169)		BRCA - Breast invasive adenocarcinoma(193;0.000302)|KIRC - Kidney renal clear cell carcinoma(197;0.00732)|Kidney(197;0.00844)		GTTCCTTTATGAAGGAAAAAC	0.378			"""N, F, S, Mis"""		clear cell renal carcinoma																																		Rec	yes		3	3p21.31	29072	SET domain containing 2		E	0													123.0	132.0	129.0					3																	47162726		2202	4300	6502	SO:0001583	missense			AJ238403	CCDS2749.2	3p21.31	2014-09-17			ENSG00000181555	ENSG00000181555	29072		"""Chromatin-modifying enzymes / K-methyltransferases"""	18420	protein-coding gene	gene with protein product		612778				16118227, 11461154	Standard	NM_014159	NM_014159		Approved	HYPB, HIF-1, KIAA1732, FLJ23184, KMT3A	uc003cqs.3	Q9BYW2	OTTHUMG00000133514	ENST00000409792.3:c.3400C>T	chr3.hg19:g.47162726G>A	ENSP00000386759:p.His1134Tyr		O75397|O75405|Q17RW8|Q5BKS9|Q5QGN2|Q69YI5|Q6IN64|Q6ZN53|Q6ZS25|Q8N3R0|Q8TCN0|Q9C0D1|Q9H696|Q9NZW9	True	hg19	CCDS2749.2	.	.	.	.	.	.	.	.	.	.	G	9.410	1.080180	0.20309	.	.	ENSG00000181555	ENST00000451092;ENST00000543224;ENST00000409792;ENST00000412450	D;T	0.88201	-2.35;1.53	5.55	3.73	0.42828	.	0.207572	0.33438	N	0.004914	T	0.76026	0.3930	N	0.14661	0.345	0.32041	N	0.598267	B;B	0.12630	0.006;0.003	B;B	0.12156	0.007;0.002	T	0.69030	-0.5253	10	0.11794	T	0.64	.	9.2936	0.37802	0.2202:0.0:0.7798:0.0	.	1134;1134	F2Z317;Q9BYW2	.;SETD2_HUMAN	Y	1134;1134;1134;1090	ENSP00000386759:H1134Y;ENSP00000416401:H1090Y	ENSP00000386759:H1134Y	H	-	1	0	SETD2	47137730	0.990000	0.36364	0.998000	0.56505	0.965000	0.64279	1.522000	0.35921	1.582000	0.49881	0.655000	0.94253	CAT	SETD2-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000257479.2		29.0		-	ENST00000409792.3
PHOX2B	8929	__UNKNOWN__	__UNKNOWN__	4	41747947	41747947	__UNKNOWN__	Silent	SNP	A	A	G			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr4:41747947A>G	ENST00000226382.2	-	3	1181	c.822T>C	c.(820-822)gcT>gcC	p.A274A		NM_003924.3	NP_003915.2	Q99453	PHX2B_HUMAN	paired-like homeobox 2b	274					autonomic nervous system development (GO:0048483)|brainstem development (GO:0003360)|cell differentiation in hindbrain (GO:0021533)|cellular response to BMP stimulus (GO:0071773)|dopaminergic neuron differentiation (GO:0071542)|efferent axon development in a lateral line nerve (GO:0048894)|enteric nervous system development (GO:0048484)|glial cell differentiation (GO:0010001)|hindbrain tangential cell migration (GO:0021934)|inner ear development (GO:0048839)|medullary reticular formation development (GO:0021723)|negative regulation of cell cycle arrest (GO:0071157)|negative regulation of cell proliferation (GO:0008285)|negative regulation of neuron differentiation (GO:0045665)|neural crest cell migration involved in autonomic nervous system development (GO:1901166)|neuron migration (GO:0001764)|noradrenergic neuron development (GO:0003358)|noradrenergic neuron differentiation (GO:0003357)|parasympathetic nervous system development (GO:0048486)|positive regulation of G2/M transition of mitotic cell cycle (GO:0010971)|positive regulation of neuron differentiation (GO:0045666)|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|regulation of gene expression (GO:0010468)|regulation of respiratory gaseous exchange by neurological system process (GO:0002087)|respiratory system development (GO:0060541)|retrotrapezoid nucleus neuron differentiation (GO:0061452)|skeletal muscle cell differentiation (GO:0035914)|sympathetic ganglion development (GO:0061549)|sympathetic nervous system development (GO:0048485)|transcription, DNA-templated (GO:0006351)	nuclear chromatin (GO:0000790)	RNA polymerase II core promoter proximal region sequence-specific DNA binding (GO:0000978)|RNA polymerase II regulatory region sequence-specific DNA binding (GO:0000977)			autonomic_ganglia(7)|central_nervous_system(1)|endometrium(2)|large_intestine(5)|lung(11)|ovary(2)|skin(1)|urinary_tract(1)	30						CGGGGCCGGGAGCCCAGCCTT	0.746			"""Mis, F"""		neuroblastoma	neuroblastoma	congenital central hypoventilation syndrome		Neuroblastoma, Familial Clustering of;Congenital Central Hypoventilation Syndrome																													yes	Rec	yes	familial neuroblastoma	4	4p12	8929	paired-like homeobox 2b	yes	O	0													12.0	18.0	16.0					4																	41747947		2188	4287	6475	SO:0001819	synonymous_variant	Familial Cancer Database	Familial Neuroblastoma;CCHS, Ondine Curse, incl. Ondine-Hirschsprung Disease	D82344	CCDS3463.1	4p13	2014-09-17	2003-02-10	2003-02-14	ENSG00000109132	ENSG00000109132	8929		"""Homeoboxes / PRD class"""	9143	protein-coding gene	gene with protein product		603851	"""paired mesoderm homeobox 2b"""	PMX2B		9039501, 10395798	Standard		NM_003924		Approved	Phox2b, NBPhox	uc003gwf.4	Q99453	OTTHUMG00000099379	ENST00000226382.2:c.822T>C	chr4.hg19:g.41747947A>G			Q6PJD9	True	hg19	CCDS3463.1																																																																																			PHOX2B-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000216832.2		34.0		-	ENST00000226382.2
PHOX2B	8929	__UNKNOWN__	__UNKNOWN__	4	41748043	41748043	__UNKNOWN__	Silent	SNP	T	T	G			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr4:41748043T>G	ENST00000226382.2	-	3	1085	c.726A>C	c.(724-726)gcA>gcC	p.A242A		NM_003924.3	NP_003915.2	Q99453	PHX2B_HUMAN	paired-like homeobox 2b	242	Poly-Ala.				autonomic nervous system development (GO:0048483)|brainstem development (GO:0003360)|cell differentiation in hindbrain (GO:0021533)|cellular response to BMP stimulus (GO:0071773)|dopaminergic neuron differentiation (GO:0071542)|efferent axon development in a lateral line nerve (GO:0048894)|enteric nervous system development (GO:0048484)|glial cell differentiation (GO:0010001)|hindbrain tangential cell migration (GO:0021934)|inner ear development (GO:0048839)|medullary reticular formation development (GO:0021723)|negative regulation of cell cycle arrest (GO:0071157)|negative regulation of cell proliferation (GO:0008285)|negative regulation of neuron differentiation (GO:0045665)|neural crest cell migration involved in autonomic nervous system development (GO:1901166)|neuron migration (GO:0001764)|noradrenergic neuron development (GO:0003358)|noradrenergic neuron differentiation (GO:0003357)|parasympathetic nervous system development (GO:0048486)|positive regulation of G2/M transition of mitotic cell cycle (GO:0010971)|positive regulation of neuron differentiation (GO:0045666)|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|regulation of gene expression (GO:0010468)|regulation of respiratory gaseous exchange by neurological system process (GO:0002087)|respiratory system development (GO:0060541)|retrotrapezoid nucleus neuron differentiation (GO:0061452)|skeletal muscle cell differentiation (GO:0035914)|sympathetic ganglion development (GO:0061549)|sympathetic nervous system development (GO:0048485)|transcription, DNA-templated (GO:0006351)	nuclear chromatin (GO:0000790)	RNA polymerase II core promoter proximal region sequence-specific DNA binding (GO:0000978)|RNA polymerase II regulatory region sequence-specific DNA binding (GO:0000977)	p.A241fs*69(3)|p.A241fs*64(1)		autonomic_ganglia(7)|central_nervous_system(1)|endometrium(2)|large_intestine(5)|lung(11)|ovary(2)|skin(1)|urinary_tract(1)	30						ccgccgctgctgctgcgccgc	0.846			"""Mis, F"""		neuroblastoma	neuroblastoma	congenital central hypoventilation syndrome		Neuroblastoma, Familial Clustering of;Congenital Central Hypoventilation Syndrome																													yes	Rec	yes	familial neuroblastoma	4	4p12	8929	paired-like homeobox 2b	yes	O	4	Deletion - Frameshift(4)	autonomic_ganglia(4)																																								SO:0001819	synonymous_variant	Familial Cancer Database	Familial Neuroblastoma;CCHS, Ondine Curse, incl. Ondine-Hirschsprung Disease	D82344	CCDS3463.1	4p13	2014-09-17	2003-02-10	2003-02-14	ENSG00000109132	ENSG00000109132	8929		"""Homeoboxes / PRD class"""	9143	protein-coding gene	gene with protein product		603851	"""paired mesoderm homeobox 2b"""	PMX2B		9039501, 10395798	Standard		NM_003924		Approved	Phox2b, NBPhox	uc003gwf.4	Q99453	OTTHUMG00000099379	ENST00000226382.2:c.726A>C	chr4.hg19:g.41748043T>G			Q6PJD9	True	hg19	CCDS3463.1																																																																																			PHOX2B-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000216832.2		26.0		-	ENST00000226382.2
PHOX2B	8929	__UNKNOWN__	__UNKNOWN__	4	41748081	41748081	__UNKNOWN__	Missense_Mutation	SNP	C	C	G			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr4:41748081C>G	ENST00000226382.2	-	3	1047	c.688G>C	c.(688-690)Ggg>Cgg	p.G230R		NM_003924.3	NP_003915.2	Q99453	PHX2B_HUMAN	paired-like homeobox 2b	230					autonomic nervous system development (GO:0048483)|brainstem development (GO:0003360)|cell differentiation in hindbrain (GO:0021533)|cellular response to BMP stimulus (GO:0071773)|dopaminergic neuron differentiation (GO:0071542)|efferent axon development in a lateral line nerve (GO:0048894)|enteric nervous system development (GO:0048484)|glial cell differentiation (GO:0010001)|hindbrain tangential cell migration (GO:0021934)|inner ear development (GO:0048839)|medullary reticular formation development (GO:0021723)|negative regulation of cell cycle arrest (GO:0071157)|negative regulation of cell proliferation (GO:0008285)|negative regulation of neuron differentiation (GO:0045665)|neural crest cell migration involved in autonomic nervous system development (GO:1901166)|neuron migration (GO:0001764)|noradrenergic neuron development (GO:0003358)|noradrenergic neuron differentiation (GO:0003357)|parasympathetic nervous system development (GO:0048486)|positive regulation of G2/M transition of mitotic cell cycle (GO:0010971)|positive regulation of neuron differentiation (GO:0045666)|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|regulation of gene expression (GO:0010468)|regulation of respiratory gaseous exchange by neurological system process (GO:0002087)|respiratory system development (GO:0060541)|retrotrapezoid nucleus neuron differentiation (GO:0061452)|skeletal muscle cell differentiation (GO:0035914)|sympathetic ganglion development (GO:0061549)|sympathetic nervous system development (GO:0048485)|transcription, DNA-templated (GO:0006351)	nuclear chromatin (GO:0000790)	RNA polymerase II core promoter proximal region sequence-specific DNA binding (GO:0000978)|RNA polymerase II regulatory region sequence-specific DNA binding (GO:0000977)			autonomic_ganglia(7)|central_nervous_system(1)|endometrium(2)|large_intestine(5)|lung(11)|ovary(2)|skin(1)|urinary_tract(1)	30						cccgggcccccgggccccgcc	0.836			"""Mis, F"""		neuroblastoma	neuroblastoma	congenital central hypoventilation syndrome		Neuroblastoma, Familial Clustering of;Congenital Central Hypoventilation Syndrome																													yes	Rec	yes	familial neuroblastoma	4	4p12	8929	paired-like homeobox 2b	yes	O	0													2.0	3.0	3.0					4																	41748081		991	2119	3110	SO:0001583	missense	Familial Cancer Database	Familial Neuroblastoma;CCHS, Ondine Curse, incl. Ondine-Hirschsprung Disease	D82344	CCDS3463.1	4p13	2014-09-17	2003-02-10	2003-02-14	ENSG00000109132	ENSG00000109132	8929		"""Homeoboxes / PRD class"""	9143	protein-coding gene	gene with protein product		603851	"""paired mesoderm homeobox 2b"""	PMX2B		9039501, 10395798	Standard		NM_003924		Approved	Phox2b, NBPhox	uc003gwf.4	Q99453	OTTHUMG00000099379	ENST00000226382.2:c.688G>C	chr4.hg19:g.41748081C>G	ENSP00000226382:p.Gly230Arg		Q6PJD9	True	hg19	CCDS3463.1	.	.	.	.	.	.	.	.	.	.	C	6.503	0.460941	0.12342	.	.	ENSG00000109132	ENST00000226382	D	0.95622	-3.76	4.25	1.47	0.22746	.	0.841098	0.09973	U	0.732052	D	0.85745	0.5768	N	0.08118	0	0.09310	N	1	B	0.02656	0.0	B	0.01281	0.0	T	0.73427	-0.3986	10	0.14656	T	0.56	.	3.4933	0.07646	0.3516:0.4547:0.0:0.1936	.	230	Q99453	PHX2B_HUMAN	R	230	ENSP00000226382:G230R	ENSP00000226382:G230R	G	-	1	0	PHOX2B	41442838	0.926000	0.31397	0.001000	0.08648	0.016000	0.09150	0.000000	0.12993	0.068000	0.16574	0.561000	0.74099	GGG	PHOX2B-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000216832.2		21.0		-	ENST00000226382.2
TENM3	55714	__UNKNOWN__	__UNKNOWN__	4	183721272	183721272	__UNKNOWN__	Missense_Mutation	SNP	A	A	G			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr4:183721272A>G	ENST00000511685.1	+	28	7991	c.7868A>G	c.(7867-7869)cAg>cGg	p.Q2623R	TENM3_ENST00000406950.2_Missense_Mutation_p.Q2623R			Q9P273	TEN3_HUMAN	teneurin transmembrane protein 3	2623					camera-type eye morphogenesis (GO:0048593)|homophilic cell adhesion (GO:0007156)|positive regulation of neuron projection development (GO:0010976)|self proteolysis (GO:0097264)|signal transduction (GO:0007165)	cell projection (GO:0042995)|integral component of membrane (GO:0016021)|membrane (GO:0016020)	protein heterodimerization activity (GO:0046982)|protein homodimerization activity (GO:0042803)										ATCCTGGAGCAGGCGCGGCAG	0.756																																																0													7.0	9.0	8.0					4																	183721272		1990	4145	6135	SO:0001583	missense			AF195420	CCDS47165.1	4q35	2012-10-02	2012-10-02	2012-10-02	ENSG00000218336	ENSG00000218336	55714			29944	protein-coding gene	gene with protein product		610083	"""odz, odd Oz/ten-m homolog 3 (Drosophila)"""	ODZ3		10331952, 10625539	Standard		NM_001080477		Approved	Ten-M3, KIAA1455	uc003ivd.1	Q9P273	OTTHUMG00000160682	ENST00000511685.1:c.7868A>G	chr4.hg19:g.183721272A>G	ENSP00000424226:p.Gln2623Arg		Q5XUL9|Q96SY2|Q9NV77|Q9NVW1|Q9NZJ2	True	hg19	CCDS47165.1	.	.	.	.	.	.	.	.	.	.	A	15.93	2.977850	0.53720	.	.	ENSG00000218336	ENST00000511685;ENST00000406950	D;D	0.86097	-2.07;-2.07	4.16	4.16	0.48862	.	.	.	.	.	T	0.78400	0.4277	L	0.43152	1.355	0.46203	D	0.998921	B	0.31655	0.334	B	0.26202	0.067	T	0.75825	-0.3181	9	0.27785	T	0.31	.	13.6439	0.62270	1.0:0.0:0.0:0.0	.	2623	Q9P273	TEN3_HUMAN	R	2623	ENSP00000424226:Q2623R;ENSP00000385276:Q2623R	ENSP00000385276:Q2623R	Q	+	2	0	ODZ3	183958266	1.000000	0.71417	1.000000	0.80357	0.994000	0.84299	6.976000	0.76135	1.874000	0.54306	0.374000	0.22700	CAG	TENM3-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000361734.1		21.0		+	ENST00000511685.1
TENM3	55714	__UNKNOWN__	__UNKNOWN__	4	183721273	183721273	__UNKNOWN__	Missense_Mutation	SNP	G	G	C			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr4:183721273G>C	ENST00000511685.1	+	28	7992	c.7869G>C	c.(7867-7869)caG>caC	p.Q2623H	TENM3_ENST00000406950.2_Missense_Mutation_p.Q2623H			Q9P273	TEN3_HUMAN	teneurin transmembrane protein 3	2623					camera-type eye morphogenesis (GO:0048593)|homophilic cell adhesion (GO:0007156)|positive regulation of neuron projection development (GO:0010976)|self proteolysis (GO:0097264)|signal transduction (GO:0007165)	cell projection (GO:0042995)|integral component of membrane (GO:0016021)|membrane (GO:0016020)	protein heterodimerization activity (GO:0046982)|protein homodimerization activity (GO:0042803)										TCCTGGAGCAGGCGCGGCAGC	0.761																																																0													7.0	9.0	8.0					4																	183721273		1987	4147	6134	SO:0001583	missense			AF195420	CCDS47165.1	4q35	2012-10-02	2012-10-02	2012-10-02	ENSG00000218336	ENSG00000218336	55714			29944	protein-coding gene	gene with protein product		610083	"""odz, odd Oz/ten-m homolog 3 (Drosophila)"""	ODZ3		10331952, 10625539	Standard		NM_001080477		Approved	Ten-M3, KIAA1455	uc003ivd.1	Q9P273	OTTHUMG00000160682	ENST00000511685.1:c.7869G>C	chr4.hg19:g.183721273G>C	ENSP00000424226:p.Gln2623His		Q5XUL9|Q96SY2|Q9NV77|Q9NVW1|Q9NZJ2	True	hg19	CCDS47165.1	.	.	.	.	.	.	.	.	.	.	G	12.88	2.069849	0.36566	.	.	ENSG00000218336	ENST00000511685;ENST00000406950	D;D	0.85088	-1.94;-1.94	4.16	4.16	0.48862	.	.	.	.	.	T	0.70150	0.3191	N	0.19112	0.55	0.47245	D	0.999364	P	0.44734	0.842	B	0.41571	0.36	T	0.68655	-0.5351	9	0.06757	T	0.87	.	7.8558	0.29480	0.1945:0.0:0.8055:0.0	.	2623	Q9P273	TEN3_HUMAN	H	2623	ENSP00000424226:Q2623H;ENSP00000385276:Q2623H	ENSP00000385276:Q2623H	Q	+	3	2	ODZ3	183958267	1.000000	0.71417	1.000000	0.80357	0.995000	0.86356	3.628000	0.54259	2.312000	0.78011	0.455000	0.32223	CAG	TENM3-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000361734.1		21.0		+	ENST00000511685.1
TENM3	55714	__UNKNOWN__	__UNKNOWN__	4	183721278	183721278	__UNKNOWN__	Missense_Mutation	SNP	G	G	T			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr4:183721278G>T	ENST00000511685.1	+	28	7997	c.7874G>T	c.(7873-7875)cGg>cTg	p.R2625L	TENM3_ENST00000406950.2_Missense_Mutation_p.R2625L			Q9P273	TEN3_HUMAN	teneurin transmembrane protein 3	2625					camera-type eye morphogenesis (GO:0048593)|homophilic cell adhesion (GO:0007156)|positive regulation of neuron projection development (GO:0010976)|self proteolysis (GO:0097264)|signal transduction (GO:0007165)	cell projection (GO:0042995)|integral component of membrane (GO:0016021)|membrane (GO:0016020)	protein heterodimerization activity (GO:0046982)|protein homodimerization activity (GO:0042803)										GAGCAGGCGCGGCAGCGCGCG	0.751																																																0													6.0	7.0	6.0					4																	183721278		1878	4020	5898	SO:0001583	missense			AF195420	CCDS47165.1	4q35	2012-10-02	2012-10-02	2012-10-02	ENSG00000218336	ENSG00000218336	55714			29944	protein-coding gene	gene with protein product		610083	"""odz, odd Oz/ten-m homolog 3 (Drosophila)"""	ODZ3		10331952, 10625539	Standard		NM_001080477		Approved	Ten-M3, KIAA1455	uc003ivd.1	Q9P273	OTTHUMG00000160682	ENST00000511685.1:c.7874G>T	chr4.hg19:g.183721278G>T	ENSP00000424226:p.Arg2625Leu		Q5XUL9|Q96SY2|Q9NV77|Q9NVW1|Q9NZJ2	True	hg19	CCDS47165.1	.	.	.	.	.	.	.	.	.	.	G	27.5	4.838177	0.91117	.	.	ENSG00000218336	ENST00000511685;ENST00000406950	D;D	0.88896	-2.44;-2.44	4.16	4.16	0.48862	.	.	.	.	.	D	0.94879	0.8345	M	0.87038	2.855	0.80722	D	1	D	0.56968	0.978	D	0.71184	0.972	D	0.95878	0.8896	9	0.87932	D	0	.	16.9951	0.86365	0.0:0.0:1.0:0.0	.	2625	Q9P273	TEN3_HUMAN	L	2625	ENSP00000424226:R2625L;ENSP00000385276:R2625L	ENSP00000385276:R2625L	R	+	2	0	ODZ3	183958272	1.000000	0.71417	1.000000	0.80357	0.993000	0.82548	9.505000	0.97989	2.312000	0.78011	0.455000	0.32223	CGG	TENM3-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000361734.1		23.0		+	ENST00000511685.1
TENM3	55714	__UNKNOWN__	__UNKNOWN__	4	183721286	183721286	__UNKNOWN__	Missense_Mutation	SNP	G	G	T			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr4:183721286G>T	ENST00000511685.1	+	28	8005	c.7882G>T	c.(7882-7884)Gcg>Tcg	p.A2628S	TENM3_ENST00000406950.2_Missense_Mutation_p.A2628S			Q9P273	TEN3_HUMAN	teneurin transmembrane protein 3	2628					camera-type eye morphogenesis (GO:0048593)|homophilic cell adhesion (GO:0007156)|positive regulation of neuron projection development (GO:0010976)|self proteolysis (GO:0097264)|signal transduction (GO:0007165)	cell projection (GO:0042995)|integral component of membrane (GO:0016021)|membrane (GO:0016020)	protein heterodimerization activity (GO:0046982)|protein homodimerization activity (GO:0042803)										GCGGCAGCGCGCGCTCGCCCG	0.756																																																0													4.0	5.0	5.0					4																	183721286		1675	3746	5421	SO:0001583	missense			AF195420	CCDS47165.1	4q35	2012-10-02	2012-10-02	2012-10-02	ENSG00000218336	ENSG00000218336	55714			29944	protein-coding gene	gene with protein product		610083	"""odz, odd Oz/ten-m homolog 3 (Drosophila)"""	ODZ3		10331952, 10625539	Standard		NM_001080477		Approved	Ten-M3, KIAA1455	uc003ivd.1	Q9P273	OTTHUMG00000160682	ENST00000511685.1:c.7882G>T	chr4.hg19:g.183721286G>T	ENSP00000424226:p.Ala2628Ser		Q5XUL9|Q96SY2|Q9NV77|Q9NVW1|Q9NZJ2	True	hg19	CCDS47165.1	.	.	.	.	.	.	.	.	.	.	G	22.2	4.258775	0.80246	.	.	ENSG00000218336	ENST00000511685;ENST00000406950	D;D	0.90133	-2.62;-2.62	4.16	4.16	0.48862	.	.	.	.	.	D	0.92328	0.7566	M	0.90650	3.135	0.80722	D	1	B	0.18863	0.031	B	0.16289	0.015	D	0.92056	0.5652	9	0.87932	D	0	.	16.9951	0.86365	0.0:0.0:1.0:0.0	.	2628	Q9P273	TEN3_HUMAN	S	2628	ENSP00000424226:A2628S;ENSP00000385276:A2628S	ENSP00000385276:A2628S	A	+	1	0	ODZ3	183958280	1.000000	0.71417	1.000000	0.80357	0.960000	0.62799	6.391000	0.73208	2.312000	0.78011	0.455000	0.32223	GCG	TENM3-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000361734.1		45.0		+	ENST00000511685.1
TENM3	55714	__UNKNOWN__	__UNKNOWN__	4	183721290	183721290	__UNKNOWN__	Missense_Mutation	SNP	T	T	G			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr4:183721290T>G	ENST00000511685.1	+	28	8009	c.7886T>G	c.(7885-7887)cTc>cGc	p.L2629R	TENM3_ENST00000406950.2_Missense_Mutation_p.L2629R			Q9P273	TEN3_HUMAN	teneurin transmembrane protein 3	2629					camera-type eye morphogenesis (GO:0048593)|homophilic cell adhesion (GO:0007156)|positive regulation of neuron projection development (GO:0010976)|self proteolysis (GO:0097264)|signal transduction (GO:0007165)	cell projection (GO:0042995)|integral component of membrane (GO:0016021)|membrane (GO:0016020)	protein heterodimerization activity (GO:0046982)|protein homodimerization activity (GO:0042803)										CAGCGCGCGCTCGCCCGGGCC	0.761																																																0													4.0	5.0	4.0					4																	183721290		1608	3619	5227	SO:0001583	missense			AF195420	CCDS47165.1	4q35	2012-10-02	2012-10-02	2012-10-02	ENSG00000218336	ENSG00000218336	55714			29944	protein-coding gene	gene with protein product		610083	"""odz, odd Oz/ten-m homolog 3 (Drosophila)"""	ODZ3		10331952, 10625539	Standard		NM_001080477		Approved	Ten-M3, KIAA1455	uc003ivd.1	Q9P273	OTTHUMG00000160682	ENST00000511685.1:c.7886T>G	chr4.hg19:g.183721290T>G	ENSP00000424226:p.Leu2629Arg		Q5XUL9|Q96SY2|Q9NV77|Q9NVW1|Q9NZJ2	True	hg19	CCDS47165.1	.	.	.	.	.	.	.	.	.	.	T	21.3	4.122395	0.77436	.	.	ENSG00000218336	ENST00000511685;ENST00000406950	D;D	0.86769	-2.17;-2.17	4.16	4.16	0.48862	.	.	.	.	.	D	0.92473	0.7610	M	0.73962	2.25	0.80722	D	1	D	0.64830	0.994	D	0.77557	0.99	D	0.93390	0.6751	9	0.87932	D	0	.	13.6439	0.62270	0.0:0.0:0.0:1.0	.	2629	Q9P273	TEN3_HUMAN	R	2629	ENSP00000424226:L2629R;ENSP00000385276:L2629R	ENSP00000385276:L2629R	L	+	2	0	ODZ3	183958284	1.000000	0.71417	0.999000	0.59377	0.943000	0.58893	6.020000	0.70826	1.874000	0.54306	0.374000	0.22700	CTC	TENM3-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000361734.1		69.0		+	ENST00000511685.1
TENM3	55714	__UNKNOWN__	__UNKNOWN__	4	183721296	183721296	__UNKNOWN__	Missense_Mutation	SNP	G	G	A			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr4:183721296G>A	ENST00000511685.1	+	28	8015	c.7892G>A	c.(7891-7893)cGg>cAg	p.R2631Q	TENM3_ENST00000406950.2_Missense_Mutation_p.R2631Q			Q9P273	TEN3_HUMAN	teneurin transmembrane protein 3	2631					camera-type eye morphogenesis (GO:0048593)|homophilic cell adhesion (GO:0007156)|positive regulation of neuron projection development (GO:0010976)|self proteolysis (GO:0097264)|signal transduction (GO:0007165)	cell projection (GO:0042995)|integral component of membrane (GO:0016021)|membrane (GO:0016020)	protein heterodimerization activity (GO:0046982)|protein homodimerization activity (GO:0042803)										GCGCTCGCCCGGGCCTGGGCG	0.756																																																0													3.0	4.0	4.0					4																	183721296		1439	3318	4757	SO:0001583	missense			AF195420	CCDS47165.1	4q35	2012-10-02	2012-10-02	2012-10-02	ENSG00000218336	ENSG00000218336	55714			29944	protein-coding gene	gene with protein product		610083	"""odz, odd Oz/ten-m homolog 3 (Drosophila)"""	ODZ3		10331952, 10625539	Standard		NM_001080477		Approved	Ten-M3, KIAA1455	uc003ivd.1	Q9P273	OTTHUMG00000160682	ENST00000511685.1:c.7892G>A	chr4.hg19:g.183721296G>A	ENSP00000424226:p.Arg2631Gln		Q5XUL9|Q96SY2|Q9NV77|Q9NVW1|Q9NZJ2	True	hg19	CCDS47165.1	.	.	.	.	.	.	.	.	.	.	G	5.186	0.219944	0.09863	.	.	ENSG00000218336	ENST00000511685;ENST00000406950	D;D	0.85773	-2.03;-2.03	4.16	3.3	0.37823	.	.	.	.	.	T	0.57125	0.2032	N	0.01352	-0.895	0.26035	N	0.98169	B	0.06786	0.001	B	0.01281	0.0	T	0.53070	-0.8490	9	0.02654	T	1	.	7.5189	0.27616	0.2487:0.0:0.7513:0.0	.	2631	Q9P273	TEN3_HUMAN	Q	2631	ENSP00000424226:R2631Q;ENSP00000385276:R2631Q	ENSP00000385276:R2631Q	R	+	2	0	ODZ3	183958290	1.000000	0.71417	1.000000	0.80357	0.984000	0.73092	3.273000	0.51623	2.312000	0.78011	0.455000	0.32223	CGG	TENM3-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000361734.1		100.0		+	ENST00000511685.1
TENM3	55714	__UNKNOWN__	__UNKNOWN__	4	183721307	183721307	__UNKNOWN__	Missense_Mutation	SNP	C	C	G			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr4:183721307C>G	ENST00000511685.1	+	28	8026	c.7903C>G	c.(7903-7905)Cgc>Ggc	p.R2635G	TENM3_ENST00000406950.2_Missense_Mutation_p.R2635G			Q9P273	TEN3_HUMAN	teneurin transmembrane protein 3	2635					camera-type eye morphogenesis (GO:0048593)|homophilic cell adhesion (GO:0007156)|positive regulation of neuron projection development (GO:0010976)|self proteolysis (GO:0097264)|signal transduction (GO:0007165)	cell projection (GO:0042995)|integral component of membrane (GO:0016021)|membrane (GO:0016020)	protein heterodimerization activity (GO:0046982)|protein homodimerization activity (GO:0042803)										GGCCTGGGCGCGCGAGCAGCA	0.761																																																0													3.0	4.0	4.0					4																	183721307		1383	3186	4569	SO:0001583	missense			AF195420	CCDS47165.1	4q35	2012-10-02	2012-10-02	2012-10-02	ENSG00000218336	ENSG00000218336	55714			29944	protein-coding gene	gene with protein product		610083	"""odz, odd Oz/ten-m homolog 3 (Drosophila)"""	ODZ3		10331952, 10625539	Standard		NM_001080477		Approved	Ten-M3, KIAA1455	uc003ivd.1	Q9P273	OTTHUMG00000160682	ENST00000511685.1:c.7903C>G	chr4.hg19:g.183721307C>G	ENSP00000424226:p.Arg2635Gly		Q5XUL9|Q96SY2|Q9NV77|Q9NVW1|Q9NZJ2	True	hg19	CCDS47165.1	.	.	.	.	.	.	.	.	.	.	C	13.03	2.115574	0.37339	.	.	ENSG00000218336	ENST00000511685;ENST00000406950	D;D	0.87334	-2.24;-2.24	4.16	3.23	0.37069	.	.	.	.	.	D	0.86431	0.5931	M	0.74881	2.28	0.53688	D	0.999971	P	0.46578	0.88	B	0.42851	0.4	D	0.87771	0.2605	9	0.56958	D	0.05	.	11.742	0.51799	0.2855:0.7145:0.0:0.0	.	2635	Q9P273	TEN3_HUMAN	G	2635	ENSP00000424226:R2635G;ENSP00000385276:R2635G	ENSP00000385276:R2635G	R	+	1	0	ODZ3	183958301	1.000000	0.71417	1.000000	0.80357	0.995000	0.86356	1.739000	0.38217	2.312000	0.78011	0.455000	0.32223	CGC	TENM3-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000361734.1		30.0		+	ENST00000511685.1
TENM3	55714	__UNKNOWN__	__UNKNOWN__	4	183721311	183721311	__UNKNOWN__	Missense_Mutation	SNP	A	A	C			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr4:183721311A>C	ENST00000511685.1	+	28	8030	c.7907A>C	c.(7906-7908)gAg>gCg	p.E2636A	TENM3_ENST00000406950.2_Missense_Mutation_p.E2636A			Q9P273	TEN3_HUMAN	teneurin transmembrane protein 3	2636					camera-type eye morphogenesis (GO:0048593)|homophilic cell adhesion (GO:0007156)|positive regulation of neuron projection development (GO:0010976)|self proteolysis (GO:0097264)|signal transduction (GO:0007165)	cell projection (GO:0042995)|integral component of membrane (GO:0016021)|membrane (GO:0016020)	protein heterodimerization activity (GO:0046982)|protein homodimerization activity (GO:0042803)										TGGGCGCGCGAGCAGCAGCGC	0.761																																																0													3.0	4.0	4.0					4																	183721311		1453	3293	4746	SO:0001583	missense			AF195420	CCDS47165.1	4q35	2012-10-02	2012-10-02	2012-10-02	ENSG00000218336	ENSG00000218336	55714			29944	protein-coding gene	gene with protein product		610083	"""odz, odd Oz/ten-m homolog 3 (Drosophila)"""	ODZ3		10331952, 10625539	Standard		NM_001080477		Approved	Ten-M3, KIAA1455	uc003ivd.1	Q9P273	OTTHUMG00000160682	ENST00000511685.1:c.7907A>C	chr4.hg19:g.183721311A>C	ENSP00000424226:p.Glu2636Ala		Q5XUL9|Q96SY2|Q9NV77|Q9NVW1|Q9NZJ2	True	hg19	CCDS47165.1	.	.	.	.	.	.	.	.	.	.	A	21.8	4.202598	0.79127	.	.	ENSG00000218336	ENST00000511685;ENST00000406950	D;D	0.95853	-3.83;-3.83	3.89	3.89	0.44902	.	.	.	.	.	D	0.97751	0.9262	M	0.90814	3.15	0.80722	D	1	D	0.57571	0.98	D	0.68192	0.956	D	0.98521	1.0623	9	0.87932	D	0	.	13.17	0.59593	1.0:0.0:0.0:0.0	.	2636	Q9P273	TEN3_HUMAN	A	2636	ENSP00000424226:E2636A;ENSP00000385276:E2636A	ENSP00000385276:E2636A	E	+	2	0	ODZ3	183958305	1.000000	0.71417	1.000000	0.80357	0.991000	0.79684	8.821000	0.92009	1.754000	0.51921	0.374000	0.22700	GAG	TENM3-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000361734.1		28.0		+	ENST00000511685.1
FGFR4	2264	__UNKNOWN__	__UNKNOWN__	5	176522596	176522596	__UNKNOWN__	Missense_Mutation	SNP	C	C	T			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr5:176522596C>T	ENST00000292408.4	+	13	1938	c.1693C>T	c.(1693-1695)Cgg>Tgg	p.R565W	FGFR4_ENST00000393648.2_Missense_Mutation_p.R497W|FGFR4_ENST00000393637.1_Missense_Mutation_p.R525W|FGFR4_ENST00000502906.1_Missense_Mutation_p.R565W|FGFR4_ENST00000292410.3_Missense_Mutation_p.R525W	NM_002011.3|NM_213647.1	NP_002002.3|NP_998812.1	P22455	FGFR4_HUMAN	fibroblast growth factor receptor 4	565	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.				alveolar secondary septum development (GO:0061144)|cell migration (GO:0016477)|epidermal growth factor receptor signaling pathway (GO:0007173)|Fc-epsilon receptor signaling pathway (GO:0038095)|fibroblast growth factor receptor signaling pathway (GO:0008543)|glucose homeostasis (GO:0042593)|innate immune response (GO:0045087)|insulin receptor signaling pathway (GO:0008286)|neurotrophin TRK receptor signaling pathway (GO:0048011)|organ induction (GO:0001759)|peptidyl-tyrosine phosphorylation (GO:0018108)|phosphate ion homeostasis (GO:0055062)|phosphatidylinositol-mediated signaling (GO:0048015)|positive regulation of cell proliferation (GO:0008284)|positive regulation of DNA biosynthetic process (GO:2000573)|positive regulation of ERK1 and ERK2 cascade (GO:0070374)|positive regulation of metalloenzyme activity (GO:0048554)|positive regulation of proteolysis (GO:0045862)|protein autophosphorylation (GO:0046777)|regulation of bile acid biosynthetic process (GO:0070857)|regulation of cholesterol homeostasis (GO:2000188)|regulation of extracellular matrix disassembly (GO:0010715)|regulation of lipid metabolic process (GO:0019216)	cytoplasm (GO:0005737)|endoplasmic reticulum (GO:0005783)|endosome (GO:0005768)|extracellular region (GO:0005576)|integral component of plasma membrane (GO:0005887)|nucleus (GO:0005634)|plasma membrane (GO:0005886)	ATP binding (GO:0005524)|fibroblast growth factor binding (GO:0017134)|fibroblast growth factor-activated receptor activity (GO:0005007)|heparin binding (GO:0008201)|protein tyrosine kinase activity (GO:0004713)			breast(1)|central_nervous_system(1)|endometrium(3)|haematopoietic_and_lymphoid_tissue(1)|kidney(1)|large_intestine(3)|lung(16)|ovary(1)|prostate(2)|skin(2)|stomach(1)|urinary_tract(2)	34	all_cancers(89;5.93e-05)|Renal(175;0.000269)|Lung NSC(126;0.0088)|all_lung(126;0.0142)	all_neural(177;0.00409)|Medulloblastoma(196;0.00498)|all_hematologic(541;0.21)	Kidney(164;2.23e-05)|KIRC - Kidney renal clear cell carcinoma(164;0.000178)		Palifermin(DB00039)|Ponatinib(DB08901)	CCTGCGGGCCCGGCGCCCCCC	0.716										TSP Lung(9;0.080)																																						0													16.0	20.0	18.0					5																	176522596		2195	4293	6488	SO:0001583	missense			AF202063	CCDS4410.1, CCDS4411.1	5q35.2	2013-09-19			ENSG00000160867	ENSG00000160867	2264		"""CD molecules"", ""Immunoglobulin superfamily / I-set domain containing"""	3691	protein-coding gene	gene with protein product		134935					Standard		XM_005265837		Approved	JTK2, CD334	uc003mfm.3	P22455	OTTHUMG00000151523	ENST00000292408.4:c.1693C>T	chr5.hg19:g.176522596C>T	ENSP00000292408:p.Arg565Trp		G3JVM2|G3JVM5|G3JVM7|G3JVM9|O43785|Q14309|Q71TW8|Q8TDA0|Q96KE5	True	hg19	CCDS4410.1	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	C|C	22.2|22.2	4.260727|4.260727	0.80246|0.80246	.|.	.|.	ENSG00000160867|ENSG00000160867	ENST00000511076|ENST00000292408;ENST00000393648;ENST00000502906;ENST00000292410;ENST00000393637;ENST00000377207	.|D;D;D;D;D	.|0.83506	.|-1.73;-1.73;-1.73;-1.73;-1.73	5.29|5.29	4.34|4.34	0.51931|0.51931	.|Serine-threonine/tyrosine-protein kinase (1);Protein kinase-like domain (1);Tyrosine-protein kinase, catalytic domain (1);Protein kinase, catalytic domain (1);	.|0.052606	.|0.64402	.|D	.|0.000001	D|D	0.91338|0.91338	0.7268|0.7268	M|M	0.84511|0.84511	2.7|2.7	0.53005|0.53005	D|D	0.999964|0.999964	.|D;D;D	.|0.89917	.|1.0;1.0;1.0	.|D;D;D	.|0.97110	.|1.0;1.0;1.0	D|D	0.92594|0.92594	0.6085|0.6085	5|10	.|0.87932	.|D	.|0	.|.	14.5618|14.5618	0.68144|0.68144	0.2371:0.7629:0.0:0.0|0.2371:0.7629:0.0:0.0	.|.	.|497;525;565	.|B4DVP5;P22455-2;P22455	.|.;.;FGFR4_HUMAN	L|W	196|565;497;565;525;525;793	.|ENSP00000292408:R565W;ENSP00000377259:R497W;ENSP00000424960:R565W;ENSP00000292410:R525W;ENSP00000377254:R525W	.|ENSP00000292408:R565W	P|R	+|+	2|1	0|2	FGFR4|FGFR4	176455202|176455202	0.997000|0.997000	0.39634|0.39634	1.000000|1.000000	0.80357|0.80357	0.948000|0.948000	0.59901|0.59901	2.452000|2.452000	0.44961|0.44961	2.478000|2.478000	0.83669|0.83669	0.561000|0.561000	0.74099|0.74099	CCG|CGG	FGFR4-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000253410.1		27.0		+	ENST00000292408.4
FGFR4	2264	__UNKNOWN__	__UNKNOWN__	5	176522599	176522599	__UNKNOWN__	Missense_Mutation	SNP	C	C	G			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr5:176522599C>G	ENST00000292408.4	+	13	1941	c.1696C>G	c.(1696-1698)Cgc>Ggc	p.R566G	FGFR4_ENST00000393648.2_Missense_Mutation_p.R498G|FGFR4_ENST00000393637.1_Missense_Mutation_p.R526G|FGFR4_ENST00000502906.1_Missense_Mutation_p.R566G|FGFR4_ENST00000292410.3_Missense_Mutation_p.R526G	NM_002011.3|NM_213647.1	NP_002002.3|NP_998812.1	P22455	FGFR4_HUMAN	fibroblast growth factor receptor 4	566	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.				alveolar secondary septum development (GO:0061144)|cell migration (GO:0016477)|epidermal growth factor receptor signaling pathway (GO:0007173)|Fc-epsilon receptor signaling pathway (GO:0038095)|fibroblast growth factor receptor signaling pathway (GO:0008543)|glucose homeostasis (GO:0042593)|innate immune response (GO:0045087)|insulin receptor signaling pathway (GO:0008286)|neurotrophin TRK receptor signaling pathway (GO:0048011)|organ induction (GO:0001759)|peptidyl-tyrosine phosphorylation (GO:0018108)|phosphate ion homeostasis (GO:0055062)|phosphatidylinositol-mediated signaling (GO:0048015)|positive regulation of cell proliferation (GO:0008284)|positive regulation of DNA biosynthetic process (GO:2000573)|positive regulation of ERK1 and ERK2 cascade (GO:0070374)|positive regulation of metalloenzyme activity (GO:0048554)|positive regulation of proteolysis (GO:0045862)|protein autophosphorylation (GO:0046777)|regulation of bile acid biosynthetic process (GO:0070857)|regulation of cholesterol homeostasis (GO:2000188)|regulation of extracellular matrix disassembly (GO:0010715)|regulation of lipid metabolic process (GO:0019216)	cytoplasm (GO:0005737)|endoplasmic reticulum (GO:0005783)|endosome (GO:0005768)|extracellular region (GO:0005576)|integral component of plasma membrane (GO:0005887)|nucleus (GO:0005634)|plasma membrane (GO:0005886)	ATP binding (GO:0005524)|fibroblast growth factor binding (GO:0017134)|fibroblast growth factor-activated receptor activity (GO:0005007)|heparin binding (GO:0008201)|protein tyrosine kinase activity (GO:0004713)			breast(1)|central_nervous_system(1)|endometrium(3)|haematopoietic_and_lymphoid_tissue(1)|kidney(1)|large_intestine(3)|lung(16)|ovary(1)|prostate(2)|skin(2)|stomach(1)|urinary_tract(2)	34	all_cancers(89;5.93e-05)|Renal(175;0.000269)|Lung NSC(126;0.0088)|all_lung(126;0.0142)	all_neural(177;0.00409)|Medulloblastoma(196;0.00498)|all_hematologic(541;0.21)	Kidney(164;2.23e-05)|KIRC - Kidney renal clear cell carcinoma(164;0.000178)		Palifermin(DB00039)|Ponatinib(DB08901)	GCGGGCCCGGCGCCCCCCAGG	0.721										TSP Lung(9;0.080)																																						0													16.0	20.0	18.0					5																	176522599		2196	4294	6490	SO:0001583	missense			AF202063	CCDS4410.1, CCDS4411.1	5q35.2	2013-09-19			ENSG00000160867	ENSG00000160867	2264		"""CD molecules"", ""Immunoglobulin superfamily / I-set domain containing"""	3691	protein-coding gene	gene with protein product		134935					Standard		XM_005265837		Approved	JTK2, CD334	uc003mfm.3	P22455	OTTHUMG00000151523	ENST00000292408.4:c.1696C>G	chr5.hg19:g.176522599C>G	ENSP00000292408:p.Arg566Gly		G3JVM2|G3JVM5|G3JVM7|G3JVM9|O43785|Q14309|Q71TW8|Q8TDA0|Q96KE5	True	hg19	CCDS4410.1	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	C|C	23.6|23.6	4.441432|4.441432	0.83993|0.83993	.|.	.|.	ENSG00000160867|ENSG00000160867	ENST00000511076|ENST00000292408;ENST00000393648;ENST00000502906;ENST00000292410;ENST00000393637;ENST00000377207	.|D;D;D;D;D	.|0.90900	.|-2.75;-2.75;-2.75;-2.75;-2.75	5.29|5.29	4.34|4.34	0.51931|0.51931	.|Serine-threonine/tyrosine-protein kinase (1);Protein kinase-like domain (1);Tyrosine-protein kinase, catalytic domain (1);Protein kinase, catalytic domain (1);	.|0.000000	.|0.85682	.|D	.|0.000000	D|D	0.94231|0.94231	0.8148|0.8148	M|M	0.63169|0.63169	1.94|1.94	0.80722|0.80722	D|D	1|1	.|D;D;D	.|0.89917	.|1.0;1.0;1.0	.|D;D;D	.|0.97110	.|0.998;1.0;0.998	D|D	0.94798|0.94798	0.7968|0.7968	5|10	.|0.87932	.|D	.|0	.|.	16.2917|16.2917	0.82756|0.82756	0.1414:0.8586:0.0:0.0|0.1414:0.8586:0.0:0.0	.|.	.|498;526;566	.|B4DVP5;P22455-2;P22455	.|.;.;FGFR4_HUMAN	G|G	197|566;498;566;526;526;794	.|ENSP00000292408:R566G;ENSP00000377259:R498G;ENSP00000424960:R566G;ENSP00000292410:R526G;ENSP00000377254:R526G	.|ENSP00000292408:R566G	A|R	+|+	2|1	0|0	FGFR4|FGFR4	176455205|176455205	0.995000|0.995000	0.38212|0.38212	0.996000|0.996000	0.52242|0.52242	0.906000|0.906000	0.53458|0.53458	3.280000|3.280000	0.51677|0.51677	2.478000|2.478000	0.83669|0.83669	0.561000|0.561000	0.74099|0.74099	GCG|CGC	FGFR4-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000253410.1		20.0		+	ENST00000292408.4
FGFR4	2264	__UNKNOWN__	__UNKNOWN__	5	176522601	176522601	__UNKNOWN__	Silent	SNP	C	C	G			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr5:176522601C>G	ENST00000292408.4	+	13	1943	c.1698C>G	c.(1696-1698)cgC>cgG	p.R566R	FGFR4_ENST00000393648.2_Silent_p.R498R|FGFR4_ENST00000393637.1_Silent_p.R526R|FGFR4_ENST00000502906.1_Silent_p.R566R|FGFR4_ENST00000292410.3_Silent_p.R526R	NM_002011.3|NM_213647.1	NP_002002.3|NP_998812.1	P22455	FGFR4_HUMAN	fibroblast growth factor receptor 4	566	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.				alveolar secondary septum development (GO:0061144)|cell migration (GO:0016477)|epidermal growth factor receptor signaling pathway (GO:0007173)|Fc-epsilon receptor signaling pathway (GO:0038095)|fibroblast growth factor receptor signaling pathway (GO:0008543)|glucose homeostasis (GO:0042593)|innate immune response (GO:0045087)|insulin receptor signaling pathway (GO:0008286)|neurotrophin TRK receptor signaling pathway (GO:0048011)|organ induction (GO:0001759)|peptidyl-tyrosine phosphorylation (GO:0018108)|phosphate ion homeostasis (GO:0055062)|phosphatidylinositol-mediated signaling (GO:0048015)|positive regulation of cell proliferation (GO:0008284)|positive regulation of DNA biosynthetic process (GO:2000573)|positive regulation of ERK1 and ERK2 cascade (GO:0070374)|positive regulation of metalloenzyme activity (GO:0048554)|positive regulation of proteolysis (GO:0045862)|protein autophosphorylation (GO:0046777)|regulation of bile acid biosynthetic process (GO:0070857)|regulation of cholesterol homeostasis (GO:2000188)|regulation of extracellular matrix disassembly (GO:0010715)|regulation of lipid metabolic process (GO:0019216)	cytoplasm (GO:0005737)|endoplasmic reticulum (GO:0005783)|endosome (GO:0005768)|extracellular region (GO:0005576)|integral component of plasma membrane (GO:0005887)|nucleus (GO:0005634)|plasma membrane (GO:0005886)	ATP binding (GO:0005524)|fibroblast growth factor binding (GO:0017134)|fibroblast growth factor-activated receptor activity (GO:0005007)|heparin binding (GO:0008201)|protein tyrosine kinase activity (GO:0004713)			breast(1)|central_nervous_system(1)|endometrium(3)|haematopoietic_and_lymphoid_tissue(1)|kidney(1)|large_intestine(3)|lung(16)|ovary(1)|prostate(2)|skin(2)|stomach(1)|urinary_tract(2)	34	all_cancers(89;5.93e-05)|Renal(175;0.000269)|Lung NSC(126;0.0088)|all_lung(126;0.0142)	all_neural(177;0.00409)|Medulloblastoma(196;0.00498)|all_hematologic(541;0.21)	Kidney(164;2.23e-05)|KIRC - Kidney renal clear cell carcinoma(164;0.000178)		Palifermin(DB00039)|Ponatinib(DB08901)	GGGCCCGGCGCCCCCCAGGCC	0.716										TSP Lung(9;0.080)																																						0													16.0	20.0	19.0					5																	176522601		2196	4294	6490	SO:0001819	synonymous_variant			AF202063	CCDS4410.1, CCDS4411.1	5q35.2	2013-09-19			ENSG00000160867	ENSG00000160867	2264		"""CD molecules"", ""Immunoglobulin superfamily / I-set domain containing"""	3691	protein-coding gene	gene with protein product		134935					Standard		XM_005265837		Approved	JTK2, CD334	uc003mfm.3	P22455	OTTHUMG00000151523	ENST00000292408.4:c.1698C>G	chr5.hg19:g.176522601C>G			G3JVM2|G3JVM5|G3JVM7|G3JVM9|O43785|Q14309|Q71TW8|Q8TDA0|Q96KE5	True	hg19	CCDS4410.1	.	.	.	.	.	.	.	.	.	.	C	9.335	1.061457	0.19987	.	.	ENSG00000160867	ENST00000511076	.	.	.	5.29	-8.31	0.01001	.	.	.	.	.	T	0.33030	0.0849	.	.	.	0.80722	D	1	.	.	.	.	.	.	T	0.42120	-0.9470	4	.	.	.	.	1.4045	0.02278	0.2564:0.3229:0.2372:0.1835	.	.	.	.	A	198	.	.	P	+	1	0	FGFR4	176455207	0.000000	0.05858	0.837000	0.33122	0.830000	0.47004	-2.313000	0.01126	-1.204000	0.02648	0.561000	0.74099	CCC	FGFR4-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000253410.1		26.0		+	ENST00000292408.4
FGFR4	2264	__UNKNOWN__	__UNKNOWN__	5	176522602	176522602	__UNKNOWN__	Missense_Mutation	SNP	C	C	G			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr5:176522602C>G	ENST00000292408.4	+	13	1944	c.1699C>G	c.(1699-1701)Ccc>Gcc	p.P567A	FGFR4_ENST00000393648.2_Missense_Mutation_p.P499A|FGFR4_ENST00000393637.1_Missense_Mutation_p.P527A|FGFR4_ENST00000502906.1_Missense_Mutation_p.P567A|FGFR4_ENST00000292410.3_Missense_Mutation_p.P527A	NM_002011.3|NM_213647.1	NP_002002.3|NP_998812.1	P22455	FGFR4_HUMAN	fibroblast growth factor receptor 4	567	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.				alveolar secondary septum development (GO:0061144)|cell migration (GO:0016477)|epidermal growth factor receptor signaling pathway (GO:0007173)|Fc-epsilon receptor signaling pathway (GO:0038095)|fibroblast growth factor receptor signaling pathway (GO:0008543)|glucose homeostasis (GO:0042593)|innate immune response (GO:0045087)|insulin receptor signaling pathway (GO:0008286)|neurotrophin TRK receptor signaling pathway (GO:0048011)|organ induction (GO:0001759)|peptidyl-tyrosine phosphorylation (GO:0018108)|phosphate ion homeostasis (GO:0055062)|phosphatidylinositol-mediated signaling (GO:0048015)|positive regulation of cell proliferation (GO:0008284)|positive regulation of DNA biosynthetic process (GO:2000573)|positive regulation of ERK1 and ERK2 cascade (GO:0070374)|positive regulation of metalloenzyme activity (GO:0048554)|positive regulation of proteolysis (GO:0045862)|protein autophosphorylation (GO:0046777)|regulation of bile acid biosynthetic process (GO:0070857)|regulation of cholesterol homeostasis (GO:2000188)|regulation of extracellular matrix disassembly (GO:0010715)|regulation of lipid metabolic process (GO:0019216)	cytoplasm (GO:0005737)|endoplasmic reticulum (GO:0005783)|endosome (GO:0005768)|extracellular region (GO:0005576)|integral component of plasma membrane (GO:0005887)|nucleus (GO:0005634)|plasma membrane (GO:0005886)	ATP binding (GO:0005524)|fibroblast growth factor binding (GO:0017134)|fibroblast growth factor-activated receptor activity (GO:0005007)|heparin binding (GO:0008201)|protein tyrosine kinase activity (GO:0004713)			breast(1)|central_nervous_system(1)|endometrium(3)|haematopoietic_and_lymphoid_tissue(1)|kidney(1)|large_intestine(3)|lung(16)|ovary(1)|prostate(2)|skin(2)|stomach(1)|urinary_tract(2)	34	all_cancers(89;5.93e-05)|Renal(175;0.000269)|Lung NSC(126;0.0088)|all_lung(126;0.0142)	all_neural(177;0.00409)|Medulloblastoma(196;0.00498)|all_hematologic(541;0.21)	Kidney(164;2.23e-05)|KIRC - Kidney renal clear cell carcinoma(164;0.000178)		Palifermin(DB00039)|Ponatinib(DB08901)	GGCCCGGCGCCCCCCAGGCCC	0.716										TSP Lung(9;0.080)																																						0													16.0	20.0	19.0					5																	176522602		2195	4294	6489	SO:0001583	missense			AF202063	CCDS4410.1, CCDS4411.1	5q35.2	2013-09-19			ENSG00000160867	ENSG00000160867	2264		"""CD molecules"", ""Immunoglobulin superfamily / I-set domain containing"""	3691	protein-coding gene	gene with protein product		134935					Standard		XM_005265837		Approved	JTK2, CD334	uc003mfm.3	P22455	OTTHUMG00000151523	ENST00000292408.4:c.1699C>G	chr5.hg19:g.176522602C>G	ENSP00000292408:p.Pro567Ala		G3JVM2|G3JVM5|G3JVM7|G3JVM9|O43785|Q14309|Q71TW8|Q8TDA0|Q96KE5	True	hg19	CCDS4410.1	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	C|C	24.1|24.1	4.498847|4.498847	0.85069|0.85069	.|.	.|.	ENSG00000160867|ENSG00000160867	ENST00000292408;ENST00000393648;ENST00000502906;ENST00000292410;ENST00000393637;ENST00000377207|ENST00000511076	D;D;D;D;D|.	0.91068|.	-2.78;-2.78;-2.78;-2.78;-2.78|.	5.11|5.11	5.11|5.11	0.69529|0.69529	Serine-threonine/tyrosine-protein kinase (1);Protein kinase-like domain (1);Tyrosine-protein kinase, catalytic domain (1);Protein kinase, catalytic domain (1);|.	0.000000|0.000000	0.85682|0.85682	D|D	0.000000|0.000000	T|T	0.53222|0.53222	0.1783|0.1783	N|N	0.20685|0.20685	0.6|0.6	0.80722|0.80722	D|D	1|1	D;D;D|.	0.76494|.	0.999;0.999;0.999|.	D;D;D|.	0.80764|.	0.992;0.987;0.994|.	T|T	0.49466|0.49466	-0.8937|-0.8937	10|6	0.87932|.	D|.	0|.	.|.	18.1667|18.1667	0.89731|0.89731	0.0:1.0:0.0:0.0|0.0:1.0:0.0:0.0	.|.	499;527;567|.	B4DVP5;P22455-2;P22455|.	.;.;FGFR4_HUMAN|.	A|R	567;499;567;527;527;795|198	ENSP00000292408:P567A;ENSP00000377259:P499A;ENSP00000424960:P567A;ENSP00000292410:P527A;ENSP00000377254:P527A|.	ENSP00000292408:P567A|.	P|P	+|+	1|2	0|0	FGFR4|FGFR4	176455208|176455208	1.000000|1.000000	0.71417|0.71417	0.925000|0.925000	0.36789|0.36789	0.762000|0.762000	0.43233|0.43233	7.747000|7.747000	0.85070|0.85070	2.375000|2.375000	0.81037|0.81037	0.561000|0.561000	0.74099|0.74099	CCC|CCC	FGFR4-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000253410.1		20.0		+	ENST00000292408.4
FGFR4	2264	__UNKNOWN__	__UNKNOWN__	5	176522607	176522607	__UNKNOWN__	Silent	SNP	A	A	G			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr5:176522607A>G	ENST00000292408.4	+	13	1949	c.1704A>G	c.(1702-1704)ccA>ccG	p.P568P	FGFR4_ENST00000393648.2_Silent_p.P500P|FGFR4_ENST00000393637.1_Silent_p.P528P|FGFR4_ENST00000502906.1_Silent_p.P568P|FGFR4_ENST00000292410.3_Silent_p.P528P	NM_002011.3|NM_213647.1	NP_002002.3|NP_998812.1	P22455	FGFR4_HUMAN	fibroblast growth factor receptor 4	568	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.				alveolar secondary septum development (GO:0061144)|cell migration (GO:0016477)|epidermal growth factor receptor signaling pathway (GO:0007173)|Fc-epsilon receptor signaling pathway (GO:0038095)|fibroblast growth factor receptor signaling pathway (GO:0008543)|glucose homeostasis (GO:0042593)|innate immune response (GO:0045087)|insulin receptor signaling pathway (GO:0008286)|neurotrophin TRK receptor signaling pathway (GO:0048011)|organ induction (GO:0001759)|peptidyl-tyrosine phosphorylation (GO:0018108)|phosphate ion homeostasis (GO:0055062)|phosphatidylinositol-mediated signaling (GO:0048015)|positive regulation of cell proliferation (GO:0008284)|positive regulation of DNA biosynthetic process (GO:2000573)|positive regulation of ERK1 and ERK2 cascade (GO:0070374)|positive regulation of metalloenzyme activity (GO:0048554)|positive regulation of proteolysis (GO:0045862)|protein autophosphorylation (GO:0046777)|regulation of bile acid biosynthetic process (GO:0070857)|regulation of cholesterol homeostasis (GO:2000188)|regulation of extracellular matrix disassembly (GO:0010715)|regulation of lipid metabolic process (GO:0019216)	cytoplasm (GO:0005737)|endoplasmic reticulum (GO:0005783)|endosome (GO:0005768)|extracellular region (GO:0005576)|integral component of plasma membrane (GO:0005887)|nucleus (GO:0005634)|plasma membrane (GO:0005886)	ATP binding (GO:0005524)|fibroblast growth factor binding (GO:0017134)|fibroblast growth factor-activated receptor activity (GO:0005007)|heparin binding (GO:0008201)|protein tyrosine kinase activity (GO:0004713)			breast(1)|central_nervous_system(1)|endometrium(3)|haematopoietic_and_lymphoid_tissue(1)|kidney(1)|large_intestine(3)|lung(16)|ovary(1)|prostate(2)|skin(2)|stomach(1)|urinary_tract(2)	34	all_cancers(89;5.93e-05)|Renal(175;0.000269)|Lung NSC(126;0.0088)|all_lung(126;0.0142)	all_neural(177;0.00409)|Medulloblastoma(196;0.00498)|all_hematologic(541;0.21)	Kidney(164;2.23e-05)|KIRC - Kidney renal clear cell carcinoma(164;0.000178)		Palifermin(DB00039)|Ponatinib(DB08901)	GGCGCCCCCCAGGCCCCGACC	0.711										TSP Lung(9;0.080)																																						0													16.0	20.0	19.0					5																	176522607		2196	4292	6488	SO:0001819	synonymous_variant			AF202063	CCDS4410.1, CCDS4411.1	5q35.2	2013-09-19			ENSG00000160867	ENSG00000160867	2264		"""CD molecules"", ""Immunoglobulin superfamily / I-set domain containing"""	3691	protein-coding gene	gene with protein product		134935					Standard		XM_005265837		Approved	JTK2, CD334	uc003mfm.3	P22455	OTTHUMG00000151523	ENST00000292408.4:c.1704A>G	chr5.hg19:g.176522607A>G			G3JVM2|G3JVM5|G3JVM7|G3JVM9|O43785|Q14309|Q71TW8|Q8TDA0|Q96KE5	True	hg19	CCDS4410.1	.	.	.	.	.	.	.	.	.	.	A	2.347	-0.349776	0.05173	.	.	ENSG00000160867	ENST00000511076	.	.	.	5.29	-10.6	0.00265	.	.	.	.	.	T	0.33030	0.0849	.	.	.	0.80722	D	1	.	.	.	.	.	.	T	0.41215	-0.9521	4	.	.	.	.	2.216	0.03960	0.2992:0.1987:0.3426:0.1595	.	.	.	.	G	200	.	.	R	+	1	2	FGFR4	176455213	0.000000	0.05858	0.332000	0.25469	0.192000	0.23643	-1.902000	0.01596	-2.778000	0.00362	-2.060000	0.00399	AGG	FGFR4-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000253410.1		20.0		+	ENST00000292408.4
ROS1	6098	__UNKNOWN__	__UNKNOWN__	6	117642797	117642797	__UNKNOWN__	Intron	SNP	T	T	G			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr6:117642797T>G	ENST00000368508.3	-	35	5840				GOPC_ENST00000467125.1_Intron|ROS1_ENST00000368507.3_Intron	NM_002944.2	NP_002935.2	P08922	ROS1_HUMAN	ROS proto-oncogene 1 , receptor tyrosine kinase						cell differentiation (GO:0030154)|cell growth (GO:0016049)|cell proliferation (GO:0008283)|columnar/cuboidal epithelial cell development (GO:0002066)|negative regulation of gene expression (GO:0010629)|peptidyl-tyrosine phosphorylation (GO:0018108)|protein phosphorylation (GO:0006468)|regulation of ERK1 and ERK2 cascade (GO:0070372)|regulation of phosphate transport (GO:0010966)|regulation of TOR signaling (GO:0032006)|spermatogenesis (GO:0007283)|transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169)	integral component of membrane (GO:0016021)|membrane (GO:0016020)|plasma membrane (GO:0005886)	ATP binding (GO:0005524)|protein phosphatase binding (GO:0019903)|protein tyrosine kinase activity (GO:0004713)|transmembrane receptor protein tyrosine kinase activity (GO:0004714)		TPM3_ENST00000368530/ROS1(4)|LRIG3/ROS1(2)|CD74_ENST00000009530/ROS1(32)|SLC34A2/ROS1(14)|EZR/ROS1(4)|GOPC/ROS1(14)|SDC4/ROS1(7)	NS(2)|breast(7)|central_nervous_system(5)|endometrium(7)|haematopoietic_and_lymphoid_tissue(2)|kidney(12)|large_intestine(28)|lung(56)|ovary(8)|prostate(5)|skin(19)|stomach(3)|upper_aerodigestive_tract(5)|urinary_tract(3)	162		all_cancers(87;0.00846)|all_epithelial(87;0.0242)		GBM - Glioblastoma multiforme(226;0.0387)|OV - Ovarian serous cystadenocarcinoma(136;0.0954)|all cancers(137;0.137)		TCTTAAAATTTAATGTATTTC	0.214			T	"""GOPC, SDC4, SLC34A2, EZR, LRIG3"""	"""glioblastoma, NSCLC"""																																		Dom	yes		6	6q22	6098	v-ros UR2 sarcoma virus oncogene homolog 1 (avian)		"""O, E"""	0																																										SO:0001627	intron_variant			M13599	CCDS5116.1	6q21-q22	2014-06-26	2014-06-26		ENSG00000047936	ENSG00000047936	6098		"""Fibronectin type III domain containing"""	10261	protein-coding gene	gene with protein product		165020	"""v-ros avian UR2 sarcoma virus oncogene homolog 1"", ""v-ros UR2 sarcoma virus oncogene homolog 1 (avian)"", ""c-ros oncogene 1 , receptor tyrosine kinase"""			1611909	Standard		NM_002944		Approved	MCF3, ROS, c-ros-1	uc003pxp.1	P08922	OTTHUMG00000016188	ENST00000368508.3:c.5642-240A>C	chr6.hg19:g.117642797T>G			Q15368|Q5TDB5	True	hg19	CCDS5116.1																																																																																			ROS1-001	KNOWN	basic|appris_candidate_longest|CCDS	protein_coding		protein_coding	OTTHUMT00000043464.1		100.0		-	ENST00000368508.3
ROS1	6098	__UNKNOWN__	__UNKNOWN__	6	117650909	117650909	__UNKNOWN__	Intron	SNP	A	A	G			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr6:117650909A>G	ENST00000368508.3	-	32	5447				GOPC_ENST00000467125.1_Intron|ROS1_ENST00000368507.3_Intron	NM_002944.2	NP_002935.2	P08922	ROS1_HUMAN	ROS proto-oncogene 1 , receptor tyrosine kinase						cell differentiation (GO:0030154)|cell growth (GO:0016049)|cell proliferation (GO:0008283)|columnar/cuboidal epithelial cell development (GO:0002066)|negative regulation of gene expression (GO:0010629)|peptidyl-tyrosine phosphorylation (GO:0018108)|protein phosphorylation (GO:0006468)|regulation of ERK1 and ERK2 cascade (GO:0070372)|regulation of phosphate transport (GO:0010966)|regulation of TOR signaling (GO:0032006)|spermatogenesis (GO:0007283)|transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169)	integral component of membrane (GO:0016021)|membrane (GO:0016020)|plasma membrane (GO:0005886)	ATP binding (GO:0005524)|protein phosphatase binding (GO:0019903)|protein tyrosine kinase activity (GO:0004713)|transmembrane receptor protein tyrosine kinase activity (GO:0004714)		TPM3_ENST00000368530/ROS1(4)|LRIG3/ROS1(2)|CD74_ENST00000009530/ROS1(32)|SLC34A2/ROS1(14)|EZR/ROS1(4)|GOPC/ROS1(14)|SDC4/ROS1(7)	NS(2)|breast(7)|central_nervous_system(5)|endometrium(7)|haematopoietic_and_lymphoid_tissue(2)|kidney(12)|large_intestine(28)|lung(56)|ovary(8)|prostate(5)|skin(19)|stomach(3)|upper_aerodigestive_tract(5)|urinary_tract(3)	162		all_cancers(87;0.00846)|all_epithelial(87;0.0242)		GBM - Glioblastoma multiforme(226;0.0387)|OV - Ovarian serous cystadenocarcinoma(136;0.0954)|all cancers(137;0.137)		ccacacggggaaggggaaccc	0.572			T	"""GOPC, SDC4, SLC34A2, EZR, LRIG3"""	"""glioblastoma, NSCLC"""																																		Dom	yes		6	6q22	6098	v-ros UR2 sarcoma virus oncogene homolog 1 (avian)		"""O, E"""	0																																										SO:0001627	intron_variant			M13599	CCDS5116.1	6q21-q22	2014-06-26	2014-06-26		ENSG00000047936	ENSG00000047936	6098		"""Fibronectin type III domain containing"""	10261	protein-coding gene	gene with protein product		165020	"""v-ros avian UR2 sarcoma virus oncogene homolog 1"", ""v-ros UR2 sarcoma virus oncogene homolog 1 (avian)"", ""c-ros oncogene 1 , receptor tyrosine kinase"""			1611909	Standard		NM_002944		Approved	MCF3, ROS, c-ros-1	uc003pxp.1	P08922	OTTHUMG00000016188	ENST00000368508.3:c.5249-300T>C	chr6.hg19:g.117650909A>G			Q15368|Q5TDB5	True	hg19	CCDS5116.1																																																																																			ROS1-001	KNOWN	basic|appris_candidate_longest|CCDS	protein_coding		protein_coding	OTTHUMT00000043464.1		32.0		-	ENST00000368508.3
ROS1	6098	__UNKNOWN__	__UNKNOWN__	6	117650942	117650942	__UNKNOWN__	Intron	SNP	C	C	G			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr6:117650942C>G	ENST00000368508.3	-	32	5447				GOPC_ENST00000467125.1_Intron|ROS1_ENST00000368507.3_Intron	NM_002944.2	NP_002935.2	P08922	ROS1_HUMAN	ROS proto-oncogene 1 , receptor tyrosine kinase						cell differentiation (GO:0030154)|cell growth (GO:0016049)|cell proliferation (GO:0008283)|columnar/cuboidal epithelial cell development (GO:0002066)|negative regulation of gene expression (GO:0010629)|peptidyl-tyrosine phosphorylation (GO:0018108)|protein phosphorylation (GO:0006468)|regulation of ERK1 and ERK2 cascade (GO:0070372)|regulation of phosphate transport (GO:0010966)|regulation of TOR signaling (GO:0032006)|spermatogenesis (GO:0007283)|transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169)	integral component of membrane (GO:0016021)|membrane (GO:0016020)|plasma membrane (GO:0005886)	ATP binding (GO:0005524)|protein phosphatase binding (GO:0019903)|protein tyrosine kinase activity (GO:0004713)|transmembrane receptor protein tyrosine kinase activity (GO:0004714)		TPM3_ENST00000368530/ROS1(4)|LRIG3/ROS1(2)|CD74_ENST00000009530/ROS1(32)|SLC34A2/ROS1(14)|EZR/ROS1(4)|GOPC/ROS1(14)|SDC4/ROS1(7)	NS(2)|breast(7)|central_nervous_system(5)|endometrium(7)|haematopoietic_and_lymphoid_tissue(2)|kidney(12)|large_intestine(28)|lung(56)|ovary(8)|prostate(5)|skin(19)|stomach(3)|upper_aerodigestive_tract(5)|urinary_tract(3)	162		all_cancers(87;0.00846)|all_epithelial(87;0.0242)		GBM - Glioblastoma multiforme(226;0.0387)|OV - Ovarian serous cystadenocarcinoma(136;0.0954)|all cancers(137;0.137)		ccaaggggagcggcgagcgag	0.602			T	"""GOPC, SDC4, SLC34A2, EZR, LRIG3"""	"""glioblastoma, NSCLC"""																																		Dom	yes		6	6q22	6098	v-ros UR2 sarcoma virus oncogene homolog 1 (avian)		"""O, E"""	0																																										SO:0001627	intron_variant			M13599	CCDS5116.1	6q21-q22	2014-06-26	2014-06-26		ENSG00000047936	ENSG00000047936	6098		"""Fibronectin type III domain containing"""	10261	protein-coding gene	gene with protein product		165020	"""v-ros avian UR2 sarcoma virus oncogene homolog 1"", ""v-ros UR2 sarcoma virus oncogene homolog 1 (avian)"", ""c-ros oncogene 1 , receptor tyrosine kinase"""			1611909	Standard		NM_002944		Approved	MCF3, ROS, c-ros-1	uc003pxp.1	P08922	OTTHUMG00000016188	ENST00000368508.3:c.5249-333G>C	chr6.hg19:g.117650942C>G			Q15368|Q5TDB5	True	hg19	CCDS5116.1																																																																																			ROS1-001	KNOWN	basic|appris_candidate_longest|CCDS	protein_coding		protein_coding	OTTHUMT00000043464.1		28.0		-	ENST00000368508.3
ARID1B	57492	__UNKNOWN__	__UNKNOWN__	6	157100005	157100005	__UNKNOWN__	Silent	SNP	C	C	A	rs587779748|rs184815562		__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr6:157100005C>A	ENST00000346085.5	+	1	943	c.942C>A	c.(940-942)ggC>ggA	p.G314G	ARID1B_ENST00000367148.1_Silent_p.G314G|ARID1B_ENST00000275248.4_Silent_p.G256G|ARID1B_ENST00000350026.5_Silent_p.G314G	NM_020732.3	NP_065783.3	Q8NFD5	ARI1B_HUMAN	AT rich interactive domain 1B (SWI1-like)	314	Gly-rich.				chromatin-mediated maintenance of transcription (GO:0048096)|nervous system development (GO:0007399)|transcription, DNA-templated (GO:0006351)	cytoplasm (GO:0005737)|nucleus (GO:0005634)|SWI/SNF complex (GO:0016514)	DNA binding (GO:0003677)|transcription coactivator activity (GO:0003713)			NS(2)|breast(5)|central_nervous_system(4)|endometrium(12)|kidney(4)|large_intestine(11)|lung(30)|ovary(3)|pancreas(1)|prostate(4)|skin(2)|urinary_tract(3)	81		Breast(66;0.000162)|Ovarian(120;0.0265)		OV - Ovarian serous cystadenocarcinoma(65;3.19e-17)|BRCA - Breast invasive adenocarcinoma(81;1.01e-05)		gcggcggcggcggaggaggag	0.756																																																0													1.0	1.0	1.0					6																	157100005		538	1345	1883	SO:0001819	synonymous_variant			AF521671	CCDS5251.1, CCDS5251.2, CCDS55072.1	6q25.3	2014-09-17			ENSG00000049618	ENSG00000049618	57492		"""-"""	18040	protein-coding gene	gene with protein product		614556					Standard	NM_020732	NM_017519		Approved	KIAA1235, ELD/OSA1, p250R, BAF250b, DAN15, 6A3-5	uc003qqo.3	Q8NFD5	OTTHUMG00000015890	ENST00000346085.5:c.942C>A	chr6.hg19:g.157100005C>A			Q5JRD1|Q5VYC4|Q8IZY8|Q8TEV0|Q8TF02|Q99491|Q9ULI5	True	hg19	CCDS55072.1																																																																																			ARID1B-001	KNOWN	basic|appris_candidate|CCDS	protein_coding		protein_coding	OTTHUMT00000042827.3		42.0		+	ENST00000346085.5
ARID1B	57492	__UNKNOWN__	__UNKNOWN__	6	157100463	157100463	__UNKNOWN__	Frame_Shift_Del	DEL	A	A	-			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr6:157100463delA	ENST00000346085.5	+	1	1401	c.1400delA	c.(1399-1401)cagfs	p.Q468fs	ARID1B_ENST00000367148.1_Frame_Shift_Del_p.Q468fs|ARID1B_ENST00000275248.4_Frame_Shift_Del_p.Q410fs|ARID1B_ENST00000350026.5_Frame_Shift_Del_p.Q468fs	NM_020732.3	NP_065783.3	Q8NFD5	ARI1B_HUMAN	AT rich interactive domain 1B (SWI1-like)	468	Ala-rich.				chromatin-mediated maintenance of transcription (GO:0048096)|nervous system development (GO:0007399)|transcription, DNA-templated (GO:0006351)	cytoplasm (GO:0005737)|nucleus (GO:0005634)|SWI/SNF complex (GO:0016514)	DNA binding (GO:0003677)|transcription coactivator activity (GO:0003713)			NS(2)|breast(5)|central_nervous_system(4)|endometrium(12)|kidney(4)|large_intestine(11)|lung(30)|ovary(3)|pancreas(1)|prostate(4)|skin(2)|urinary_tract(3)	81		Breast(66;0.000162)|Ovarian(120;0.0265)		OV - Ovarian serous cystadenocarcinoma(65;3.19e-17)|BRCA - Breast invasive adenocarcinoma(81;1.01e-05)		gcggGCGGCCAGCAGGCGGCC	0.806																																																0													1.0	1.0	1.0					6																	157100463		534	1563	2097	SO:0001589	frameshift_variant			AF521671	CCDS5251.1, CCDS5251.2, CCDS55072.1	6q25.3	2014-09-17			ENSG00000049618	ENSG00000049618	57492		"""-"""	18040	protein-coding gene	gene with protein product		614556					Standard	NM_020732	NM_017519		Approved	KIAA1235, ELD/OSA1, p250R, BAF250b, DAN15, 6A3-5	uc003qqo.3	Q8NFD5	OTTHUMG00000015890	ENST00000346085.5:c.1400delA	chr6.hg19:g.157100463delA	ENSP00000344546:p.Gln468fs		Q5JRD1|Q5VYC4|Q8IZY8|Q8TEV0|Q8TF02|Q99491|Q9ULI5	True	hg19	CCDS55072.1																																																																																			ARID1B-001	KNOWN	basic|appris_candidate|CCDS	protein_coding		protein_coding	OTTHUMT00000042827.3		20.0		+	ENST00000346085.5
ARID1B	57492	__UNKNOWN__	__UNKNOWN__	6	157100466	157100466	__UNKNOWN__	Missense_Mutation	SNP	A	A	C			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr6:157100466A>C	ENST00000346085.5	+	1	1404	c.1403A>C	c.(1402-1404)cAg>cCg	p.Q468P	ARID1B_ENST00000367148.1_Missense_Mutation_p.Q468P|ARID1B_ENST00000275248.4_Missense_Mutation_p.Q410P|ARID1B_ENST00000350026.5_Missense_Mutation_p.Q468P	NM_020732.3	NP_065783.3	Q8NFD5	ARI1B_HUMAN	AT rich interactive domain 1B (SWI1-like)	468	Ala-rich.				chromatin-mediated maintenance of transcription (GO:0048096)|nervous system development (GO:0007399)|transcription, DNA-templated (GO:0006351)	cytoplasm (GO:0005737)|nucleus (GO:0005634)|SWI/SNF complex (GO:0016514)	DNA binding (GO:0003677)|transcription coactivator activity (GO:0003713)			NS(2)|breast(5)|central_nervous_system(4)|endometrium(12)|kidney(4)|large_intestine(11)|lung(30)|ovary(3)|pancreas(1)|prostate(4)|skin(2)|urinary_tract(3)	81		Breast(66;0.000162)|Ovarian(120;0.0265)		OV - Ovarian serous cystadenocarcinoma(65;3.19e-17)|BRCA - Breast invasive adenocarcinoma(81;1.01e-05)		gGCGGCCAGCAGGCGGCCGCG	0.796																																																0													1.0	1.0	1.0					6																	157100466		622	1797	2419	SO:0001583	missense			AF521671	CCDS5251.1, CCDS5251.2, CCDS55072.1	6q25.3	2014-09-17			ENSG00000049618	ENSG00000049618	57492		"""-"""	18040	protein-coding gene	gene with protein product		614556					Standard	NM_020732	NM_017519		Approved	KIAA1235, ELD/OSA1, p250R, BAF250b, DAN15, 6A3-5	uc003qqo.3	Q8NFD5	OTTHUMG00000015890	ENST00000346085.5:c.1403A>C	chr6.hg19:g.157100466A>C	ENSP00000344546:p.Gln468Pro		Q5JRD1|Q5VYC4|Q8IZY8|Q8TEV0|Q8TF02|Q99491|Q9ULI5	True	hg19	CCDS55072.1	.	.	.	.	.	.	.	.	.	.	a	2.769	-0.256192	0.05829	.	.	ENSG00000049618	ENST00000346085;ENST00000350026;ENST00000367148;ENST00000275248	T;T;T;T	0.01767	4.65;4.7;4.7;4.7	2.47	2.47	0.30058	.	.	.	.	.	T	0.00580	0.0019	L	0.39898	1.24	0.22435	N	0.999109	B;P;P	0.36144	0.404;0.539;0.539	B;B;B	0.26310	0.031;0.068;0.068	T	0.48833	-0.9000	9	0.31617	T	0.26	.	8.5158	0.33246	1.0:0.0:0.0:0.0	.	468;468;410	Q8NFD5;Q8NFD5-2;G3XAA0	ARI1B_HUMAN;.;.	P	468;468;468;410	ENSP00000344546:Q468P;ENSP00000055163:Q468P;ENSP00000356116:Q468P;ENSP00000275248:Q410P	ENSP00000275248:Q410P	Q	+	2	0	ARID1B	157142158	1.000000	0.71417	0.838000	0.33150	0.774000	0.43823	3.906000	0.56340	0.919000	0.36945	0.063000	0.15292	CAG	ARID1B-001	KNOWN	basic|appris_candidate|CCDS	protein_coding		protein_coding	OTTHUMT00000042827.3		20.0		+	ENST00000346085.5
ARID1B	57492	__UNKNOWN__	__UNKNOWN__	6	157100469	157100470	__UNKNOWN__	Frame_Shift_Ins	INS	-	-	T			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr6:157100469_157100470insT	ENST00000346085.5	+	1	1407_1408	c.1406_1407insT	c.(1405-1410)gcggccfs	p.A470fs	ARID1B_ENST00000367148.1_Frame_Shift_Ins_p.A470fs|ARID1B_ENST00000275248.4_Frame_Shift_Ins_p.A412fs|ARID1B_ENST00000350026.5_Frame_Shift_Ins_p.A470fs	NM_020732.3	NP_065783.3	Q8NFD5	ARI1B_HUMAN	AT rich interactive domain 1B (SWI1-like)	470	Ala-rich.				chromatin-mediated maintenance of transcription (GO:0048096)|nervous system development (GO:0007399)|transcription, DNA-templated (GO:0006351)	cytoplasm (GO:0005737)|nucleus (GO:0005634)|SWI/SNF complex (GO:0016514)	DNA binding (GO:0003677)|transcription coactivator activity (GO:0003713)			NS(2)|breast(5)|central_nervous_system(4)|endometrium(12)|kidney(4)|large_intestine(11)|lung(30)|ovary(3)|pancreas(1)|prostate(4)|skin(2)|urinary_tract(3)	81		Breast(66;0.000162)|Ovarian(120;0.0265)		OV - Ovarian serous cystadenocarcinoma(65;3.19e-17)|BRCA - Breast invasive adenocarcinoma(81;1.01e-05)		GGCCAGCAGGCGGCCGCGGGCA	0.792																																																0																																										SO:0001589	frameshift_variant			AF521671	CCDS5251.1, CCDS5251.2, CCDS55072.1	6q25.3	2014-09-17			ENSG00000049618	ENSG00000049618	57492		"""-"""	18040	protein-coding gene	gene with protein product		614556					Standard	NM_020732	NM_017519		Approved	KIAA1235, ELD/OSA1, p250R, BAF250b, DAN15, 6A3-5	uc003qqo.3	Q8NFD5	OTTHUMG00000015890	ENST00000346085.5:c.1406_1407insT	chr6.hg19:g.157100469_157100470insT	ENSP00000344546:p.Ala470fs		Q5JRD1|Q5VYC4|Q8IZY8|Q8TEV0|Q8TF02|Q99491|Q9ULI5	True	hg19	CCDS55072.1																																																																																			ARID1B-001	KNOWN	basic|appris_candidate|CCDS	protein_coding		protein_coding	OTTHUMT00000042827.3		29.0		+	ENST00000346085.5
BRAF	673	__UNKNOWN__	__UNKNOWN__	7	140488451	140488451	__UNKNOWN__	Intron	SNP	T	T	C			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr7:140488451T>C	ENST00000288602.6	-	9	1201					NM_004333.4	NP_004324.2	P15056	BRAF_HUMAN	B-Raf proto-oncogene, serine/threonine kinase						activation of MAPKK activity (GO:0000186)|CD4-positive, alpha-beta T cell differentiation (GO:0043367)|cellular response to calcium ion (GO:0071277)|cellular response to drug (GO:0035690)|fibroblast growth factor receptor signaling pathway (GO:0008543)|long-term synaptic potentiation (GO:0060291)|myeloid progenitor cell differentiation (GO:0002318)|negative regulation of apoptotic process (GO:0043066)|negative regulation of endothelial cell apoptotic process (GO:2000352)|negative regulation of fibroblast migration (GO:0010764)|negative regulation of neuron apoptotic process (GO:0043524)|negative regulation of synaptic vesicle exocytosis (GO:2000301)|neurotrophin TRK receptor signaling pathway (GO:0048011)|organ morphogenesis (GO:0009887)|positive regulation of ERK1 and ERK2 cascade (GO:0070374)|positive regulation of gene expression (GO:0010628)|positive regulation of peptidyl-serine phosphorylation (GO:0033138)|positive regulation of stress fiber assembly (GO:0051496)|positive regulation of substrate adhesion-dependent cell spreading (GO:1900026)|positive T cell selection (GO:0043368)|protein heterooligomerization (GO:0051291)|protein phosphorylation (GO:0006468)|regulation of cell proliferation (GO:0042127)|response to cAMP (GO:0051591)|response to epidermal growth factor (GO:0070849)|response to peptide hormone (GO:0043434)|small GTPase mediated signal transduction (GO:0007264)|somatic stem cell maintenance (GO:0035019)|synaptic transmission (GO:0007268)|visual learning (GO:0008542)	cell body (GO:0044297)|cytosol (GO:0005829)|mitochondrion (GO:0005739)|neuron projection (GO:0043005)|nucleus (GO:0005634)|plasma membrane (GO:0005886)	ATP binding (GO:0005524)|calcium ion binding (GO:0005509)|identical protein binding (GO:0042802)|MAP kinase kinase kinase activity (GO:0004709)|protein kinase activity (GO:0004672)|protein serine/threonine kinase activity (GO:0004674)		SLC45A3/BRAF(2)|AGTRAP/BRAF(2)|FAM131B_ENST00000443739/BRAF(7)|AKAP9_ENST00000356239/BRAF(10)|KIAA1549/BRAF(703)|FCHSD1/BRAF(2)	NS(588)|adrenal_gland(3)|autonomic_ganglia(3)|biliary_tract(29)|bone(7)|breast(21)|central_nervous_system(99)|cervix(6)|endometrium(33)|eye(72)|gastrointestinal_tract_(site_indeterminate)(2)|genital_tract(4)|haematopoietic_and_lymphoid_tissue(436)|kidney(3)|large_intestine(6953)|liver(17)|lung(192)|oesophagus(4)|ovary(275)|pancreas(15)|pituitary(1)|prostate(25)|salivary_gland(1)|skin(6285)|small_intestine(12)|soft_tissue(40)|stomach(11)|testis(7)|thyroid(12220)|upper_aerodigestive_tract(13)|urinary_tract(3)	27380	Melanoma(164;0.00956)				Dabrafenib(DB08912)|Regorafenib(DB08896)|Sorafenib(DB00398)|Vemurafenib(DB08881)	tgcagtggcgtgatcttggct	0.493		61	"""Mis, T, O"""	"""AKAP9, KIAA1549"""	"""melanoma, colorectal, papillary thyroid, borderline ov, Non small-cell lung cancer (NSCLC), cholangiocarcinoma, pilocytic astrocytoma"""		Cardio-facio-cutaneous syndrome		Cardiofaciocutaneous syndrome																												Colon(40;35 892 2973 5743 27438)		Dom	yes		7	7q34	673	v-raf murine sarcoma viral oncogene homolog B1	yes	E	0																																										SO:0001627	intron_variant	Familial Cancer Database	CFC, CFCS	M95712	CCDS5863.1	7q34	2014-09-17	2014-06-26		ENSG00000157764	ENSG00000157764	673			1097	protein-coding gene	gene with protein product		164757	"""v-raf murine sarcoma viral oncogene homolog B"""			2284096, 1565476	Standard	NM_004333	NM_004333		Approved	BRAF1	uc003vwc.4	P15056	OTTHUMG00000157457	ENST00000288602.6:c.1141-1067A>G	chr7.hg19:g.140488451T>C			A4D1T4|B6HY61|B6HY62|B6HY63|B6HY64|B6HY65|B6HY66|Q13878|Q3MIN6|Q9UDP8|Q9Y6T3	True	hg19	CCDS5863.1																																																																																			BRAF-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000348886.1		25.0		-	ENST00000288602.6
BRAF	673	__UNKNOWN__	__UNKNOWN__	7	140488462	140488462	__UNKNOWN__	Intron	SNP	T	T	C			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr7:140488462T>C	ENST00000288602.6	-	9	1201					NM_004333.4	NP_004324.2	P15056	BRAF_HUMAN	B-Raf proto-oncogene, serine/threonine kinase						activation of MAPKK activity (GO:0000186)|CD4-positive, alpha-beta T cell differentiation (GO:0043367)|cellular response to calcium ion (GO:0071277)|cellular response to drug (GO:0035690)|fibroblast growth factor receptor signaling pathway (GO:0008543)|long-term synaptic potentiation (GO:0060291)|myeloid progenitor cell differentiation (GO:0002318)|negative regulation of apoptotic process (GO:0043066)|negative regulation of endothelial cell apoptotic process (GO:2000352)|negative regulation of fibroblast migration (GO:0010764)|negative regulation of neuron apoptotic process (GO:0043524)|negative regulation of synaptic vesicle exocytosis (GO:2000301)|neurotrophin TRK receptor signaling pathway (GO:0048011)|organ morphogenesis (GO:0009887)|positive regulation of ERK1 and ERK2 cascade (GO:0070374)|positive regulation of gene expression (GO:0010628)|positive regulation of peptidyl-serine phosphorylation (GO:0033138)|positive regulation of stress fiber assembly (GO:0051496)|positive regulation of substrate adhesion-dependent cell spreading (GO:1900026)|positive T cell selection (GO:0043368)|protein heterooligomerization (GO:0051291)|protein phosphorylation (GO:0006468)|regulation of cell proliferation (GO:0042127)|response to cAMP (GO:0051591)|response to epidermal growth factor (GO:0070849)|response to peptide hormone (GO:0043434)|small GTPase mediated signal transduction (GO:0007264)|somatic stem cell maintenance (GO:0035019)|synaptic transmission (GO:0007268)|visual learning (GO:0008542)	cell body (GO:0044297)|cytosol (GO:0005829)|mitochondrion (GO:0005739)|neuron projection (GO:0043005)|nucleus (GO:0005634)|plasma membrane (GO:0005886)	ATP binding (GO:0005524)|calcium ion binding (GO:0005509)|identical protein binding (GO:0042802)|MAP kinase kinase kinase activity (GO:0004709)|protein kinase activity (GO:0004672)|protein serine/threonine kinase activity (GO:0004674)		SLC45A3/BRAF(2)|AGTRAP/BRAF(2)|FAM131B_ENST00000443739/BRAF(7)|AKAP9_ENST00000356239/BRAF(10)|KIAA1549/BRAF(703)|FCHSD1/BRAF(2)	NS(588)|adrenal_gland(3)|autonomic_ganglia(3)|biliary_tract(29)|bone(7)|breast(21)|central_nervous_system(99)|cervix(6)|endometrium(33)|eye(72)|gastrointestinal_tract_(site_indeterminate)(2)|genital_tract(4)|haematopoietic_and_lymphoid_tissue(436)|kidney(3)|large_intestine(6953)|liver(17)|lung(192)|oesophagus(4)|ovary(275)|pancreas(15)|pituitary(1)|prostate(25)|salivary_gland(1)|skin(6285)|small_intestine(12)|soft_tissue(40)|stomach(11)|testis(7)|thyroid(12220)|upper_aerodigestive_tract(13)|urinary_tract(3)	27380	Melanoma(164;0.00956)				Dabrafenib(DB08912)|Regorafenib(DB08896)|Sorafenib(DB00398)|Vemurafenib(DB08881)	gatcttggcttattgcaacct	0.483		61	"""Mis, T, O"""	"""AKAP9, KIAA1549"""	"""melanoma, colorectal, papillary thyroid, borderline ov, Non small-cell lung cancer (NSCLC), cholangiocarcinoma, pilocytic astrocytoma"""		Cardio-facio-cutaneous syndrome		Cardiofaciocutaneous syndrome																												Colon(40;35 892 2973 5743 27438)		Dom	yes		7	7q34	673	v-raf murine sarcoma viral oncogene homolog B1	yes	E	0																																										SO:0001627	intron_variant	Familial Cancer Database	CFC, CFCS	M95712	CCDS5863.1	7q34	2014-09-17	2014-06-26		ENSG00000157764	ENSG00000157764	673			1097	protein-coding gene	gene with protein product		164757	"""v-raf murine sarcoma viral oncogene homolog B"""			2284096, 1565476	Standard	NM_004333	NM_004333		Approved	BRAF1	uc003vwc.4	P15056	OTTHUMG00000157457	ENST00000288602.6:c.1141-1078A>G	chr7.hg19:g.140488462T>C			A4D1T4|B6HY61|B6HY62|B6HY63|B6HY64|B6HY65|B6HY66|Q13878|Q3MIN6|Q9UDP8|Q9Y6T3	True	hg19	CCDS5863.1																																																																																			BRAF-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000348886.1		44.0		-	ENST00000288602.6
BRAF	673	__UNKNOWN__	__UNKNOWN__	7	140488464	140488464	__UNKNOWN__	Intron	SNP	T	T	C	rs187534485		__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr7:140488464T>C	ENST00000288602.6	-	9	1201					NM_004333.4	NP_004324.2	P15056	BRAF_HUMAN	B-Raf proto-oncogene, serine/threonine kinase						activation of MAPKK activity (GO:0000186)|CD4-positive, alpha-beta T cell differentiation (GO:0043367)|cellular response to calcium ion (GO:0071277)|cellular response to drug (GO:0035690)|fibroblast growth factor receptor signaling pathway (GO:0008543)|long-term synaptic potentiation (GO:0060291)|myeloid progenitor cell differentiation (GO:0002318)|negative regulation of apoptotic process (GO:0043066)|negative regulation of endothelial cell apoptotic process (GO:2000352)|negative regulation of fibroblast migration (GO:0010764)|negative regulation of neuron apoptotic process (GO:0043524)|negative regulation of synaptic vesicle exocytosis (GO:2000301)|neurotrophin TRK receptor signaling pathway (GO:0048011)|organ morphogenesis (GO:0009887)|positive regulation of ERK1 and ERK2 cascade (GO:0070374)|positive regulation of gene expression (GO:0010628)|positive regulation of peptidyl-serine phosphorylation (GO:0033138)|positive regulation of stress fiber assembly (GO:0051496)|positive regulation of substrate adhesion-dependent cell spreading (GO:1900026)|positive T cell selection (GO:0043368)|protein heterooligomerization (GO:0051291)|protein phosphorylation (GO:0006468)|regulation of cell proliferation (GO:0042127)|response to cAMP (GO:0051591)|response to epidermal growth factor (GO:0070849)|response to peptide hormone (GO:0043434)|small GTPase mediated signal transduction (GO:0007264)|somatic stem cell maintenance (GO:0035019)|synaptic transmission (GO:0007268)|visual learning (GO:0008542)	cell body (GO:0044297)|cytosol (GO:0005829)|mitochondrion (GO:0005739)|neuron projection (GO:0043005)|nucleus (GO:0005634)|plasma membrane (GO:0005886)	ATP binding (GO:0005524)|calcium ion binding (GO:0005509)|identical protein binding (GO:0042802)|MAP kinase kinase kinase activity (GO:0004709)|protein kinase activity (GO:0004672)|protein serine/threonine kinase activity (GO:0004674)		SLC45A3/BRAF(2)|AGTRAP/BRAF(2)|FAM131B_ENST00000443739/BRAF(7)|AKAP9_ENST00000356239/BRAF(10)|KIAA1549/BRAF(703)|FCHSD1/BRAF(2)	NS(588)|adrenal_gland(3)|autonomic_ganglia(3)|biliary_tract(29)|bone(7)|breast(21)|central_nervous_system(99)|cervix(6)|endometrium(33)|eye(72)|gastrointestinal_tract_(site_indeterminate)(2)|genital_tract(4)|haematopoietic_and_lymphoid_tissue(436)|kidney(3)|large_intestine(6953)|liver(17)|lung(192)|oesophagus(4)|ovary(275)|pancreas(15)|pituitary(1)|prostate(25)|salivary_gland(1)|skin(6285)|small_intestine(12)|soft_tissue(40)|stomach(11)|testis(7)|thyroid(12220)|upper_aerodigestive_tract(13)|urinary_tract(3)	27380	Melanoma(164;0.00956)				Dabrafenib(DB08912)|Regorafenib(DB08896)|Sorafenib(DB00398)|Vemurafenib(DB08881)	tcttggcttattgcaacctct	0.478		61	"""Mis, T, O"""	"""AKAP9, KIAA1549"""	"""melanoma, colorectal, papillary thyroid, borderline ov, Non small-cell lung cancer (NSCLC), cholangiocarcinoma, pilocytic astrocytoma"""		Cardio-facio-cutaneous syndrome		Cardiofaciocutaneous syndrome																												Colon(40;35 892 2973 5743 27438)		Dom	yes		7	7q34	673	v-raf murine sarcoma viral oncogene homolog B1	yes	E	0																																										SO:0001627	intron_variant	Familial Cancer Database	CFC, CFCS	M95712	CCDS5863.1	7q34	2014-09-17	2014-06-26		ENSG00000157764	ENSG00000157764	673			1097	protein-coding gene	gene with protein product		164757	"""v-raf murine sarcoma viral oncogene homolog B"""			2284096, 1565476	Standard	NM_004333	NM_004333		Approved	BRAF1	uc003vwc.4	P15056	OTTHUMG00000157457	ENST00000288602.6:c.1141-1080A>G	chr7.hg19:g.140488464T>C			A4D1T4|B6HY61|B6HY62|B6HY63|B6HY64|B6HY65|B6HY66|Q13878|Q3MIN6|Q9UDP8|Q9Y6T3	True	hg19	CCDS5863.1																																																																																			BRAF-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000348886.1		44.0		-	ENST00000288602.6
BRAF	673	__UNKNOWN__	__UNKNOWN__	7	140488480	140488480	__UNKNOWN__	Intron	SNP	T	T	C			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr7:140488480T>C	ENST00000288602.6	-	9	1201					NM_004333.4	NP_004324.2	P15056	BRAF_HUMAN	B-Raf proto-oncogene, serine/threonine kinase						activation of MAPKK activity (GO:0000186)|CD4-positive, alpha-beta T cell differentiation (GO:0043367)|cellular response to calcium ion (GO:0071277)|cellular response to drug (GO:0035690)|fibroblast growth factor receptor signaling pathway (GO:0008543)|long-term synaptic potentiation (GO:0060291)|myeloid progenitor cell differentiation (GO:0002318)|negative regulation of apoptotic process (GO:0043066)|negative regulation of endothelial cell apoptotic process (GO:2000352)|negative regulation of fibroblast migration (GO:0010764)|negative regulation of neuron apoptotic process (GO:0043524)|negative regulation of synaptic vesicle exocytosis (GO:2000301)|neurotrophin TRK receptor signaling pathway (GO:0048011)|organ morphogenesis (GO:0009887)|positive regulation of ERK1 and ERK2 cascade (GO:0070374)|positive regulation of gene expression (GO:0010628)|positive regulation of peptidyl-serine phosphorylation (GO:0033138)|positive regulation of stress fiber assembly (GO:0051496)|positive regulation of substrate adhesion-dependent cell spreading (GO:1900026)|positive T cell selection (GO:0043368)|protein heterooligomerization (GO:0051291)|protein phosphorylation (GO:0006468)|regulation of cell proliferation (GO:0042127)|response to cAMP (GO:0051591)|response to epidermal growth factor (GO:0070849)|response to peptide hormone (GO:0043434)|small GTPase mediated signal transduction (GO:0007264)|somatic stem cell maintenance (GO:0035019)|synaptic transmission (GO:0007268)|visual learning (GO:0008542)	cell body (GO:0044297)|cytosol (GO:0005829)|mitochondrion (GO:0005739)|neuron projection (GO:0043005)|nucleus (GO:0005634)|plasma membrane (GO:0005886)	ATP binding (GO:0005524)|calcium ion binding (GO:0005509)|identical protein binding (GO:0042802)|MAP kinase kinase kinase activity (GO:0004709)|protein kinase activity (GO:0004672)|protein serine/threonine kinase activity (GO:0004674)		SLC45A3/BRAF(2)|AGTRAP/BRAF(2)|FAM131B_ENST00000443739/BRAF(7)|AKAP9_ENST00000356239/BRAF(10)|KIAA1549/BRAF(703)|FCHSD1/BRAF(2)	NS(588)|adrenal_gland(3)|autonomic_ganglia(3)|biliary_tract(29)|bone(7)|breast(21)|central_nervous_system(99)|cervix(6)|endometrium(33)|eye(72)|gastrointestinal_tract_(site_indeterminate)(2)|genital_tract(4)|haematopoietic_and_lymphoid_tissue(436)|kidney(3)|large_intestine(6953)|liver(17)|lung(192)|oesophagus(4)|ovary(275)|pancreas(15)|pituitary(1)|prostate(25)|salivary_gland(1)|skin(6285)|small_intestine(12)|soft_tissue(40)|stomach(11)|testis(7)|thyroid(12220)|upper_aerodigestive_tract(13)|urinary_tract(3)	27380	Melanoma(164;0.00956)				Dabrafenib(DB08912)|Regorafenib(DB08896)|Sorafenib(DB00398)|Vemurafenib(DB08881)	cctctgcctcttgggttcaag	0.483		61	"""Mis, T, O"""	"""AKAP9, KIAA1549"""	"""melanoma, colorectal, papillary thyroid, borderline ov, Non small-cell lung cancer (NSCLC), cholangiocarcinoma, pilocytic astrocytoma"""		Cardio-facio-cutaneous syndrome		Cardiofaciocutaneous syndrome																												Colon(40;35 892 2973 5743 27438)		Dom	yes		7	7q34	673	v-raf murine sarcoma viral oncogene homolog B1	yes	E	0																																										SO:0001627	intron_variant	Familial Cancer Database	CFC, CFCS	M95712	CCDS5863.1	7q34	2014-09-17	2014-06-26		ENSG00000157764	ENSG00000157764	673			1097	protein-coding gene	gene with protein product		164757	"""v-raf murine sarcoma viral oncogene homolog B"""			2284096, 1565476	Standard	NM_004333	NM_004333		Approved	BRAF1	uc003vwc.4	P15056	OTTHUMG00000157457	ENST00000288602.6:c.1141-1096A>G	chr7.hg19:g.140488480T>C			A4D1T4|B6HY61|B6HY62|B6HY63|B6HY64|B6HY65|B6HY66|Q13878|Q3MIN6|Q9UDP8|Q9Y6T3	True	hg19	CCDS5863.1																																																																																			BRAF-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000348886.1		29.0		-	ENST00000288602.6
BRAF	673	__UNKNOWN__	__UNKNOWN__	7	140488495	140488495	__UNKNOWN__	Intron	SNP	C	C	T			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr7:140488495C>T	ENST00000288602.6	-	9	1201					NM_004333.4	NP_004324.2	P15056	BRAF_HUMAN	B-Raf proto-oncogene, serine/threonine kinase						activation of MAPKK activity (GO:0000186)|CD4-positive, alpha-beta T cell differentiation (GO:0043367)|cellular response to calcium ion (GO:0071277)|cellular response to drug (GO:0035690)|fibroblast growth factor receptor signaling pathway (GO:0008543)|long-term synaptic potentiation (GO:0060291)|myeloid progenitor cell differentiation (GO:0002318)|negative regulation of apoptotic process (GO:0043066)|negative regulation of endothelial cell apoptotic process (GO:2000352)|negative regulation of fibroblast migration (GO:0010764)|negative regulation of neuron apoptotic process (GO:0043524)|negative regulation of synaptic vesicle exocytosis (GO:2000301)|neurotrophin TRK receptor signaling pathway (GO:0048011)|organ morphogenesis (GO:0009887)|positive regulation of ERK1 and ERK2 cascade (GO:0070374)|positive regulation of gene expression (GO:0010628)|positive regulation of peptidyl-serine phosphorylation (GO:0033138)|positive regulation of stress fiber assembly (GO:0051496)|positive regulation of substrate adhesion-dependent cell spreading (GO:1900026)|positive T cell selection (GO:0043368)|protein heterooligomerization (GO:0051291)|protein phosphorylation (GO:0006468)|regulation of cell proliferation (GO:0042127)|response to cAMP (GO:0051591)|response to epidermal growth factor (GO:0070849)|response to peptide hormone (GO:0043434)|small GTPase mediated signal transduction (GO:0007264)|somatic stem cell maintenance (GO:0035019)|synaptic transmission (GO:0007268)|visual learning (GO:0008542)	cell body (GO:0044297)|cytosol (GO:0005829)|mitochondrion (GO:0005739)|neuron projection (GO:0043005)|nucleus (GO:0005634)|plasma membrane (GO:0005886)	ATP binding (GO:0005524)|calcium ion binding (GO:0005509)|identical protein binding (GO:0042802)|MAP kinase kinase kinase activity (GO:0004709)|protein kinase activity (GO:0004672)|protein serine/threonine kinase activity (GO:0004674)		SLC45A3/BRAF(2)|AGTRAP/BRAF(2)|FAM131B_ENST00000443739/BRAF(7)|AKAP9_ENST00000356239/BRAF(10)|KIAA1549/BRAF(703)|FCHSD1/BRAF(2)	NS(588)|adrenal_gland(3)|autonomic_ganglia(3)|biliary_tract(29)|bone(7)|breast(21)|central_nervous_system(99)|cervix(6)|endometrium(33)|eye(72)|gastrointestinal_tract_(site_indeterminate)(2)|genital_tract(4)|haematopoietic_and_lymphoid_tissue(436)|kidney(3)|large_intestine(6953)|liver(17)|lung(192)|oesophagus(4)|ovary(275)|pancreas(15)|pituitary(1)|prostate(25)|salivary_gland(1)|skin(6285)|small_intestine(12)|soft_tissue(40)|stomach(11)|testis(7)|thyroid(12220)|upper_aerodigestive_tract(13)|urinary_tract(3)	27380	Melanoma(164;0.00956)				Dabrafenib(DB08912)|Regorafenib(DB08896)|Sorafenib(DB00398)|Vemurafenib(DB08881)	ttcaagtgatcctcctgcctc	0.502		61	"""Mis, T, O"""	"""AKAP9, KIAA1549"""	"""melanoma, colorectal, papillary thyroid, borderline ov, Non small-cell lung cancer (NSCLC), cholangiocarcinoma, pilocytic astrocytoma"""		Cardio-facio-cutaneous syndrome		Cardiofaciocutaneous syndrome																												Colon(40;35 892 2973 5743 27438)		Dom	yes		7	7q34	673	v-raf murine sarcoma viral oncogene homolog B1	yes	E	0																																										SO:0001627	intron_variant	Familial Cancer Database	CFC, CFCS	M95712	CCDS5863.1	7q34	2014-09-17	2014-06-26		ENSG00000157764	ENSG00000157764	673			1097	protein-coding gene	gene with protein product		164757	"""v-raf murine sarcoma viral oncogene homolog B"""			2284096, 1565476	Standard	NM_004333	NM_004333		Approved	BRAF1	uc003vwc.4	P15056	OTTHUMG00000157457	ENST00000288602.6:c.1141-1111G>A	chr7.hg19:g.140488495C>T			A4D1T4|B6HY61|B6HY62|B6HY63|B6HY64|B6HY65|B6HY66|Q13878|Q3MIN6|Q9UDP8|Q9Y6T3	True	hg19	CCDS5863.1																																																																																			BRAF-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000348886.1		23.0		-	ENST00000288602.6
BRAF	673	__UNKNOWN__	__UNKNOWN__	7	140488935	140488935	__UNKNOWN__	Intron	SNP	T	T	G	rs201619426		__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr7:140488935T>G	ENST00000288602.6	-	9	1201					NM_004333.4	NP_004324.2	P15056	BRAF_HUMAN	B-Raf proto-oncogene, serine/threonine kinase						activation of MAPKK activity (GO:0000186)|CD4-positive, alpha-beta T cell differentiation (GO:0043367)|cellular response to calcium ion (GO:0071277)|cellular response to drug (GO:0035690)|fibroblast growth factor receptor signaling pathway (GO:0008543)|long-term synaptic potentiation (GO:0060291)|myeloid progenitor cell differentiation (GO:0002318)|negative regulation of apoptotic process (GO:0043066)|negative regulation of endothelial cell apoptotic process (GO:2000352)|negative regulation of fibroblast migration (GO:0010764)|negative regulation of neuron apoptotic process (GO:0043524)|negative regulation of synaptic vesicle exocytosis (GO:2000301)|neurotrophin TRK receptor signaling pathway (GO:0048011)|organ morphogenesis (GO:0009887)|positive regulation of ERK1 and ERK2 cascade (GO:0070374)|positive regulation of gene expression (GO:0010628)|positive regulation of peptidyl-serine phosphorylation (GO:0033138)|positive regulation of stress fiber assembly (GO:0051496)|positive regulation of substrate adhesion-dependent cell spreading (GO:1900026)|positive T cell selection (GO:0043368)|protein heterooligomerization (GO:0051291)|protein phosphorylation (GO:0006468)|regulation of cell proliferation (GO:0042127)|response to cAMP (GO:0051591)|response to epidermal growth factor (GO:0070849)|response to peptide hormone (GO:0043434)|small GTPase mediated signal transduction (GO:0007264)|somatic stem cell maintenance (GO:0035019)|synaptic transmission (GO:0007268)|visual learning (GO:0008542)	cell body (GO:0044297)|cytosol (GO:0005829)|mitochondrion (GO:0005739)|neuron projection (GO:0043005)|nucleus (GO:0005634)|plasma membrane (GO:0005886)	ATP binding (GO:0005524)|calcium ion binding (GO:0005509)|identical protein binding (GO:0042802)|MAP kinase kinase kinase activity (GO:0004709)|protein kinase activity (GO:0004672)|protein serine/threonine kinase activity (GO:0004674)		SLC45A3/BRAF(2)|AGTRAP/BRAF(2)|FAM131B_ENST00000443739/BRAF(7)|AKAP9_ENST00000356239/BRAF(10)|KIAA1549/BRAF(703)|FCHSD1/BRAF(2)	NS(588)|adrenal_gland(3)|autonomic_ganglia(3)|biliary_tract(29)|bone(7)|breast(21)|central_nervous_system(99)|cervix(6)|endometrium(33)|eye(72)|gastrointestinal_tract_(site_indeterminate)(2)|genital_tract(4)|haematopoietic_and_lymphoid_tissue(436)|kidney(3)|large_intestine(6953)|liver(17)|lung(192)|oesophagus(4)|ovary(275)|pancreas(15)|pituitary(1)|prostate(25)|salivary_gland(1)|skin(6285)|small_intestine(12)|soft_tissue(40)|stomach(11)|testis(7)|thyroid(12220)|upper_aerodigestive_tract(13)|urinary_tract(3)	27380	Melanoma(164;0.00956)				Dabrafenib(DB08912)|Regorafenib(DB08896)|Sorafenib(DB00398)|Vemurafenib(DB08881)	cttgaacctgtgaggcggagg	0.453		61	"""Mis, T, O"""	"""AKAP9, KIAA1549"""	"""melanoma, colorectal, papillary thyroid, borderline ov, Non small-cell lung cancer (NSCLC), cholangiocarcinoma, pilocytic astrocytoma"""		Cardio-facio-cutaneous syndrome		Cardiofaciocutaneous syndrome																												Colon(40;35 892 2973 5743 27438)		Dom	yes		7	7q34	673	v-raf murine sarcoma viral oncogene homolog B1	yes	E	0																																										SO:0001627	intron_variant	Familial Cancer Database	CFC, CFCS	M95712	CCDS5863.1	7q34	2014-09-17	2014-06-26		ENSG00000157764	ENSG00000157764	673			1097	protein-coding gene	gene with protein product		164757	"""v-raf murine sarcoma viral oncogene homolog B"""			2284096, 1565476	Standard	NM_004333	NM_004333		Approved	BRAF1	uc003vwc.4	P15056	OTTHUMG00000157457	ENST00000288602.6:c.1141-1551A>C	chr7.hg19:g.140488935T>G			A4D1T4|B6HY61|B6HY62|B6HY63|B6HY64|B6HY65|B6HY66|Q13878|Q3MIN6|Q9UDP8|Q9Y6T3	True	hg19	CCDS5863.1																																																																																			BRAF-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000348886.1		24.0		-	ENST00000288602.6
BRAF	673	__UNKNOWN__	__UNKNOWN__	7	140490784	140490784	__UNKNOWN__	Intron	SNP	G	G	C			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr7:140490784G>C	ENST00000288602.6	-	8	1201					NM_004333.4	NP_004324.2	P15056	BRAF_HUMAN	B-Raf proto-oncogene, serine/threonine kinase						activation of MAPKK activity (GO:0000186)|CD4-positive, alpha-beta T cell differentiation (GO:0043367)|cellular response to calcium ion (GO:0071277)|cellular response to drug (GO:0035690)|fibroblast growth factor receptor signaling pathway (GO:0008543)|long-term synaptic potentiation (GO:0060291)|myeloid progenitor cell differentiation (GO:0002318)|negative regulation of apoptotic process (GO:0043066)|negative regulation of endothelial cell apoptotic process (GO:2000352)|negative regulation of fibroblast migration (GO:0010764)|negative regulation of neuron apoptotic process (GO:0043524)|negative regulation of synaptic vesicle exocytosis (GO:2000301)|neurotrophin TRK receptor signaling pathway (GO:0048011)|organ morphogenesis (GO:0009887)|positive regulation of ERK1 and ERK2 cascade (GO:0070374)|positive regulation of gene expression (GO:0010628)|positive regulation of peptidyl-serine phosphorylation (GO:0033138)|positive regulation of stress fiber assembly (GO:0051496)|positive regulation of substrate adhesion-dependent cell spreading (GO:1900026)|positive T cell selection (GO:0043368)|protein heterooligomerization (GO:0051291)|protein phosphorylation (GO:0006468)|regulation of cell proliferation (GO:0042127)|response to cAMP (GO:0051591)|response to epidermal growth factor (GO:0070849)|response to peptide hormone (GO:0043434)|small GTPase mediated signal transduction (GO:0007264)|somatic stem cell maintenance (GO:0035019)|synaptic transmission (GO:0007268)|visual learning (GO:0008542)	cell body (GO:0044297)|cytosol (GO:0005829)|mitochondrion (GO:0005739)|neuron projection (GO:0043005)|nucleus (GO:0005634)|plasma membrane (GO:0005886)	ATP binding (GO:0005524)|calcium ion binding (GO:0005509)|identical protein binding (GO:0042802)|MAP kinase kinase kinase activity (GO:0004709)|protein kinase activity (GO:0004672)|protein serine/threonine kinase activity (GO:0004674)		SLC45A3/BRAF(2)|AGTRAP/BRAF(2)|FAM131B_ENST00000443739/BRAF(7)|AKAP9_ENST00000356239/BRAF(10)|KIAA1549/BRAF(703)|FCHSD1/BRAF(2)	NS(588)|adrenal_gland(3)|autonomic_ganglia(3)|biliary_tract(29)|bone(7)|breast(21)|central_nervous_system(99)|cervix(6)|endometrium(33)|eye(72)|gastrointestinal_tract_(site_indeterminate)(2)|genital_tract(4)|haematopoietic_and_lymphoid_tissue(436)|kidney(3)|large_intestine(6953)|liver(17)|lung(192)|oesophagus(4)|ovary(275)|pancreas(15)|pituitary(1)|prostate(25)|salivary_gland(1)|skin(6285)|small_intestine(12)|soft_tissue(40)|stomach(11)|testis(7)|thyroid(12220)|upper_aerodigestive_tract(13)|urinary_tract(3)	27380	Melanoma(164;0.00956)				Dabrafenib(DB08912)|Regorafenib(DB08896)|Sorafenib(DB00398)|Vemurafenib(DB08881)	gcctgtaatcgcagctactcg	0.542		61	"""Mis, T, O"""	"""AKAP9, KIAA1549"""	"""melanoma, colorectal, papillary thyroid, borderline ov, Non small-cell lung cancer (NSCLC), cholangiocarcinoma, pilocytic astrocytoma"""		Cardio-facio-cutaneous syndrome		Cardiofaciocutaneous syndrome																												Colon(40;35 892 2973 5743 27438)		Dom	yes		7	7q34	673	v-raf murine sarcoma viral oncogene homolog B1	yes	E	0																																										SO:0001627	intron_variant	Familial Cancer Database	CFC, CFCS	M95712	CCDS5863.1	7q34	2014-09-17	2014-06-26		ENSG00000157764	ENSG00000157764	673			1097	protein-coding gene	gene with protein product		164757	"""v-raf murine sarcoma viral oncogene homolog B"""			2284096, 1565476	Standard	NM_004333	NM_004333		Approved	BRAF1	uc003vwc.4	P15056	OTTHUMG00000157457	ENST00000288602.6:c.1140+3323C>G	chr7.hg19:g.140490784G>C			A4D1T4|B6HY61|B6HY62|B6HY63|B6HY64|B6HY65|B6HY66|Q13878|Q3MIN6|Q9UDP8|Q9Y6T3	True	hg19	CCDS5863.1																																																																																			BRAF-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000348886.1		20.0		-	ENST00000288602.6
FGFR1	2260	__UNKNOWN__	__UNKNOWN__	8	38286727	38286727	__UNKNOWN__	Intron	SNP	C	C	A			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr8:38286727C>A	ENST00000397103.1	-	2	148				FGFR1_ENST00000356207.5_Intron|FGFR1_ENST00000341462.5_Intron|FGFR1_ENST00000447712.2_Intron|FGFR1_ENST00000397113.2_Intron|FGFR1_ENST00000532791.1_Intron|FGFR1_ENST00000397108.4_Intron|FGFR1_ENST00000425967.3_Intron|FGFR1_ENST00000326324.6_Intron|FGFR1_ENST00000397091.5_Intron|FGFR1_ENST00000335922.5_Intron			P11362	FGFR1_HUMAN	fibroblast growth factor receptor 1						angiogenesis (GO:0001525)|auditory receptor cell development (GO:0060117)|axon guidance (GO:0007411)|branching involved in salivary gland morphogenesis (GO:0060445)|cell maturation (GO:0048469)|cell migration (GO:0016477)|chondrocyte differentiation (GO:0002062)|chordate embryonic development (GO:0043009)|embryonic limb morphogenesis (GO:0030326)|epidermal growth factor receptor signaling pathway (GO:0007173)|Fc-epsilon receptor signaling pathway (GO:0038095)|fibroblast growth factor receptor signaling pathway (GO:0008543)|fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development (GO:0035607)|in utero embryonic development (GO:0001701)|innate immune response (GO:0045087)|inner ear morphogenesis (GO:0042472)|insulin receptor signaling pathway (GO:0008286)|lung-associated mesenchyme development (GO:0060484)|MAPK cascade (GO:0000165)|mesenchymal cell differentiation (GO:0048762)|midbrain development (GO:0030901)|middle ear morphogenesis (GO:0042474)|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|neuron migration (GO:0001764)|neurotrophin TRK receptor signaling pathway (GO:0048011)|organ induction (GO:0001759)|outer ear morphogenesis (GO:0042473)|paraxial mesoderm development (GO:0048339)|peptidyl-tyrosine phosphorylation (GO:0018108)|phosphatidylinositol-mediated signaling (GO:0048015)|positive regulation of cardiac muscle cell proliferation (GO:0060045)|positive regulation of cell cycle (GO:0045787)|positive regulation of cell proliferation (GO:0008284)|positive regulation of MAP kinase activity (GO:0043406)|positive regulation of MAPK cascade (GO:0043410)|positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway (GO:0090080)|positive regulation of mesenchymal cell proliferation (GO:0002053)|positive regulation of neuron differentiation (GO:0045666)|positive regulation of neuron projection development (GO:0010976)|positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068)|positive regulation of phospholipase activity (GO:0010518)|positive regulation of phospholipase C activity (GO:0010863)|protein autophosphorylation (GO:0046777)|protein phosphorylation (GO:0006468)|regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling (GO:0060665)|regulation of cell differentiation (GO:0045595)|regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239)|regulation of lateral mesodermal cell fate specification (GO:0048378)|sensory perception of sound (GO:0007605)|skeletal system development (GO:0001501)|skeletal system morphogenesis (GO:0048705)|transcription, DNA-templated (GO:0006351)|ureteric bud development (GO:0001657)|ventricular zone neuroblast division (GO:0021847)	cytoplasmic vesicle (GO:0031410)|extracellular region (GO:0005576)|integral component of membrane (GO:0016021)|integral component of plasma membrane (GO:0005887)|nucleus (GO:0005634)|plasma membrane (GO:0005886)|receptor complex (GO:0043235)	ATP binding (GO:0005524)|fibroblast growth factor binding (GO:0017134)|fibroblast growth factor-activated receptor activity (GO:0005007)|heparin binding (GO:0008201)|identical protein binding (GO:0042802)|protein homodimerization activity (GO:0042803)|protein tyrosine kinase activity (GO:0004713)		FGFR1/ZNF703(2)	breast(2)|central_nervous_system(7)|endometrium(4)|haematopoietic_and_lymphoid_tissue(1)|kidney(4)|large_intestine(8)|lung(18)|ovary(1)|prostate(1)|stomach(2)|urinary_tract(2)	50	all_cancers(2;9.05e-47)|all_epithelial(2;2.64e-50)|all_lung(3;1.71e-23)|Lung NSC(2;3.61e-23)|Colorectal(12;0.000442)	Breast(189;1.48e-05)|all_lung(54;0.00354)|Lung NSC(58;0.0138)|Hepatocellular(245;0.065)	Epithelial(3;3.96e-34)|all cancers(3;3.06e-30)|BRCA - Breast invasive adenocarcinoma(5;2.28e-21)|COAD - Colon adenocarcinoma(9;0.24)		Palifermin(DB00039)|Ponatinib(DB08901)|Regorafenib(DB08896)|Sorafenib(DB00398)	AGCTCCAGGGCTCCCTGGCTG	0.527		1	T	"""BCR, FOP, ZNF198, CEP1"""	"""MPD, NHL"""		"""Pfeiffer syndrome, Kallman syndrome"""																														Melanoma(146;1153 1840 21453 21841 43625)		Dom	yes		8	8p11.2-p11.1	2260	fibroblast growth factor receptor 1	yes	L	0																																										SO:0001627	intron_variant			M34185	CCDS6107.2, CCDS43730.1, CCDS43731.1, CCDS43732.1, CCDS55221.1, CCDS55222.1, CCDS55223.1	8p11.23-p11.22	2014-04-03	2008-08-01		ENSG00000077782	ENSG00000077782	2260	2.7.10.1	"""CD molecules"", ""Immunoglobulin superfamily / I-set domain containing"""	3688	protein-coding gene	gene with protein product	"""Pfeiffer syndrome"""	136350	"""fms-related tyrosine kinase 2"""	FLT2, KAL2		2162671	Standard		NM_015850		Approved	H2, H3, H4, H5, CEK, FLG, BFGFR, N-SAM, CD331	uc011lbu.2	P11362	OTTHUMG00000147366	ENST00000397103.1:c.92-774G>T	chr8.hg19:g.38286727C>A			A8K6T9|A8K8V5|C1KBH8|P17049|Q02063|Q02065|Q14306|Q14307|Q53H63|Q59H40|Q5BJG2|Q8N685|Q9UD50|Q9UDF0|Q9UDF1|Q9UDF2	True	hg19																																																																																				FGFR1-011	NOVEL	non_canonical_conserved|basic|exp_conf	protein_coding		protein_coding	OTTHUMT00000304020.1		35.0		-	ENST00000397103.1
FGFR1	2260	__UNKNOWN__	__UNKNOWN__	8	38286728	38286728	__UNKNOWN__	Intron	SNP	T	T	G			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr8:38286728T>G	ENST00000397103.1	-	2	148				FGFR1_ENST00000356207.5_Intron|FGFR1_ENST00000341462.5_Intron|FGFR1_ENST00000447712.2_Intron|FGFR1_ENST00000397113.2_Intron|FGFR1_ENST00000532791.1_Intron|FGFR1_ENST00000397108.4_Intron|FGFR1_ENST00000425967.3_Intron|FGFR1_ENST00000326324.6_Intron|FGFR1_ENST00000397091.5_Intron|FGFR1_ENST00000335922.5_Intron			P11362	FGFR1_HUMAN	fibroblast growth factor receptor 1						angiogenesis (GO:0001525)|auditory receptor cell development (GO:0060117)|axon guidance (GO:0007411)|branching involved in salivary gland morphogenesis (GO:0060445)|cell maturation (GO:0048469)|cell migration (GO:0016477)|chondrocyte differentiation (GO:0002062)|chordate embryonic development (GO:0043009)|embryonic limb morphogenesis (GO:0030326)|epidermal growth factor receptor signaling pathway (GO:0007173)|Fc-epsilon receptor signaling pathway (GO:0038095)|fibroblast growth factor receptor signaling pathway (GO:0008543)|fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development (GO:0035607)|in utero embryonic development (GO:0001701)|innate immune response (GO:0045087)|inner ear morphogenesis (GO:0042472)|insulin receptor signaling pathway (GO:0008286)|lung-associated mesenchyme development (GO:0060484)|MAPK cascade (GO:0000165)|mesenchymal cell differentiation (GO:0048762)|midbrain development (GO:0030901)|middle ear morphogenesis (GO:0042474)|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|neuron migration (GO:0001764)|neurotrophin TRK receptor signaling pathway (GO:0048011)|organ induction (GO:0001759)|outer ear morphogenesis (GO:0042473)|paraxial mesoderm development (GO:0048339)|peptidyl-tyrosine phosphorylation (GO:0018108)|phosphatidylinositol-mediated signaling (GO:0048015)|positive regulation of cardiac muscle cell proliferation (GO:0060045)|positive regulation of cell cycle (GO:0045787)|positive regulation of cell proliferation (GO:0008284)|positive regulation of MAP kinase activity (GO:0043406)|positive regulation of MAPK cascade (GO:0043410)|positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway (GO:0090080)|positive regulation of mesenchymal cell proliferation (GO:0002053)|positive regulation of neuron differentiation (GO:0045666)|positive regulation of neuron projection development (GO:0010976)|positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068)|positive regulation of phospholipase activity (GO:0010518)|positive regulation of phospholipase C activity (GO:0010863)|protein autophosphorylation (GO:0046777)|protein phosphorylation (GO:0006468)|regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling (GO:0060665)|regulation of cell differentiation (GO:0045595)|regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239)|regulation of lateral mesodermal cell fate specification (GO:0048378)|sensory perception of sound (GO:0007605)|skeletal system development (GO:0001501)|skeletal system morphogenesis (GO:0048705)|transcription, DNA-templated (GO:0006351)|ureteric bud development (GO:0001657)|ventricular zone neuroblast division (GO:0021847)	cytoplasmic vesicle (GO:0031410)|extracellular region (GO:0005576)|integral component of membrane (GO:0016021)|integral component of plasma membrane (GO:0005887)|nucleus (GO:0005634)|plasma membrane (GO:0005886)|receptor complex (GO:0043235)	ATP binding (GO:0005524)|fibroblast growth factor binding (GO:0017134)|fibroblast growth factor-activated receptor activity (GO:0005007)|heparin binding (GO:0008201)|identical protein binding (GO:0042802)|protein homodimerization activity (GO:0042803)|protein tyrosine kinase activity (GO:0004713)		FGFR1/ZNF703(2)	breast(2)|central_nervous_system(7)|endometrium(4)|haematopoietic_and_lymphoid_tissue(1)|kidney(4)|large_intestine(8)|lung(18)|ovary(1)|prostate(1)|stomach(2)|urinary_tract(2)	50	all_cancers(2;9.05e-47)|all_epithelial(2;2.64e-50)|all_lung(3;1.71e-23)|Lung NSC(2;3.61e-23)|Colorectal(12;0.000442)	Breast(189;1.48e-05)|all_lung(54;0.00354)|Lung NSC(58;0.0138)|Hepatocellular(245;0.065)	Epithelial(3;3.96e-34)|all cancers(3;3.06e-30)|BRCA - Breast invasive adenocarcinoma(5;2.28e-21)|COAD - Colon adenocarcinoma(9;0.24)		Palifermin(DB00039)|Ponatinib(DB08901)|Regorafenib(DB08896)|Sorafenib(DB00398)	GCTCCAGGGCTCCCTGGCTGC	0.532		1	T	"""BCR, FOP, ZNF198, CEP1"""	"""MPD, NHL"""		"""Pfeiffer syndrome, Kallman syndrome"""																														Melanoma(146;1153 1840 21453 21841 43625)		Dom	yes		8	8p11.2-p11.1	2260	fibroblast growth factor receptor 1	yes	L	0																																										SO:0001627	intron_variant			M34185	CCDS6107.2, CCDS43730.1, CCDS43731.1, CCDS43732.1, CCDS55221.1, CCDS55222.1, CCDS55223.1	8p11.23-p11.22	2014-04-03	2008-08-01		ENSG00000077782	ENSG00000077782	2260	2.7.10.1	"""CD molecules"", ""Immunoglobulin superfamily / I-set domain containing"""	3688	protein-coding gene	gene with protein product	"""Pfeiffer syndrome"""	136350	"""fms-related tyrosine kinase 2"""	FLT2, KAL2		2162671	Standard		NM_015850		Approved	H2, H3, H4, H5, CEK, FLG, BFGFR, N-SAM, CD331	uc011lbu.2	P11362	OTTHUMG00000147366	ENST00000397103.1:c.92-775A>C	chr8.hg19:g.38286728T>G			A8K6T9|A8K8V5|C1KBH8|P17049|Q02063|Q02065|Q14306|Q14307|Q53H63|Q59H40|Q5BJG2|Q8N685|Q9UD50|Q9UDF0|Q9UDF1|Q9UDF2	True	hg19																																																																																				FGFR1-011	NOVEL	non_canonical_conserved|basic|exp_conf	protein_coding		protein_coding	OTTHUMT00000304020.1		40.0		-	ENST00000397103.1
NCOA2	10499	__UNKNOWN__	__UNKNOWN__	8	71061728	71061728	__UNKNOWN__	Intron	SNP	A	A	G			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr8:71061728A>G	ENST00000452400.2	-	12	2576					NM_006540.2	NP_006531.1	Q15596	NCOA2_HUMAN	nuclear receptor coactivator 2						cellular lipid metabolic process (GO:0044255)|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|regulation of glucose metabolic process (GO:0010906)|regulation of transcription, DNA-templated (GO:0006355)|small molecule metabolic process (GO:0044281)|transcription, DNA-templated (GO:0006351)	cytoplasm (GO:0005737)|nucleoplasm (GO:0005654)	chromatin binding (GO:0003682)|histone acetyltransferase activity (GO:0004402)|ligand-dependent nuclear receptor binding (GO:0016922)|ligand-dependent nuclear receptor transcription coactivator activity (GO:0030374)|nuclear hormone receptor binding (GO:0035257)|signal transducer activity (GO:0004871)|thyroid hormone receptor coactivator activity (GO:0030375)|transcription coactivator activity (GO:0003713)		PAX3/NCOA2(4)|HEY1/NCOA2(10)	NS(1)|breast(4)|endometrium(7)|kidney(4)|large_intestine(10)|lung(25)|ovary(1)|pancreas(2)|prostate(2)|skin(4)	60	Breast(64;0.201)		Epithelial(68;0.0147)|OV - Ovarian serous cystadenocarcinoma(28;0.0455)|all cancers(69;0.0606)			ctcctgcctcagcttcccaaa	0.413			T	"""RUNXBP2, HEY1"""	"""AML, Chondrosarcoma"""																																		Dom	yes		8	8q13.1	10499	nuclear receptor coactivator 2 (TIF2)		L	0																																										SO:0001627	intron_variant			X97674	CCDS47872.1	8q13.3	2011-07-01			ENSG00000140396	ENSG00000140396	10499		"""Chromatin-modifying enzymes / K-acetyltransferases"", ""Basic helix-loop-helix proteins"""	7669	protein-coding gene	gene with protein product		601993				9111344, 8670870	Standard		XM_005251128		Approved	TIF2, GRIP1, NCoA-2, KAT13C, bHLHe75	uc003xyn.1	Q15596	OTTHUMG00000164671	ENST00000452400.2:c.2395-1010T>C	chr8.hg19:g.71061728A>G			Q14CD2	True	hg19	CCDS47872.1																																																																																			NCOA2-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000379696.1		21.0		-	ENST00000452400.2
NCOA2	10499	__UNKNOWN__	__UNKNOWN__	8	71061731	71061731	__UNKNOWN__	Intron	SNP	T	T	C			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr8:71061731T>C	ENST00000452400.2	-	12	2576					NM_006540.2	NP_006531.1	Q15596	NCOA2_HUMAN	nuclear receptor coactivator 2						cellular lipid metabolic process (GO:0044255)|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|regulation of glucose metabolic process (GO:0010906)|regulation of transcription, DNA-templated (GO:0006355)|small molecule metabolic process (GO:0044281)|transcription, DNA-templated (GO:0006351)	cytoplasm (GO:0005737)|nucleoplasm (GO:0005654)	chromatin binding (GO:0003682)|histone acetyltransferase activity (GO:0004402)|ligand-dependent nuclear receptor binding (GO:0016922)|ligand-dependent nuclear receptor transcription coactivator activity (GO:0030374)|nuclear hormone receptor binding (GO:0035257)|signal transducer activity (GO:0004871)|thyroid hormone receptor coactivator activity (GO:0030375)|transcription coactivator activity (GO:0003713)		PAX3/NCOA2(4)|HEY1/NCOA2(10)	NS(1)|breast(4)|endometrium(7)|kidney(4)|large_intestine(10)|lung(25)|ovary(1)|pancreas(2)|prostate(2)|skin(4)	60	Breast(64;0.201)		Epithelial(68;0.0147)|OV - Ovarian serous cystadenocarcinoma(28;0.0455)|all cancers(69;0.0606)			ctgcctcagcttcccaaagtg	0.403			T	"""RUNXBP2, HEY1"""	"""AML, Chondrosarcoma"""																																		Dom	yes		8	8q13.1	10499	nuclear receptor coactivator 2 (TIF2)		L	0																																										SO:0001627	intron_variant			X97674	CCDS47872.1	8q13.3	2011-07-01			ENSG00000140396	ENSG00000140396	10499		"""Chromatin-modifying enzymes / K-acetyltransferases"", ""Basic helix-loop-helix proteins"""	7669	protein-coding gene	gene with protein product		601993				9111344, 8670870	Standard		XM_005251128		Approved	TIF2, GRIP1, NCoA-2, KAT13C, bHLHe75	uc003xyn.1	Q15596	OTTHUMG00000164671	ENST00000452400.2:c.2395-1013A>G	chr8.hg19:g.71061731T>C			Q14CD2	True	hg19	CCDS47872.1																																																																																			NCOA2-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000379696.1		26.0		-	ENST00000452400.2
NCOA2	10499	__UNKNOWN__	__UNKNOWN__	8	71062260	71062261	__UNKNOWN__	Intron	INS	-	-	T			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr8:71062260_71062261insT	ENST00000452400.2	-	12	2576					NM_006540.2	NP_006531.1	Q15596	NCOA2_HUMAN	nuclear receptor coactivator 2						cellular lipid metabolic process (GO:0044255)|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|regulation of glucose metabolic process (GO:0010906)|regulation of transcription, DNA-templated (GO:0006355)|small molecule metabolic process (GO:0044281)|transcription, DNA-templated (GO:0006351)	cytoplasm (GO:0005737)|nucleoplasm (GO:0005654)	chromatin binding (GO:0003682)|histone acetyltransferase activity (GO:0004402)|ligand-dependent nuclear receptor binding (GO:0016922)|ligand-dependent nuclear receptor transcription coactivator activity (GO:0030374)|nuclear hormone receptor binding (GO:0035257)|signal transducer activity (GO:0004871)|thyroid hormone receptor coactivator activity (GO:0030375)|transcription coactivator activity (GO:0003713)		PAX3/NCOA2(4)|HEY1/NCOA2(10)	NS(1)|breast(4)|endometrium(7)|kidney(4)|large_intestine(10)|lung(25)|ovary(1)|pancreas(2)|prostate(2)|skin(4)	60	Breast(64;0.201)		Epithelial(68;0.0147)|OV - Ovarian serous cystadenocarcinoma(28;0.0455)|all cancers(69;0.0606)			AATTTAACATCCATATGAGATG	0.342			T	"""RUNXBP2, HEY1"""	"""AML, Chondrosarcoma"""																																		Dom	yes		8	8q13.1	10499	nuclear receptor coactivator 2 (TIF2)		L	0																																										SO:0001627	intron_variant			X97674	CCDS47872.1	8q13.3	2011-07-01			ENSG00000140396	ENSG00000140396	10499		"""Chromatin-modifying enzymes / K-acetyltransferases"", ""Basic helix-loop-helix proteins"""	7669	protein-coding gene	gene with protein product		601993				9111344, 8670870	Standard		XM_005251128		Approved	TIF2, GRIP1, NCoA-2, KAT13C, bHLHe75	uc003xyn.1	Q15596	OTTHUMG00000164671	ENST00000452400.2:c.2395-1542->A	chr8.hg19:g.71062260_71062261insT			Q14CD2	True	hg19	CCDS47872.1																																																																																			NCOA2-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000379696.1		21.0		-	ENST00000452400.2
NCOA2	10499	__UNKNOWN__	__UNKNOWN__	8	71063539	71063539	__UNKNOWN__	Intron	SNP	T	T	G			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr8:71063539T>G	ENST00000452400.2	-	12	2576					NM_006540.2	NP_006531.1	Q15596	NCOA2_HUMAN	nuclear receptor coactivator 2						cellular lipid metabolic process (GO:0044255)|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|regulation of glucose metabolic process (GO:0010906)|regulation of transcription, DNA-templated (GO:0006355)|small molecule metabolic process (GO:0044281)|transcription, DNA-templated (GO:0006351)	cytoplasm (GO:0005737)|nucleoplasm (GO:0005654)	chromatin binding (GO:0003682)|histone acetyltransferase activity (GO:0004402)|ligand-dependent nuclear receptor binding (GO:0016922)|ligand-dependent nuclear receptor transcription coactivator activity (GO:0030374)|nuclear hormone receptor binding (GO:0035257)|signal transducer activity (GO:0004871)|thyroid hormone receptor coactivator activity (GO:0030375)|transcription coactivator activity (GO:0003713)		PAX3/NCOA2(4)|HEY1/NCOA2(10)	NS(1)|breast(4)|endometrium(7)|kidney(4)|large_intestine(10)|lung(25)|ovary(1)|pancreas(2)|prostate(2)|skin(4)	60	Breast(64;0.201)		Epithelial(68;0.0147)|OV - Ovarian serous cystadenocarcinoma(28;0.0455)|all cancers(69;0.0606)			tttttttttttggagacaagg	0.418			T	"""RUNXBP2, HEY1"""	"""AML, Chondrosarcoma"""																																		Dom	yes		8	8q13.1	10499	nuclear receptor coactivator 2 (TIF2)		L	0																																										SO:0001627	intron_variant			X97674	CCDS47872.1	8q13.3	2011-07-01			ENSG00000140396	ENSG00000140396	10499		"""Chromatin-modifying enzymes / K-acetyltransferases"", ""Basic helix-loop-helix proteins"""	7669	protein-coding gene	gene with protein product		601993				9111344, 8670870	Standard		XM_005251128		Approved	TIF2, GRIP1, NCoA-2, KAT13C, bHLHe75	uc003xyn.1	Q15596	OTTHUMG00000164671	ENST00000452400.2:c.2395-2821A>C	chr8.hg19:g.71063539T>G			Q14CD2	True	hg19	CCDS47872.1																																																																																			NCOA2-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000379696.1		100.0		-	ENST00000452400.2
NCOA2	10499	__UNKNOWN__	__UNKNOWN__	8	71063542	71063542	__UNKNOWN__	Intron	SNP	A	A	G			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr8:71063542A>G	ENST00000452400.2	-	12	2576					NM_006540.2	NP_006531.1	Q15596	NCOA2_HUMAN	nuclear receptor coactivator 2						cellular lipid metabolic process (GO:0044255)|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|regulation of glucose metabolic process (GO:0010906)|regulation of transcription, DNA-templated (GO:0006355)|small molecule metabolic process (GO:0044281)|transcription, DNA-templated (GO:0006351)	cytoplasm (GO:0005737)|nucleoplasm (GO:0005654)	chromatin binding (GO:0003682)|histone acetyltransferase activity (GO:0004402)|ligand-dependent nuclear receptor binding (GO:0016922)|ligand-dependent nuclear receptor transcription coactivator activity (GO:0030374)|nuclear hormone receptor binding (GO:0035257)|signal transducer activity (GO:0004871)|thyroid hormone receptor coactivator activity (GO:0030375)|transcription coactivator activity (GO:0003713)		PAX3/NCOA2(4)|HEY1/NCOA2(10)	NS(1)|breast(4)|endometrium(7)|kidney(4)|large_intestine(10)|lung(25)|ovary(1)|pancreas(2)|prostate(2)|skin(4)	60	Breast(64;0.201)		Epithelial(68;0.0147)|OV - Ovarian serous cystadenocarcinoma(28;0.0455)|all cancers(69;0.0606)			ttttttttggagacaaggtct	0.428			T	"""RUNXBP2, HEY1"""	"""AML, Chondrosarcoma"""																																		Dom	yes		8	8q13.1	10499	nuclear receptor coactivator 2 (TIF2)		L	0																																										SO:0001627	intron_variant			X97674	CCDS47872.1	8q13.3	2011-07-01			ENSG00000140396	ENSG00000140396	10499		"""Chromatin-modifying enzymes / K-acetyltransferases"", ""Basic helix-loop-helix proteins"""	7669	protein-coding gene	gene with protein product		601993				9111344, 8670870	Standard		XM_005251128		Approved	TIF2, GRIP1, NCoA-2, KAT13C, bHLHe75	uc003xyn.1	Q15596	OTTHUMG00000164671	ENST00000452400.2:c.2395-2824T>C	chr8.hg19:g.71063542A>G			Q14CD2	True	hg19	CCDS47872.1																																																																																			NCOA2-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000379696.1		26.0		-	ENST00000452400.2
CDKN2A	1029	__UNKNOWN__	__UNKNOWN__	9	21974763	21974763	__UNKNOWN__	Frame_Shift_Del	DEL	G	G	-	rs374921006		__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr9:21974763delG	ENST00000498124.1	-	1	102	c.64delC	c.(64-66)cggfs	p.R22fs	CDKN2A_ENST00000304494.5_Frame_Shift_Del_p.R22fs|CDKN2A_ENST00000361570.3_Intron|CDKN2A_ENST00000494262.1_Intron|CDKN2A_ENST00000530628.2_Intron|CDKN2A_ENST00000446177.1_Frame_Shift_Del_p.R22fs|RP11-145E5.5_ENST00000404796.2_Intron|CDKN2A_ENST00000498628.2_Intron|CDKN2A_ENST00000579122.1_Frame_Shift_Del_p.R22fs|CDKN2A_ENST00000579755.1_Intron	NM_001195132.1	NP_001182061.1	P42771	CD2A1_HUMAN	cyclin-dependent kinase inhibitor 2A	22					cell cycle arrest (GO:0007050)|cell cycle checkpoint (GO:0000075)|G1/S transition of mitotic cell cycle (GO:0000082)|mitotic cell cycle (GO:0000278)|negative regulation of cell growth (GO:0030308)|negative regulation of cell proliferation (GO:0008285)|negative regulation of cell-matrix adhesion (GO:0001953)|negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736)|negative regulation of NF-kappaB transcription factor activity (GO:0032088)|negative regulation of phosphorylation (GO:0042326)|negative regulation of transcription, DNA-templated (GO:0045892)|positive regulation of cellular senescence (GO:2000774)|positive regulation of macrophage apoptotic process (GO:2000111)|positive regulation of smooth muscle cell apoptotic process (GO:0034393)|Ras protein signal transduction (GO:0007265)|replicative senescence (GO:0090399)|senescence-associated heterochromatin focus assembly (GO:0035986)	cytoplasm (GO:0005737)|cytosol (GO:0005829)|nucleus (GO:0005634)|senescence-associated heterochromatin focus (GO:0035985)	cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861)|NF-kappaB binding (GO:0051059)|poly(A) RNA binding (GO:0044822)|protein kinase binding (GO:0019901)	p.0?(1315)|p.?(23)|p.0(1)|p.R22fs*14(1)|p.S12fs*20(1)		NS(28)|adrenal_gland(6)|autonomic_ganglia(11)|biliary_tract(74)|bone(84)|breast(46)|central_nervous_system(522)|cervix(23)|endometrium(14)|eye(4)|genital_tract(15)|haematopoietic_and_lymphoid_tissue(698)|kidney(39)|large_intestine(11)|liver(92)|lung(365)|meninges(18)|oesophagus(239)|ovary(98)|pancreas(263)|pleura(94)|prostate(13)|salivary_gland(10)|skin(541)|small_intestine(1)|soft_tissue(93)|stomach(48)|thymus(4)|thyroid(24)|upper_aerodigestive_tract(436)|urinary_tract(283)|vulva(2)	4199		all_cancers(5;0)|Acute lymphoblastic leukemia(3;0)|all_hematologic(3;0)|all_epithelial(2;2.37e-290)|Lung NSC(2;1.26e-139)|all_lung(2;4.48e-131)|Glioma(2;3.26e-60)|all_neural(2;2.1e-52)|Renal(3;1.07e-46)|Esophageal squamous(3;3.83e-46)|Melanoma(2;2.74e-34)|Breast(3;1.14e-11)|Ovarian(3;0.000128)|Hepatocellular(5;0.00162)|Colorectal(97;0.172)		all cancers(2;0)|GBM - Glioblastoma multiforme(3;0)|Lung(2;4.07e-74)|Epithelial(2;1.08e-61)|LUSC - Lung squamous cell carcinoma(2;3.82e-48)|LUAD - Lung adenocarcinoma(2;4.56e-26)|OV - Ovarian serous cystadenocarcinoma(39;7.64e-10)|BRCA - Breast invasive adenocarcinoma(2;5.01e-09)|STAD - Stomach adenocarcinoma(4;4.63e-07)|Kidney(2;5.79e-07)|KIRC - Kidney renal clear cell carcinoma(2;7.27e-07)|COAD - Colon adenocarcinoma(8;5.15e-05)		ACCCGACCCCGGGCCGCGGCC	0.736		17								HNSCC(2;<9.43e_08)|TSP Lung(5;3.83e-07)																																						1341	Whole gene deletion(1316)|Unknown(23)|Deletion - Frameshift(2)	haematopoietic_and_lymphoid_tissue(279)|skin(168)|central_nervous_system(163)|lung(146)|urinary_tract(90)|bone(73)|soft_tissue(57)|pleura(52)|oesophagus(50)|upper_aerodigestive_tract(47)|ovary(34)|kidney(31)|breast(30)|pancreas(29)|thyroid(14)|biliary_tract(13)|NS(12)|stomach(12)|autonomic_ganglia(7)|liver(7)|meninges(7)|large_intestine(6)|salivary_gland(4)|thymus(4)|vulva(2)|endometrium(2)|prostate(2)											14.0	19.0	17.0					9																	21974763		1863	3820	5683	SO:0001589	frameshift_variant			L27211	CCDS6510.1, CCDS6511.1, CCDS6511.2, CCDS56565.1	9p21	2014-09-17	2012-03-08		ENSG00000147889	ENSG00000147889	1029			1787	protein-coding gene	gene with protein product		600160	"""cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4)"""	CDKN2, MLM		8152487, 7606716	Standard	NM_000077	NM_058195		Approved	CDK4I, p16, INK4a, MTS1, CMM2, ARF, p19, p14, INK4, p16INK4a, p19Arf	uc003zpk.3	P42771	OTTHUMG00000019686	ENST00000498124.1:c.64delC	chr9.hg19:g.21974763delG	ENSP00000418915:p.Arg22fs		A5X2G7|D3DRK1|O95440|Q15191|Q5VVJ5|Q96B52|Q9NP05	True	hg19	CCDS56565.1																																																																																			CDKN2A-009	KNOWN	NMD_exception|basic|appris_candidate_longest|CCDS	protein_coding		protein_coding	OTTHUMT00000354927.1		21.0		-	ENST00000498124.1
CDKN2B	1030	__UNKNOWN__	__UNKNOWN__	9	22008882	22008882	__UNKNOWN__	Missense_Mutation	SNP	C	C	A			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr9:22008882C>A	ENST00000276925.6	-	1	480	c.71G>T	c.(70-72)cGg>cTg	p.R24L	CDKN2B-AS1_ENST00000584020.1_RNA|CDKN2B-AS1_ENST00000585267.1_RNA|CDKN2B-AS1_ENST00000584351.1_RNA|CDKN2B-AS1_ENST00000468603.2_RNA|CDKN2B-AS1_ENST00000577551.1_RNA|CDKN2B-AS1_ENST00000580467.1_RNA|CDKN2B-AS1_ENST00000582301.1_RNA|CDKN2B-AS1_ENST00000584816.1_RNA|CDKN2B-AS1_ENST00000581051.1_RNA|CDKN2B-AS1_ENST00000582072.1_RNA|CDKN2B-AS1_ENST00000583719.1_RNA|CDKN2B-AS1_ENST00000428597.1_RNA|CDKN2B-AS1_ENST00000455933.2_RNA|RP11-145E5.5_ENST00000404796.2_Intron|CDKN2B_ENST00000380142.4_Missense_Mutation_p.R24L|CDKN2B_ENST00000539462.1_Missense_Mutation_p.R24L|CDKN2B-AS1_ENST00000584637.1_RNA|CDKN2B-AS1_ENST00000580576.1_RNA	NM_004936.3|NM_078487.2	NP_004927.2|NP_511042.1	P42772	CDN2B_HUMAN	cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)	24					aging (GO:0007568)|cell cycle arrest (GO:0007050)|cellular response to extracellular stimulus (GO:0031668)|cellular response to nutrient (GO:0031670)|G2/M transition of mitotic cell cycle (GO:0000086)|gene expression (GO:0010467)|liver development (GO:0001889)|megakaryocyte differentiation (GO:0030219)|mitotic cell cycle (GO:0000278)|mitotic cell cycle checkpoint (GO:0007093)|negative regulation of cell proliferation (GO:0008285)|negative regulation of epithelial cell proliferation (GO:0050680)|negative regulation of G1/S transition of mitotic cell cycle (GO:2000134)|negative regulation of phosphorylation (GO:0042326)|negative regulation of protein serine/threonine kinase activity (GO:0071901)|positive regulation of epithelial cell differentiation (GO:0030858)|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511)|regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079)|response to cytokine (GO:0034097)|response to organic cyclic compound (GO:0014070)|spleen development (GO:0048536)|transcription initiation from RNA polymerase II promoter (GO:0006367)|transcription, DNA-templated (GO:0006351)|transforming growth factor beta receptor signaling pathway (GO:0007179)	cytoplasm (GO:0005737)|cytosol (GO:0005829)|nucleus (GO:0005634)	cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861)|protein kinase binding (GO:0019901)	p.0(1)|p.0?(1)		lung(2)	2		all_cancers(5;0)|Acute lymphoblastic leukemia(3;0)|all_hematologic(3;0)|all_epithelial(2;1.31e-280)|Lung NSC(2;2.28e-131)|all_lung(2;2.11e-123)|Glioma(2;5.66e-57)|all_neural(2;3.05e-50)|Renal(3;1.07e-46)|Esophageal squamous(3;3.83e-46)|Melanoma(2;8.01e-33)|Breast(3;1.14e-11)|Ovarian(3;0.000128)|Hepatocellular(5;0.00369)|Colorectal(97;0.172)		all cancers(2;0)|GBM - Glioblastoma multiforme(3;0)|Lung(2;3.29e-71)|Epithelial(2;9.08e-60)|LUSC - Lung squamous cell carcinoma(2;5.8e-46)|LUAD - Lung adenocarcinoma(2;1.43e-25)|BRCA - Breast invasive adenocarcinoma(2;5.37e-09)|STAD - Stomach adenocarcinoma(4;4.63e-07)|Kidney(2;6.92e-07)|KIRC - Kidney renal clear cell carcinoma(2;8.63e-07)|OV - Ovarian serous cystadenocarcinoma(39;0.014)|COAD - Colon adenocarcinoma(8;0.143)		CACTAGTCCCCGCGCCGCGGC	0.716											OREG0019127	type=REGULATORY REGION|TFbs=CTCF|Dataset=CTCF ChIP-chip sites (Ren lab)|EvidenceSubtype=ChIP-on-chip (ChIP-chip)																																				2	Whole gene deletion(2)	lung(2)											12.0	14.0	13.0					9																	22008882		2189	4287	6476	SO:0001583	missense			AB060808	CCDS6512.1, CCDS6513.1	9p21	2008-07-21			ENSG00000147883	ENSG00000147883	1030			1788	protein-coding gene	gene with protein product		600431				8078588	Standard	NM_004936	NM_004936		Approved	P15, MTS2, INK4B, TP15, CDK4I, p15INK4b	uc003zpo.3	P42772	OTTHUMG00000019691	ENST00000276925.6:c.71G>T	chr9.hg19:g.22008882C>A	ENSP00000276925:p.Arg24Leu	752	O15125|Q6FI09	True	hg19	CCDS6512.1	.	.	.	.	.	.	.	.	.	.	C	17.57	3.421706	0.62622	.	.	ENSG00000147883	ENST00000276925;ENST00000380142;ENST00000539462	T;T;T	0.79749	-1.3;1.54;1.54	5.86	4.02	0.46733	Ankyrin repeat-containing domain (3);	0.483859	0.19871	N	0.104190	T	0.73590	0.3606	L	0.37800	1.135	0.36463	D	0.866794	B;P	0.41748	0.032;0.761	B;B	0.44163	0.061;0.443	T	0.76745	-0.2846	10	0.46703	T	0.11	-11.6989	8.1845	0.31330	0.0:0.8234:0.0:0.1766	.	24;24	P42772;O15125	CDN2B_HUMAN;.	L	24	ENSP00000276925:R24L;ENSP00000369487:R24L;ENSP00000445136:R24L	ENSP00000276925:R24L	R	-	2	0	CDKN2B	21998882	0.069000	0.21087	1.000000	0.80357	0.590000	0.36582	0.293000	0.19029	1.484000	0.48361	0.650000	0.86243	CGG	CDKN2B-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000051932.2		46.0		-	ENST00000276925.6
RET	5979	__UNKNOWN__	__UNKNOWN__	10	43610208	43610209	__UNKNOWN__	Intron	DEL	AA	AA	-			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr10:43610208_43610209delAA	ENST00000355710.3	+	11	2368				RET_ENST00000340058.5_Intron	NM_020975.4	NP_066124.1	P07949	RET_HUMAN	ret proto-oncogene						activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919)|cellular response to retinoic acid (GO:0071300)|embryonic epithelial tube formation (GO:0001838)|enteric nervous system development (GO:0048484)|homophilic cell adhesion (GO:0007156)|innervation (GO:0060384)|lymphocyte migration into lymphoid organs (GO:0097021)|MAPK cascade (GO:0000165)|membrane protein proteolysis (GO:0033619)|neural crest cell migration (GO:0001755)|neuron cell-cell adhesion (GO:0007158)|neuron maturation (GO:0042551)|peptidyl-tyrosine phosphorylation (GO:0018108)|Peyer's patch morphogenesis (GO:0061146)|positive regulation of cell adhesion mediated by integrin (GO:0033630)|positive regulation of cell migration (GO:0030335)|positive regulation of cell size (GO:0045793)|positive regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001241)|positive regulation of metanephric glomerulus development (GO:0072300)|positive regulation of neuron maturation (GO:0014042)|positive regulation of neuron projection development (GO:0010976)|positive regulation of transcription, DNA-templated (GO:0045893)|posterior midgut development (GO:0007497)|protein phosphorylation (GO:0006468)|regulation of axonogenesis (GO:0050770)|regulation of cell adhesion (GO:0030155)|response to drug (GO:0042493)|response to pain (GO:0048265)|retina development in camera-type eye (GO:0060041)|signal transduction (GO:0007165)|transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169)|ureter maturation (GO:0035799)|ureteric bud development (GO:0001657)	endosome membrane (GO:0010008)|integral component of plasma membrane (GO:0005887)|membrane raft (GO:0045121)|receptor complex (GO:0043235)	ATP binding (GO:0005524)|calcium ion binding (GO:0005509)|protein tyrosine kinase activity (GO:0004713)|receptor activity (GO:0004872)|transmembrane receptor protein tyrosine kinase activity (GO:0004714)		CCDC6/RET(4)|KIF5B/RET(79)	NS(2)|adrenal_gland(26)|breast(5)|central_nervous_system(3)|endometrium(6)|haematopoietic_and_lymphoid_tissue(7)|kidney(2)|large_intestine(14)|lung(27)|ovary(5)|prostate(3)|skin(1)|thyroid(504)|upper_aerodigestive_tract(1)|urinary_tract(1)	607		Ovarian(717;0.0423)			Cabozantinib(DB08875)|Ponatinib(DB08901)|Regorafenib(DB08896)|Sorafenib(DB00398)	CGGGGCAGGGAAGATCCCCTGC	0.678		1	"""T, Mis, N, F"""	"""H4, PRKAR1A, NCOA4, PCM1, GOLGA5, TRIM33, KTN1, TRIM27, HOOK3, KIF5B, CCDC6"""	"""medullary thyroid,  papillary thyroid, pheochromocytoma, NSCLC"""	"""medullary thyroid,  papillary thyroid, pheochromocytoma"""	Hirschsprung disease		Multiple Endocrine Neoplasia, type 2B;Multiple Endocrine Neoplasia, type 2A;Familial Medullary Thyroid Carcinoma																												Melanoma(102;360 522 3376 9752 9881 14372 17251 18341 20876 24662 34807 43144 48149)	yes	Dom	yes	Multiple endocrine neoplasia 2A/2B	10	10q11.2	5979	ret proto-oncogene	yes	"""E, O"""	0																																										SO:0001627	intron_variant	Familial Cancer Database	MEN2B, Wagenmann-Froboese s.;MEN2A, Sipple disease, incl MEN2C;FMTC	BC004257	CCDS7200.1, CCDS53525.1	10q11.2	2014-09-17	2007-02-16		ENSG00000165731	ENSG00000165731	5979		"""Cadherins / Cadherin-related"""	9967	protein-coding gene	gene with protein product	"""cadherin-related family member 16"""	164761	"""multiple endocrine neoplasia and medullary thyroid carcinoma 1"", ""Hirschsprung disease 1"""	HSCR1, MEN2A, MTC1, MEN2B		2687772, 1611909	Standard	NM_020975	NM_020975		Approved	PTC, CDHF12, RET51, CDHR16	uc001jal.3	P07949	OTTHUMG00000018024	ENST00000355710.3:c.2136+24AA>-	chr10.hg19:g.43610208_43610209delAA			A8K6Z2|Q15250|Q9BTB0|Q9H4A2	True	hg19	CCDS7200.1																																																																																			RET-001	KNOWN	basic|appris_candidate_longest|CCDS	protein_coding		protein_coding	OTTHUMT00000047694.2		32.0		+	ENST00000355710.3
RET	5979	__UNKNOWN__	__UNKNOWN__	10	43610213	43610214	__UNKNOWN__	Intron	INS	-	-	TT			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr10:43610213_43610214insTT	ENST00000355710.3	+	11	2368				RET_ENST00000340058.5_Intron	NM_020975.4	NP_066124.1	P07949	RET_HUMAN	ret proto-oncogene						activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919)|cellular response to retinoic acid (GO:0071300)|embryonic epithelial tube formation (GO:0001838)|enteric nervous system development (GO:0048484)|homophilic cell adhesion (GO:0007156)|innervation (GO:0060384)|lymphocyte migration into lymphoid organs (GO:0097021)|MAPK cascade (GO:0000165)|membrane protein proteolysis (GO:0033619)|neural crest cell migration (GO:0001755)|neuron cell-cell adhesion (GO:0007158)|neuron maturation (GO:0042551)|peptidyl-tyrosine phosphorylation (GO:0018108)|Peyer's patch morphogenesis (GO:0061146)|positive regulation of cell adhesion mediated by integrin (GO:0033630)|positive regulation of cell migration (GO:0030335)|positive regulation of cell size (GO:0045793)|positive regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001241)|positive regulation of metanephric glomerulus development (GO:0072300)|positive regulation of neuron maturation (GO:0014042)|positive regulation of neuron projection development (GO:0010976)|positive regulation of transcription, DNA-templated (GO:0045893)|posterior midgut development (GO:0007497)|protein phosphorylation (GO:0006468)|regulation of axonogenesis (GO:0050770)|regulation of cell adhesion (GO:0030155)|response to drug (GO:0042493)|response to pain (GO:0048265)|retina development in camera-type eye (GO:0060041)|signal transduction (GO:0007165)|transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169)|ureter maturation (GO:0035799)|ureteric bud development (GO:0001657)	endosome membrane (GO:0010008)|integral component of plasma membrane (GO:0005887)|membrane raft (GO:0045121)|receptor complex (GO:0043235)	ATP binding (GO:0005524)|calcium ion binding (GO:0005509)|protein tyrosine kinase activity (GO:0004713)|receptor activity (GO:0004872)|transmembrane receptor protein tyrosine kinase activity (GO:0004714)		CCDC6/RET(4)|KIF5B/RET(79)	NS(2)|adrenal_gland(26)|breast(5)|central_nervous_system(3)|endometrium(6)|haematopoietic_and_lymphoid_tissue(7)|kidney(2)|large_intestine(14)|lung(27)|ovary(5)|prostate(3)|skin(1)|thyroid(504)|upper_aerodigestive_tract(1)|urinary_tract(1)	607		Ovarian(717;0.0423)			Cabozantinib(DB08875)|Ponatinib(DB08901)|Regorafenib(DB08896)|Sorafenib(DB00398)	CAGGGAAGATCCCCTGCCCTCC	0.673		1	"""T, Mis, N, F"""	"""H4, PRKAR1A, NCOA4, PCM1, GOLGA5, TRIM33, KTN1, TRIM27, HOOK3, KIF5B, CCDC6"""	"""medullary thyroid,  papillary thyroid, pheochromocytoma, NSCLC"""	"""medullary thyroid,  papillary thyroid, pheochromocytoma"""	Hirschsprung disease		Multiple Endocrine Neoplasia, type 2B;Multiple Endocrine Neoplasia, type 2A;Familial Medullary Thyroid Carcinoma																												Melanoma(102;360 522 3376 9752 9881 14372 17251 18341 20876 24662 34807 43144 48149)	yes	Dom	yes	Multiple endocrine neoplasia 2A/2B	10	10q11.2	5979	ret proto-oncogene	yes	"""E, O"""	0																																										SO:0001627	intron_variant	Familial Cancer Database	MEN2B, Wagenmann-Froboese s.;MEN2A, Sipple disease, incl MEN2C;FMTC	BC004257	CCDS7200.1, CCDS53525.1	10q11.2	2014-09-17	2007-02-16		ENSG00000165731	ENSG00000165731	5979		"""Cadherins / Cadherin-related"""	9967	protein-coding gene	gene with protein product	"""cadherin-related family member 16"""	164761	"""multiple endocrine neoplasia and medullary thyroid carcinoma 1"", ""Hirschsprung disease 1"""	HSCR1, MEN2A, MTC1, MEN2B		2687772, 1611909	Standard	NM_020975	NM_020975		Approved	PTC, CDHF12, RET51, CDHR16	uc001jal.3	P07949	OTTHUMG00000018024	ENST00000355710.3:c.2136+29->TT	chr10.hg19:g.43610213_43610214insTT			A8K6Z2|Q15250|Q9BTB0|Q9H4A2	True	hg19	CCDS7200.1																																																																																			RET-001	KNOWN	basic|appris_candidate_longest|CCDS	protein_coding		protein_coding	OTTHUMT00000047694.2		32.0		+	ENST00000355710.3
MYOD1	4654	__UNKNOWN__	__UNKNOWN__	11	17741541	17741542	__UNKNOWN__	Frame_Shift_Del	DEL	CG	CG	-	rs370560475		__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr11:17741541_17741542delCG	ENST00000250003.3	+	1	427_428	c.212_213delCG	c.(211-213)ccgfs	p.P71fs		NM_002478.4	NP_002469.2	P15172	MYOD1_HUMAN	myogenic differentiation 1	71					cellular response to estradiol stimulus (GO:0071392)|cellular response to glucocorticoid stimulus (GO:0071385)|cellular response to oxygen levels (GO:0071453)|cellular response to starvation (GO:0009267)|histone H3 acetylation (GO:0043966)|histone H4 acetylation (GO:0043967)|muscle cell differentiation (GO:0042692)|muscle cell fate commitment (GO:0042693)|muscle organ development (GO:0007517)|myoblast fate determination (GO:0007518)|myotube cell development (GO:0014904)|myotube differentiation involved in skeletal muscle regeneration (GO:0014908)|positive regulation of muscle cell differentiation (GO:0051149)|positive regulation of myoblast fusion (GO:1901741)|positive regulation of skeletal muscle tissue regeneration (GO:0043415)|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|protein phosphorylation (GO:0006468)|regulation of alternative mRNA splicing, via spliceosome (GO:0000381)|regulation of RNA splicing (GO:0043484)|regulation of transcription from RNA polymerase II promoter (GO:0006357)|skeletal muscle fiber adaptation (GO:0043503)|skeletal muscle fiber development (GO:0048741)|skeletal muscle tissue development (GO:0007519)|transcription from RNA polymerase II promoter (GO:0006366)	myofibril (GO:0030016)|nuclear chromatin (GO:0000790)|nucleoplasm (GO:0005654)|nucleus (GO:0005634)|transcription factor complex (GO:0005667)	chromatin DNA binding (GO:0031490)|core promoter binding (GO:0001047)|E-box binding (GO:0070888)|nuclear hormone receptor binding (GO:0035257)|protein heterodimerization activity (GO:0046982)|RNA polymerase II core promoter proximal region sequence-specific DNA binding (GO:0000978)|RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity (GO:0003705)|RNA polymerase II regulatory region sequence-specific DNA binding (GO:0000977)|RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription (GO:0001228)|transcription coactivator activity (GO:0003713)			breast(2)|endometrium(2)|large_intestine(2)|lung(9)|ovary(1)|prostate(1)	17						GCGGTGCACCCGGCCCCGGGCG	0.718																																																0																																										SO:0001589	frameshift_variant			AF027148	CCDS7826.1	11p15	2013-05-21	2005-09-12			ENSG00000129152	4654		"""Basic helix-loop-helix proteins"""	7611	protein-coding gene	gene with protein product	"""myoblast determination protein 1"""	159970	"""myogenic factor 3"""	MYF3			Standard	NM_002478	NM_002478		Approved	PUM, MYOD, bHLHc1	uc001mni.3	P15172		ENST00000250003.3:c.212_213delCG	chr11.hg19:g.17741541_17741542delCG	ENSP00000250003:p.Pro71fs		O75321	True	hg19	CCDS7826.1																																																																																			MYOD1-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000389387.1		24.0		+	ENST00000250003.3
MYOD1	4654	__UNKNOWN__	__UNKNOWN__	11	17741546	17741546	__UNKNOWN__	Missense_Mutation	SNP	C	C	G			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr11:17741546C>G	ENST00000250003.3	+	1	432	c.217C>G	c.(217-219)Ccg>Gcg	p.P73A		NM_002478.4	NP_002469.2	P15172	MYOD1_HUMAN	myogenic differentiation 1	73					cellular response to estradiol stimulus (GO:0071392)|cellular response to glucocorticoid stimulus (GO:0071385)|cellular response to oxygen levels (GO:0071453)|cellular response to starvation (GO:0009267)|histone H3 acetylation (GO:0043966)|histone H4 acetylation (GO:0043967)|muscle cell differentiation (GO:0042692)|muscle cell fate commitment (GO:0042693)|muscle organ development (GO:0007517)|myoblast fate determination (GO:0007518)|myotube cell development (GO:0014904)|myotube differentiation involved in skeletal muscle regeneration (GO:0014908)|positive regulation of muscle cell differentiation (GO:0051149)|positive regulation of myoblast fusion (GO:1901741)|positive regulation of skeletal muscle tissue regeneration (GO:0043415)|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|protein phosphorylation (GO:0006468)|regulation of alternative mRNA splicing, via spliceosome (GO:0000381)|regulation of RNA splicing (GO:0043484)|regulation of transcription from RNA polymerase II promoter (GO:0006357)|skeletal muscle fiber adaptation (GO:0043503)|skeletal muscle fiber development (GO:0048741)|skeletal muscle tissue development (GO:0007519)|transcription from RNA polymerase II promoter (GO:0006366)	myofibril (GO:0030016)|nuclear chromatin (GO:0000790)|nucleoplasm (GO:0005654)|nucleus (GO:0005634)|transcription factor complex (GO:0005667)	chromatin DNA binding (GO:0031490)|core promoter binding (GO:0001047)|E-box binding (GO:0070888)|nuclear hormone receptor binding (GO:0035257)|protein heterodimerization activity (GO:0046982)|RNA polymerase II core promoter proximal region sequence-specific DNA binding (GO:0000978)|RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity (GO:0003705)|RNA polymerase II regulatory region sequence-specific DNA binding (GO:0000977)|RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription (GO:0001228)|transcription coactivator activity (GO:0003713)			breast(2)|endometrium(2)|large_intestine(2)|lung(9)|ovary(1)|prostate(1)	17						GCACCCGGCCCCGGGCGCACG	0.716																																																0													12.0	13.0	13.0					11																	17741546		2184	4260	6444	SO:0001583	missense			AF027148	CCDS7826.1	11p15	2013-05-21	2005-09-12			ENSG00000129152	4654		"""Basic helix-loop-helix proteins"""	7611	protein-coding gene	gene with protein product	"""myoblast determination protein 1"""	159970	"""myogenic factor 3"""	MYF3			Standard	NM_002478	NM_002478		Approved	PUM, MYOD, bHLHc1	uc001mni.3	P15172		ENST00000250003.3:c.217C>G	chr11.hg19:g.17741546C>G	ENSP00000250003:p.Pro73Ala		O75321	True	hg19	CCDS7826.1	.	.	.	.	.	.	.	.	.	.	C	0.201	-1.044796	0.01997	.	.	ENSG00000129152	ENST00000250003	T	0.75589	-0.95	5.01	3.16	0.36331	Myogenic basic muscle-specific protein (2);	0.213853	0.38058	N	0.001835	T	0.41305	0.1153	N	0.03608	-0.345	0.09310	N	1	B	0.06786	0.001	B	0.04013	0.001	T	0.33214	-0.9877	10	0.05721	T	0.95	-12.6442	4.4258	0.11501	0.1911:0.6249:0.0:0.184	.	73	P15172	MYOD1_HUMAN	A	73	ENSP00000250003:P73A	ENSP00000250003:P73A	P	+	1	0	MYOD1	17698122	0.119000	0.22226	0.005000	0.12908	0.010000	0.07245	0.211000	0.17474	0.717000	0.32145	0.655000	0.94253	CCG	MYOD1-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000389387.1		26.0		+	ENST00000250003.3
WT1	7490	__UNKNOWN__	__UNKNOWN__	11	32456516	32456516	__UNKNOWN__	Missense_Mutation	SNP	G	G	C	rs564706633		__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr11:32456516G>C	ENST00000332351.3	-	1	660	c.376C>G	c.(376-378)Ccg>Gcg	p.P126A	WT1_ENST00000448076.3_Missense_Mutation_p.P126A	NM_024424.3|NM_024426.4	NP_077742.2|NP_077744	P19544	WT1_HUMAN	Wilms tumor 1	58					adrenal cortex formation (GO:0035802)|adrenal gland development (GO:0030325)|branching involved in ureteric bud morphogenesis (GO:0001658)|camera-type eye development (GO:0043010)|cardiac muscle cell fate commitment (GO:0060923)|cellular response to cAMP (GO:0071320)|cellular response to gonadotropin stimulus (GO:0071371)|diaphragm development (GO:0060539)|epithelial cell differentiation (GO:0030855)|germ cell development (GO:0007281)|glomerular basement membrane development (GO:0032836)|glomerular visceral epithelial cell differentiation (GO:0072112)|glomerulus development (GO:0032835)|gonad development (GO:0008406)|heart development (GO:0007507)|kidney development (GO:0001822)|male genitalia development (GO:0030539)|male gonad development (GO:0008584)|mesenchymal to epithelial transition (GO:0060231)|metanephric epithelium development (GO:0072207)|metanephric mesenchyme development (GO:0072075)|metanephric S-shaped body morphogenesis (GO:0072284)|negative regulation of apoptotic process (GO:0043066)|negative regulation of cell growth (GO:0030308)|negative regulation of cell proliferation (GO:0008285)|negative regulation of female gonad development (GO:2000195)|negative regulation of metanephric glomerular mesangial cell proliferation (GO:0072302)|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|negative regulation of transcription, DNA-templated (GO:0045892)|negative regulation of translation (GO:0017148)|positive regulation of apoptotic process (GO:0043065)|positive regulation of heart growth (GO:0060421)|positive regulation of male gonad development (GO:2000020)|positive regulation of metanephric ureteric bud development (GO:2001076)|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|positive regulation of transcription, DNA-templated (GO:0045893)|posterior mesonephric tubule development (GO:0072166)|regulation of organ formation (GO:0003156)|regulation of transcription from RNA polymerase II promoter (GO:0006357)|regulation of transcription, DNA-templated (GO:0006355)|RNA splicing (GO:0008380)|sex determination (GO:0007530)|thorax and anterior abdomen determination (GO:0007356)|tissue development (GO:0009888)|ureteric bud development (GO:0001657)|vasculogenesis (GO:0001570)|visceral serous pericardium development (GO:0061032)	cytoplasm (GO:0005737)|nuclear speck (GO:0016607)|nucleoplasm (GO:0005654)|nucleus (GO:0005634)	C2H2 zinc finger domain binding (GO:0070742)|RNA binding (GO:0003723)|RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription (GO:0001077)|sequence-specific DNA binding (GO:0043565)|sequence-specific DNA binding transcription factor activity (GO:0003700)|transcription regulatory region DNA binding (GO:0044212)|zinc ion binding (GO:0008270)	p.P58fs*32(2)	EWSR1/WT1(234)	NS(1)|haematopoietic_and_lymphoid_tissue(348)|kidney(149)|large_intestine(9)|lung(20)|peritoneum(1)|pleura(2)|skin(2)|upper_aerodigestive_tract(1)	533	Breast(20;0.247)		OV - Ovarian serous cystadenocarcinoma(30;0.128)			ggcggagccggtggcggcgCG	0.771			"""D, Mis, N, F, S"""	EWSR1	"""Wilms, desmoplastic small round cell tumor"""	Wilms			Wilms' tumor-Aniridia-ambiguous Genitals-mental Retardation;Frasier syndrome;Familial Wilms' tumor;Denys-Drash syndrome																													yes	Rec	yes	"""Denys-Drash syndrome, Frasier syndrome, Familial Wilms tumor"""	11	11p13	7490	Wilms tumour 1 gene		O	2	Deletion - Frameshift(2)	kidney(2)											2.0	3.0	3.0					11																	32456516		883	2212	3095	SO:0001583	missense	Familial Cancer Database	WAGR syndrome; ; ;incl.: Early Onset Nephrotic Syndrome-WT1 associated		CCDS7878.2, CCDS44561.1, CCDS44562.1, CCDS55750.1, CCDS55751.1	11p13	2014-09-17			ENSG00000184937	ENSG00000184937	7490		"""Zinc fingers, C2H2-type"""	12796	protein-coding gene	gene with protein product		607102		GUD		14681303	Standard	NM_000378	NM_024424		Approved	WAGR, WIT-2, AWT1	uc001mtn.2	P19544	OTTHUMG00000039556	ENST00000332351.3:c.376C>G	chr11.hg19:g.32456516G>C	ENSP00000331327:p.Pro126Ala		A8K6S1|B3KSA5|Q15881|Q16256|Q16575|Q4VXV4|Q4VXV5|Q4VXV6|Q8IYZ5	True	hg19	CCDS7878.2	.	.	.	.	.	.	.	.	.	.	g	2.969	-0.212784	0.06140	.	.	ENSG00000184937	ENST00000332351;ENST00000452863;ENST00000448076	D;D;D	0.87491	-2.26;-2.26;-2.26	2.96	-0.54	0.11861	Wilm&apos (1);s tumour protein, N-terminal (1);	0.360303	0.19005	N	0.125224	T	0.74053	0.3666	N	0.22421	0.69	0.38045	D	0.935582	B;P;P	0.45474	0.0;0.79;0.859	B;B;B	0.41236	0.001;0.266;0.351	T	0.67845	-0.5565	10	0.49607	T	0.09	.	4.6925	0.12788	0.1429:0.4484:0.4087:0.0	.	131;58;131	P19544-8;P19544;P19544-7	.;WT1_HUMAN;.	A	126	ENSP00000331327:P126A;ENSP00000415516:P126A;ENSP00000413452:P126A	ENSP00000331327:P126A	P	-	1	0	WT1	32413092	0.998000	0.40836	0.059000	0.19551	0.005000	0.04900	0.923000	0.28757	-0.081000	0.12662	0.299000	0.19835	CCG	WT1-001	KNOWN	non_ATG_start|basic|CCDS	protein_coding		protein_coding	OTTHUMT00000095436.2		26.0		-	ENST00000332351.3
WT1	7490	__UNKNOWN__	__UNKNOWN__	11	32456517	32456517	__UNKNOWN__	Silent	SNP	T	T	A			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr11:32456517T>A	ENST00000332351.3	-	1	659	c.375A>T	c.(373-375)ccA>ccT	p.P125P	WT1_ENST00000448076.3_Silent_p.P125P	NM_024424.3|NM_024426.4	NP_077742.2|NP_077744	P19544	WT1_HUMAN	Wilms tumor 1	57					adrenal cortex formation (GO:0035802)|adrenal gland development (GO:0030325)|branching involved in ureteric bud morphogenesis (GO:0001658)|camera-type eye development (GO:0043010)|cardiac muscle cell fate commitment (GO:0060923)|cellular response to cAMP (GO:0071320)|cellular response to gonadotropin stimulus (GO:0071371)|diaphragm development (GO:0060539)|epithelial cell differentiation (GO:0030855)|germ cell development (GO:0007281)|glomerular basement membrane development (GO:0032836)|glomerular visceral epithelial cell differentiation (GO:0072112)|glomerulus development (GO:0032835)|gonad development (GO:0008406)|heart development (GO:0007507)|kidney development (GO:0001822)|male genitalia development (GO:0030539)|male gonad development (GO:0008584)|mesenchymal to epithelial transition (GO:0060231)|metanephric epithelium development (GO:0072207)|metanephric mesenchyme development (GO:0072075)|metanephric S-shaped body morphogenesis (GO:0072284)|negative regulation of apoptotic process (GO:0043066)|negative regulation of cell growth (GO:0030308)|negative regulation of cell proliferation (GO:0008285)|negative regulation of female gonad development (GO:2000195)|negative regulation of metanephric glomerular mesangial cell proliferation (GO:0072302)|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|negative regulation of transcription, DNA-templated (GO:0045892)|negative regulation of translation (GO:0017148)|positive regulation of apoptotic process (GO:0043065)|positive regulation of heart growth (GO:0060421)|positive regulation of male gonad development (GO:2000020)|positive regulation of metanephric ureteric bud development (GO:2001076)|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|positive regulation of transcription, DNA-templated (GO:0045893)|posterior mesonephric tubule development (GO:0072166)|regulation of organ formation (GO:0003156)|regulation of transcription from RNA polymerase II promoter (GO:0006357)|regulation of transcription, DNA-templated (GO:0006355)|RNA splicing (GO:0008380)|sex determination (GO:0007530)|thorax and anterior abdomen determination (GO:0007356)|tissue development (GO:0009888)|ureteric bud development (GO:0001657)|vasculogenesis (GO:0001570)|visceral serous pericardium development (GO:0061032)	cytoplasm (GO:0005737)|nuclear speck (GO:0016607)|nucleoplasm (GO:0005654)|nucleus (GO:0005634)	C2H2 zinc finger domain binding (GO:0070742)|RNA binding (GO:0003723)|RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription (GO:0001077)|sequence-specific DNA binding (GO:0043565)|sequence-specific DNA binding transcription factor activity (GO:0003700)|transcription regulatory region DNA binding (GO:0044212)|zinc ion binding (GO:0008270)		EWSR1/WT1(234)	NS(1)|haematopoietic_and_lymphoid_tissue(348)|kidney(149)|large_intestine(9)|lung(20)|peritoneum(1)|pleura(2)|skin(2)|upper_aerodigestive_tract(1)	533	Breast(20;0.247)		OV - Ovarian serous cystadenocarcinoma(30;0.128)			gcggagccggtggcggcgCGG	0.771			"""D, Mis, N, F, S"""	EWSR1	"""Wilms, desmoplastic small round cell tumor"""	Wilms			Wilms' tumor-Aniridia-ambiguous Genitals-mental Retardation;Frasier syndrome;Familial Wilms' tumor;Denys-Drash syndrome																													yes	Rec	yes	"""Denys-Drash syndrome, Frasier syndrome, Familial Wilms tumor"""	11	11p13	7490	Wilms tumour 1 gene		O	0													2.0	3.0	3.0					11																	32456517		873	2194	3067	SO:0001819	synonymous_variant	Familial Cancer Database	WAGR syndrome; ; ;incl.: Early Onset Nephrotic Syndrome-WT1 associated		CCDS7878.2, CCDS44561.1, CCDS44562.1, CCDS55750.1, CCDS55751.1	11p13	2014-09-17			ENSG00000184937	ENSG00000184937	7490		"""Zinc fingers, C2H2-type"""	12796	protein-coding gene	gene with protein product		607102		GUD		14681303	Standard	NM_000378	NM_024424		Approved	WAGR, WIT-2, AWT1	uc001mtn.2	P19544	OTTHUMG00000039556	ENST00000332351.3:c.375A>T	chr11.hg19:g.32456517T>A			A8K6S1|B3KSA5|Q15881|Q16256|Q16575|Q4VXV4|Q4VXV5|Q4VXV6|Q8IYZ5	True	hg19	CCDS7878.2																																																																																			WT1-001	KNOWN	non_ATG_start|basic|CCDS	protein_coding		protein_coding	OTTHUMT00000095436.2		26.0		-	ENST00000332351.3
WT1	7490	__UNKNOWN__	__UNKNOWN__	11	32456518	32456518	__UNKNOWN__	Missense_Mutation	SNP	G	G	C			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr11:32456518G>C	ENST00000332351.3	-	1	658	c.374C>G	c.(373-375)cCa>cGa	p.P125R	WT1_ENST00000448076.3_Missense_Mutation_p.P125R	NM_024424.3|NM_024426.4	NP_077742.2|NP_077744	P19544	WT1_HUMAN	Wilms tumor 1	57					adrenal cortex formation (GO:0035802)|adrenal gland development (GO:0030325)|branching involved in ureteric bud morphogenesis (GO:0001658)|camera-type eye development (GO:0043010)|cardiac muscle cell fate commitment (GO:0060923)|cellular response to cAMP (GO:0071320)|cellular response to gonadotropin stimulus (GO:0071371)|diaphragm development (GO:0060539)|epithelial cell differentiation (GO:0030855)|germ cell development (GO:0007281)|glomerular basement membrane development (GO:0032836)|glomerular visceral epithelial cell differentiation (GO:0072112)|glomerulus development (GO:0032835)|gonad development (GO:0008406)|heart development (GO:0007507)|kidney development (GO:0001822)|male genitalia development (GO:0030539)|male gonad development (GO:0008584)|mesenchymal to epithelial transition (GO:0060231)|metanephric epithelium development (GO:0072207)|metanephric mesenchyme development (GO:0072075)|metanephric S-shaped body morphogenesis (GO:0072284)|negative regulation of apoptotic process (GO:0043066)|negative regulation of cell growth (GO:0030308)|negative regulation of cell proliferation (GO:0008285)|negative regulation of female gonad development (GO:2000195)|negative regulation of metanephric glomerular mesangial cell proliferation (GO:0072302)|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|negative regulation of transcription, DNA-templated (GO:0045892)|negative regulation of translation (GO:0017148)|positive regulation of apoptotic process (GO:0043065)|positive regulation of heart growth (GO:0060421)|positive regulation of male gonad development (GO:2000020)|positive regulation of metanephric ureteric bud development (GO:2001076)|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|positive regulation of transcription, DNA-templated (GO:0045893)|posterior mesonephric tubule development (GO:0072166)|regulation of organ formation (GO:0003156)|regulation of transcription from RNA polymerase II promoter (GO:0006357)|regulation of transcription, DNA-templated (GO:0006355)|RNA splicing (GO:0008380)|sex determination (GO:0007530)|thorax and anterior abdomen determination (GO:0007356)|tissue development (GO:0009888)|ureteric bud development (GO:0001657)|vasculogenesis (GO:0001570)|visceral serous pericardium development (GO:0061032)	cytoplasm (GO:0005737)|nuclear speck (GO:0016607)|nucleoplasm (GO:0005654)|nucleus (GO:0005634)	C2H2 zinc finger domain binding (GO:0070742)|RNA binding (GO:0003723)|RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription (GO:0001077)|sequence-specific DNA binding (GO:0043565)|sequence-specific DNA binding transcription factor activity (GO:0003700)|transcription regulatory region DNA binding (GO:0044212)|zinc ion binding (GO:0008270)		EWSR1/WT1(234)	NS(1)|haematopoietic_and_lymphoid_tissue(348)|kidney(149)|large_intestine(9)|lung(20)|peritoneum(1)|pleura(2)|skin(2)|upper_aerodigestive_tract(1)	533	Breast(20;0.247)		OV - Ovarian serous cystadenocarcinoma(30;0.128)			cggagccggtggcggcgCGGG	0.766			"""D, Mis, N, F, S"""	EWSR1	"""Wilms, desmoplastic small round cell tumor"""	Wilms			Wilms' tumor-Aniridia-ambiguous Genitals-mental Retardation;Frasier syndrome;Familial Wilms' tumor;Denys-Drash syndrome																													yes	Rec	yes	"""Denys-Drash syndrome, Frasier syndrome, Familial Wilms tumor"""	11	11p13	7490	Wilms tumour 1 gene		O	0													2.0	3.0	3.0					11																	32456518		854	2138	2992	SO:0001583	missense	Familial Cancer Database	WAGR syndrome; ; ;incl.: Early Onset Nephrotic Syndrome-WT1 associated		CCDS7878.2, CCDS44561.1, CCDS44562.1, CCDS55750.1, CCDS55751.1	11p13	2014-09-17			ENSG00000184937	ENSG00000184937	7490		"""Zinc fingers, C2H2-type"""	12796	protein-coding gene	gene with protein product		607102		GUD		14681303	Standard	NM_000378	NM_024424		Approved	WAGR, WIT-2, AWT1	uc001mtn.2	P19544	OTTHUMG00000039556	ENST00000332351.3:c.374C>G	chr11.hg19:g.32456518G>C	ENSP00000331327:p.Pro125Arg		A8K6S1|B3KSA5|Q15881|Q16256|Q16575|Q4VXV4|Q4VXV5|Q4VXV6|Q8IYZ5	True	hg19	CCDS7878.2	.	.	.	.	.	.	.	.	.	.	g	11.65	1.701329	0.30142	.	.	ENSG00000184937	ENST00000332351;ENST00000452863;ENST00000448076	D;D;D	0.87256	-2.23;-2.23;-2.23	2.96	2.96	0.34315	Wilm&apos (1);s tumour protein, N-terminal (1);	0.126195	0.31188	U	0.008090	D	0.84955	0.5587	N	0.22421	0.69	0.80722	D	1	D;D;D	0.57899	0.974;0.97;0.981	P;P;P	0.58130	0.833;0.619;0.636	D	0.85539	0.1214	10	0.87932	D	0	.	9.7451	0.40442	0.0:0.0:1.0:0.0	.	130;57;130	P19544-8;P19544;P19544-7	.;WT1_HUMAN;.	R	125	ENSP00000331327:P125R;ENSP00000415516:P125R;ENSP00000413452:P125R	ENSP00000331327:P125R	P	-	2	0	WT1	32413094	0.997000	0.39634	0.184000	0.23157	0.009000	0.06853	0.923000	0.28757	1.351000	0.45789	0.299000	0.19835	CCA	WT1-001	KNOWN	non_ATG_start|basic|CCDS	protein_coding		protein_coding	OTTHUMT00000095436.2		27.0		-	ENST00000332351.3
WT1	7490	__UNKNOWN__	__UNKNOWN__	11	32456763	32456763	__UNKNOWN__	Silent	SNP	T	T	C			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr11:32456763T>C	ENST00000332351.3	-	1	413	c.129A>G	c.(127-129)ttA>ttG	p.L43L	WT1_ENST00000448076.3_Silent_p.L43L	NM_024424.3|NM_024426.4	NP_077742.2|NP_077744	P19544	WT1_HUMAN	Wilms tumor 1	0	Pro-rich.				adrenal cortex formation (GO:0035802)|adrenal gland development (GO:0030325)|branching involved in ureteric bud morphogenesis (GO:0001658)|camera-type eye development (GO:0043010)|cardiac muscle cell fate commitment (GO:0060923)|cellular response to cAMP (GO:0071320)|cellular response to gonadotropin stimulus (GO:0071371)|diaphragm development (GO:0060539)|epithelial cell differentiation (GO:0030855)|germ cell development (GO:0007281)|glomerular basement membrane development (GO:0032836)|glomerular visceral epithelial cell differentiation (GO:0072112)|glomerulus development (GO:0032835)|gonad development (GO:0008406)|heart development (GO:0007507)|kidney development (GO:0001822)|male genitalia development (GO:0030539)|male gonad development (GO:0008584)|mesenchymal to epithelial transition (GO:0060231)|metanephric epithelium development (GO:0072207)|metanephric mesenchyme development (GO:0072075)|metanephric S-shaped body morphogenesis (GO:0072284)|negative regulation of apoptotic process (GO:0043066)|negative regulation of cell growth (GO:0030308)|negative regulation of cell proliferation (GO:0008285)|negative regulation of female gonad development (GO:2000195)|negative regulation of metanephric glomerular mesangial cell proliferation (GO:0072302)|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|negative regulation of transcription, DNA-templated (GO:0045892)|negative regulation of translation (GO:0017148)|positive regulation of apoptotic process (GO:0043065)|positive regulation of heart growth (GO:0060421)|positive regulation of male gonad development (GO:2000020)|positive regulation of metanephric ureteric bud development (GO:2001076)|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|positive regulation of transcription, DNA-templated (GO:0045893)|posterior mesonephric tubule development (GO:0072166)|regulation of organ formation (GO:0003156)|regulation of transcription from RNA polymerase II promoter (GO:0006357)|regulation of transcription, DNA-templated (GO:0006355)|RNA splicing (GO:0008380)|sex determination (GO:0007530)|thorax and anterior abdomen determination (GO:0007356)|tissue development (GO:0009888)|ureteric bud development (GO:0001657)|vasculogenesis (GO:0001570)|visceral serous pericardium development (GO:0061032)	cytoplasm (GO:0005737)|nuclear speck (GO:0016607)|nucleoplasm (GO:0005654)|nucleus (GO:0005634)	C2H2 zinc finger domain binding (GO:0070742)|RNA binding (GO:0003723)|RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription (GO:0001077)|sequence-specific DNA binding (GO:0043565)|sequence-specific DNA binding transcription factor activity (GO:0003700)|transcription regulatory region DNA binding (GO:0044212)|zinc ion binding (GO:0008270)		EWSR1/WT1(234)	NS(1)|haematopoietic_and_lymphoid_tissue(348)|kidney(149)|large_intestine(9)|lung(20)|peritoneum(1)|pleura(2)|skin(2)|upper_aerodigestive_tract(1)	533	Breast(20;0.247)		OV - Ovarian serous cystadenocarcinoma(30;0.128)			CGGCGGCGCCTAACTTGGCCC	0.731			"""D, Mis, N, F, S"""	EWSR1	"""Wilms, desmoplastic small round cell tumor"""	Wilms			Wilms' tumor-Aniridia-ambiguous Genitals-mental Retardation;Frasier syndrome;Familial Wilms' tumor;Denys-Drash syndrome																													yes	Rec	yes	"""Denys-Drash syndrome, Frasier syndrome, Familial Wilms tumor"""	11	11p13	7490	Wilms tumour 1 gene		O	0													2.0	3.0	3.0					11																	32456763		1823	3768	5591	SO:0001819	synonymous_variant	Familial Cancer Database	WAGR syndrome; ; ;incl.: Early Onset Nephrotic Syndrome-WT1 associated		CCDS7878.2, CCDS44561.1, CCDS44562.1, CCDS55750.1, CCDS55751.1	11p13	2014-09-17			ENSG00000184937	ENSG00000184937	7490		"""Zinc fingers, C2H2-type"""	12796	protein-coding gene	gene with protein product		607102		GUD		14681303	Standard	NM_000378	NM_024424		Approved	WAGR, WIT-2, AWT1	uc001mtn.2	P19544	OTTHUMG00000039556	ENST00000332351.3:c.129A>G	chr11.hg19:g.32456763T>C			A8K6S1|B3KSA5|Q15881|Q16256|Q16575|Q4VXV4|Q4VXV5|Q4VXV6|Q8IYZ5	True	hg19	CCDS7878.2																																																																																			WT1-001	KNOWN	non_ATG_start|basic|CCDS	protein_coding		protein_coding	OTTHUMT00000095436.2		25.0		-	ENST00000332351.3
ATM	472	__UNKNOWN__	__UNKNOWN__	11	108121426	108121426	__UNKNOWN__	Splice_Site	SNP	A	A	T	rs80159221|rs587782572		__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr11:108121426A>T	ENST00000452508.2	+	11	1424		c.e11-1		ATM_ENST00000278616.4_Splice_Site			Q13315	ATM_HUMAN	ATM serine/threonine kinase						brain development (GO:0007420)|cell cycle arrest (GO:0007050)|cellular response to DNA damage stimulus (GO:0006974)|cellular response to gamma radiation (GO:0071480)|DNA damage induced protein phosphorylation (GO:0006975)|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)|DNA repair (GO:0006281)|double-strand break repair (GO:0006302)|double-strand break repair via homologous recombination (GO:0000724)|heart development (GO:0007507)|histone mRNA catabolic process (GO:0071044)|intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630)|lipoprotein catabolic process (GO:0042159)|mitotic spindle assembly checkpoint (GO:0007094)|negative regulation of B cell proliferation (GO:0030889)|neuron apoptotic process (GO:0051402)|oocyte development (GO:0048599)|peptidyl-serine phosphorylation (GO:0018105)|phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092)|positive regulation of apoptotic process (GO:0043065)|positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)|positive regulation of neuron apoptotic process (GO:0043525)|pre-B cell allelic exclusion (GO:0002331)|protein autophosphorylation (GO:0046777)|protein phosphorylation (GO:0006468)|reciprocal meiotic recombination (GO:0007131)|replicative senescence (GO:0090399)|response to hypoxia (GO:0001666)|response to ionizing radiation (GO:0010212)|signal transduction (GO:0007165)|signal transduction involved in mitotic G2 DNA damage checkpoint (GO:0072434)|somitogenesis (GO:0001756)|telomere maintenance (GO:0000723)	cytoplasmic vesicle (GO:0031410)|nucleoplasm (GO:0005654)|spindle (GO:0005819)	1-phosphatidylinositol-3-kinase activity (GO:0016303)|ATP binding (GO:0005524)|DNA binding (GO:0003677)|DNA-dependent protein kinase activity (GO:0004677)|histone serine kinase activity (GO:0035174)|protein complex binding (GO:0032403)|protein dimerization activity (GO:0046983)|protein N-terminus binding (GO:0047485)|protein serine/threonine kinase activity (GO:0004674)			NS(4)|breast(23)|central_nervous_system(11)|endometrium(10)|haematopoietic_and_lymphoid_tissue(227)|kidney(19)|large_intestine(53)|liver(5)|lung(62)|ovary(6)|pancreas(4)|prostate(13)|skin(4)|stomach(1)|upper_aerodigestive_tract(3)|urinary_tract(3)	448		all_cancers(61;9.64e-12)|all_epithelial(67;9.97e-08)|Melanoma(852;2.55e-06)|Acute lymphoblastic leukemia(157;3.95e-05)|all_hematologic(158;0.00014)|Breast(348;0.0258)|all_neural(303;0.072)		Epithelial(105;9.05e-06)|BRCA - Breast invasive adenocarcinoma(274;1.06e-05)|all cancers(92;0.000208)|Colorectal(284;0.116)|OV - Ovarian serous cystadenocarcinoma(223;0.147)	Caffeine(DB00201)	TTTTTTTTTTAGGCTACAGAT	0.318			"""D, Mis, N, F, S"""		T-PLL	"""leukemia, lymphoma, medulloblastoma, glioma"""		Genes defective in diseases associated with sensitivity to DNA damaging agents	Ataxia Telangiectasia	TSP Lung(14;0.12)																												yes	Rec	yes	Ataxia-telangiectasia	11	11q22.3	472	ataxia telangiectasia mutated		"""L, O"""	0			GRCh37	CS040126	ATM	S	rs80159221						45.0	47.0	46.0					11																	108121426		2201	4295	6496	SO:0001630	splice_region_variant	Familial Cancer Database	AT, Louis-Bar syndrome	AB209133	CCDS31669.1	11q22-q23	2014-09-17	2014-06-17		ENSG00000149311	ENSG00000149311	472			795	protein-coding gene	gene with protein product	"""TEL1, telomere maintenance 1, homolog (S. cerevisiae)"""	607585	"""ataxia telangiectasia mutated (includes complementation groups A, C and D)"", ""ataxia telangiectasia mutated"""	ATA, ATDC, ATC, ATD			Standard	NM_000051	XM_005271561		Approved	TEL1, TELO1	uc001pkb.1	Q13315	OTTHUMG00000166480	ENST00000452508.2:c.1236-1A>T	chr11.hg19:g.108121426A>T			B2RNX5|O15429|Q12758|Q16551|Q93007|Q9NP02|Q9UCX7	True	hg19	CCDS31669.1	.	.	.	.	.	.	.	.	.	.	A	18.64	3.666580	0.67814	.	.	ENSG00000149311	ENST00000527805;ENST00000278616;ENST00000452508	.	.	.	5.79	5.79	0.91817	.	.	.	.	.	.	.	.	.	.	.	0.80722	D	1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	16.1113	0.81266	1.0:0.0:0.0:0.0	.	.	.	.	.	-1	.	.	.	+	.	.	ATM	107626636	1.000000	0.71417	0.993000	0.49108	0.719000	0.41307	8.809000	0.91944	2.213000	0.71641	0.482000	0.46254	.	ATM-003	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000389938.1	rs80159221	26.0	Intron	+	ENST00000452508.2
ETV6	2120	__UNKNOWN__	__UNKNOWN__	12	12006958	12006959	__UNKNOWN__	Intron	INS	-	-	G			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr12:12006958_12006959insG	ENST00000396373.4	+	4	737					NM_001987.4	NP_001978.1	P41212	ETV6_HUMAN	ets variant 6						cell differentiation (GO:0030154)|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|regulation of transcription from RNA polymerase II promoter (GO:0006357)|transcription from RNA polymerase II promoter (GO:0006366)	cytoplasm (GO:0005737)|nucleolus (GO:0005730)	protein domain specific binding (GO:0019904)|RNA polymerase II core promoter proximal region sequence-specific DNA binding (GO:0000978)|RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription (GO:0001077)|RNA polymerase II regulatory region sequence-specific DNA binding (GO:0000977)|RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription (GO:0001227)|sequence-specific DNA binding RNA polymerase II transcription factor activity (GO:0000981)|sequence-specific DNA binding transcription factor activity (GO:0003700)		ETV6/JAK2(11)|ETV6/ITPR2(2)|ETV6/NTRK3(238)	breast(3)|endometrium(1)|haematopoietic_and_lymphoid_tissue(15)|kidney(1)|large_intestine(6)|lung(10)|ovary(2)|pancreas(1)|skin(3)|upper_aerodigestive_tract(2)|urinary_tract(1)	45		all_cancers(2;1.88e-12)|Acute lymphoblastic leukemia(2;6.91e-39)|all_hematologic(2;2.7e-36)				tattacattatcatacataatg	0.406			T	"""NTRK3, RUNX1, PDGFRB, ABL1, MN1, ABL2, FACL6, CHIC2, ARNT, JAK2, EVI1, CDX2, STL, HLXB9, MDS2, PER1, SYK, TTL, FGFR3, PAX5"""	"""congenital fibrosarcoma, multiple leukemia and lymphoma,  secretory breast, MDS, ALL"""																																		Dom	yes		12	12p13	2120	ets variant gene 6 (TEL oncogene)		"""L, E, M"""	0																																										SO:0001627	intron_variant			BC043399	CCDS8643.1	12p13	2014-09-17	2008-09-12		ENSG00000139083	ENSG00000139083	2120			3495	protein-coding gene	gene with protein product	"""TEL oncogene"""	600618	"""ets variant gene 6 (TEL oncogene)"""			7731705	Standard	NM_001987	NM_001987		Approved	TEL	uc001qzz.3	P41212	OTTHUMG00000168538	ENST00000396373.4:c.463+463->G	chr12.hg19:g.12006958_12006959insG			A3QVP6|A8K076|Q9UMF6|Q9UMF7|Q9UMG0	True	hg19	CCDS8643.1																																																																																			ETV6-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000400130.2		20.0		+	ENST00000396373.4
ETV6	2120	__UNKNOWN__	__UNKNOWN__	12	12006959	12006959	__UNKNOWN__	Intron	SNP	C	C	T			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr12:12006959C>T	ENST00000396373.4	+	4	737					NM_001987.4	NP_001978.1	P41212	ETV6_HUMAN	ets variant 6						cell differentiation (GO:0030154)|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|regulation of transcription from RNA polymerase II promoter (GO:0006357)|transcription from RNA polymerase II promoter (GO:0006366)	cytoplasm (GO:0005737)|nucleolus (GO:0005730)	protein domain specific binding (GO:0019904)|RNA polymerase II core promoter proximal region sequence-specific DNA binding (GO:0000978)|RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription (GO:0001077)|RNA polymerase II regulatory region sequence-specific DNA binding (GO:0000977)|RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription (GO:0001227)|sequence-specific DNA binding RNA polymerase II transcription factor activity (GO:0000981)|sequence-specific DNA binding transcription factor activity (GO:0003700)		ETV6/JAK2(11)|ETV6/ITPR2(2)|ETV6/NTRK3(238)	breast(3)|endometrium(1)|haematopoietic_and_lymphoid_tissue(15)|kidney(1)|large_intestine(6)|lung(10)|ovary(2)|pancreas(1)|skin(3)|upper_aerodigestive_tract(2)|urinary_tract(1)	45		all_cancers(2;1.88e-12)|Acute lymphoblastic leukemia(2;6.91e-39)|all_hematologic(2;2.7e-36)				attacattatcatacataatg	0.403			T	"""NTRK3, RUNX1, PDGFRB, ABL1, MN1, ABL2, FACL6, CHIC2, ARNT, JAK2, EVI1, CDX2, STL, HLXB9, MDS2, PER1, SYK, TTL, FGFR3, PAX5"""	"""congenital fibrosarcoma, multiple leukemia and lymphoma,  secretory breast, MDS, ALL"""																																		Dom	yes		12	12p13	2120	ets variant gene 6 (TEL oncogene)		"""L, E, M"""	0																																										SO:0001627	intron_variant			BC043399	CCDS8643.1	12p13	2014-09-17	2008-09-12		ENSG00000139083	ENSG00000139083	2120			3495	protein-coding gene	gene with protein product	"""TEL oncogene"""	600618	"""ets variant gene 6 (TEL oncogene)"""			7731705	Standard	NM_001987	NM_001987		Approved	TEL	uc001qzz.3	P41212	OTTHUMG00000168538	ENST00000396373.4:c.463+464C>T	chr12.hg19:g.12006959C>T			A3QVP6|A8K076|Q9UMF6|Q9UMF7|Q9UMG0	True	hg19	CCDS8643.1																																																																																			ETV6-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000400130.2		20.0		+	ENST00000396373.4
ETV6	2120	__UNKNOWN__	__UNKNOWN__	12	12006962	12006962	__UNKNOWN__	Intron	DEL	A	A	-			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr12:12006962delA	ENST00000396373.4	+	4	737					NM_001987.4	NP_001978.1	P41212	ETV6_HUMAN	ets variant 6						cell differentiation (GO:0030154)|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|regulation of transcription from RNA polymerase II promoter (GO:0006357)|transcription from RNA polymerase II promoter (GO:0006366)	cytoplasm (GO:0005737)|nucleolus (GO:0005730)	protein domain specific binding (GO:0019904)|RNA polymerase II core promoter proximal region sequence-specific DNA binding (GO:0000978)|RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription (GO:0001077)|RNA polymerase II regulatory region sequence-specific DNA binding (GO:0000977)|RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription (GO:0001227)|sequence-specific DNA binding RNA polymerase II transcription factor activity (GO:0000981)|sequence-specific DNA binding transcription factor activity (GO:0003700)		ETV6/JAK2(11)|ETV6/ITPR2(2)|ETV6/NTRK3(238)	breast(3)|endometrium(1)|haematopoietic_and_lymphoid_tissue(15)|kidney(1)|large_intestine(6)|lung(10)|ovary(2)|pancreas(1)|skin(3)|upper_aerodigestive_tract(2)|urinary_tract(1)	45		all_cancers(2;1.88e-12)|Acute lymphoblastic leukemia(2;6.91e-39)|all_hematologic(2;2.7e-36)				acattatcatacataatgaaa	0.403			T	"""NTRK3, RUNX1, PDGFRB, ABL1, MN1, ABL2, FACL6, CHIC2, ARNT, JAK2, EVI1, CDX2, STL, HLXB9, MDS2, PER1, SYK, TTL, FGFR3, PAX5"""	"""congenital fibrosarcoma, multiple leukemia and lymphoma,  secretory breast, MDS, ALL"""																																		Dom	yes		12	12p13	2120	ets variant gene 6 (TEL oncogene)		"""L, E, M"""	0																																										SO:0001627	intron_variant			BC043399	CCDS8643.1	12p13	2014-09-17	2008-09-12		ENSG00000139083	ENSG00000139083	2120			3495	protein-coding gene	gene with protein product	"""TEL oncogene"""	600618	"""ets variant gene 6 (TEL oncogene)"""			7731705	Standard	NM_001987	NM_001987		Approved	TEL	uc001qzz.3	P41212	OTTHUMG00000168538	ENST00000396373.4:c.463+467A>-	chr12.hg19:g.12006962delA			A3QVP6|A8K076|Q9UMF6|Q9UMF7|Q9UMG0	True	hg19	CCDS8643.1																																																																																			ETV6-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000400130.2		20.0		+	ENST00000396373.4
ETV6	2120	__UNKNOWN__	__UNKNOWN__	12	12006963	12006963	__UNKNOWN__	Intron	SNP	C	C	G			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr12:12006963C>G	ENST00000396373.4	+	4	737					NM_001987.4	NP_001978.1	P41212	ETV6_HUMAN	ets variant 6						cell differentiation (GO:0030154)|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|regulation of transcription from RNA polymerase II promoter (GO:0006357)|transcription from RNA polymerase II promoter (GO:0006366)	cytoplasm (GO:0005737)|nucleolus (GO:0005730)	protein domain specific binding (GO:0019904)|RNA polymerase II core promoter proximal region sequence-specific DNA binding (GO:0000978)|RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription (GO:0001077)|RNA polymerase II regulatory region sequence-specific DNA binding (GO:0000977)|RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription (GO:0001227)|sequence-specific DNA binding RNA polymerase II transcription factor activity (GO:0000981)|sequence-specific DNA binding transcription factor activity (GO:0003700)		ETV6/JAK2(11)|ETV6/ITPR2(2)|ETV6/NTRK3(238)	breast(3)|endometrium(1)|haematopoietic_and_lymphoid_tissue(15)|kidney(1)|large_intestine(6)|lung(10)|ovary(2)|pancreas(1)|skin(3)|upper_aerodigestive_tract(2)|urinary_tract(1)	45		all_cancers(2;1.88e-12)|Acute lymphoblastic leukemia(2;6.91e-39)|all_hematologic(2;2.7e-36)				cattatcatacataatgaaat	0.403			T	"""NTRK3, RUNX1, PDGFRB, ABL1, MN1, ABL2, FACL6, CHIC2, ARNT, JAK2, EVI1, CDX2, STL, HLXB9, MDS2, PER1, SYK, TTL, FGFR3, PAX5"""	"""congenital fibrosarcoma, multiple leukemia and lymphoma,  secretory breast, MDS, ALL"""																																		Dom	yes		12	12p13	2120	ets variant gene 6 (TEL oncogene)		"""L, E, M"""	0																																										SO:0001627	intron_variant			BC043399	CCDS8643.1	12p13	2014-09-17	2008-09-12		ENSG00000139083	ENSG00000139083	2120			3495	protein-coding gene	gene with protein product	"""TEL oncogene"""	600618	"""ets variant gene 6 (TEL oncogene)"""			7731705	Standard	NM_001987	NM_001987		Approved	TEL	uc001qzz.3	P41212	OTTHUMG00000168538	ENST00000396373.4:c.463+468C>G	chr12.hg19:g.12006963C>G			A3QVP6|A8K076|Q9UMF6|Q9UMF7|Q9UMG0	True	hg19	CCDS8643.1																																																																																			ETV6-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000400130.2		20.0		+	ENST00000396373.4
ETV6	2120	__UNKNOWN__	__UNKNOWN__	12	12006970	12006970	__UNKNOWN__	Intron	SNP	A	A	T			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr12:12006970A>T	ENST00000396373.4	+	4	737					NM_001987.4	NP_001978.1	P41212	ETV6_HUMAN	ets variant 6						cell differentiation (GO:0030154)|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|regulation of transcription from RNA polymerase II promoter (GO:0006357)|transcription from RNA polymerase II promoter (GO:0006366)	cytoplasm (GO:0005737)|nucleolus (GO:0005730)	protein domain specific binding (GO:0019904)|RNA polymerase II core promoter proximal region sequence-specific DNA binding (GO:0000978)|RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription (GO:0001077)|RNA polymerase II regulatory region sequence-specific DNA binding (GO:0000977)|RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription (GO:0001227)|sequence-specific DNA binding RNA polymerase II transcription factor activity (GO:0000981)|sequence-specific DNA binding transcription factor activity (GO:0003700)		ETV6/JAK2(11)|ETV6/ITPR2(2)|ETV6/NTRK3(238)	breast(3)|endometrium(1)|haematopoietic_and_lymphoid_tissue(15)|kidney(1)|large_intestine(6)|lung(10)|ovary(2)|pancreas(1)|skin(3)|upper_aerodigestive_tract(2)|urinary_tract(1)	45		all_cancers(2;1.88e-12)|Acute lymphoblastic leukemia(2;6.91e-39)|all_hematologic(2;2.7e-36)				atacataatgaaataattata	0.408			T	"""NTRK3, RUNX1, PDGFRB, ABL1, MN1, ABL2, FACL6, CHIC2, ARNT, JAK2, EVI1, CDX2, STL, HLXB9, MDS2, PER1, SYK, TTL, FGFR3, PAX5"""	"""congenital fibrosarcoma, multiple leukemia and lymphoma,  secretory breast, MDS, ALL"""																																		Dom	yes		12	12p13	2120	ets variant gene 6 (TEL oncogene)		"""L, E, M"""	0																																										SO:0001627	intron_variant			BC043399	CCDS8643.1	12p13	2014-09-17	2008-09-12		ENSG00000139083	ENSG00000139083	2120			3495	protein-coding gene	gene with protein product	"""TEL oncogene"""	600618	"""ets variant gene 6 (TEL oncogene)"""			7731705	Standard	NM_001987	NM_001987		Approved	TEL	uc001qzz.3	P41212	OTTHUMG00000168538	ENST00000396373.4:c.463+475A>T	chr12.hg19:g.12006970A>T			A3QVP6|A8K076|Q9UMF6|Q9UMF7|Q9UMG0	True	hg19	CCDS8643.1																																																																																			ETV6-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000400130.2		20.0		+	ENST00000396373.4
ETV6	2120	__UNKNOWN__	__UNKNOWN__	12	12012031	12012031	__UNKNOWN__	Intron	SNP	G	G	A			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr12:12012031G>A	ENST00000396373.4	+	4	737					NM_001987.4	NP_001978.1	P41212	ETV6_HUMAN	ets variant 6						cell differentiation (GO:0030154)|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|regulation of transcription from RNA polymerase II promoter (GO:0006357)|transcription from RNA polymerase II promoter (GO:0006366)	cytoplasm (GO:0005737)|nucleolus (GO:0005730)	protein domain specific binding (GO:0019904)|RNA polymerase II core promoter proximal region sequence-specific DNA binding (GO:0000978)|RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription (GO:0001077)|RNA polymerase II regulatory region sequence-specific DNA binding (GO:0000977)|RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription (GO:0001227)|sequence-specific DNA binding RNA polymerase II transcription factor activity (GO:0000981)|sequence-specific DNA binding transcription factor activity (GO:0003700)		ETV6/JAK2(11)|ETV6/ITPR2(2)|ETV6/NTRK3(238)	breast(3)|endometrium(1)|haematopoietic_and_lymphoid_tissue(15)|kidney(1)|large_intestine(6)|lung(10)|ovary(2)|pancreas(1)|skin(3)|upper_aerodigestive_tract(2)|urinary_tract(1)	45		all_cancers(2;1.88e-12)|Acute lymphoblastic leukemia(2;6.91e-39)|all_hematologic(2;2.7e-36)				GATAATTAAAGAAGATGAGGT	0.383			T	"""NTRK3, RUNX1, PDGFRB, ABL1, MN1, ABL2, FACL6, CHIC2, ARNT, JAK2, EVI1, CDX2, STL, HLXB9, MDS2, PER1, SYK, TTL, FGFR3, PAX5"""	"""congenital fibrosarcoma, multiple leukemia and lymphoma,  secretory breast, MDS, ALL"""																																		Dom	yes		12	12p13	2120	ets variant gene 6 (TEL oncogene)		"""L, E, M"""	0																																										SO:0001627	intron_variant			BC043399	CCDS8643.1	12p13	2014-09-17	2008-09-12		ENSG00000139083	ENSG00000139083	2120			3495	protein-coding gene	gene with protein product	"""TEL oncogene"""	600618	"""ets variant gene 6 (TEL oncogene)"""			7731705	Standard	NM_001987	NM_001987		Approved	TEL	uc001qzz.3	P41212	OTTHUMG00000168538	ENST00000396373.4:c.463+5536G>A	chr12.hg19:g.12012031G>A			A3QVP6|A8K076|Q9UMF6|Q9UMF7|Q9UMG0	True	hg19	CCDS8643.1																																																																																			ETV6-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000400130.2		66.0		+	ENST00000396373.4
ETV6	2120	__UNKNOWN__	__UNKNOWN__	12	12012108	12012108	__UNKNOWN__	Intron	SNP	C	C	T	rs199976966		__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr12:12012108C>T	ENST00000396373.4	+	4	737					NM_001987.4	NP_001978.1	P41212	ETV6_HUMAN	ets variant 6						cell differentiation (GO:0030154)|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|regulation of transcription from RNA polymerase II promoter (GO:0006357)|transcription from RNA polymerase II promoter (GO:0006366)	cytoplasm (GO:0005737)|nucleolus (GO:0005730)	protein domain specific binding (GO:0019904)|RNA polymerase II core promoter proximal region sequence-specific DNA binding (GO:0000978)|RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription (GO:0001077)|RNA polymerase II regulatory region sequence-specific DNA binding (GO:0000977)|RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription (GO:0001227)|sequence-specific DNA binding RNA polymerase II transcription factor activity (GO:0000981)|sequence-specific DNA binding transcription factor activity (GO:0003700)		ETV6/JAK2(11)|ETV6/ITPR2(2)|ETV6/NTRK3(238)	breast(3)|endometrium(1)|haematopoietic_and_lymphoid_tissue(15)|kidney(1)|large_intestine(6)|lung(10)|ovary(2)|pancreas(1)|skin(3)|upper_aerodigestive_tract(2)|urinary_tract(1)	45		all_cancers(2;1.88e-12)|Acute lymphoblastic leukemia(2;6.91e-39)|all_hematologic(2;2.7e-36)				aggagtcttgctctgtcgccc	0.398			T	"""NTRK3, RUNX1, PDGFRB, ABL1, MN1, ABL2, FACL6, CHIC2, ARNT, JAK2, EVI1, CDX2, STL, HLXB9, MDS2, PER1, SYK, TTL, FGFR3, PAX5"""	"""congenital fibrosarcoma, multiple leukemia and lymphoma,  secretory breast, MDS, ALL"""																																		Dom	yes		12	12p13	2120	ets variant gene 6 (TEL oncogene)		"""L, E, M"""	0																																										SO:0001627	intron_variant			BC043399	CCDS8643.1	12p13	2014-09-17	2008-09-12		ENSG00000139083	ENSG00000139083	2120			3495	protein-coding gene	gene with protein product	"""TEL oncogene"""	600618	"""ets variant gene 6 (TEL oncogene)"""			7731705	Standard	NM_001987	NM_001987		Approved	TEL	uc001qzz.3	P41212	OTTHUMG00000168538	ENST00000396373.4:c.463+5613C>T	chr12.hg19:g.12012108C>T			A3QVP6|A8K076|Q9UMF6|Q9UMF7|Q9UMG0	True	hg19	CCDS8643.1																																																																																			ETV6-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000400130.2		20.0		+	ENST00000396373.4
ETV6	2120	__UNKNOWN__	__UNKNOWN__	12	12012130	12012130	__UNKNOWN__	Intron	SNP	C	C	T			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr12:12012130C>T	ENST00000396373.4	+	4	737					NM_001987.4	NP_001978.1	P41212	ETV6_HUMAN	ets variant 6						cell differentiation (GO:0030154)|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|regulation of transcription from RNA polymerase II promoter (GO:0006357)|transcription from RNA polymerase II promoter (GO:0006366)	cytoplasm (GO:0005737)|nucleolus (GO:0005730)	protein domain specific binding (GO:0019904)|RNA polymerase II core promoter proximal region sequence-specific DNA binding (GO:0000978)|RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription (GO:0001077)|RNA polymerase II regulatory region sequence-specific DNA binding (GO:0000977)|RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription (GO:0001227)|sequence-specific DNA binding RNA polymerase II transcription factor activity (GO:0000981)|sequence-specific DNA binding transcription factor activity (GO:0003700)		ETV6/JAK2(11)|ETV6/ITPR2(2)|ETV6/NTRK3(238)	breast(3)|endometrium(1)|haematopoietic_and_lymphoid_tissue(15)|kidney(1)|large_intestine(6)|lung(10)|ovary(2)|pancreas(1)|skin(3)|upper_aerodigestive_tract(2)|urinary_tract(1)	45		all_cancers(2;1.88e-12)|Acute lymphoblastic leukemia(2;6.91e-39)|all_hematologic(2;2.7e-36)				ggctggagtgcagtggtgcga	0.458			T	"""NTRK3, RUNX1, PDGFRB, ABL1, MN1, ABL2, FACL6, CHIC2, ARNT, JAK2, EVI1, CDX2, STL, HLXB9, MDS2, PER1, SYK, TTL, FGFR3, PAX5"""	"""congenital fibrosarcoma, multiple leukemia and lymphoma,  secretory breast, MDS, ALL"""																																		Dom	yes		12	12p13	2120	ets variant gene 6 (TEL oncogene)		"""L, E, M"""	0																																										SO:0001627	intron_variant			BC043399	CCDS8643.1	12p13	2014-09-17	2008-09-12		ENSG00000139083	ENSG00000139083	2120			3495	protein-coding gene	gene with protein product	"""TEL oncogene"""	600618	"""ets variant gene 6 (TEL oncogene)"""			7731705	Standard	NM_001987	NM_001987		Approved	TEL	uc001qzz.3	P41212	OTTHUMG00000168538	ENST00000396373.4:c.463+5635C>T	chr12.hg19:g.12012130C>T			A3QVP6|A8K076|Q9UMF6|Q9UMF7|Q9UMG0	True	hg19	CCDS8643.1																																																																																			ETV6-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000400130.2		24.0		+	ENST00000396373.4
ETV6	2120	__UNKNOWN__	__UNKNOWN__	12	12012138	12012138	__UNKNOWN__	Intron	SNP	C	C	T			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr12:12012138C>T	ENST00000396373.4	+	4	737					NM_001987.4	NP_001978.1	P41212	ETV6_HUMAN	ets variant 6						cell differentiation (GO:0030154)|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|regulation of transcription from RNA polymerase II promoter (GO:0006357)|transcription from RNA polymerase II promoter (GO:0006366)	cytoplasm (GO:0005737)|nucleolus (GO:0005730)	protein domain specific binding (GO:0019904)|RNA polymerase II core promoter proximal region sequence-specific DNA binding (GO:0000978)|RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription (GO:0001077)|RNA polymerase II regulatory region sequence-specific DNA binding (GO:0000977)|RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription (GO:0001227)|sequence-specific DNA binding RNA polymerase II transcription factor activity (GO:0000981)|sequence-specific DNA binding transcription factor activity (GO:0003700)		ETV6/JAK2(11)|ETV6/ITPR2(2)|ETV6/NTRK3(238)	breast(3)|endometrium(1)|haematopoietic_and_lymphoid_tissue(15)|kidney(1)|large_intestine(6)|lung(10)|ovary(2)|pancreas(1)|skin(3)|upper_aerodigestive_tract(2)|urinary_tract(1)	45		all_cancers(2;1.88e-12)|Acute lymphoblastic leukemia(2;6.91e-39)|all_hematologic(2;2.7e-36)				tgcagtggtgcgatctcggtt	0.473			T	"""NTRK3, RUNX1, PDGFRB, ABL1, MN1, ABL2, FACL6, CHIC2, ARNT, JAK2, EVI1, CDX2, STL, HLXB9, MDS2, PER1, SYK, TTL, FGFR3, PAX5"""	"""congenital fibrosarcoma, multiple leukemia and lymphoma,  secretory breast, MDS, ALL"""																																		Dom	yes		12	12p13	2120	ets variant gene 6 (TEL oncogene)		"""L, E, M"""	0																																										SO:0001627	intron_variant			BC043399	CCDS8643.1	12p13	2014-09-17	2008-09-12		ENSG00000139083	ENSG00000139083	2120			3495	protein-coding gene	gene with protein product	"""TEL oncogene"""	600618	"""ets variant gene 6 (TEL oncogene)"""			7731705	Standard	NM_001987	NM_001987		Approved	TEL	uc001qzz.3	P41212	OTTHUMG00000168538	ENST00000396373.4:c.463+5643C>T	chr12.hg19:g.12012138C>T			A3QVP6|A8K076|Q9UMF6|Q9UMF7|Q9UMG0	True	hg19	CCDS8643.1																																																																																			ETV6-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000400130.2		40.0		+	ENST00000396373.4
ETV6	2120	__UNKNOWN__	__UNKNOWN__	12	12012142	12012142	__UNKNOWN__	Intron	SNP	C	C	T			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr12:12012142C>T	ENST00000396373.4	+	4	737					NM_001987.4	NP_001978.1	P41212	ETV6_HUMAN	ets variant 6						cell differentiation (GO:0030154)|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|regulation of transcription from RNA polymerase II promoter (GO:0006357)|transcription from RNA polymerase II promoter (GO:0006366)	cytoplasm (GO:0005737)|nucleolus (GO:0005730)	protein domain specific binding (GO:0019904)|RNA polymerase II core promoter proximal region sequence-specific DNA binding (GO:0000978)|RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription (GO:0001077)|RNA polymerase II regulatory region sequence-specific DNA binding (GO:0000977)|RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription (GO:0001227)|sequence-specific DNA binding RNA polymerase II transcription factor activity (GO:0000981)|sequence-specific DNA binding transcription factor activity (GO:0003700)		ETV6/JAK2(11)|ETV6/ITPR2(2)|ETV6/NTRK3(238)	breast(3)|endometrium(1)|haematopoietic_and_lymphoid_tissue(15)|kidney(1)|large_intestine(6)|lung(10)|ovary(2)|pancreas(1)|skin(3)|upper_aerodigestive_tract(2)|urinary_tract(1)	45		all_cancers(2;1.88e-12)|Acute lymphoblastic leukemia(2;6.91e-39)|all_hematologic(2;2.7e-36)				gtggtgcgatctcggttcact	0.468			T	"""NTRK3, RUNX1, PDGFRB, ABL1, MN1, ABL2, FACL6, CHIC2, ARNT, JAK2, EVI1, CDX2, STL, HLXB9, MDS2, PER1, SYK, TTL, FGFR3, PAX5"""	"""congenital fibrosarcoma, multiple leukemia and lymphoma,  secretory breast, MDS, ALL"""																																		Dom	yes		12	12p13	2120	ets variant gene 6 (TEL oncogene)		"""L, E, M"""	0																																										SO:0001627	intron_variant			BC043399	CCDS8643.1	12p13	2014-09-17	2008-09-12		ENSG00000139083	ENSG00000139083	2120			3495	protein-coding gene	gene with protein product	"""TEL oncogene"""	600618	"""ets variant gene 6 (TEL oncogene)"""			7731705	Standard	NM_001987	NM_001987		Approved	TEL	uc001qzz.3	P41212	OTTHUMG00000168538	ENST00000396373.4:c.463+5647C>T	chr12.hg19:g.12012142C>T			A3QVP6|A8K076|Q9UMF6|Q9UMF7|Q9UMG0	True	hg19	CCDS8643.1																																																																																			ETV6-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000400130.2		44.0		+	ENST00000396373.4
ETV6	2120	__UNKNOWN__	__UNKNOWN__	12	12012144	12012144	__UNKNOWN__	Intron	SNP	C	C	T			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr12:12012144C>T	ENST00000396373.4	+	4	737					NM_001987.4	NP_001978.1	P41212	ETV6_HUMAN	ets variant 6						cell differentiation (GO:0030154)|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|regulation of transcription from RNA polymerase II promoter (GO:0006357)|transcription from RNA polymerase II promoter (GO:0006366)	cytoplasm (GO:0005737)|nucleolus (GO:0005730)	protein domain specific binding (GO:0019904)|RNA polymerase II core promoter proximal region sequence-specific DNA binding (GO:0000978)|RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription (GO:0001077)|RNA polymerase II regulatory region sequence-specific DNA binding (GO:0000977)|RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription (GO:0001227)|sequence-specific DNA binding RNA polymerase II transcription factor activity (GO:0000981)|sequence-specific DNA binding transcription factor activity (GO:0003700)		ETV6/JAK2(11)|ETV6/ITPR2(2)|ETV6/NTRK3(238)	breast(3)|endometrium(1)|haematopoietic_and_lymphoid_tissue(15)|kidney(1)|large_intestine(6)|lung(10)|ovary(2)|pancreas(1)|skin(3)|upper_aerodigestive_tract(2)|urinary_tract(1)	45		all_cancers(2;1.88e-12)|Acute lymphoblastic leukemia(2;6.91e-39)|all_hematologic(2;2.7e-36)				ggtgcgatctcggttcactgc	0.468			T	"""NTRK3, RUNX1, PDGFRB, ABL1, MN1, ABL2, FACL6, CHIC2, ARNT, JAK2, EVI1, CDX2, STL, HLXB9, MDS2, PER1, SYK, TTL, FGFR3, PAX5"""	"""congenital fibrosarcoma, multiple leukemia and lymphoma,  secretory breast, MDS, ALL"""																																		Dom	yes		12	12p13	2120	ets variant gene 6 (TEL oncogene)		"""L, E, M"""	0																																										SO:0001627	intron_variant			BC043399	CCDS8643.1	12p13	2014-09-17	2008-09-12		ENSG00000139083	ENSG00000139083	2120			3495	protein-coding gene	gene with protein product	"""TEL oncogene"""	600618	"""ets variant gene 6 (TEL oncogene)"""			7731705	Standard	NM_001987	NM_001987		Approved	TEL	uc001qzz.3	P41212	OTTHUMG00000168538	ENST00000396373.4:c.463+5649C>T	chr12.hg19:g.12012144C>T			A3QVP6|A8K076|Q9UMF6|Q9UMF7|Q9UMG0	True	hg19	CCDS8643.1																																																																																			ETV6-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000400130.2		31.0		+	ENST00000396373.4
ETV6	2120	__UNKNOWN__	__UNKNOWN__	12	12012169	12012169	__UNKNOWN__	Intron	SNP	G	G	A			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr12:12012169G>A	ENST00000396373.4	+	4	737					NM_001987.4	NP_001978.1	P41212	ETV6_HUMAN	ets variant 6						cell differentiation (GO:0030154)|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|regulation of transcription from RNA polymerase II promoter (GO:0006357)|transcription from RNA polymerase II promoter (GO:0006366)	cytoplasm (GO:0005737)|nucleolus (GO:0005730)	protein domain specific binding (GO:0019904)|RNA polymerase II core promoter proximal region sequence-specific DNA binding (GO:0000978)|RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription (GO:0001077)|RNA polymerase II regulatory region sequence-specific DNA binding (GO:0000977)|RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription (GO:0001227)|sequence-specific DNA binding RNA polymerase II transcription factor activity (GO:0000981)|sequence-specific DNA binding transcription factor activity (GO:0003700)		ETV6/JAK2(11)|ETV6/ITPR2(2)|ETV6/NTRK3(238)	breast(3)|endometrium(1)|haematopoietic_and_lymphoid_tissue(15)|kidney(1)|large_intestine(6)|lung(10)|ovary(2)|pancreas(1)|skin(3)|upper_aerodigestive_tract(2)|urinary_tract(1)	45		all_cancers(2;1.88e-12)|Acute lymphoblastic leukemia(2;6.91e-39)|all_hematologic(2;2.7e-36)				tccacctcctgggttcactcc	0.488			T	"""NTRK3, RUNX1, PDGFRB, ABL1, MN1, ABL2, FACL6, CHIC2, ARNT, JAK2, EVI1, CDX2, STL, HLXB9, MDS2, PER1, SYK, TTL, FGFR3, PAX5"""	"""congenital fibrosarcoma, multiple leukemia and lymphoma,  secretory breast, MDS, ALL"""																																		Dom	yes		12	12p13	2120	ets variant gene 6 (TEL oncogene)		"""L, E, M"""	0																																										SO:0001627	intron_variant			BC043399	CCDS8643.1	12p13	2014-09-17	2008-09-12		ENSG00000139083	ENSG00000139083	2120			3495	protein-coding gene	gene with protein product	"""TEL oncogene"""	600618	"""ets variant gene 6 (TEL oncogene)"""			7731705	Standard	NM_001987	NM_001987		Approved	TEL	uc001qzz.3	P41212	OTTHUMG00000168538	ENST00000396373.4:c.463+5674G>A	chr12.hg19:g.12012169G>A			A3QVP6|A8K076|Q9UMF6|Q9UMF7|Q9UMG0	True	hg19	CCDS8643.1																																																																																			ETV6-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000400130.2		23.0		+	ENST00000396373.4
ETV6	2120	__UNKNOWN__	__UNKNOWN__	12	12012208	12012208	__UNKNOWN__	Intron	SNP	A	A	T			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr12:12012208A>T	ENST00000396373.4	+	4	737					NM_001987.4	NP_001978.1	P41212	ETV6_HUMAN	ets variant 6						cell differentiation (GO:0030154)|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|regulation of transcription from RNA polymerase II promoter (GO:0006357)|transcription from RNA polymerase II promoter (GO:0006366)	cytoplasm (GO:0005737)|nucleolus (GO:0005730)	protein domain specific binding (GO:0019904)|RNA polymerase II core promoter proximal region sequence-specific DNA binding (GO:0000978)|RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription (GO:0001077)|RNA polymerase II regulatory region sequence-specific DNA binding (GO:0000977)|RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription (GO:0001227)|sequence-specific DNA binding RNA polymerase II transcription factor activity (GO:0000981)|sequence-specific DNA binding transcription factor activity (GO:0003700)		ETV6/JAK2(11)|ETV6/ITPR2(2)|ETV6/NTRK3(238)	breast(3)|endometrium(1)|haematopoietic_and_lymphoid_tissue(15)|kidney(1)|large_intestine(6)|lung(10)|ovary(2)|pancreas(1)|skin(3)|upper_aerodigestive_tract(2)|urinary_tract(1)	45		all_cancers(2;1.88e-12)|Acute lymphoblastic leukemia(2;6.91e-39)|all_hematologic(2;2.7e-36)				cccaagtagcagggactacag	0.562			T	"""NTRK3, RUNX1, PDGFRB, ABL1, MN1, ABL2, FACL6, CHIC2, ARNT, JAK2, EVI1, CDX2, STL, HLXB9, MDS2, PER1, SYK, TTL, FGFR3, PAX5"""	"""congenital fibrosarcoma, multiple leukemia and lymphoma,  secretory breast, MDS, ALL"""																																		Dom	yes		12	12p13	2120	ets variant gene 6 (TEL oncogene)		"""L, E, M"""	0																																										SO:0001627	intron_variant			BC043399	CCDS8643.1	12p13	2014-09-17	2008-09-12		ENSG00000139083	ENSG00000139083	2120			3495	protein-coding gene	gene with protein product	"""TEL oncogene"""	600618	"""ets variant gene 6 (TEL oncogene)"""			7731705	Standard	NM_001987	NM_001987		Approved	TEL	uc001qzz.3	P41212	OTTHUMG00000168538	ENST00000396373.4:c.463+5713A>T	chr12.hg19:g.12012208A>T			A3QVP6|A8K076|Q9UMF6|Q9UMF7|Q9UMG0	True	hg19	CCDS8643.1																																																																																			ETV6-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000400130.2		28.0		+	ENST00000396373.4
ETV6	2120	__UNKNOWN__	__UNKNOWN__	12	12012213	12012213	__UNKNOWN__	Intron	SNP	C	C	T	rs111404191	byFrequency	__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr12:12012213C>T	ENST00000396373.4	+	4	737					NM_001987.4	NP_001978.1	P41212	ETV6_HUMAN	ets variant 6						cell differentiation (GO:0030154)|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|regulation of transcription from RNA polymerase II promoter (GO:0006357)|transcription from RNA polymerase II promoter (GO:0006366)	cytoplasm (GO:0005737)|nucleolus (GO:0005730)	protein domain specific binding (GO:0019904)|RNA polymerase II core promoter proximal region sequence-specific DNA binding (GO:0000978)|RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription (GO:0001077)|RNA polymerase II regulatory region sequence-specific DNA binding (GO:0000977)|RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription (GO:0001227)|sequence-specific DNA binding RNA polymerase II transcription factor activity (GO:0000981)|sequence-specific DNA binding transcription factor activity (GO:0003700)		ETV6/JAK2(11)|ETV6/ITPR2(2)|ETV6/NTRK3(238)	breast(3)|endometrium(1)|haematopoietic_and_lymphoid_tissue(15)|kidney(1)|large_intestine(6)|lung(10)|ovary(2)|pancreas(1)|skin(3)|upper_aerodigestive_tract(2)|urinary_tract(1)	45		all_cancers(2;1.88e-12)|Acute lymphoblastic leukemia(2;6.91e-39)|all_hematologic(2;2.7e-36)				gtagcagggactacaggcatc	0.562			T	"""NTRK3, RUNX1, PDGFRB, ABL1, MN1, ABL2, FACL6, CHIC2, ARNT, JAK2, EVI1, CDX2, STL, HLXB9, MDS2, PER1, SYK, TTL, FGFR3, PAX5"""	"""congenital fibrosarcoma, multiple leukemia and lymphoma,  secretory breast, MDS, ALL"""								C|||	16	0.00319489	0.0121	0.0	5008	,	,		12506	0.0		0.0	False		,,,				2504	0.0						Dom	yes		12	12p13	2120	ets variant gene 6 (TEL oncogene)		"""L, E, M"""	0																																										SO:0001627	intron_variant			BC043399	CCDS8643.1	12p13	2014-09-17	2008-09-12		ENSG00000139083	ENSG00000139083	2120			3495	protein-coding gene	gene with protein product	"""TEL oncogene"""	600618	"""ets variant gene 6 (TEL oncogene)"""			7731705	Standard	NM_001987	NM_001987		Approved	TEL	uc001qzz.3	P41212	OTTHUMG00000168538	ENST00000396373.4:c.463+5718C>T	chr12.hg19:g.12012213C>T			A3QVP6|A8K076|Q9UMF6|Q9UMF7|Q9UMG0	True	hg19	CCDS8643.1																																																																																			ETV6-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000400130.2	rs73277184	28.0		+	ENST00000396373.4
ETV6	2120	__UNKNOWN__	__UNKNOWN__	12	12013497	12013497	__UNKNOWN__	Intron	SNP	T	T	C			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr12:12013497T>C	ENST00000396373.4	+	4	737					NM_001987.4	NP_001978.1	P41212	ETV6_HUMAN	ets variant 6						cell differentiation (GO:0030154)|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|regulation of transcription from RNA polymerase II promoter (GO:0006357)|transcription from RNA polymerase II promoter (GO:0006366)	cytoplasm (GO:0005737)|nucleolus (GO:0005730)	protein domain specific binding (GO:0019904)|RNA polymerase II core promoter proximal region sequence-specific DNA binding (GO:0000978)|RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription (GO:0001077)|RNA polymerase II regulatory region sequence-specific DNA binding (GO:0000977)|RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription (GO:0001227)|sequence-specific DNA binding RNA polymerase II transcription factor activity (GO:0000981)|sequence-specific DNA binding transcription factor activity (GO:0003700)		ETV6/JAK2(11)|ETV6/ITPR2(2)|ETV6/NTRK3(238)	breast(3)|endometrium(1)|haematopoietic_and_lymphoid_tissue(15)|kidney(1)|large_intestine(6)|lung(10)|ovary(2)|pancreas(1)|skin(3)|upper_aerodigestive_tract(2)|urinary_tract(1)	45		all_cancers(2;1.88e-12)|Acute lymphoblastic leukemia(2;6.91e-39)|all_hematologic(2;2.7e-36)				agactctgtctcaaaaaaaaa	0.363			T	"""NTRK3, RUNX1, PDGFRB, ABL1, MN1, ABL2, FACL6, CHIC2, ARNT, JAK2, EVI1, CDX2, STL, HLXB9, MDS2, PER1, SYK, TTL, FGFR3, PAX5"""	"""congenital fibrosarcoma, multiple leukemia and lymphoma,  secretory breast, MDS, ALL"""																																		Dom	yes		12	12p13	2120	ets variant gene 6 (TEL oncogene)		"""L, E, M"""	0																																										SO:0001627	intron_variant			BC043399	CCDS8643.1	12p13	2014-09-17	2008-09-12		ENSG00000139083	ENSG00000139083	2120			3495	protein-coding gene	gene with protein product	"""TEL oncogene"""	600618	"""ets variant gene 6 (TEL oncogene)"""			7731705	Standard	NM_001987	NM_001987		Approved	TEL	uc001qzz.3	P41212	OTTHUMG00000168538	ENST00000396373.4:c.463+7002T>C	chr12.hg19:g.12013497T>C			A3QVP6|A8K076|Q9UMF6|Q9UMF7|Q9UMG0	True	hg19	CCDS8643.1																																																																																			ETV6-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000400130.2		53.0		+	ENST00000396373.4
ETV6	2120	__UNKNOWN__	__UNKNOWN__	12	12014579	12014579	__UNKNOWN__	Intron	SNP	C	C	A			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr12:12014579C>A	ENST00000396373.4	+	5	737					NM_001987.4	NP_001978.1	P41212	ETV6_HUMAN	ets variant 6						cell differentiation (GO:0030154)|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|regulation of transcription from RNA polymerase II promoter (GO:0006357)|transcription from RNA polymerase II promoter (GO:0006366)	cytoplasm (GO:0005737)|nucleolus (GO:0005730)	protein domain specific binding (GO:0019904)|RNA polymerase II core promoter proximal region sequence-specific DNA binding (GO:0000978)|RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription (GO:0001077)|RNA polymerase II regulatory region sequence-specific DNA binding (GO:0000977)|RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription (GO:0001227)|sequence-specific DNA binding RNA polymerase II transcription factor activity (GO:0000981)|sequence-specific DNA binding transcription factor activity (GO:0003700)		ETV6/JAK2(11)|ETV6/ITPR2(2)|ETV6/NTRK3(238)	breast(3)|endometrium(1)|haematopoietic_and_lymphoid_tissue(15)|kidney(1)|large_intestine(6)|lung(10)|ovary(2)|pancreas(1)|skin(3)|upper_aerodigestive_tract(2)|urinary_tract(1)	45		all_cancers(2;1.88e-12)|Acute lymphoblastic leukemia(2;6.91e-39)|all_hematologic(2;2.7e-36)				ACAAGACAGGCAGGAAGTCTC	0.483			T	"""NTRK3, RUNX1, PDGFRB, ABL1, MN1, ABL2, FACL6, CHIC2, ARNT, JAK2, EVI1, CDX2, STL, HLXB9, MDS2, PER1, SYK, TTL, FGFR3, PAX5"""	"""congenital fibrosarcoma, multiple leukemia and lymphoma,  secretory breast, MDS, ALL"""																																		Dom	yes		12	12p13	2120	ets variant gene 6 (TEL oncogene)		"""L, E, M"""	0																																										SO:0001627	intron_variant			BC043399	CCDS8643.1	12p13	2014-09-17	2008-09-12		ENSG00000139083	ENSG00000139083	2120			3495	protein-coding gene	gene with protein product	"""TEL oncogene"""	600618	"""ets variant gene 6 (TEL oncogene)"""			7731705	Standard	NM_001987	NM_001987		Approved	TEL	uc001qzz.3	P41212	OTTHUMG00000168538	ENST00000396373.4:c.464-7779C>A	chr12.hg19:g.12014579C>A			A3QVP6|A8K076|Q9UMF6|Q9UMF7|Q9UMG0	True	hg19	CCDS8643.1																																																																																			ETV6-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000400130.2		21.0		+	ENST00000396373.4
ETV6	2120	__UNKNOWN__	__UNKNOWN__	12	12018183	12018183	__UNKNOWN__	Intron	SNP	T	T	C			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr12:12018183T>C	ENST00000396373.4	+	5	737					NM_001987.4	NP_001978.1	P41212	ETV6_HUMAN	ets variant 6						cell differentiation (GO:0030154)|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|regulation of transcription from RNA polymerase II promoter (GO:0006357)|transcription from RNA polymerase II promoter (GO:0006366)	cytoplasm (GO:0005737)|nucleolus (GO:0005730)	protein domain specific binding (GO:0019904)|RNA polymerase II core promoter proximal region sequence-specific DNA binding (GO:0000978)|RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription (GO:0001077)|RNA polymerase II regulatory region sequence-specific DNA binding (GO:0000977)|RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription (GO:0001227)|sequence-specific DNA binding RNA polymerase II transcription factor activity (GO:0000981)|sequence-specific DNA binding transcription factor activity (GO:0003700)		ETV6/JAK2(11)|ETV6/ITPR2(2)|ETV6/NTRK3(238)	breast(3)|endometrium(1)|haematopoietic_and_lymphoid_tissue(15)|kidney(1)|large_intestine(6)|lung(10)|ovary(2)|pancreas(1)|skin(3)|upper_aerodigestive_tract(2)|urinary_tract(1)	45		all_cancers(2;1.88e-12)|Acute lymphoblastic leukemia(2;6.91e-39)|all_hematologic(2;2.7e-36)				agactccgtctcaaaaaaaaa	0.438			T	"""NTRK3, RUNX1, PDGFRB, ABL1, MN1, ABL2, FACL6, CHIC2, ARNT, JAK2, EVI1, CDX2, STL, HLXB9, MDS2, PER1, SYK, TTL, FGFR3, PAX5"""	"""congenital fibrosarcoma, multiple leukemia and lymphoma,  secretory breast, MDS, ALL"""																																		Dom	yes		12	12p13	2120	ets variant gene 6 (TEL oncogene)		"""L, E, M"""	0																																										SO:0001627	intron_variant			BC043399	CCDS8643.1	12p13	2014-09-17	2008-09-12		ENSG00000139083	ENSG00000139083	2120			3495	protein-coding gene	gene with protein product	"""TEL oncogene"""	600618	"""ets variant gene 6 (TEL oncogene)"""			7731705	Standard	NM_001987	NM_001987		Approved	TEL	uc001qzz.3	P41212	OTTHUMG00000168538	ENST00000396373.4:c.464-4175T>C	chr12.hg19:g.12018183T>C			A3QVP6|A8K076|Q9UMF6|Q9UMF7|Q9UMG0	True	hg19	CCDS8643.1																																																																																			ETV6-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000400130.2		36.0		+	ENST00000396373.4
ETV6	2120	__UNKNOWN__	__UNKNOWN__	12	12018230	12018230	__UNKNOWN__	Intron	SNP	G	G	A			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr12:12018230G>A	ENST00000396373.4	+	5	737					NM_001987.4	NP_001978.1	P41212	ETV6_HUMAN	ets variant 6						cell differentiation (GO:0030154)|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|regulation of transcription from RNA polymerase II promoter (GO:0006357)|transcription from RNA polymerase II promoter (GO:0006366)	cytoplasm (GO:0005737)|nucleolus (GO:0005730)	protein domain specific binding (GO:0019904)|RNA polymerase II core promoter proximal region sequence-specific DNA binding (GO:0000978)|RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription (GO:0001077)|RNA polymerase II regulatory region sequence-specific DNA binding (GO:0000977)|RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription (GO:0001227)|sequence-specific DNA binding RNA polymerase II transcription factor activity (GO:0000981)|sequence-specific DNA binding transcription factor activity (GO:0003700)		ETV6/JAK2(11)|ETV6/ITPR2(2)|ETV6/NTRK3(238)	breast(3)|endometrium(1)|haematopoietic_and_lymphoid_tissue(15)|kidney(1)|large_intestine(6)|lung(10)|ovary(2)|pancreas(1)|skin(3)|upper_aerodigestive_tract(2)|urinary_tract(1)	45		all_cancers(2;1.88e-12)|Acute lymphoblastic leukemia(2;6.91e-39)|all_hematologic(2;2.7e-36)				ctcaaaaaaagactataaaat	0.373			T	"""NTRK3, RUNX1, PDGFRB, ABL1, MN1, ABL2, FACL6, CHIC2, ARNT, JAK2, EVI1, CDX2, STL, HLXB9, MDS2, PER1, SYK, TTL, FGFR3, PAX5"""	"""congenital fibrosarcoma, multiple leukemia and lymphoma,  secretory breast, MDS, ALL"""																																		Dom	yes		12	12p13	2120	ets variant gene 6 (TEL oncogene)		"""L, E, M"""	0																																										SO:0001627	intron_variant			BC043399	CCDS8643.1	12p13	2014-09-17	2008-09-12		ENSG00000139083	ENSG00000139083	2120			3495	protein-coding gene	gene with protein product	"""TEL oncogene"""	600618	"""ets variant gene 6 (TEL oncogene)"""			7731705	Standard	NM_001987	NM_001987		Approved	TEL	uc001qzz.3	P41212	OTTHUMG00000168538	ENST00000396373.4:c.464-4128G>A	chr12.hg19:g.12018230G>A			A3QVP6|A8K076|Q9UMF6|Q9UMF7|Q9UMG0	True	hg19	CCDS8643.1																																																																																			ETV6-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000400130.2		77.0		+	ENST00000396373.4
ETV6	2120	__UNKNOWN__	__UNKNOWN__	12	12018534	12018534	__UNKNOWN__	Intron	SNP	T	T	A			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr12:12018534T>A	ENST00000396373.4	+	5	737					NM_001987.4	NP_001978.1	P41212	ETV6_HUMAN	ets variant 6						cell differentiation (GO:0030154)|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|regulation of transcription from RNA polymerase II promoter (GO:0006357)|transcription from RNA polymerase II promoter (GO:0006366)	cytoplasm (GO:0005737)|nucleolus (GO:0005730)	protein domain specific binding (GO:0019904)|RNA polymerase II core promoter proximal region sequence-specific DNA binding (GO:0000978)|RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription (GO:0001077)|RNA polymerase II regulatory region sequence-specific DNA binding (GO:0000977)|RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription (GO:0001227)|sequence-specific DNA binding RNA polymerase II transcription factor activity (GO:0000981)|sequence-specific DNA binding transcription factor activity (GO:0003700)		ETV6/JAK2(11)|ETV6/ITPR2(2)|ETV6/NTRK3(238)	breast(3)|endometrium(1)|haematopoietic_and_lymphoid_tissue(15)|kidney(1)|large_intestine(6)|lung(10)|ovary(2)|pancreas(1)|skin(3)|upper_aerodigestive_tract(2)|urinary_tract(1)	45		all_cancers(2;1.88e-12)|Acute lymphoblastic leukemia(2;6.91e-39)|all_hematologic(2;2.7e-36)				ttatatatattaGCGTAGGCT	0.249			T	"""NTRK3, RUNX1, PDGFRB, ABL1, MN1, ABL2, FACL6, CHIC2, ARNT, JAK2, EVI1, CDX2, STL, HLXB9, MDS2, PER1, SYK, TTL, FGFR3, PAX5"""	"""congenital fibrosarcoma, multiple leukemia and lymphoma,  secretory breast, MDS, ALL"""																																		Dom	yes		12	12p13	2120	ets variant gene 6 (TEL oncogene)		"""L, E, M"""	0																																										SO:0001627	intron_variant			BC043399	CCDS8643.1	12p13	2014-09-17	2008-09-12		ENSG00000139083	ENSG00000139083	2120			3495	protein-coding gene	gene with protein product	"""TEL oncogene"""	600618	"""ets variant gene 6 (TEL oncogene)"""			7731705	Standard	NM_001987	NM_001987		Approved	TEL	uc001qzz.3	P41212	OTTHUMG00000168538	ENST00000396373.4:c.464-3824T>A	chr12.hg19:g.12018534T>A			A3QVP6|A8K076|Q9UMF6|Q9UMF7|Q9UMG0	True	hg19	CCDS8643.1																																																																																			ETV6-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000400130.2		35.0		+	ENST00000396373.4
ETV6	2120	__UNKNOWN__	__UNKNOWN__	12	12018538	12018538	__UNKNOWN__	Intron	SNP	G	G	C	rs556510726		__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr12:12018538G>C	ENST00000396373.4	+	5	737					NM_001987.4	NP_001978.1	P41212	ETV6_HUMAN	ets variant 6						cell differentiation (GO:0030154)|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|regulation of transcription from RNA polymerase II promoter (GO:0006357)|transcription from RNA polymerase II promoter (GO:0006366)	cytoplasm (GO:0005737)|nucleolus (GO:0005730)	protein domain specific binding (GO:0019904)|RNA polymerase II core promoter proximal region sequence-specific DNA binding (GO:0000978)|RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription (GO:0001077)|RNA polymerase II regulatory region sequence-specific DNA binding (GO:0000977)|RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription (GO:0001227)|sequence-specific DNA binding RNA polymerase II transcription factor activity (GO:0000981)|sequence-specific DNA binding transcription factor activity (GO:0003700)		ETV6/JAK2(11)|ETV6/ITPR2(2)|ETV6/NTRK3(238)	breast(3)|endometrium(1)|haematopoietic_and_lymphoid_tissue(15)|kidney(1)|large_intestine(6)|lung(10)|ovary(2)|pancreas(1)|skin(3)|upper_aerodigestive_tract(2)|urinary_tract(1)	45		all_cancers(2;1.88e-12)|Acute lymphoblastic leukemia(2;6.91e-39)|all_hematologic(2;2.7e-36)				atatattaGCGTAGGCTtata	0.249			T	"""NTRK3, RUNX1, PDGFRB, ABL1, MN1, ABL2, FACL6, CHIC2, ARNT, JAK2, EVI1, CDX2, STL, HLXB9, MDS2, PER1, SYK, TTL, FGFR3, PAX5"""	"""congenital fibrosarcoma, multiple leukemia and lymphoma,  secretory breast, MDS, ALL"""																																		Dom	yes		12	12p13	2120	ets variant gene 6 (TEL oncogene)		"""L, E, M"""	0																																										SO:0001627	intron_variant			BC043399	CCDS8643.1	12p13	2014-09-17	2008-09-12		ENSG00000139083	ENSG00000139083	2120			3495	protein-coding gene	gene with protein product	"""TEL oncogene"""	600618	"""ets variant gene 6 (TEL oncogene)"""			7731705	Standard	NM_001987	NM_001987		Approved	TEL	uc001qzz.3	P41212	OTTHUMG00000168538	ENST00000396373.4:c.464-3820G>C	chr12.hg19:g.12018538G>C			A3QVP6|A8K076|Q9UMF6|Q9UMF7|Q9UMG0	True	hg19	CCDS8643.1																																																																																			ETV6-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000400130.2		41.0		+	ENST00000396373.4
ETV6	2120	__UNKNOWN__	__UNKNOWN__	12	12018541	12018541	__UNKNOWN__	Intron	SNP	G	G	C			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr12:12018541G>C	ENST00000396373.4	+	5	737					NM_001987.4	NP_001978.1	P41212	ETV6_HUMAN	ets variant 6						cell differentiation (GO:0030154)|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|regulation of transcription from RNA polymerase II promoter (GO:0006357)|transcription from RNA polymerase II promoter (GO:0006366)	cytoplasm (GO:0005737)|nucleolus (GO:0005730)	protein domain specific binding (GO:0019904)|RNA polymerase II core promoter proximal region sequence-specific DNA binding (GO:0000978)|RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription (GO:0001077)|RNA polymerase II regulatory region sequence-specific DNA binding (GO:0000977)|RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription (GO:0001227)|sequence-specific DNA binding RNA polymerase II transcription factor activity (GO:0000981)|sequence-specific DNA binding transcription factor activity (GO:0003700)		ETV6/JAK2(11)|ETV6/ITPR2(2)|ETV6/NTRK3(238)	breast(3)|endometrium(1)|haematopoietic_and_lymphoid_tissue(15)|kidney(1)|large_intestine(6)|lung(10)|ovary(2)|pancreas(1)|skin(3)|upper_aerodigestive_tract(2)|urinary_tract(1)	45		all_cancers(2;1.88e-12)|Acute lymphoblastic leukemia(2;6.91e-39)|all_hematologic(2;2.7e-36)				tattaGCGTAGGCTtatatat	0.244			T	"""NTRK3, RUNX1, PDGFRB, ABL1, MN1, ABL2, FACL6, CHIC2, ARNT, JAK2, EVI1, CDX2, STL, HLXB9, MDS2, PER1, SYK, TTL, FGFR3, PAX5"""	"""congenital fibrosarcoma, multiple leukemia and lymphoma,  secretory breast, MDS, ALL"""																																		Dom	yes		12	12p13	2120	ets variant gene 6 (TEL oncogene)		"""L, E, M"""	0																																										SO:0001627	intron_variant			BC043399	CCDS8643.1	12p13	2014-09-17	2008-09-12		ENSG00000139083	ENSG00000139083	2120			3495	protein-coding gene	gene with protein product	"""TEL oncogene"""	600618	"""ets variant gene 6 (TEL oncogene)"""			7731705	Standard	NM_001987	NM_001987		Approved	TEL	uc001qzz.3	P41212	OTTHUMG00000168538	ENST00000396373.4:c.464-3817G>C	chr12.hg19:g.12018541G>C			A3QVP6|A8K076|Q9UMF6|Q9UMF7|Q9UMG0	True	hg19	CCDS8643.1																																																																																			ETV6-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000400130.2		38.0		+	ENST00000396373.4
ETV6	2120	__UNKNOWN__	__UNKNOWN__	12	12018570	12018570	__UNKNOWN__	Intron	SNP	T	T	A	rs536033921		__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr12:12018570T>A	ENST00000396373.4	+	5	737					NM_001987.4	NP_001978.1	P41212	ETV6_HUMAN	ets variant 6						cell differentiation (GO:0030154)|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|regulation of transcription from RNA polymerase II promoter (GO:0006357)|transcription from RNA polymerase II promoter (GO:0006366)	cytoplasm (GO:0005737)|nucleolus (GO:0005730)	protein domain specific binding (GO:0019904)|RNA polymerase II core promoter proximal region sequence-specific DNA binding (GO:0000978)|RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription (GO:0001077)|RNA polymerase II regulatory region sequence-specific DNA binding (GO:0000977)|RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription (GO:0001227)|sequence-specific DNA binding RNA polymerase II transcription factor activity (GO:0000981)|sequence-specific DNA binding transcription factor activity (GO:0003700)		ETV6/JAK2(11)|ETV6/ITPR2(2)|ETV6/NTRK3(238)	breast(3)|endometrium(1)|haematopoietic_and_lymphoid_tissue(15)|kidney(1)|large_intestine(6)|lung(10)|ovary(2)|pancreas(1)|skin(3)|upper_aerodigestive_tract(2)|urinary_tract(1)	45		all_cancers(2;1.88e-12)|Acute lymphoblastic leukemia(2;6.91e-39)|all_hematologic(2;2.7e-36)				agtatatacttatatagtatt	0.199			T	"""NTRK3, RUNX1, PDGFRB, ABL1, MN1, ABL2, FACL6, CHIC2, ARNT, JAK2, EVI1, CDX2, STL, HLXB9, MDS2, PER1, SYK, TTL, FGFR3, PAX5"""	"""congenital fibrosarcoma, multiple leukemia and lymphoma,  secretory breast, MDS, ALL"""																																		Dom	yes		12	12p13	2120	ets variant gene 6 (TEL oncogene)		"""L, E, M"""	0																																										SO:0001627	intron_variant			BC043399	CCDS8643.1	12p13	2014-09-17	2008-09-12		ENSG00000139083	ENSG00000139083	2120			3495	protein-coding gene	gene with protein product	"""TEL oncogene"""	600618	"""ets variant gene 6 (TEL oncogene)"""			7731705	Standard	NM_001987	NM_001987		Approved	TEL	uc001qzz.3	P41212	OTTHUMG00000168538	ENST00000396373.4:c.464-3788T>A	chr12.hg19:g.12018570T>A			A3QVP6|A8K076|Q9UMF6|Q9UMF7|Q9UMG0	True	hg19	CCDS8643.1																																																																																			ETV6-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000400130.2		31.0		+	ENST00000396373.4
ETV6	2120	__UNKNOWN__	__UNKNOWN__	12	12018648	12018648	__UNKNOWN__	Intron	SNP	C	C	G			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr12:12018648C>G	ENST00000396373.4	+	5	737					NM_001987.4	NP_001978.1	P41212	ETV6_HUMAN	ets variant 6						cell differentiation (GO:0030154)|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|regulation of transcription from RNA polymerase II promoter (GO:0006357)|transcription from RNA polymerase II promoter (GO:0006366)	cytoplasm (GO:0005737)|nucleolus (GO:0005730)	protein domain specific binding (GO:0019904)|RNA polymerase II core promoter proximal region sequence-specific DNA binding (GO:0000978)|RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription (GO:0001077)|RNA polymerase II regulatory region sequence-specific DNA binding (GO:0000977)|RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription (GO:0001227)|sequence-specific DNA binding RNA polymerase II transcription factor activity (GO:0000981)|sequence-specific DNA binding transcription factor activity (GO:0003700)		ETV6/JAK2(11)|ETV6/ITPR2(2)|ETV6/NTRK3(238)	breast(3)|endometrium(1)|haematopoietic_and_lymphoid_tissue(15)|kidney(1)|large_intestine(6)|lung(10)|ovary(2)|pancreas(1)|skin(3)|upper_aerodigestive_tract(2)|urinary_tract(1)	45		all_cancers(2;1.88e-12)|Acute lymphoblastic leukemia(2;6.91e-39)|all_hematologic(2;2.7e-36)				tatatatatactatatatcat	0.224			T	"""NTRK3, RUNX1, PDGFRB, ABL1, MN1, ABL2, FACL6, CHIC2, ARNT, JAK2, EVI1, CDX2, STL, HLXB9, MDS2, PER1, SYK, TTL, FGFR3, PAX5"""	"""congenital fibrosarcoma, multiple leukemia and lymphoma,  secretory breast, MDS, ALL"""																																		Dom	yes		12	12p13	2120	ets variant gene 6 (TEL oncogene)		"""L, E, M"""	0																																										SO:0001627	intron_variant			BC043399	CCDS8643.1	12p13	2014-09-17	2008-09-12		ENSG00000139083	ENSG00000139083	2120			3495	protein-coding gene	gene with protein product	"""TEL oncogene"""	600618	"""ets variant gene 6 (TEL oncogene)"""			7731705	Standard	NM_001987	NM_001987		Approved	TEL	uc001qzz.3	P41212	OTTHUMG00000168538	ENST00000396373.4:c.464-3710C>G	chr12.hg19:g.12018648C>G			A3QVP6|A8K076|Q9UMF6|Q9UMF7|Q9UMG0	True	hg19	CCDS8643.1																																																																																			ETV6-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000400130.2		49.0		+	ENST00000396373.4
ETV6	2120	__UNKNOWN__	__UNKNOWN__	12	12021376	12021376	__UNKNOWN__	Intron	SNP	T	T	C			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr12:12021376T>C	ENST00000396373.4	+	5	737					NM_001987.4	NP_001978.1	P41212	ETV6_HUMAN	ets variant 6						cell differentiation (GO:0030154)|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|regulation of transcription from RNA polymerase II promoter (GO:0006357)|transcription from RNA polymerase II promoter (GO:0006366)	cytoplasm (GO:0005737)|nucleolus (GO:0005730)	protein domain specific binding (GO:0019904)|RNA polymerase II core promoter proximal region sequence-specific DNA binding (GO:0000978)|RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription (GO:0001077)|RNA polymerase II regulatory region sequence-specific DNA binding (GO:0000977)|RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription (GO:0001227)|sequence-specific DNA binding RNA polymerase II transcription factor activity (GO:0000981)|sequence-specific DNA binding transcription factor activity (GO:0003700)		ETV6/JAK2(11)|ETV6/ITPR2(2)|ETV6/NTRK3(238)	breast(3)|endometrium(1)|haematopoietic_and_lymphoid_tissue(15)|kidney(1)|large_intestine(6)|lung(10)|ovary(2)|pancreas(1)|skin(3)|upper_aerodigestive_tract(2)|urinary_tract(1)	45		all_cancers(2;1.88e-12)|Acute lymphoblastic leukemia(2;6.91e-39)|all_hematologic(2;2.7e-36)				tttcttctttttttttttttt	0.418			T	"""NTRK3, RUNX1, PDGFRB, ABL1, MN1, ABL2, FACL6, CHIC2, ARNT, JAK2, EVI1, CDX2, STL, HLXB9, MDS2, PER1, SYK, TTL, FGFR3, PAX5"""	"""congenital fibrosarcoma, multiple leukemia and lymphoma,  secretory breast, MDS, ALL"""																																		Dom	yes		12	12p13	2120	ets variant gene 6 (TEL oncogene)		"""L, E, M"""	0																																										SO:0001627	intron_variant			BC043399	CCDS8643.1	12p13	2014-09-17	2008-09-12		ENSG00000139083	ENSG00000139083	2120			3495	protein-coding gene	gene with protein product	"""TEL oncogene"""	600618	"""ets variant gene 6 (TEL oncogene)"""			7731705	Standard	NM_001987	NM_001987		Approved	TEL	uc001qzz.3	P41212	OTTHUMG00000168538	ENST00000396373.4:c.464-982T>C	chr12.hg19:g.12021376T>C			A3QVP6|A8K076|Q9UMF6|Q9UMF7|Q9UMG0	True	hg19	CCDS8643.1																																																																																			ETV6-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000400130.2		45.0		+	ENST00000396373.4
ETV6	2120	__UNKNOWN__	__UNKNOWN__	12	12021391	12021391	__UNKNOWN__	Intron	SNP	A	A	T			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr12:12021391A>T	ENST00000396373.4	+	5	737					NM_001987.4	NP_001978.1	P41212	ETV6_HUMAN	ets variant 6						cell differentiation (GO:0030154)|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|regulation of transcription from RNA polymerase II promoter (GO:0006357)|transcription from RNA polymerase II promoter (GO:0006366)	cytoplasm (GO:0005737)|nucleolus (GO:0005730)	protein domain specific binding (GO:0019904)|RNA polymerase II core promoter proximal region sequence-specific DNA binding (GO:0000978)|RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription (GO:0001077)|RNA polymerase II regulatory region sequence-specific DNA binding (GO:0000977)|RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription (GO:0001227)|sequence-specific DNA binding RNA polymerase II transcription factor activity (GO:0000981)|sequence-specific DNA binding transcription factor activity (GO:0003700)		ETV6/JAK2(11)|ETV6/ITPR2(2)|ETV6/NTRK3(238)	breast(3)|endometrium(1)|haematopoietic_and_lymphoid_tissue(15)|kidney(1)|large_intestine(6)|lung(10)|ovary(2)|pancreas(1)|skin(3)|upper_aerodigestive_tract(2)|urinary_tract(1)	45		all_cancers(2;1.88e-12)|Acute lymphoblastic leukemia(2;6.91e-39)|all_hematologic(2;2.7e-36)				tttttttttgagacaaagttt	0.433			T	"""NTRK3, RUNX1, PDGFRB, ABL1, MN1, ABL2, FACL6, CHIC2, ARNT, JAK2, EVI1, CDX2, STL, HLXB9, MDS2, PER1, SYK, TTL, FGFR3, PAX5"""	"""congenital fibrosarcoma, multiple leukemia and lymphoma,  secretory breast, MDS, ALL"""																																		Dom	yes		12	12p13	2120	ets variant gene 6 (TEL oncogene)		"""L, E, M"""	0																																										SO:0001627	intron_variant			BC043399	CCDS8643.1	12p13	2014-09-17	2008-09-12		ENSG00000139083	ENSG00000139083	2120			3495	protein-coding gene	gene with protein product	"""TEL oncogene"""	600618	"""ets variant gene 6 (TEL oncogene)"""			7731705	Standard	NM_001987	NM_001987		Approved	TEL	uc001qzz.3	P41212	OTTHUMG00000168538	ENST00000396373.4:c.464-967A>T	chr12.hg19:g.12021391A>T			A3QVP6|A8K076|Q9UMF6|Q9UMF7|Q9UMG0	True	hg19	CCDS8643.1																																																																																			ETV6-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000400130.2		78.0		+	ENST00000396373.4
ETV6	2120	__UNKNOWN__	__UNKNOWN__	12	12021446	12021446	__UNKNOWN__	Intron	SNP	G	G	A			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr12:12021446G>A	ENST00000396373.4	+	5	737					NM_001987.4	NP_001978.1	P41212	ETV6_HUMAN	ets variant 6						cell differentiation (GO:0030154)|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|regulation of transcription from RNA polymerase II promoter (GO:0006357)|transcription from RNA polymerase II promoter (GO:0006366)	cytoplasm (GO:0005737)|nucleolus (GO:0005730)	protein domain specific binding (GO:0019904)|RNA polymerase II core promoter proximal region sequence-specific DNA binding (GO:0000978)|RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription (GO:0001077)|RNA polymerase II regulatory region sequence-specific DNA binding (GO:0000977)|RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription (GO:0001227)|sequence-specific DNA binding RNA polymerase II transcription factor activity (GO:0000981)|sequence-specific DNA binding transcription factor activity (GO:0003700)		ETV6/JAK2(11)|ETV6/ITPR2(2)|ETV6/NTRK3(238)	breast(3)|endometrium(1)|haematopoietic_and_lymphoid_tissue(15)|kidney(1)|large_intestine(6)|lung(10)|ovary(2)|pancreas(1)|skin(3)|upper_aerodigestive_tract(2)|urinary_tract(1)	45		all_cancers(2;1.88e-12)|Acute lymphoblastic leukemia(2;6.91e-39)|all_hematologic(2;2.7e-36)				atcttggctcgctgcaacctc	0.498			T	"""NTRK3, RUNX1, PDGFRB, ABL1, MN1, ABL2, FACL6, CHIC2, ARNT, JAK2, EVI1, CDX2, STL, HLXB9, MDS2, PER1, SYK, TTL, FGFR3, PAX5"""	"""congenital fibrosarcoma, multiple leukemia and lymphoma,  secretory breast, MDS, ALL"""																																		Dom	yes		12	12p13	2120	ets variant gene 6 (TEL oncogene)		"""L, E, M"""	0																																										SO:0001627	intron_variant			BC043399	CCDS8643.1	12p13	2014-09-17	2008-09-12		ENSG00000139083	ENSG00000139083	2120			3495	protein-coding gene	gene with protein product	"""TEL oncogene"""	600618	"""ets variant gene 6 (TEL oncogene)"""			7731705	Standard	NM_001987	NM_001987		Approved	TEL	uc001qzz.3	P41212	OTTHUMG00000168538	ENST00000396373.4:c.464-912G>A	chr12.hg19:g.12021446G>A			A3QVP6|A8K076|Q9UMF6|Q9UMF7|Q9UMG0	True	hg19	CCDS8643.1																																																																																			ETV6-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000400130.2		24.0		+	ENST00000396373.4
ETV6	2120	__UNKNOWN__	__UNKNOWN__	12	12021529	12021529	__UNKNOWN__	Intron	SNP	A	A	T			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr12:12021529A>T	ENST00000396373.4	+	5	737					NM_001987.4	NP_001978.1	P41212	ETV6_HUMAN	ets variant 6						cell differentiation (GO:0030154)|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|regulation of transcription from RNA polymerase II promoter (GO:0006357)|transcription from RNA polymerase II promoter (GO:0006366)	cytoplasm (GO:0005737)|nucleolus (GO:0005730)	protein domain specific binding (GO:0019904)|RNA polymerase II core promoter proximal region sequence-specific DNA binding (GO:0000978)|RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription (GO:0001077)|RNA polymerase II regulatory region sequence-specific DNA binding (GO:0000977)|RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription (GO:0001227)|sequence-specific DNA binding RNA polymerase II transcription factor activity (GO:0000981)|sequence-specific DNA binding transcription factor activity (GO:0003700)		ETV6/JAK2(11)|ETV6/ITPR2(2)|ETV6/NTRK3(238)	breast(3)|endometrium(1)|haematopoietic_and_lymphoid_tissue(15)|kidney(1)|large_intestine(6)|lung(10)|ovary(2)|pancreas(1)|skin(3)|upper_aerodigestive_tract(2)|urinary_tract(1)	45		all_cancers(2;1.88e-12)|Acute lymphoblastic leukemia(2;6.91e-39)|all_hematologic(2;2.7e-36)				gagccaccgcacccagcCAGG	0.428			T	"""NTRK3, RUNX1, PDGFRB, ABL1, MN1, ABL2, FACL6, CHIC2, ARNT, JAK2, EVI1, CDX2, STL, HLXB9, MDS2, PER1, SYK, TTL, FGFR3, PAX5"""	"""congenital fibrosarcoma, multiple leukemia and lymphoma,  secretory breast, MDS, ALL"""																																		Dom	yes		12	12p13	2120	ets variant gene 6 (TEL oncogene)		"""L, E, M"""	0																																										SO:0001627	intron_variant			BC043399	CCDS8643.1	12p13	2014-09-17	2008-09-12		ENSG00000139083	ENSG00000139083	2120			3495	protein-coding gene	gene with protein product	"""TEL oncogene"""	600618	"""ets variant gene 6 (TEL oncogene)"""			7731705	Standard	NM_001987	NM_001987		Approved	TEL	uc001qzz.3	P41212	OTTHUMG00000168538	ENST00000396373.4:c.464-829A>T	chr12.hg19:g.12021529A>T			A3QVP6|A8K076|Q9UMF6|Q9UMF7|Q9UMG0	True	hg19	CCDS8643.1																																																																																			ETV6-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000400130.2		21.0		+	ENST00000396373.4
ETV6	2120	__UNKNOWN__	__UNKNOWN__	12	12022174	12022174	__UNKNOWN__	Intron	SNP	A	A	G			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr12:12022174A>G	ENST00000396373.4	+	5	737					NM_001987.4	NP_001978.1	P41212	ETV6_HUMAN	ets variant 6						cell differentiation (GO:0030154)|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|regulation of transcription from RNA polymerase II promoter (GO:0006357)|transcription from RNA polymerase II promoter (GO:0006366)	cytoplasm (GO:0005737)|nucleolus (GO:0005730)	protein domain specific binding (GO:0019904)|RNA polymerase II core promoter proximal region sequence-specific DNA binding (GO:0000978)|RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription (GO:0001077)|RNA polymerase II regulatory region sequence-specific DNA binding (GO:0000977)|RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription (GO:0001227)|sequence-specific DNA binding RNA polymerase II transcription factor activity (GO:0000981)|sequence-specific DNA binding transcription factor activity (GO:0003700)		ETV6/JAK2(11)|ETV6/ITPR2(2)|ETV6/NTRK3(238)	breast(3)|endometrium(1)|haematopoietic_and_lymphoid_tissue(15)|kidney(1)|large_intestine(6)|lung(10)|ovary(2)|pancreas(1)|skin(3)|upper_aerodigestive_tract(2)|urinary_tract(1)	45		all_cancers(2;1.88e-12)|Acute lymphoblastic leukemia(2;6.91e-39)|all_hematologic(2;2.7e-36)				catctcaaacagaaaaaaaaa	0.493			T	"""NTRK3, RUNX1, PDGFRB, ABL1, MN1, ABL2, FACL6, CHIC2, ARNT, JAK2, EVI1, CDX2, STL, HLXB9, MDS2, PER1, SYK, TTL, FGFR3, PAX5"""	"""congenital fibrosarcoma, multiple leukemia and lymphoma,  secretory breast, MDS, ALL"""																																		Dom	yes		12	12p13	2120	ets variant gene 6 (TEL oncogene)		"""L, E, M"""	0																																										SO:0001627	intron_variant			BC043399	CCDS8643.1	12p13	2014-09-17	2008-09-12		ENSG00000139083	ENSG00000139083	2120			3495	protein-coding gene	gene with protein product	"""TEL oncogene"""	600618	"""ets variant gene 6 (TEL oncogene)"""			7731705	Standard	NM_001987	NM_001987		Approved	TEL	uc001qzz.3	P41212	OTTHUMG00000168538	ENST00000396373.4:c.464-184A>G	chr12.hg19:g.12022174A>G			A3QVP6|A8K076|Q9UMF6|Q9UMF7|Q9UMG0	True	hg19	CCDS8643.1																																																																																			ETV6-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000400130.2		36.0		+	ENST00000396373.4
KMT2D	8085	__UNKNOWN__	__UNKNOWN__	12	49420995	49420995	__UNKNOWN__	Silent	SNP	A	A	G			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr12:49420995A>G	ENST00000301067.7	-	48	14753	c.14754T>C	c.(14752-14754)ccT>ccC	p.P4918P		NM_003482.3	NP_003473.3	O14686	KMT2D_HUMAN	lysine (K)-specific methyltransferase 2D	4918	Pro-rich.				chromatin silencing (GO:0006342)|histone H3-K4 methylation (GO:0051568)|oocyte growth (GO:0001555)|oogenesis (GO:0048477)|positive regulation of cell proliferation (GO:0008284)|positive regulation of intracellular estrogen receptor signaling pathway (GO:0033148)|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|regulation of transcription, DNA-templated (GO:0006355)|response to estrogen (GO:0043627)|transcription, DNA-templated (GO:0006351)	histone methyltransferase complex (GO:0035097)|nucleus (GO:0005634)	DNA binding (GO:0003677)|histone-lysine N-methyltransferase activity (GO:0018024)|transcription regulatory region DNA binding (GO:0044212)|zinc ion binding (GO:0008270)										CCAAGGGGGAAGGGGGCGGGG	0.627																																																0													39.0	45.0	43.0					12																	49420995		1852	4042	5894	SO:0001819	synonymous_variant			AF010403	CCDS44873.1	12q13.12	2013-05-09	2013-05-09	2013-05-09	ENSG00000167548	ENSG00000167548	8085		"""Chromatin-modifying enzymes / K-methyltransferases"", ""Zinc fingers, PHD-type"""	7133	protein-coding gene	gene with protein product		602113	"""trinucleotide repeat containing 21"", ""myeloid/lymphoid or mixed-lineage leukemia 2"""	TNRC21, MLL2		9247308	Standard		NM_003482		Approved	ALR, MLL4, CAGL114		O14686	OTTHUMG00000166524	ENST00000301067.7:c.14754T>C	chr12.hg19:g.49420995A>G			O14687	True	hg19	CCDS44873.1																																																																																			KMT2D-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000390183.2		83.0		-	ENST00000301067.7
KMT2D	8085	__UNKNOWN__	__UNKNOWN__	12	49421001	49421001	__UNKNOWN__	Silent	SNP	C	C	G			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr12:49421001C>G	ENST00000301067.7	-	48	14747	c.14748G>C	c.(14746-14748)ccG>ccC	p.P4916P		NM_003482.3	NP_003473.3	O14686	KMT2D_HUMAN	lysine (K)-specific methyltransferase 2D	4916	Pro-rich.				chromatin silencing (GO:0006342)|histone H3-K4 methylation (GO:0051568)|oocyte growth (GO:0001555)|oogenesis (GO:0048477)|positive regulation of cell proliferation (GO:0008284)|positive regulation of intracellular estrogen receptor signaling pathway (GO:0033148)|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|regulation of transcription, DNA-templated (GO:0006355)|response to estrogen (GO:0043627)|transcription, DNA-templated (GO:0006351)	histone methyltransferase complex (GO:0035097)|nucleus (GO:0005634)	DNA binding (GO:0003677)|histone-lysine N-methyltransferase activity (GO:0018024)|transcription regulatory region DNA binding (GO:0044212)|zinc ion binding (GO:0008270)	p.P4916P(1)|p.P4646P(1)									GGGAAGGGGGCGGGGAGGGTT	0.637																																																2	Substitution - coding silent(2)	endometrium(2)											41.0	47.0	45.0					12																	49421001		1861	4058	5919	SO:0001819	synonymous_variant			AF010403	CCDS44873.1	12q13.12	2013-05-09	2013-05-09	2013-05-09	ENSG00000167548	ENSG00000167548	8085		"""Chromatin-modifying enzymes / K-methyltransferases"", ""Zinc fingers, PHD-type"""	7133	protein-coding gene	gene with protein product		602113	"""trinucleotide repeat containing 21"", ""myeloid/lymphoid or mixed-lineage leukemia 2"""	TNRC21, MLL2		9247308	Standard		NM_003482		Approved	ALR, MLL4, CAGL114		O14686	OTTHUMG00000166524	ENST00000301067.7:c.14748G>C	chr12.hg19:g.49421001C>G			O14687	True	hg19	CCDS44873.1																																																																																			KMT2D-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000390183.2		30.0		-	ENST00000301067.7
KMT2D	8085	__UNKNOWN__	__UNKNOWN__	12	49421108	49421108	__UNKNOWN__	Intron	SNP	G	G	A			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr12:49421108G>A	ENST00000301067.7	-	48	14643					NM_003482.3	NP_003473.3	O14686	KMT2D_HUMAN	lysine (K)-specific methyltransferase 2D						chromatin silencing (GO:0006342)|histone H3-K4 methylation (GO:0051568)|oocyte growth (GO:0001555)|oogenesis (GO:0048477)|positive regulation of cell proliferation (GO:0008284)|positive regulation of intracellular estrogen receptor signaling pathway (GO:0033148)|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|regulation of transcription, DNA-templated (GO:0006355)|response to estrogen (GO:0043627)|transcription, DNA-templated (GO:0006351)	histone methyltransferase complex (GO:0035097)|nucleus (GO:0005634)	DNA binding (GO:0003677)|histone-lysine N-methyltransferase activity (GO:0018024)|transcription regulatory region DNA binding (GO:0044212)|zinc ion binding (GO:0008270)										GGGCTCTCCTGTAGGAGGGTG	0.572																																																0													83.0	89.0	87.0					12																	49421108		1788	3841	5629	SO:0001627	intron_variant			AF010403	CCDS44873.1	12q13.12	2013-05-09	2013-05-09	2013-05-09	ENSG00000167548	ENSG00000167548	8085		"""Chromatin-modifying enzymes / K-methyltransferases"", ""Zinc fingers, PHD-type"""	7133	protein-coding gene	gene with protein product		602113	"""trinucleotide repeat containing 21"", ""myeloid/lymphoid or mixed-lineage leukemia 2"""	TNRC21, MLL2		9247308	Standard		NM_003482		Approved	ALR, MLL4, CAGL114		O14686	OTTHUMG00000166524	ENST00000301067.7:c.14644-3C>T	chr12.hg19:g.49421108G>A			O14687	True	hg19	CCDS44873.1																																																																																			KMT2D-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000390183.2		33.0		-	ENST00000301067.7
KMT2D	8085	__UNKNOWN__	__UNKNOWN__	12	49421109	49421109	__UNKNOWN__	Intron	SNP	T	T	C	rs551869111		__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr12:49421109T>C	ENST00000301067.7	-	48	14643					NM_003482.3	NP_003473.3	O14686	KMT2D_HUMAN	lysine (K)-specific methyltransferase 2D						chromatin silencing (GO:0006342)|histone H3-K4 methylation (GO:0051568)|oocyte growth (GO:0001555)|oogenesis (GO:0048477)|positive regulation of cell proliferation (GO:0008284)|positive regulation of intracellular estrogen receptor signaling pathway (GO:0033148)|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|regulation of transcription, DNA-templated (GO:0006355)|response to estrogen (GO:0043627)|transcription, DNA-templated (GO:0006351)	histone methyltransferase complex (GO:0035097)|nucleus (GO:0005634)	DNA binding (GO:0003677)|histone-lysine N-methyltransferase activity (GO:0018024)|transcription regulatory region DNA binding (GO:0044212)|zinc ion binding (GO:0008270)										GGCTCTCCTGTAGGAGGGTGC	0.567													T|||	1	0.000199681	0.0	0.0	5008	,	,		12708	0.001		0.0	False		,,,				2504	0.0															0													81.0	88.0	86.0					12																	49421109		1794	3832	5626	SO:0001627	intron_variant			AF010403	CCDS44873.1	12q13.12	2013-05-09	2013-05-09	2013-05-09	ENSG00000167548	ENSG00000167548	8085		"""Chromatin-modifying enzymes / K-methyltransferases"", ""Zinc fingers, PHD-type"""	7133	protein-coding gene	gene with protein product		602113	"""trinucleotide repeat containing 21"", ""myeloid/lymphoid or mixed-lineage leukemia 2"""	TNRC21, MLL2		9247308	Standard		NM_003482		Approved	ALR, MLL4, CAGL114		O14686	OTTHUMG00000166524	ENST00000301067.7:c.14644-4A>G	chr12.hg19:g.49421109T>C			O14687	True	hg19	CCDS44873.1																																																																																			KMT2D-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000390183.2		27.0		-	ENST00000301067.7
KMT2D	8085	__UNKNOWN__	__UNKNOWN__	12	49424130	49424130	__UNKNOWN__	Silent	SNP	T	T	G			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr12:49424130T>G	ENST00000301067.7	-	42	13931	c.13932A>C	c.(13930-13932)ccA>ccC	p.P4644P		NM_003482.3	NP_003473.3	O14686	KMT2D_HUMAN	lysine (K)-specific methyltransferase 2D	4644					chromatin silencing (GO:0006342)|histone H3-K4 methylation (GO:0051568)|oocyte growth (GO:0001555)|oogenesis (GO:0048477)|positive regulation of cell proliferation (GO:0008284)|positive regulation of intracellular estrogen receptor signaling pathway (GO:0033148)|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|regulation of transcription, DNA-templated (GO:0006355)|response to estrogen (GO:0043627)|transcription, DNA-templated (GO:0006351)	histone methyltransferase complex (GO:0035097)|nucleus (GO:0005634)	DNA binding (GO:0003677)|histone-lysine N-methyltransferase activity (GO:0018024)|transcription regulatory region DNA binding (GO:0044212)|zinc ion binding (GO:0008270)										GCTCTTCAGATGGGGTGACGC	0.627																																																0													21.0	22.0	21.0					12																	49424130		1887	4122	6009	SO:0001819	synonymous_variant			AF010403	CCDS44873.1	12q13.12	2013-05-09	2013-05-09	2013-05-09	ENSG00000167548	ENSG00000167548	8085		"""Chromatin-modifying enzymes / K-methyltransferases"", ""Zinc fingers, PHD-type"""	7133	protein-coding gene	gene with protein product		602113	"""trinucleotide repeat containing 21"", ""myeloid/lymphoid or mixed-lineage leukemia 2"""	TNRC21, MLL2		9247308	Standard		NM_003482		Approved	ALR, MLL4, CAGL114		O14686	OTTHUMG00000166524	ENST00000301067.7:c.13932A>C	chr12.hg19:g.49424130T>G			O14687	True	hg19	CCDS44873.1																																																																																			KMT2D-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000390183.2		20.0		-	ENST00000301067.7
KMT2D	8085	__UNKNOWN__	__UNKNOWN__	12	49424165	49424165	__UNKNOWN__	Missense_Mutation	SNP	A	A	G			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr12:49424165A>G	ENST00000301067.7	-	42	13896	c.13897T>C	c.(13897-13899)Tcg>Ccg	p.S4633P		NM_003482.3	NP_003473.3	O14686	KMT2D_HUMAN	lysine (K)-specific methyltransferase 2D	4633					chromatin silencing (GO:0006342)|histone H3-K4 methylation (GO:0051568)|oocyte growth (GO:0001555)|oogenesis (GO:0048477)|positive regulation of cell proliferation (GO:0008284)|positive regulation of intracellular estrogen receptor signaling pathway (GO:0033148)|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|regulation of transcription, DNA-templated (GO:0006355)|response to estrogen (GO:0043627)|transcription, DNA-templated (GO:0006351)	histone methyltransferase complex (GO:0035097)|nucleus (GO:0005634)	DNA binding (GO:0003677)|histone-lysine N-methyltransferase activity (GO:0018024)|transcription regulatory region DNA binding (GO:0044212)|zinc ion binding (GO:0008270)										TGCTGCACCGATGGGGGTGGG	0.627																																																0													13.0	14.0	14.0					12																	49424165		1841	4084	5925	SO:0001583	missense			AF010403	CCDS44873.1	12q13.12	2013-05-09	2013-05-09	2013-05-09	ENSG00000167548	ENSG00000167548	8085		"""Chromatin-modifying enzymes / K-methyltransferases"", ""Zinc fingers, PHD-type"""	7133	protein-coding gene	gene with protein product		602113	"""trinucleotide repeat containing 21"", ""myeloid/lymphoid or mixed-lineage leukemia 2"""	TNRC21, MLL2		9247308	Standard		NM_003482		Approved	ALR, MLL4, CAGL114		O14686	OTTHUMG00000166524	ENST00000301067.7:c.13897T>C	chr12.hg19:g.49424165A>G	ENSP00000301067:p.Ser4633Pro		O14687	True	hg19	CCDS44873.1	.	.	.	.	.	.	.	.	.	.	A	11.62	1.692056	0.30052	.	.	ENSG00000167548	ENST00000301067	T	0.80909	-1.43	5.58	5.58	0.84498	.	0.000000	0.33438	N	0.004904	T	0.74935	0.3782	L	0.43152	1.355	0.58432	D	0.999993	P	0.48503	0.911	B	0.39805	0.31	T	0.79514	-0.1772	10	0.87932	D	0	.	15.0503	0.71862	1.0:0.0:0.0:0.0	.	4633	O14686	MLL2_HUMAN	P	4633	ENSP00000301067:S4633P	ENSP00000301067:S4633P	S	-	1	0	MLL2	47710432	0.984000	0.35163	1.000000	0.80357	0.999000	0.98932	1.844000	0.39269	2.269000	0.75478	0.533000	0.62120	TCG	KMT2D-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000390183.2		33.0		-	ENST00000301067.7
KMT2D	8085	__UNKNOWN__	__UNKNOWN__	12	49424190	49424190	__UNKNOWN__	Silent	SNP	C	C	G			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr12:49424190C>G	ENST00000301067.7	-	42	13871	c.13872G>C	c.(13870-13872)tcG>tcC	p.S4624S		NM_003482.3	NP_003473.3	O14686	KMT2D_HUMAN	lysine (K)-specific methyltransferase 2D	4624					chromatin silencing (GO:0006342)|histone H3-K4 methylation (GO:0051568)|oocyte growth (GO:0001555)|oogenesis (GO:0048477)|positive regulation of cell proliferation (GO:0008284)|positive regulation of intracellular estrogen receptor signaling pathway (GO:0033148)|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|regulation of transcription, DNA-templated (GO:0006355)|response to estrogen (GO:0043627)|transcription, DNA-templated (GO:0006351)	histone methyltransferase complex (GO:0035097)|nucleus (GO:0005634)	DNA binding (GO:0003677)|histone-lysine N-methyltransferase activity (GO:0018024)|transcription regulatory region DNA binding (GO:0044212)|zinc ion binding (GO:0008270)										GGGGCAGCGACGAGGGTGGTG	0.617																																																0													11.0	12.0	12.0					12																	49424190		1832	4073	5905	SO:0001819	synonymous_variant			AF010403	CCDS44873.1	12q13.12	2013-05-09	2013-05-09	2013-05-09	ENSG00000167548	ENSG00000167548	8085		"""Chromatin-modifying enzymes / K-methyltransferases"", ""Zinc fingers, PHD-type"""	7133	protein-coding gene	gene with protein product		602113	"""trinucleotide repeat containing 21"", ""myeloid/lymphoid or mixed-lineage leukemia 2"""	TNRC21, MLL2		9247308	Standard		NM_003482		Approved	ALR, MLL4, CAGL114		O14686	OTTHUMG00000166524	ENST00000301067.7:c.13872G>C	chr12.hg19:g.49424190C>G			O14687	True	hg19	CCDS44873.1																																																																																			KMT2D-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000390183.2		32.0		-	ENST00000301067.7
KMT2D	8085	__UNKNOWN__	__UNKNOWN__	12	49424192	49424192	__UNKNOWN__	Missense_Mutation	SNP	A	A	G			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr12:49424192A>G	ENST00000301067.7	-	42	13869	c.13870T>C	c.(13870-13872)Tcg>Ccg	p.S4624P		NM_003482.3	NP_003473.3	O14686	KMT2D_HUMAN	lysine (K)-specific methyltransferase 2D	4624					chromatin silencing (GO:0006342)|histone H3-K4 methylation (GO:0051568)|oocyte growth (GO:0001555)|oogenesis (GO:0048477)|positive regulation of cell proliferation (GO:0008284)|positive regulation of intracellular estrogen receptor signaling pathway (GO:0033148)|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|regulation of transcription, DNA-templated (GO:0006355)|response to estrogen (GO:0043627)|transcription, DNA-templated (GO:0006351)	histone methyltransferase complex (GO:0035097)|nucleus (GO:0005634)	DNA binding (GO:0003677)|histone-lysine N-methyltransferase activity (GO:0018024)|transcription regulatory region DNA binding (GO:0044212)|zinc ion binding (GO:0008270)										GGCAGCGACGAGGGTGGTGTC	0.617																																																0													11.0	12.0	12.0					12																	49424192		1825	4079	5904	SO:0001583	missense			AF010403	CCDS44873.1	12q13.12	2013-05-09	2013-05-09	2013-05-09	ENSG00000167548	ENSG00000167548	8085		"""Chromatin-modifying enzymes / K-methyltransferases"", ""Zinc fingers, PHD-type"""	7133	protein-coding gene	gene with protein product		602113	"""trinucleotide repeat containing 21"", ""myeloid/lymphoid or mixed-lineage leukemia 2"""	TNRC21, MLL2		9247308	Standard		NM_003482		Approved	ALR, MLL4, CAGL114		O14686	OTTHUMG00000166524	ENST00000301067.7:c.13870T>C	chr12.hg19:g.49424192A>G	ENSP00000301067:p.Ser4624Pro		O14687	True	hg19	CCDS44873.1	.	.	.	.	.	.	.	.	.	.	A	10.12	1.262745	0.23051	.	.	ENSG00000167548	ENST00000301067	D	0.82619	-1.63	5.45	5.45	0.79879	.	0.000000	0.33438	N	0.004904	D	0.87877	0.6288	L	0.56769	1.78	0.48288	D	0.999629	D	0.89917	1.0	D	0.71870	0.975	D	0.88564	0.3125	10	0.87932	D	0	.	10.11	0.42557	0.8503:0.0:0.0:0.1497	.	4624	O14686	MLL2_HUMAN	P	4624	ENSP00000301067:S4624P	ENSP00000301067:S4624P	S	-	1	0	MLL2	47710459	0.707000	0.27866	1.000000	0.80357	0.998000	0.95712	1.239000	0.32719	2.215000	0.71742	0.459000	0.35465	TCG	KMT2D-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000390183.2		41.0		-	ENST00000301067.7
KMT2D	8085	__UNKNOWN__	__UNKNOWN__	12	49424224	49424224	__UNKNOWN__	Splice_Site	SNP	T	T	G			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr12:49424224T>G	ENST00000301067.7	-	42	13839		c.e42-2			NM_003482.3	NP_003473.3	O14686	KMT2D_HUMAN	lysine (K)-specific methyltransferase 2D						chromatin silencing (GO:0006342)|histone H3-K4 methylation (GO:0051568)|oocyte growth (GO:0001555)|oogenesis (GO:0048477)|positive regulation of cell proliferation (GO:0008284)|positive regulation of intracellular estrogen receptor signaling pathway (GO:0033148)|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|regulation of transcription, DNA-templated (GO:0006355)|response to estrogen (GO:0043627)|transcription, DNA-templated (GO:0006351)	histone methyltransferase complex (GO:0035097)|nucleus (GO:0005634)	DNA binding (GO:0003677)|histone-lysine N-methyltransferase activity (GO:0018024)|transcription regulatory region DNA binding (GO:0044212)|zinc ion binding (GO:0008270)										CAGGTTATTCTGAGGGGTGGG	0.567																																																0													6.0	7.0	7.0					12																	49424224		1806	4049	5855	SO:0001630	splice_region_variant			AF010403	CCDS44873.1	12q13.12	2013-05-09	2013-05-09	2013-05-09	ENSG00000167548	ENSG00000167548	8085		"""Chromatin-modifying enzymes / K-methyltransferases"", ""Zinc fingers, PHD-type"""	7133	protein-coding gene	gene with protein product		602113	"""trinucleotide repeat containing 21"", ""myeloid/lymphoid or mixed-lineage leukemia 2"""	TNRC21, MLL2		9247308	Standard		NM_003482		Approved	ALR, MLL4, CAGL114		O14686	OTTHUMG00000166524	ENST00000301067.7:c.13840-2A>C	chr12.hg19:g.49424224T>G			O14687	True	hg19	CCDS44873.1	.	.	.	.	.	.	.	.	.	.	T	17.08	3.297769	0.60086	.	.	ENSG00000167548	ENST00000301067	.	.	.	5.45	5.45	0.79879	.	.	.	.	.	.	.	.	.	.	.	0.80722	D	1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	14.8043	0.69942	0.0:0.0:0.0:1.0	.	.	.	.	.	-1	.	.	.	-	.	.	MLL2	47710491	1.000000	0.71417	1.000000	0.80357	0.984000	0.73092	7.935000	0.87658	2.215000	0.71742	0.459000	0.35465	.	KMT2D-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000390183.2		21.0	Intron	-	ENST00000301067.7
KMT2D	8085	__UNKNOWN__	__UNKNOWN__	12	49424226	49424226	__UNKNOWN__	Intron	SNP	A	A	G			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr12:49424226A>G	ENST00000301067.7	-	42	13839					NM_003482.3	NP_003473.3	O14686	KMT2D_HUMAN	lysine (K)-specific methyltransferase 2D						chromatin silencing (GO:0006342)|histone H3-K4 methylation (GO:0051568)|oocyte growth (GO:0001555)|oogenesis (GO:0048477)|positive regulation of cell proliferation (GO:0008284)|positive regulation of intracellular estrogen receptor signaling pathway (GO:0033148)|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|regulation of transcription, DNA-templated (GO:0006355)|response to estrogen (GO:0043627)|transcription, DNA-templated (GO:0006351)	histone methyltransferase complex (GO:0035097)|nucleus (GO:0005634)	DNA binding (GO:0003677)|histone-lysine N-methyltransferase activity (GO:0018024)|transcription regulatory region DNA binding (GO:0044212)|zinc ion binding (GO:0008270)										GGTTATTCTGAGGGGTGGGGG	0.577																																																0													5.0	6.0	6.0					12																	49424226		1797	4043	5840	SO:0001627	intron_variant			AF010403	CCDS44873.1	12q13.12	2013-05-09	2013-05-09	2013-05-09	ENSG00000167548	ENSG00000167548	8085		"""Chromatin-modifying enzymes / K-methyltransferases"", ""Zinc fingers, PHD-type"""	7133	protein-coding gene	gene with protein product		602113	"""trinucleotide repeat containing 21"", ""myeloid/lymphoid or mixed-lineage leukemia 2"""	TNRC21, MLL2		9247308	Standard		NM_003482		Approved	ALR, MLL4, CAGL114		O14686	OTTHUMG00000166524	ENST00000301067.7:c.13840-4T>C	chr12.hg19:g.49424226A>G			O14687	True	hg19	CCDS44873.1																																																																																			KMT2D-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000390183.2		83.0		-	ENST00000301067.7
KMT2D	8085	__UNKNOWN__	__UNKNOWN__	12	49426906	49426908	__UNKNOWN__	In_Frame_Del	DEL	TGC	TGC	-			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr12:49426906_49426908delTGC	ENST00000301067.7	-	39	11579_11581	c.11580_11582delGCA	c.(11578-11583)cagcaa>caa	p.3860_3861QQ>Q		NM_003482.3	NP_003473.3	O14686	KMT2D_HUMAN	lysine (K)-specific methyltransferase 2D	3860	Gln-rich.				chromatin silencing (GO:0006342)|histone H3-K4 methylation (GO:0051568)|oocyte growth (GO:0001555)|oogenesis (GO:0048477)|positive regulation of cell proliferation (GO:0008284)|positive regulation of intracellular estrogen receptor signaling pathway (GO:0033148)|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|regulation of transcription, DNA-templated (GO:0006355)|response to estrogen (GO:0043627)|transcription, DNA-templated (GO:0006351)	histone methyltransferase complex (GO:0035097)|nucleus (GO:0005634)	DNA binding (GO:0003677)|histone-lysine N-methyltransferase activity (GO:0018024)|transcription regulatory region DNA binding (GO:0044212)|zinc ion binding (GO:0008270)										gtgctgttgttgctgctgctgct	0.611																																																0																																										SO:0001651	inframe_deletion			AF010403	CCDS44873.1	12q13.12	2013-05-09	2013-05-09	2013-05-09	ENSG00000167548	ENSG00000167548	8085		"""Chromatin-modifying enzymes / K-methyltransferases"", ""Zinc fingers, PHD-type"""	7133	protein-coding gene	gene with protein product		602113	"""trinucleotide repeat containing 21"", ""myeloid/lymphoid or mixed-lineage leukemia 2"""	TNRC21, MLL2		9247308	Standard		NM_003482		Approved	ALR, MLL4, CAGL114		O14686	OTTHUMG00000166524	ENST00000301067.7:c.11580_11582delGCA	chr12.hg19:g.49426915_49426917delTGC	ENSP00000301067:p.Gln3863del		O14687	True	hg19	CCDS44873.1																																																																																			KMT2D-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000390183.2		40.0		-	ENST00000301067.7
KMT2D	8085	__UNKNOWN__	__UNKNOWN__	12	49427047	49427047	__UNKNOWN__	Missense_Mutation	SNP	T	T	G			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr12:49427047T>G	ENST00000301067.7	-	39	11440	c.11441A>C	c.(11440-11442)cAc>cCc	p.H3814P		NM_003482.3	NP_003473.3	O14686	KMT2D_HUMAN	lysine (K)-specific methyltransferase 2D	3814	Gln-rich.				chromatin silencing (GO:0006342)|histone H3-K4 methylation (GO:0051568)|oocyte growth (GO:0001555)|oogenesis (GO:0048477)|positive regulation of cell proliferation (GO:0008284)|positive regulation of intracellular estrogen receptor signaling pathway (GO:0033148)|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|regulation of transcription, DNA-templated (GO:0006355)|response to estrogen (GO:0043627)|transcription, DNA-templated (GO:0006351)	histone methyltransferase complex (GO:0035097)|nucleus (GO:0005634)	DNA binding (GO:0003677)|histone-lysine N-methyltransferase activity (GO:0018024)|transcription regulatory region DNA binding (GO:0044212)|zinc ion binding (GO:0008270)										AGCTCCAGGGTGCTGCTGCTG	0.682																																																0													9.0	10.0	10.0					12																	49427047		1880	4082	5962	SO:0001583	missense			AF010403	CCDS44873.1	12q13.12	2013-05-09	2013-05-09	2013-05-09	ENSG00000167548	ENSG00000167548	8085		"""Chromatin-modifying enzymes / K-methyltransferases"", ""Zinc fingers, PHD-type"""	7133	protein-coding gene	gene with protein product		602113	"""trinucleotide repeat containing 21"", ""myeloid/lymphoid or mixed-lineage leukemia 2"""	TNRC21, MLL2		9247308	Standard		NM_003482		Approved	ALR, MLL4, CAGL114		O14686	OTTHUMG00000166524	ENST00000301067.7:c.11441A>C	chr12.hg19:g.49427047T>G	ENSP00000301067:p.His3814Pro		O14687	True	hg19	CCDS44873.1	.	.	.	.	.	.	.	.	.	.	T	10.57	1.387043	0.25031	.	.	ENSG00000167548	ENST00000301067	T	0.79749	-1.3	5.21	5.21	0.72293	.	0.000000	0.36519	N	0.002547	T	0.72708	0.3494	N	0.04508	-0.205	0.40333	D	0.978946	D	0.67145	0.996	P	0.53649	0.731	T	0.80839	-0.1203	10	0.87932	D	0	.	14.3536	0.66722	0.0:0.0:0.0:1.0	.	3814	O14686	MLL2_HUMAN	P	3814	ENSP00000301067:H3814P	ENSP00000301067:H3814P	H	-	2	0	MLL2	47713314	0.942000	0.31987	0.995000	0.50966	0.941000	0.58515	1.083000	0.30815	2.093000	0.63338	0.460000	0.39030	CAC	KMT2D-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000390183.2		24.0		-	ENST00000301067.7
KMT2D	8085	__UNKNOWN__	__UNKNOWN__	12	49427302	49427302	__UNKNOWN__	Missense_Mutation	SNP	T	T	A			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr12:49427302T>A	ENST00000301067.7	-	39	11185	c.11186A>T	c.(11185-11187)cAg>cTg	p.Q3729L		NM_003482.3	NP_003473.3	O14686	KMT2D_HUMAN	lysine (K)-specific methyltransferase 2D	3729	Gln-rich.				chromatin silencing (GO:0006342)|histone H3-K4 methylation (GO:0051568)|oocyte growth (GO:0001555)|oogenesis (GO:0048477)|positive regulation of cell proliferation (GO:0008284)|positive regulation of intracellular estrogen receptor signaling pathway (GO:0033148)|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|regulation of transcription, DNA-templated (GO:0006355)|response to estrogen (GO:0043627)|transcription, DNA-templated (GO:0006351)	histone methyltransferase complex (GO:0035097)|nucleus (GO:0005634)	DNA binding (GO:0003677)|histone-lysine N-methyltransferase activity (GO:0018024)|transcription regulatory region DNA binding (GO:0044212)|zinc ion binding (GO:0008270)										CTGGGCCAGCTGCATACGTTG	0.582																																																0													19.0	23.0	21.0					12																	49427302		2193	4291	6484	SO:0001583	missense			AF010403	CCDS44873.1	12q13.12	2013-05-09	2013-05-09	2013-05-09	ENSG00000167548	ENSG00000167548	8085		"""Chromatin-modifying enzymes / K-methyltransferases"", ""Zinc fingers, PHD-type"""	7133	protein-coding gene	gene with protein product		602113	"""trinucleotide repeat containing 21"", ""myeloid/lymphoid or mixed-lineage leukemia 2"""	TNRC21, MLL2		9247308	Standard		NM_003482		Approved	ALR, MLL4, CAGL114		O14686	OTTHUMG00000166524	ENST00000301067.7:c.11186A>T	chr12.hg19:g.49427302T>A	ENSP00000301067:p.Gln3729Leu		O14687	True	hg19	CCDS44873.1	.	.	.	.	.	.	.	.	.	.	T	9.844	1.191855	0.21954	.	.	ENSG00000167548	ENST00000301067	D	0.83837	-1.77	5.11	5.11	0.69529	.	0.000000	0.33199	N	0.005177	T	0.77916	0.4202	N	0.24115	0.695	0.41089	D	0.985585	P	0.52577	0.954	P	0.47206	0.541	T	0.82080	-0.0634	10	0.87932	D	0	.	14.1821	0.65580	0.0:0.0:0.0:1.0	.	3729	O14686	MLL2_HUMAN	L	3729	ENSP00000301067:Q3729L	ENSP00000301067:Q3729L	Q	-	2	0	MLL2	47713569	1.000000	0.71417	0.998000	0.56505	0.899000	0.52679	7.266000	0.78452	2.059000	0.61396	0.379000	0.24179	CAG	KMT2D-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000390183.2		22.0		-	ENST00000301067.7
KMT2D	8085	__UNKNOWN__	__UNKNOWN__	12	49434590	49434590	__UNKNOWN__	Silent	SNP	T	T	C			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr12:49434590T>C	ENST00000301067.7	-	31	6962	c.6963A>G	c.(6961-6963)ttA>ttG	p.L2321L		NM_003482.3	NP_003473.3	O14686	KMT2D_HUMAN	lysine (K)-specific methyltransferase 2D	2321	Pro-rich.				chromatin silencing (GO:0006342)|histone H3-K4 methylation (GO:0051568)|oocyte growth (GO:0001555)|oogenesis (GO:0048477)|positive regulation of cell proliferation (GO:0008284)|positive regulation of intracellular estrogen receptor signaling pathway (GO:0033148)|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|regulation of transcription, DNA-templated (GO:0006355)|response to estrogen (GO:0043627)|transcription, DNA-templated (GO:0006351)	histone methyltransferase complex (GO:0035097)|nucleus (GO:0005634)	DNA binding (GO:0003677)|histone-lysine N-methyltransferase activity (GO:0018024)|transcription regulatory region DNA binding (GO:0044212)|zinc ion binding (GO:0008270)										CAGGTGTCTTTAACTCCAGGC	0.627																																																0													22.0	25.0	24.0					12																	49434590		1843	4089	5932	SO:0001819	synonymous_variant			AF010403	CCDS44873.1	12q13.12	2013-05-09	2013-05-09	2013-05-09	ENSG00000167548	ENSG00000167548	8085		"""Chromatin-modifying enzymes / K-methyltransferases"", ""Zinc fingers, PHD-type"""	7133	protein-coding gene	gene with protein product		602113	"""trinucleotide repeat containing 21"", ""myeloid/lymphoid or mixed-lineage leukemia 2"""	TNRC21, MLL2		9247308	Standard		NM_003482		Approved	ALR, MLL4, CAGL114		O14686	OTTHUMG00000166524	ENST00000301067.7:c.6963A>G	chr12.hg19:g.49434590T>C			O14687	True	hg19	CCDS44873.1																																																																																			KMT2D-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000390183.2		31.0		-	ENST00000301067.7
KMT2D	8085	__UNKNOWN__	__UNKNOWN__	12	49435198	49435198	__UNKNOWN__	Missense_Mutation	SNP	C	C	G			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr12:49435198C>G	ENST00000301067.7	-	31	6354	c.6355G>C	c.(6355-6357)Gct>Cct	p.A2119P		NM_003482.3	NP_003473.3	O14686	KMT2D_HUMAN	lysine (K)-specific methyltransferase 2D	2119	Pro-rich.				chromatin silencing (GO:0006342)|histone H3-K4 methylation (GO:0051568)|oocyte growth (GO:0001555)|oogenesis (GO:0048477)|positive regulation of cell proliferation (GO:0008284)|positive regulation of intracellular estrogen receptor signaling pathway (GO:0033148)|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|regulation of transcription, DNA-templated (GO:0006355)|response to estrogen (GO:0043627)|transcription, DNA-templated (GO:0006351)	histone methyltransferase complex (GO:0035097)|nucleus (GO:0005634)	DNA binding (GO:0003677)|histone-lysine N-methyltransferase activity (GO:0018024)|transcription regulatory region DNA binding (GO:0044212)|zinc ion binding (GO:0008270)	p.A2119fs*36(1)|p.A1849fs*36(1)									GGGGCAGCAGCGGGGGGCGGG	0.692																																																2	Insertion - Frameshift(2)	central_nervous_system(2)											15.0	17.0	17.0					12																	49435198		1846	4040	5886	SO:0001583	missense			AF010403	CCDS44873.1	12q13.12	2013-05-09	2013-05-09	2013-05-09	ENSG00000167548	ENSG00000167548	8085		"""Chromatin-modifying enzymes / K-methyltransferases"", ""Zinc fingers, PHD-type"""	7133	protein-coding gene	gene with protein product		602113	"""trinucleotide repeat containing 21"", ""myeloid/lymphoid or mixed-lineage leukemia 2"""	TNRC21, MLL2		9247308	Standard		NM_003482		Approved	ALR, MLL4, CAGL114		O14686	OTTHUMG00000166524	ENST00000301067.7:c.6355G>C	chr12.hg19:g.49435198C>G	ENSP00000301067:p.Ala2119Pro		O14687	True	hg19	CCDS44873.1	.	.	.	.	.	.	.	.	.	.	C	8.975	0.973788	0.18736	.	.	ENSG00000167548	ENST00000301067	T	0.79940	-1.32	4.14	4.14	0.48551	.	0.000000	0.32769	N	0.005666	T	0.78052	0.4223	N	0.08118	0	0.28412	N	0.918121	D	0.76494	0.999	P	0.62298	0.9	T	0.75590	-0.3265	10	0.87932	D	0	.	16.3809	0.83461	0.0:1.0:0.0:0.0	.	2119	O14686	MLL2_HUMAN	P	2119	ENSP00000301067:A2119P	ENSP00000301067:A2119P	A	-	1	0	MLL2	47721465	0.933000	0.31639	0.987000	0.45799	0.811000	0.45836	1.817000	0.39002	2.599000	0.87857	0.561000	0.74099	GCT	KMT2D-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000390183.2		26.0		-	ENST00000301067.7
KMT2D	8085	__UNKNOWN__	__UNKNOWN__	12	49444106	49444106	__UNKNOWN__	Missense_Mutation	SNP	T	T	A			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr12:49444106T>A	ENST00000301067.7	-	11	3264	c.3265A>T	c.(3265-3267)Agt>Tgt	p.S1089C		NM_003482.3	NP_003473.3	O14686	KMT2D_HUMAN	lysine (K)-specific methyltransferase 2D	1089	Pro-rich.				chromatin silencing (GO:0006342)|histone H3-K4 methylation (GO:0051568)|oocyte growth (GO:0001555)|oogenesis (GO:0048477)|positive regulation of cell proliferation (GO:0008284)|positive regulation of intracellular estrogen receptor signaling pathway (GO:0033148)|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|regulation of transcription, DNA-templated (GO:0006355)|response to estrogen (GO:0043627)|transcription, DNA-templated (GO:0006351)	histone methyltransferase complex (GO:0035097)|nucleus (GO:0005634)	DNA binding (GO:0003677)|histone-lysine N-methyltransferase activity (GO:0018024)|transcription regulatory region DNA binding (GO:0044212)|zinc ion binding (GO:0008270)										CTGGTGGCACTGGGTTCCAAG	0.607																																																0													27.0	30.0	29.0					12																	49444106		2008	4147	6155	SO:0001583	missense			AF010403	CCDS44873.1	12q13.12	2013-05-09	2013-05-09	2013-05-09	ENSG00000167548	ENSG00000167548	8085		"""Chromatin-modifying enzymes / K-methyltransferases"", ""Zinc fingers, PHD-type"""	7133	protein-coding gene	gene with protein product		602113	"""trinucleotide repeat containing 21"", ""myeloid/lymphoid or mixed-lineage leukemia 2"""	TNRC21, MLL2		9247308	Standard		NM_003482		Approved	ALR, MLL4, CAGL114		O14686	OTTHUMG00000166524	ENST00000301067.7:c.3265A>T	chr12.hg19:g.49444106T>A	ENSP00000301067:p.Ser1089Cys		O14687	True	hg19	CCDS44873.1	.	.	.	.	.	.	.	.	.	.	T	10.27	1.303898	0.23736	.	.	ENSG00000167548	ENST00000301067	T	0.81078	-1.45	5.35	3.02	0.34903	.	0.180167	0.27319	N	0.019908	T	0.59500	0.2198	N	0.08118	0	0.22787	N	0.99874	P	0.46327	0.876	B	0.40101	0.319	T	0.56836	-0.7913	10	0.87932	D	0	.	6.3039	0.21127	0.0:0.1913:0.0:0.8087	.	1089	O14686	MLL2_HUMAN	C	1089	ENSP00000301067:S1089C	ENSP00000301067:S1089C	S	-	1	0	MLL2	47730373	1.000000	0.71417	1.000000	0.80357	0.987000	0.75469	0.900000	0.28431	0.871000	0.35750	0.460000	0.39030	AGT	KMT2D-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000390183.2		100.0		-	ENST00000301067.7
KMT2D	8085	__UNKNOWN__	__UNKNOWN__	12	49444107	49444107	__UNKNOWN__	Silent	SNP	G	G	A	rs377407254		__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr12:49444107G>A	ENST00000301067.7	-	11	3263	c.3264C>T	c.(3262-3264)ccC>ccT	p.P1088P		NM_003482.3	NP_003473.3	O14686	KMT2D_HUMAN	lysine (K)-specific methyltransferase 2D	1088	Pro-rich.				chromatin silencing (GO:0006342)|histone H3-K4 methylation (GO:0051568)|oocyte growth (GO:0001555)|oogenesis (GO:0048477)|positive regulation of cell proliferation (GO:0008284)|positive regulation of intracellular estrogen receptor signaling pathway (GO:0033148)|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|regulation of transcription, DNA-templated (GO:0006355)|response to estrogen (GO:0043627)|transcription, DNA-templated (GO:0006351)	histone methyltransferase complex (GO:0035097)|nucleus (GO:0005634)	DNA binding (GO:0003677)|histone-lysine N-methyltransferase activity (GO:0018024)|transcription regulatory region DNA binding (GO:0044212)|zinc ion binding (GO:0008270)										TGGTGGCACTGGGTTCCAAGG	0.602																																																0													28.0	30.0	29.0					12																	49444107		2008	4146	6154	SO:0001819	synonymous_variant			AF010403	CCDS44873.1	12q13.12	2013-05-09	2013-05-09	2013-05-09	ENSG00000167548	ENSG00000167548	8085		"""Chromatin-modifying enzymes / K-methyltransferases"", ""Zinc fingers, PHD-type"""	7133	protein-coding gene	gene with protein product		602113	"""trinucleotide repeat containing 21"", ""myeloid/lymphoid or mixed-lineage leukemia 2"""	TNRC21, MLL2		9247308	Standard		NM_003482		Approved	ALR, MLL4, CAGL114		O14686	OTTHUMG00000166524	ENST00000301067.7:c.3264C>T	chr12.hg19:g.49444107G>A			O14687	True	hg19	CCDS44873.1																																																																																			KMT2D-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000390183.2		100.0		-	ENST00000301067.7
KMT2D	8085	__UNKNOWN__	__UNKNOWN__	12	49445202	49445202	__UNKNOWN__	Missense_Mutation	SNP	C	C	T			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr12:49445202C>T	ENST00000301067.7	-	10	2263	c.2264G>A	c.(2263-2265)cGg>cAg	p.R755Q		NM_003482.3	NP_003473.3	O14686	KMT2D_HUMAN	lysine (K)-specific methyltransferase 2D	755	Pro-rich.			Missing (in Ref. 1; AAC51734). {ECO:0000305}.	chromatin silencing (GO:0006342)|histone H3-K4 methylation (GO:0051568)|oocyte growth (GO:0001555)|oogenesis (GO:0048477)|positive regulation of cell proliferation (GO:0008284)|positive regulation of intracellular estrogen receptor signaling pathway (GO:0033148)|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|regulation of transcription, DNA-templated (GO:0006355)|response to estrogen (GO:0043627)|transcription, DNA-templated (GO:0006351)	histone methyltransferase complex (GO:0035097)|nucleus (GO:0005634)	DNA binding (GO:0003677)|histone-lysine N-methyltransferase activity (GO:0018024)|transcription regulatory region DNA binding (GO:0044212)|zinc ion binding (GO:0008270)										CTCCTCAGGCCGGGGGGACAG	0.687																																																0													20.0	23.0	22.0					12																	49445202		1721	3769	5490	SO:0001583	missense			AF010403	CCDS44873.1	12q13.12	2013-05-09	2013-05-09	2013-05-09	ENSG00000167548	ENSG00000167548	8085		"""Chromatin-modifying enzymes / K-methyltransferases"", ""Zinc fingers, PHD-type"""	7133	protein-coding gene	gene with protein product		602113	"""trinucleotide repeat containing 21"", ""myeloid/lymphoid or mixed-lineage leukemia 2"""	TNRC21, MLL2		9247308	Standard		NM_003482		Approved	ALR, MLL4, CAGL114		O14686	OTTHUMG00000166524	ENST00000301067.7:c.2264G>A	chr12.hg19:g.49445202C>T	ENSP00000301067:p.Arg755Gln		O14687	True	hg19	CCDS44873.1	.	.	.	.	.	.	.	.	.	.	C	10.96	1.498285	0.26861	.	.	ENSG00000167548	ENST00000301067	T	0.33216	1.42	3.14	-6.28	0.02020	.	.	.	.	.	T	0.08802	0.0218	N	0.01874	-0.695	0.09310	N	1	B	0.02656	0.0	B	0.01281	0.0	T	0.28870	-1.0030	9	0.87932	D	0	.	1.4228	0.02316	0.3089:0.3696:0.1683:0.1531	.	755	O14686	MLL2_HUMAN	Q	755	ENSP00000301067:R755Q	ENSP00000301067:R755Q	R	-	2	0	MLL2	47731469	0.000000	0.05858	0.000000	0.03702	0.061000	0.15899	-4.403000	0.00239	-2.754000	0.00373	-0.440000	0.05779	CGG	KMT2D-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000390183.2		46.0		-	ENST00000301067.7
KMT2D	8085	__UNKNOWN__	__UNKNOWN__	12	49445372	49445372	__UNKNOWN__	Silent	SNP	T	T	C			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr12:49445372T>C	ENST00000301067.7	-	10	2093	c.2094A>G	c.(2092-2094)acA>acG	p.T698T		NM_003482.3	NP_003473.3	O14686	KMT2D_HUMAN	lysine (K)-specific methyltransferase 2D	698	Pro-rich.			Missing (in Ref. 1; AAC51734). {ECO:0000305}.	chromatin silencing (GO:0006342)|histone H3-K4 methylation (GO:0051568)|oocyte growth (GO:0001555)|oogenesis (GO:0048477)|positive regulation of cell proliferation (GO:0008284)|positive regulation of intracellular estrogen receptor signaling pathway (GO:0033148)|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|regulation of transcription, DNA-templated (GO:0006355)|response to estrogen (GO:0043627)|transcription, DNA-templated (GO:0006351)	histone methyltransferase complex (GO:0035097)|nucleus (GO:0005634)	DNA binding (GO:0003677)|histone-lysine N-methyltransferase activity (GO:0018024)|transcription regulatory region DNA binding (GO:0044212)|zinc ion binding (GO:0008270)										GTGGTGGGGATGTGGGGGAGT	0.657																																																0													46.0	54.0	51.0					12																	49445372		2076	4203	6279	SO:0001819	synonymous_variant			AF010403	CCDS44873.1	12q13.12	2013-05-09	2013-05-09	2013-05-09	ENSG00000167548	ENSG00000167548	8085		"""Chromatin-modifying enzymes / K-methyltransferases"", ""Zinc fingers, PHD-type"""	7133	protein-coding gene	gene with protein product		602113	"""trinucleotide repeat containing 21"", ""myeloid/lymphoid or mixed-lineage leukemia 2"""	TNRC21, MLL2		9247308	Standard		NM_003482		Approved	ALR, MLL4, CAGL114		O14686	OTTHUMG00000166524	ENST00000301067.7:c.2094A>G	chr12.hg19:g.49445372T>C			O14687	True	hg19	CCDS44873.1																																																																																			KMT2D-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000390183.2		43.0		-	ENST00000301067.7
KMT2D	8085	__UNKNOWN__	__UNKNOWN__	12	49445390	49445390	__UNKNOWN__	Silent	SNP	T	T	C			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr12:49445390T>C	ENST00000301067.7	-	10	2075	c.2076A>G	c.(2074-2076)ccA>ccG	p.P692P		NM_003482.3	NP_003473.3	O14686	KMT2D_HUMAN	lysine (K)-specific methyltransferase 2D	692	Pro-rich.		P -> T (in dbSNP:rs202076833). {ECO:0000269|PubMed:21280141}.	Missing (in Ref. 1; AAC51734). {ECO:0000305}.	chromatin silencing (GO:0006342)|histone H3-K4 methylation (GO:0051568)|oocyte growth (GO:0001555)|oogenesis (GO:0048477)|positive regulation of cell proliferation (GO:0008284)|positive regulation of intracellular estrogen receptor signaling pathway (GO:0033148)|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|regulation of transcription, DNA-templated (GO:0006355)|response to estrogen (GO:0043627)|transcription, DNA-templated (GO:0006351)	histone methyltransferase complex (GO:0035097)|nucleus (GO:0005634)	DNA binding (GO:0003677)|histone-lysine N-methyltransferase activity (GO:0018024)|transcription regulatory region DNA binding (GO:0044212)|zinc ion binding (GO:0008270)										AGTCCTCAGGTGGTGGGGAGA	0.657																																																0													45.0	52.0	50.0					12																	49445390		2068	4201	6269	SO:0001819	synonymous_variant			AF010403	CCDS44873.1	12q13.12	2013-05-09	2013-05-09	2013-05-09	ENSG00000167548	ENSG00000167548	8085		"""Chromatin-modifying enzymes / K-methyltransferases"", ""Zinc fingers, PHD-type"""	7133	protein-coding gene	gene with protein product		602113	"""trinucleotide repeat containing 21"", ""myeloid/lymphoid or mixed-lineage leukemia 2"""	TNRC21, MLL2		9247308	Standard		NM_003482		Approved	ALR, MLL4, CAGL114		O14686	OTTHUMG00000166524	ENST00000301067.7:c.2076A>G	chr12.hg19:g.49445390T>C			O14687	True	hg19	CCDS44873.1																																																																																			KMT2D-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000390183.2		22.0		-	ENST00000301067.7
KMT2D	8085	__UNKNOWN__	__UNKNOWN__	12	49445399	49445399	__UNKNOWN__	Silent	SNP	G	G	C			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr12:49445399G>C	ENST00000301067.7	-	10	2066	c.2067C>G	c.(2065-2067)ctC>ctG	p.L689L		NM_003482.3	NP_003473.3	O14686	KMT2D_HUMAN	lysine (K)-specific methyltransferase 2D	689	Pro-rich.			Missing (in Ref. 1; AAC51734). {ECO:0000305}.	chromatin silencing (GO:0006342)|histone H3-K4 methylation (GO:0051568)|oocyte growth (GO:0001555)|oogenesis (GO:0048477)|positive regulation of cell proliferation (GO:0008284)|positive regulation of intracellular estrogen receptor signaling pathway (GO:0033148)|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|regulation of transcription, DNA-templated (GO:0006355)|response to estrogen (GO:0043627)|transcription, DNA-templated (GO:0006351)	histone methyltransferase complex (GO:0035097)|nucleus (GO:0005634)	DNA binding (GO:0003677)|histone-lysine N-methyltransferase activity (GO:0018024)|transcription regulatory region DNA binding (GO:0044212)|zinc ion binding (GO:0008270)										GTGGTGGGGAGAGGCGTGAAG	0.657																																																0													45.0	52.0	50.0					12																	49445399		2084	4209	6293	SO:0001819	synonymous_variant			AF010403	CCDS44873.1	12q13.12	2013-05-09	2013-05-09	2013-05-09	ENSG00000167548	ENSG00000167548	8085		"""Chromatin-modifying enzymes / K-methyltransferases"", ""Zinc fingers, PHD-type"""	7133	protein-coding gene	gene with protein product		602113	"""trinucleotide repeat containing 21"", ""myeloid/lymphoid or mixed-lineage leukemia 2"""	TNRC21, MLL2		9247308	Standard		NM_003482		Approved	ALR, MLL4, CAGL114		O14686	OTTHUMG00000166524	ENST00000301067.7:c.2067C>G	chr12.hg19:g.49445399G>C			O14687	True	hg19	CCDS44873.1																																																																																			KMT2D-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000390183.2		24.0		-	ENST00000301067.7
MDM2	4193	__UNKNOWN__	__UNKNOWN__	12	69229647	69229647	__UNKNOWN__	Missense_Mutation	SNP	G	G	C			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr12:69229647G>C	ENST00000350057.5	+	7	630	c.630G>C	c.(628-630)tgG>tgC	p.W210C	MDM2_ENST00000299252.4_Missense_Mutation_p.W65C|MDM2_ENST00000478070.1_Intron|MDM2_ENST00000517852.1_Intron|MDM2_ENST00000428863.2_Missense_Mutation_p.W40C|MDM2_ENST00000356290.4_Missense_Mutation_p.W65C|MDM2_ENST00000393410.1_Intron|MDM2_ENST00000258149.5_Missense_Mutation_p.W180C|MDM2_ENST00000393412.3_Intron|MDM2_ENST00000540827.1_Missense_Mutation_p.W40C|MDM2_ENST00000258148.7_Missense_Mutation_p.W186C|MDM2_ENST00000462284.1_Missense_Mutation_p.W241C|MDM2_ENST00000544561.1_Intron|MDM2_ENST00000348801.2_Missense_Mutation_p.W35C|MDM2_ENST00000360430.2_Missense_Mutation_p.W40C|MDM2_ENST00000545204.1_Intron|MDM2_ENST00000393413.3_Intron			Q00987	MDM2_HUMAN	MDM2 proto-oncogene, E3 ubiquitin protein ligase	235	ARF-binding.|Interaction with MTBP. {ECO:0000250}.|Interaction with PYHIN1 and necessary for interaction with RFFL and RNF34. {ECO:0000269|PubMed:16479015, ECO:0000269|PubMed:18382127}.|Poly-Ser.				cellular response to acid chemical (GO:0071229)|cellular response to alkaloid (GO:0071312)|cellular response to antibiotic (GO:0071236)|cellular response to estrogen stimulus (GO:0071391)|cellular response to hydrogen peroxide (GO:0070301)|cellular response to hypoxia (GO:0071456)|cellular response to peptide hormone stimulus (GO:0071375)|cellular response to UV-C (GO:0071494)|cellular response to vitamin B1 (GO:0071301)|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)|epidermal growth factor receptor signaling pathway (GO:0007173)|establishment of protein localization (GO:0045184)|Fc-epsilon receptor signaling pathway (GO:0038095)|fibroblast growth factor receptor signaling pathway (GO:0008543)|innate immune response (GO:0045087)|negative regulation of apoptotic process (GO:0043066)|negative regulation of cell cycle arrest (GO:0071157)|negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154)|negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)|negative regulation of protein processing (GO:0010955)|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|negative regulation of transcription, DNA-templated (GO:0045892)|neurotrophin TRK receptor signaling pathway (GO:0048011)|peptidyl-lysine modification (GO:0018205)|phosphatidylinositol-mediated signaling (GO:0048015)|positive regulation of cell proliferation (GO:0008284)|positive regulation of gene expression (GO:0010628)|positive regulation of mitotic cell cycle (GO:0045931)|positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436)|positive regulation of protein export from nucleus (GO:0046827)|protein complex assembly (GO:0006461)|protein destabilization (GO:0031648)|protein localization to nucleus (GO:0034504)|protein ubiquitination (GO:0016567)|protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0042787)|regulation of protein catabolic process (GO:0042176)|response to antibiotic (GO:0046677)|response to carbohydrate (GO:0009743)|response to cocaine (GO:0042220)|response to drug (GO:0042493)|response to ether (GO:0045472)|response to iron ion (GO:0010039)|response to magnesium ion (GO:0032026)|response to morphine (GO:0043278)|synaptic transmission (GO:0007268)|traversing start control point of mitotic cell cycle (GO:0007089)|viral process (GO:0016032)	cytoplasm (GO:0005737)|cytosol (GO:0005829)|endocytic vesicle membrane (GO:0030666)|nucleolus (GO:0005730)|nucleoplasm (GO:0005654)|nucleus (GO:0005634)|plasma membrane (GO:0005886)|protein complex (GO:0043234)|synapse (GO:0045202)	enzyme binding (GO:0019899)|identical protein binding (GO:0042802)|ligase activity (GO:0016874)|p53 binding (GO:0002039)|ubiquitin protein ligase binding (GO:0031625)|ubiquitin-protein transferase activity (GO:0004842)|zinc ion binding (GO:0008270)			central_nervous_system(1)|endometrium(1)|kidney(1)|large_intestine(4)|liver(2)|lung(8)|prostate(1)|urinary_tract(1)	19	all_cancers(1;8.46e-121)|all_epithelial(5;3.21e-36)|Lung NSC(4;2.16e-33)|all_lung(4;3.03e-31)|Glioma(1;1.9e-09)|Breast(13;1.59e-06)|all_neural(1;1.03e-05)|Melanoma(1;0.0171)|Renal(347;0.0684)		all cancers(2;8.67e-65)|GBM - Glioblastoma multiforme(2;8.89e-62)|BRCA - Breast invasive adenocarcinoma(5;2.43e-08)|Lung(24;1.5e-05)|LUAD - Lung adenocarcinoma(15;8.5e-05)|STAD - Stomach adenocarcinoma(21;0.00372)|Kidney(9;0.143)			CAGGTGATTGGTTGGATCAGG	0.353			A		"""sarcoma, glioma, colorectal, other"""																																		Dom	yes		12	12q15	4193	Mdm2 p53 binding protein homolog		"""M, O, E, L"""	0													218.0	202.0	207.0					12																	69229647		1855	4111	5966	SO:0001583	missense				CCDS8986.2, CCDS61189.1	12q13-q14	2014-06-26	2014-06-26		ENSG00000135679	ENSG00000135679	4193			6973	protein-coding gene	gene with protein product		164785	"""mouse double minute 2, human homolog of; p53-binding protein"", ""Mdm2, transformed 3T3 cell double minute 2, p53 binding protein (mouse)"", ""Mdm2 p53 binding protein homolog (mouse)"""			1614537, 16905769	Standard	NM_006880	NM_002392		Approved	HDM2, MGC5370	uc001sui.4	Q00987	OTTHUMG00000142827	ENST00000350057.5:c.630G>C	chr12.hg19:g.69229647G>C	ENSP00000266624:p.Trp210Cys		A6NL51|A8K2S6|Q13226|Q13297|Q13298|Q13299|Q13300|Q13301|Q53XW0|Q71TW9|Q8WYJ1|Q8WYJ2|Q9UGI3|Q9UMT8	True	hg19		.	.	.	.	.	.	.	.	.	.	G	11.94	1.788832	0.31685	.	.	ENSG00000135679	ENST00000462284;ENST00000544648;ENST00000258149;ENST00000356290;ENST00000540827;ENST00000428863;ENST00000358483;ENST00000311420;ENST00000258148;ENST00000539479;ENST00000543323;ENST00000523991;ENST00000350057;ENST00000299252;ENST00000360430;ENST00000348801	T;T;T;T;T;T;T;T;T;T;T	0.49432	1.34;0.83;0.78;0.83;0.93;0.83;0.79;1.35;0.78;0.83;0.93	4.69	3.77	0.43336	.	0.238192	0.37095	N	0.002260	T	0.33265	0.0857	N	0.21448	0.665	0.80722	D	1	B;B;B;B;B;B	0.20671	0.015;0.047;0.047;0.024;0.01;0.005	B;B;B;B;B;B	0.24394	0.015;0.032;0.021;0.053;0.016;0.007	T	0.07986	-1.0744	9	.	.	.	-7.8002	13.4953	0.61421	0.0:0.1633:0.8367:0.0	.	190;40;65;186;40;241	Q00987-9;Q00987-3;Q00987-5;G3XA89;Q00987-2;Q00987-11	.;.;.;.;.;.	C	241;190;180;65;40;40;65;196;186;235;65;65;210;65;40;35	ENSP00000417281:W241C;ENSP00000258149:W180C;ENSP00000348637:W65C;ENSP00000440932:W40C;ENSP00000410694:W40C;ENSP00000258148:W186C;ENSP00000444430:W235C;ENSP00000266624:W210C;ENSP00000299252:W65C;ENSP00000353611:W40C;ENSP00000335096:W35C	.	W	+	3	0	MDM2	67515914	1.000000	0.71417	1.000000	0.80357	0.988000	0.76386	3.086000	0.50159	1.232000	0.43678	0.585000	0.79938	TGG	MDM2-033	NOVEL	basic|exp_conf	protein_coding		protein_coding	OTTHUMT00000402665.1		100.0		+	ENST00000350057.5
DICER1	23405	__UNKNOWN__	__UNKNOWN__	14	95560376	95560376	__UNKNOWN__	Missense_Mutation	SNP	G	G	A			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr14:95560376G>A	ENST00000526495.1	-	26	5504	c.5213C>T	c.(5212-5214)gCc>gTc	p.A1738V	DICER1_ENST00000393063.1_Missense_Mutation_p.A1738V|DICER1_ENST00000556045.1_Missense_Mutation_p.A636V|DICER1_ENST00000343455.3_Missense_Mutation_p.A1738V|DICER1_ENST00000527414.1_Missense_Mutation_p.A1738V|DICER1_ENST00000541352.1_Missense_Mutation_p.A1738V			Q9UPY3	DICER_HUMAN	dicer 1, ribonuclease type III	1738	RNase III 2. {ECO:0000255|PROSITE- ProRule:PRU00177}.				angiogenesis (GO:0001525)|branching morphogenesis of an epithelial tube (GO:0048754)|cardiac muscle cell development (GO:0055013)|cerebral cortex development (GO:0021987)|defense response to virus (GO:0051607)|embryonic hindlimb morphogenesis (GO:0035116)|gene expression (GO:0010467)|hair follicle cell proliferation (GO:0071335)|hair follicle morphogenesis (GO:0031069)|inner ear receptor cell development (GO:0060119)|intestinal epithelial cell development (GO:0060576)|lung development (GO:0030324)|mRNA stabilization (GO:0048255)|multicellular organism growth (GO:0035264)|negative regulation of Schwann cell proliferation (GO:0010626)|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|nerve development (GO:0021675)|neuron projection morphogenesis (GO:0048812)|olfactory bulb interneuron differentiation (GO:0021889)|peripheral nervous system myelin formation (GO:0032290)|positive regulation of gene expression (GO:0010628)|positive regulation of miRNA metabolic process (GO:2000630)|positive regulation of myelination (GO:0031643)|positive regulation of Schwann cell differentiation (GO:0014040)|post-embryonic development (GO:0009791)|pre-miRNA processing (GO:0031054)|production of miRNAs involved in gene silencing by miRNA (GO:0035196)|production of siRNA involved in RNA interference (GO:0030422)|regulation of cell cycle (GO:0051726)|regulation of enamel mineralization (GO:0070173)|regulation of neuron differentiation (GO:0045664)|regulation of oligodendrocyte differentiation (GO:0048713)|regulation of viral genome replication (GO:0045069)|reproductive structure development (GO:0048608)|RNA phosphodiester bond hydrolysis (GO:0090501)|RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)|spinal cord motor neuron differentiation (GO:0021522)|spindle assembly (GO:0051225)|spleen development (GO:0048536)|stem cell maintenance (GO:0019827)|targeting of mRNA for destruction involved in RNA interference (GO:0030423)|zygote asymmetric cell division (GO:0010070)	axon (GO:0030424)|cytosol (GO:0005829)|dendrite (GO:0030425)|endoplasmic reticulum-Golgi intermediate compartment (GO:0005793)|growth cone (GO:0030426)|RISC complex (GO:0016442)	ATP binding (GO:0005524)|double-stranded RNA binding (GO:0003725)|helicase activity (GO:0004386)|metal ion binding (GO:0046872)|miRNA binding (GO:0035198)|ribonuclease III activity (GO:0004525)			NS(1)|autonomic_ganglia(1)|biliary_tract(1)|breast(1)|central_nervous_system(1)|endometrium(13)|kidney(3)|large_intestine(10)|lung(33)|ovary(1)|pancreas(1)|prostate(3)|skin(3)|upper_aerodigestive_tract(3)	75		all_cancers(154;0.0621)|all_epithelial(191;0.223)		Epithelial(152;0.211)|COAD - Colon adenocarcinoma(157;0.215)		GTTGACCAGGGCAGACCGCAG	0.522			"""Mis F, N"""		"""sex cord-stromal tumour, TGCT, embryonal rhadomyosarcoma"""	pleuropulmonary blastoma			Familial Multinodular Goiter ;DICER 1 syndrome																													yes	Rec	yes	Familial Pleuropulmonary Blastoma	14	14q32.13	23405	"""dicer 1, ribonuclease type III """		"""E, M, O"""	0													102.0	102.0	102.0					14																	95560376		2203	4300	6503	SO:0001583	missense	Familial Cancer Database	Adolescent Multinodular Goiter, incl. Multinodular Euthyroid Goiter & Non-Medullary Thyroid Cancer;incl. Pleuropulmonary Blastoma, Familial ; Cystic Nephroma, Familial	AB028449	CCDS9931.1, CCDS55941.1	14q32.13	2014-09-17	2008-02-20		ENSG00000100697	ENSG00000100697	23405			17098	protein-coding gene	gene with protein product	"""dicer 1, double-stranded RNA-specific endoribonuclease"""	606241	"""Dicer1, Dcr-1 homolog (Drosophila)"", ""multinodular goitre 1"""	MNG1		10051563, 10786632, 21205968	Standard		NM_177438		Approved	Dicer, KIAA0928, K12H4.8-LIKE, HERNA	uc001ydw.2	Q9UPY3	OTTHUMG00000166134	ENST00000526495.1:c.5213C>T	chr14.hg19:g.95560376G>A	ENSP00000437256:p.Ala1738Val		A7E2D3|B3KRG4|E0AD28|O95943|Q9UQ02	True	hg19	CCDS9931.1	.	.	.	.	.	.	.	.	.	.	G	34	5.362011	0.95877	.	.	ENSG00000100697	ENST00000343455;ENST00000526495;ENST00000393063;ENST00000527414;ENST00000556045;ENST00000541352	T;T;T;T;T;T	0.79141	-1.24;-1.24;-1.24;-1.24;-1.24;-1.24	5.43	5.43	0.79202	Ribonuclease III (5);	0.000000	0.85682	D	0.000000	D	0.89646	0.6775	M	0.84511	2.7	0.80722	D	1	D;D	0.89917	1.0;0.999	D;D	0.79108	0.992;0.988	D	0.90708	0.4625	10	0.66056	D	0.02	-19.3397	19.2735	0.94021	0.0:0.0:1.0:0.0	.	636;1738	B3KRG4;Q9UPY3	.;DICER_HUMAN	V	1738;1738;1738;1738;636;1738	ENSP00000343745:A1738V;ENSP00000437256:A1738V;ENSP00000376783:A1738V;ENSP00000435681:A1738V;ENSP00000451041:A636V;ENSP00000444719:A1738V	ENSP00000343745:A1738V	A	-	2	0	DICER1	94630129	1.000000	0.71417	0.278000	0.24718	0.934000	0.57294	9.389000	0.97243	2.549000	0.85964	0.655000	0.94253	GCC	DICER1-004	KNOWN	alternative_5_UTR|basic|appris_principal|exp_conf|CCDS	protein_coding		protein_coding	OTTHUMT00000387997.1		46.0		-	ENST00000526495.1
DICER1	23405	__UNKNOWN__	__UNKNOWN__	14	95560401	95560401	__UNKNOWN__	Missense_Mutation	SNP	C	C	G			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr14:95560401C>G	ENST00000526495.1	-	26	5479	c.5188G>C	c.(5188-5190)Ggg>Cgg	p.G1730R	DICER1_ENST00000393063.1_Missense_Mutation_p.G1730R|DICER1_ENST00000556045.1_Missense_Mutation_p.G628R|DICER1_ENST00000343455.3_Missense_Mutation_p.G1730R|DICER1_ENST00000527414.1_Missense_Mutation_p.G1730R|DICER1_ENST00000541352.1_Missense_Mutation_p.G1730R			Q9UPY3	DICER_HUMAN	dicer 1, ribonuclease type III	1730	RNase III 2. {ECO:0000255|PROSITE- ProRule:PRU00177}.				angiogenesis (GO:0001525)|branching morphogenesis of an epithelial tube (GO:0048754)|cardiac muscle cell development (GO:0055013)|cerebral cortex development (GO:0021987)|defense response to virus (GO:0051607)|embryonic hindlimb morphogenesis (GO:0035116)|gene expression (GO:0010467)|hair follicle cell proliferation (GO:0071335)|hair follicle morphogenesis (GO:0031069)|inner ear receptor cell development (GO:0060119)|intestinal epithelial cell development (GO:0060576)|lung development (GO:0030324)|mRNA stabilization (GO:0048255)|multicellular organism growth (GO:0035264)|negative regulation of Schwann cell proliferation (GO:0010626)|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|nerve development (GO:0021675)|neuron projection morphogenesis (GO:0048812)|olfactory bulb interneuron differentiation (GO:0021889)|peripheral nervous system myelin formation (GO:0032290)|positive regulation of gene expression (GO:0010628)|positive regulation of miRNA metabolic process (GO:2000630)|positive regulation of myelination (GO:0031643)|positive regulation of Schwann cell differentiation (GO:0014040)|post-embryonic development (GO:0009791)|pre-miRNA processing (GO:0031054)|production of miRNAs involved in gene silencing by miRNA (GO:0035196)|production of siRNA involved in RNA interference (GO:0030422)|regulation of cell cycle (GO:0051726)|regulation of enamel mineralization (GO:0070173)|regulation of neuron differentiation (GO:0045664)|regulation of oligodendrocyte differentiation (GO:0048713)|regulation of viral genome replication (GO:0045069)|reproductive structure development (GO:0048608)|RNA phosphodiester bond hydrolysis (GO:0090501)|RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)|spinal cord motor neuron differentiation (GO:0021522)|spindle assembly (GO:0051225)|spleen development (GO:0048536)|stem cell maintenance (GO:0019827)|targeting of mRNA for destruction involved in RNA interference (GO:0030423)|zygote asymmetric cell division (GO:0010070)	axon (GO:0030424)|cytosol (GO:0005829)|dendrite (GO:0030425)|endoplasmic reticulum-Golgi intermediate compartment (GO:0005793)|growth cone (GO:0030426)|RISC complex (GO:0016442)	ATP binding (GO:0005524)|double-stranded RNA binding (GO:0003725)|helicase activity (GO:0004386)|metal ion binding (GO:0046872)|miRNA binding (GO:0035198)|ribonuclease III activity (GO:0004525)			NS(1)|autonomic_ganglia(1)|biliary_tract(1)|breast(1)|central_nervous_system(1)|endometrium(13)|kidney(3)|large_intestine(10)|lung(33)|ovary(1)|pancreas(1)|prostate(3)|skin(3)|upper_aerodigestive_tract(3)	75		all_cancers(154;0.0621)|all_epithelial(191;0.223)		Epithelial(152;0.211)|COAD - Colon adenocarcinoma(157;0.215)		GTCAGGACCCCCGGGGAGTGC	0.532			"""Mis F, N"""		"""sex cord-stromal tumour, TGCT, embryonal rhadomyosarcoma"""	pleuropulmonary blastoma			Familial Multinodular Goiter ;DICER 1 syndrome																													yes	Rec	yes	Familial Pleuropulmonary Blastoma	14	14q32.13	23405	"""dicer 1, ribonuclease type III """		"""E, M, O"""	0													73.0	79.0	77.0					14																	95560401		2203	4300	6503	SO:0001583	missense	Familial Cancer Database	Adolescent Multinodular Goiter, incl. Multinodular Euthyroid Goiter & Non-Medullary Thyroid Cancer;incl. Pleuropulmonary Blastoma, Familial ; Cystic Nephroma, Familial	AB028449	CCDS9931.1, CCDS55941.1	14q32.13	2014-09-17	2008-02-20		ENSG00000100697	ENSG00000100697	23405			17098	protein-coding gene	gene with protein product	"""dicer 1, double-stranded RNA-specific endoribonuclease"""	606241	"""Dicer1, Dcr-1 homolog (Drosophila)"", ""multinodular goitre 1"""	MNG1		10051563, 10786632, 21205968	Standard		NM_177438		Approved	Dicer, KIAA0928, K12H4.8-LIKE, HERNA	uc001ydw.2	Q9UPY3	OTTHUMG00000166134	ENST00000526495.1:c.5188G>C	chr14.hg19:g.95560401C>G	ENSP00000437256:p.Gly1730Arg		A7E2D3|B3KRG4|E0AD28|O95943|Q9UQ02	True	hg19	CCDS9931.1	.	.	.	.	.	.	.	.	.	.	C	33	5.207272	0.95033	.	.	ENSG00000100697	ENST00000343455;ENST00000526495;ENST00000393063;ENST00000527414;ENST00000556045;ENST00000541352	D;D;D;D;D;D	0.90385	-2.66;-2.66;-2.66;-2.66;-2.66;-2.66	5.43	5.43	0.79202	Ribonuclease III (5);	0.000000	0.85682	D	0.000000	D	0.97536	0.9193	H	0.98525	4.255	0.80722	D	1	D;D	0.89917	1.0;1.0	D;D	0.97110	1.0;1.0	D	0.98763	1.0725	10	0.66056	D	0.02	-22.3655	19.2735	0.94021	0.0:1.0:0.0:0.0	.	628;1730	B3KRG4;Q9UPY3	.;DICER_HUMAN	R	1730;1730;1730;1730;628;1730	ENSP00000343745:G1730R;ENSP00000437256:G1730R;ENSP00000376783:G1730R;ENSP00000435681:G1730R;ENSP00000451041:G628R;ENSP00000444719:G1730R	ENSP00000343745:G1730R	G	-	1	0	DICER1	94630154	1.000000	0.71417	0.956000	0.39512	0.967000	0.64934	7.421000	0.80204	2.549000	0.85964	0.655000	0.94253	GGG	DICER1-004	KNOWN	alternative_5_UTR|basic|appris_principal|exp_conf|CCDS	protein_coding		protein_coding	OTTHUMT00000387997.1		37.0		-	ENST00000526495.1
FUS	2521	__UNKNOWN__	__UNKNOWN__	16	31196236	31196236	__UNKNOWN__	Intron	SNP	T	T	A			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr16:31196236T>A	ENST00000254108.7	+	6	628				FUS_ENST00000380244.3_Intron|FUS_ENST00000568685.1_Intron	NM_001170634.1|NM_001170937.1|NM_004960.3	NP_001164105.1|NP_001164408.1|NP_004951.1	P35637	FUS_HUMAN	FUS RNA binding protein						cell death (GO:0008219)|gene expression (GO:0010467)|mRNA splicing, via spliceosome (GO:0000398)|RNA splicing (GO:0008380)	cytoplasm (GO:0005737)|nucleoplasm (GO:0005654)|nucleus (GO:0005634)	DNA binding (GO:0003677)|identical protein binding (GO:0042802)|nucleotide binding (GO:0000166)|poly(A) RNA binding (GO:0044822)|RNA binding (GO:0003723)|zinc ion binding (GO:0008270)		FUS/ERG(167)|FUS/DDIT3(631)|FUS/FEV(2)|FUS/ATF1(4)|FUS/CREB3L1(6)|FUS/CREB3L2(158)	breast(3)|endometrium(5)|kidney(3)|large_intestine(1)|lung(5)|prostate(3)|skin(1)|urinary_tract(1)	22		Renal(780;0.000219)|Breast(268;0.00957)|Hepatocellular(780;0.121)		GBM - Glioblastoma multiforme(240;2.31e-05)|Kidney(780;0.000209)		TTTTTTTTTTTAATCATTCTT	0.383			T	"""DDIT3, ERG, FEV, ATF1, CREB3L2, CREB3L1"""	"""liposarcoma, AML, Ewing sarcoma, angiomatoid fibrous histiocytoma, fibromyxoid sarcoma"""																																		Dom	yes		16	16p11.2	2521	"""fusion, derived from t(12;16) malignant liposarcoma"""		"""M, L"""	0													43.0	45.0	44.0					16																	31196236		2197	4300	6497	SO:0001627	intron_variant			AF071213	CCDS10707.1, CCDS58454.1	16p11.2	2014-09-17	2014-05-09		ENSG00000089280	ENSG00000089280	2521		"""RNA binding motif (RRM) containing"""	4010	protein-coding gene	gene with protein product	"""heterogeneous nuclear ribonucleoprotein P2"", ""translocated in liposarcoma"""	137070	"""fusion, derived from t(12;16) malignant liposarcoma"", ""amyotrophic lateral sclerosis 6"", ""fusion (involved in t(12;16) in malignant liposarcoma)"", ""fused in sarcoma"""	ALS6		2372777, 7503811, 19251628, 19251627	Standard	NM_004960	NM_004960		Approved	TLS, FUS1, hnRNP-P2, HNRNPP2	uc002ebe.2	P35637	OTTHUMG00000132395	ENST00000254108.7:c.524-24T>A	chr16.hg19:g.31196236T>A			Q9H4A8	True	hg19	CCDS10707.1																																																																																			FUS-001	KNOWN	basic|appris_candidate|CCDS	protein_coding		protein_coding	OTTHUMT00000255526.2		33.0		+	ENST00000254108.7
FUS	2521	__UNKNOWN__	__UNKNOWN__	16	31196238	31196238	__UNKNOWN__	Intron	SNP	A	A	T			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr16:31196238A>T	ENST00000254108.7	+	6	628				FUS_ENST00000380244.3_Intron|FUS_ENST00000568685.1_Intron	NM_001170634.1|NM_001170937.1|NM_004960.3	NP_001164105.1|NP_001164408.1|NP_004951.1	P35637	FUS_HUMAN	FUS RNA binding protein						cell death (GO:0008219)|gene expression (GO:0010467)|mRNA splicing, via spliceosome (GO:0000398)|RNA splicing (GO:0008380)	cytoplasm (GO:0005737)|nucleoplasm (GO:0005654)|nucleus (GO:0005634)	DNA binding (GO:0003677)|identical protein binding (GO:0042802)|nucleotide binding (GO:0000166)|poly(A) RNA binding (GO:0044822)|RNA binding (GO:0003723)|zinc ion binding (GO:0008270)		FUS/ERG(167)|FUS/DDIT3(631)|FUS/FEV(2)|FUS/ATF1(4)|FUS/CREB3L1(6)|FUS/CREB3L2(158)	breast(3)|endometrium(5)|kidney(3)|large_intestine(1)|lung(5)|prostate(3)|skin(1)|urinary_tract(1)	22		Renal(780;0.000219)|Breast(268;0.00957)|Hepatocellular(780;0.121)		GBM - Glioblastoma multiforme(240;2.31e-05)|Kidney(780;0.000209)		TTTTTTTTTAATCATTCTTTC	0.393			T	"""DDIT3, ERG, FEV, ATF1, CREB3L2, CREB3L1"""	"""liposarcoma, AML, Ewing sarcoma, angiomatoid fibrous histiocytoma, fibromyxoid sarcoma"""																																		Dom	yes		16	16p11.2	2521	"""fusion, derived from t(12;16) malignant liposarcoma"""		"""M, L"""	0													47.0	48.0	48.0					16																	31196238		2197	4300	6497	SO:0001627	intron_variant			AF071213	CCDS10707.1, CCDS58454.1	16p11.2	2014-09-17	2014-05-09		ENSG00000089280	ENSG00000089280	2521		"""RNA binding motif (RRM) containing"""	4010	protein-coding gene	gene with protein product	"""heterogeneous nuclear ribonucleoprotein P2"", ""translocated in liposarcoma"""	137070	"""fusion, derived from t(12;16) malignant liposarcoma"", ""amyotrophic lateral sclerosis 6"", ""fusion (involved in t(12;16) in malignant liposarcoma)"", ""fused in sarcoma"""	ALS6		2372777, 7503811, 19251628, 19251627	Standard	NM_004960	NM_004960		Approved	TLS, FUS1, hnRNP-P2, HNRNPP2	uc002ebe.2	P35637	OTTHUMG00000132395	ENST00000254108.7:c.524-22A>T	chr16.hg19:g.31196238A>T			Q9H4A8	True	hg19	CCDS10707.1																																																																																			FUS-001	KNOWN	basic|appris_candidate|CCDS	protein_coding		protein_coding	OTTHUMT00000255526.2		41.0		+	ENST00000254108.7
TP53	7157	__UNKNOWN__	__UNKNOWN__	17	7577124	7577124	__UNKNOWN__	Missense_Mutation	SNP	C	C	A	rs121912657		__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr17:7577124C>A	ENST00000269305.4	-	8	1003	c.814G>T	c.(814-816)Gtg>Ttg	p.V272L	TP53_ENST00000359597.4_Missense_Mutation_p.V272L|TP53_ENST00000445888.2_Missense_Mutation_p.V272L|TP53_ENST00000420246.2_Missense_Mutation_p.V272L|TP53_ENST00000413465.2_Intron|TP53_ENST00000455263.2_Missense_Mutation_p.V272L	NM_000546.5|NM_001126112.2|NM_001126118.1|NM_001276760.1|NM_001276761.1	NP_000537.3|NP_001119584.1|NP_001119590.1|NP_001263689.1|NP_001263690.1	P04637	P53_HUMAN	tumor protein p53	272	Interaction with AXIN1. {ECO:0000250}.|Interaction with E4F1.|Interaction with HIPK1. {ECO:0000250}.|Required for interaction with ZNF385A.		V -> A (in a familial cancer not matching LFS; germline mutation and in sporadic cancers; somatic mutation).|V -> E (in sporadic cancers; somatic mutation).|V -> G (in sporadic cancers; somatic mutation).|V -> L (in LFS; germline mutation and in sporadic cancers; somatic mutation). {ECO:0000269|PubMed:1737852}.|V -> M (in sporadic cancers; somatic mutation).		apoptotic process (GO:0006915)|B cell lineage commitment (GO:0002326)|base-excision repair (GO:0006284)|blood coagulation (GO:0007596)|cell aging (GO:0007569)|cell cycle arrest (GO:0007050)|cell differentiation (GO:0030154)|cell proliferation (GO:0008283)|cellular protein localization (GO:0034613)|cellular response to DNA damage stimulus (GO:0006974)|cellular response to drug (GO:0035690)|cellular response to glucose starvation (GO:0042149)|cellular response to hypoxia (GO:0071456)|cellular response to ionizing radiation (GO:0071479)|cellular response to UV (GO:0034644)|cerebellum development (GO:0021549)|chromatin assembly (GO:0031497)|determination of adult lifespan (GO:0008340)|DNA damage response, signal transduction by p53 class mediator (GO:0030330)|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)|DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)|DNA strand renaturation (GO:0000733)|double-strand break repair (GO:0006302)|embryonic organ development (GO:0048568)|ER overload response (GO:0006983)|gastrulation (GO:0007369)|in utero embryonic development (GO:0001701)|intrinsic apoptotic signaling pathway (GO:0097193)|intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332)|intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771)|mitotic cell cycle arrest (GO:0071850)|mitotic G1 DNA damage checkpoint (GO:0031571)|multicellular organism growth (GO:0035264)|multicellular organismal development (GO:0007275)|necroptotic process (GO:0070266)|negative regulation of apoptotic process (GO:0043066)|negative regulation of cell growth (GO:0030308)|negative regulation of cell proliferation (GO:0008285)|negative regulation of DNA replication (GO:0008156)|negative regulation of fibroblast proliferation (GO:0048147)|negative regulation of helicase activity (GO:0051097)|negative regulation of macromitophagy (GO:1901525)|negative regulation of neuroblast proliferation (GO:0007406)|negative regulation of reactive oxygen species metabolic process (GO:2000378)|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|negative regulation of transcription, DNA-templated (GO:0045892)|negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512)|neuron apoptotic process (GO:0051402)|Notch signaling pathway (GO:0007219)|nucleotide-excision repair (GO:0006289)|oligodendrocyte apoptotic process (GO:0097252)|oxidative stress-induced premature senescence (GO:0090403)|positive regulation of apoptotic process (GO:0043065)|positive regulation of cardiac muscle cell apoptotic process (GO:0010666)|positive regulation of cell aging (GO:0090343)|positive regulation of cell cycle arrest (GO:0071158)|positive regulation of histone deacetylation (GO:0031065)|positive regulation of intrinsic apoptotic signaling pathway (GO:2001244)|positive regulation of mitochondrial membrane permeability (GO:0035794)|positive regulation of neuron apoptotic process (GO:0043525)|positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731)|positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740)|positive regulation of protein oligomerization (GO:0032461)|positive regulation of reactive oxygen species metabolic process (GO:2000379)|positive regulation of release of cytochrome c from mitochondria (GO:0090200)|positive regulation of thymocyte apoptotic process (GO:0070245)|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|positive regulation of transcription, DNA-templated (GO:0045893)|protein complex assembly (GO:0006461)|protein import into nucleus, translocation (GO:0000060)|protein localization (GO:0008104)|protein tetramerization (GO:0051262)|Ras protein signal transduction (GO:0007265)|regulation of apoptotic process (GO:0042981)|regulation of mitochondrial membrane permeability (GO:0046902)|regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902108)|regulation of tissue remodeling (GO:0034103)|regulation of transcription, DNA-templated (GO:0006355)|release of cytochrome c from mitochondria (GO:0001836)|replicative senescence (GO:0090399)|response to antibiotic (GO:0046677)|response to gamma radiation (GO:0010332)|response to ischemia (GO:0002931)|response to salt stress (GO:0009651)|response to X-ray (GO:0010165)|rRNA transcription (GO:0009303)|somitogenesis (GO:0001756)|T cell differentiation in thymus (GO:0033077)|T cell lineage commitment (GO:0002360)|T cell proliferation involved in immune response (GO:0002309)|transforming growth factor beta receptor signaling pathway (GO:0007179)|viral process (GO:0016032)	chromatin (GO:0000785)|cytoplasm (GO:0005737)|cytosol (GO:0005829)|endoplasmic reticulum (GO:0005783)|mitochondrial matrix (GO:0005759)|mitochondrion (GO:0005739)|nuclear chromatin (GO:0000790)|nuclear matrix (GO:0016363)|nucleolus (GO:0005730)|nucleoplasm (GO:0005654)|nucleus (GO:0005634)|PML body (GO:0016605)|protein complex (GO:0043234)|replication fork (GO:0005657)	ATP binding (GO:0005524)|chaperone binding (GO:0051087)|chromatin binding (GO:0003682)|copper ion binding (GO:0005507)|damaged DNA binding (GO:0003684)|DNA binding (GO:0003677)|enzyme binding (GO:0019899)|histone acetyltransferase binding (GO:0035035)|histone deacetylase regulator activity (GO:0035033)|identical protein binding (GO:0042802)|p53 binding (GO:0002039)|protease binding (GO:0002020)|protein heterodimerization activity (GO:0046982)|protein kinase binding (GO:0019901)|protein N-terminus binding (GO:0047485)|protein phosphatase 2A binding (GO:0051721)|protein phosphatase binding (GO:0019903)|receptor tyrosine kinase binding (GO:0030971)|RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription (GO:0001077)|RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979)|RNA polymerase II transcription factor binding (GO:0001085)|RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription (GO:0001228)|sequence-specific DNA binding transcription factor activity (GO:0003700)|transcription factor binding (GO:0008134)|transcription regulatory region DNA binding (GO:0044212)|ubiquitin protein ligase binding (GO:0031625)|zinc ion binding (GO:0008270)	p.V272M(82)|p.V272L(26)|p.0?(8)|p.V272fs*73(4)|p.?(2)|p.F270fs*72(1)|p.E271fs*73(1)|p.V272fs*34(1)|p.L265_K305del41(1)|p.S269fs*21(1)|p.E258fs*71(1)|p.G266_E271delGRNSFE(1)|p.V272fs*74(1)|p.F270_D281del12(1)|p.E271_R273delEVR(1)|p.V272_K292del21(1)		NS(16)|adrenal_gland(37)|autonomic_ganglia(16)|biliary_tract(273)|bone(108)|breast(2530)|central_nervous_system(1264)|cervix(68)|endometrium(223)|eye(24)|fallopian_tube(1)|gastrointestinal_tract_(site_indeterminate)(1)|genital_tract(16)|haematopoietic_and_lymphoid_tissue(1301)|kidney(96)|large_intestine(5124)|liver(897)|lung(2388)|meninges(5)|oesophagus(1473)|ovary(1659)|pancreas(452)|penis(10)|peritoneum(33)|pituitary(4)|placenta(1)|pleura(3)|prostate(235)|salivary_gland(43)|skin(791)|small_intestine(14)|soft_tissue(220)|stomach(1158)|testis(11)|thymus(21)|thyroid(54)|upper_aerodigestive_tract(2271)|urinary_tract(1259)|vagina(6)|vulva(79)	24185		all_cancers(10;1.01e-06)|Myeloproliferative disorder(207;0.0122)|Prostate(122;0.081)		GBM - Glioblastoma multiforme(2;1.59e-06)|READ - Rectum adenocarcinoma(115;0.174)	Acetylsalicylic acid(DB00945)	CAAACACGCACCTCAAAGCTG	0.527		111	"""Mis, N, F"""		"""breast, colorectal, lung, sarcoma, adrenocortical, glioma, multiple other tumour types"""	"""breast, sarcoma, adrenocortical carcinoma, glioma, multiple other tumour types"""		Other conserved DNA damage response genes	Osteosarcoma, Familial Clustering of;Li-Fraumeni syndrome;Hereditary Breast-Ovarian Cancer, non-BRCA1/2;Hereditary Adrenocortical Cancer;Endometrial Cancer, Familial Clustering of	HNSCC(1;<9.43e-08)|TCGA GBM(1;<1E-08)|TSP Lung(2;<1E-08)|TCGA Ovarian(1;<1.89e-07)|Multiple Myeloma(5;0.019)																											Pancreas(47;798 1329 9957 10801)	yes	Rec	yes	Li-Fraumeni syndrome	17	17p13	7157	tumor protein p53		"""L, E, M, O"""	133	Substitution - Missense(108)|Whole gene deletion(8)|Deletion - Frameshift(8)|Deletion - In frame(5)|Insertion - Frameshift(2)|Unknown(2)	large_intestine(23)|ovary(16)|lung(14)|breast(14)|oesophagus(11)|upper_aerodigestive_tract(9)|haematopoietic_and_lymphoid_tissue(9)|central_nervous_system(7)|bone(5)|stomach(4)|pancreas(4)|liver(4)|kidney(3)|urinary_tract(3)|endometrium(2)|thyroid(1)|vulva(1)|soft_tissue(1)|testis(1)|skin(1)	GRCh37	CM920676	TP53	M	rs121912657						62.0	54.0	57.0					17																	7577124		2203	4300	6503	SO:0001583	missense	Familial Cancer Database	Familial Osteogenic Sarcoma;LFS, SBLA syndrome (Sarcoma Breast Leukemia Adrenal cancer), incl.: Cancer with In Vitro Radioresistence, Familial, Li-Fraumeni-like s.;BRCAX;Familial Adrenocortical Carcinoma;	AF307851	CCDS11118.1, CCDS45605.1, CCDS45606.1, CCDS73963.1, CCDS73964.1, CCDS73965.1, CCDS73966.1, CCDS73967.1, CCDS73968.1, CCDS73969.1, CCDS73970.1, CCDS73971.1	17p13.1	2014-09-17	2008-01-16		ENSG00000141510	ENSG00000141510	7157			11998	protein-coding gene	gene with protein product	"""Li-Fraumeni syndrome"""	191170				6396087, 3456488, 2047879	Standard	NM_000546	NM_001126115		Approved	p53, LFS1	uc002gij.3	P04637	OTTHUMG00000162125	ENST00000269305.4:c.814G>T	chr17.hg19:g.7577124C>A	ENSP00000269305:p.Val272Leu		Q15086|Q15087|Q15088|Q16535|Q16807|Q16808|Q16809|Q16810|Q16811|Q16848|Q2XN98|Q3LRW1|Q3LRW2|Q3LRW3|Q3LRW4|Q3LRW5|Q86UG1|Q8J016|Q99659|Q9BTM4|Q9HAQ8|Q9NP68|Q9NPJ2|Q9NZD0|Q9UBI2|Q9UQ61	True	hg19	CCDS11118.1	.	.	.	.	.	.	.	.	.	.	C	25.5	4.645555	0.87859	.	.	ENSG00000141510	ENST00000359597;ENST00000269305;ENST00000455263;ENST00000420246;ENST00000445888;ENST00000396473;ENST00000509690	D;D;D;D;D;D	0.99824	-6.96;-6.96;-6.96;-6.96;-6.96;-6.96	5.13	5.13	0.70059	p53, DNA-binding domain (1);p53-like transcription factor, DNA-binding (1);p53/RUNT-type transcription factor, DNA-binding domain (1);	0.057604	0.64402	D	0.000002	D	0.99753	0.9901	M	0.75447	2.3	0.58432	A	0.999996	D;P;D;D	0.71674	0.997;0.84;0.998;0.99	D;P;D;D	0.72075	0.976;0.721;0.966;0.967	D	0.97041	0.9757	9	0.72032	D	0.01	-27.8222	16.1198	0.81342	0.0:1.0:0.0:0.0	.	272;272;272;272	P04637-2;P04637-3;P04637;Q1MSW8	.;.;P53_HUMAN;.	L	272;272;272;272;272;261;140	ENSP00000352610:V272L;ENSP00000269305:V272L;ENSP00000398846:V272L;ENSP00000391127:V272L;ENSP00000391478:V272L;ENSP00000425104:V140L	ENSP00000269305:V272L	V	-	1	0	TP53	7517849	1.000000	0.71417	0.986000	0.45419	0.849000	0.48306	5.871000	0.69628	2.667000	0.90743	0.462000	0.41574	GTG	TP53-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000367397.1		100.0		-	ENST00000269305.4
NF1	4763	__UNKNOWN__	__UNKNOWN__	17	29661945	29661945	__UNKNOWN__	Nonsense_Mutation	SNP	C	C	T	rs137854552		__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr17:29661945C>T	ENST00000358273.4	+	40	6285	c.5902C>T	c.(5902-5904)Cga>Tga	p.R1968*	NF1_ENST00000581113.2_3'UTR|NF1_ENST00000356175.3_Nonsense_Mutation_p.R1947*	NM_001042492.2	NP_001035957.1	P21359	NF1_HUMAN	neurofibromin 1	1968					actin cytoskeleton organization (GO:0030036)|adrenal gland development (GO:0030325)|artery morphogenesis (GO:0048844)|brain development (GO:0007420)|camera-type eye morphogenesis (GO:0048593)|cell communication (GO:0007154)|cerebral cortex development (GO:0021987)|cognition (GO:0050890)|collagen fibril organization (GO:0030199)|extracellular matrix organization (GO:0030198)|extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625)|forebrain astrocyte development (GO:0021897)|forebrain morphogenesis (GO:0048853)|heart development (GO:0007507)|liver development (GO:0001889)|MAPK cascade (GO:0000165)|metanephros development (GO:0001656)|myelination in peripheral nervous system (GO:0022011)|negative regulation of angiogenesis (GO:0016525)|negative regulation of astrocyte differentiation (GO:0048712)|negative regulation of cell migration (GO:0030336)|negative regulation of cell-matrix adhesion (GO:0001953)|negative regulation of endothelial cell proliferation (GO:0001937)|negative regulation of fibroblast proliferation (GO:0048147)|negative regulation of MAP kinase activity (GO:0043407)|negative regulation of MAPK cascade (GO:0043409)|negative regulation of neuroblast proliferation (GO:0007406)|negative regulation of neurotransmitter secretion (GO:0046929)|negative regulation of oligodendrocyte differentiation (GO:0048715)|negative regulation of osteoclast differentiation (GO:0045671)|negative regulation of protein kinase activity (GO:0006469)|negative regulation of Rac protein signal transduction (GO:0035021)|negative regulation of Ras protein signal transduction (GO:0046580)|negative regulation of transcription factor import into nucleus (GO:0042992)|neural tube development (GO:0021915)|osteoblast differentiation (GO:0001649)|peripheral nervous system development (GO:0007422)|phosphatidylinositol 3-kinase signaling (GO:0014065)|pigmentation (GO:0043473)|positive regulation of adenylate cyclase activity (GO:0045762)|positive regulation of apoptotic process (GO:0043065)|positive regulation of endothelial cell proliferation (GO:0001938)|positive regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001241)|positive regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902043)|positive regulation of neuron apoptotic process (GO:0043525)|positive regulation of Ras GTPase activity (GO:0032320)|Ras protein signal transduction (GO:0007265)|regulation of angiogenesis (GO:0045765)|regulation of blood vessel endothelial cell migration (GO:0043535)|regulation of bone resorption (GO:0045124)|regulation of cell-matrix adhesion (GO:0001952)|regulation of glial cell differentiation (GO:0045685)|regulation of long-term neuronal synaptic plasticity (GO:0048169)|regulation of Ras GTPase activity (GO:0032318)|regulation of synaptic transmission, GABAergic (GO:0032228)|response to hypoxia (GO:0001666)|Schwann cell development (GO:0014044)|skeletal muscle tissue development (GO:0007519)|smooth muscle tissue development (GO:0048745)|spinal cord development (GO:0021510)|sympathetic nervous system development (GO:0048485)|visual learning (GO:0008542)|wound healing (GO:0042060)	axon (GO:0030424)|cytoplasm (GO:0005737)|dendrite (GO:0030425)|intrinsic component of the cytoplasmic side of the plasma membrane (GO:0031235)|membrane (GO:0016020)|nucleus (GO:0005634)	phosphatidylcholine binding (GO:0031210)|phosphatidylethanolamine binding (GO:0008429)|Ras GTPase activator activity (GO:0005099)	p.0?(8)|p.R1968*(3)|p.?(3)	NF1/ACCN1(2)	autonomic_ganglia(12)|breast(11)|central_nervous_system(72)|cervix(6)|endometrium(12)|haematopoietic_and_lymphoid_tissue(59)|kidney(9)|large_intestine(39)|liver(1)|lung(80)|ovary(20)|pancreas(2)|prostate(2)|skin(8)|soft_tissue(249)|stomach(2)|thyroid(1)|upper_aerodigestive_tract(5)|urinary_tract(9)	599		all_cancers(10;1.29e-12)|all_epithelial(10;0.00347)|all_hematologic(16;0.00556)|Acute lymphoblastic leukemia(14;0.00593)|Breast(31;0.014)|Myeloproliferative disorder(56;0.0255)|all_lung(9;0.0321)|Lung NSC(157;0.0659)		UCEC - Uterine corpus endometrioid carcinoma (4;4.38e-05)|all cancers(4;1.64e-26)|Epithelial(4;9.15e-23)|OV - Ovarian serous cystadenocarcinoma(4;3.58e-21)|GBM - Glioblastoma multiforme(4;0.00146)		TGATGCCAAACGACAAAGAGT	0.368			"""D, Mis, N, F, S, O"""		"""neurofibroma, glioma"""	"""neurofibroma, glioma"""			Neurofibromatosis, type 1	TCGA GBM(6;<1E-08)|TSP Lung(7;0.0071)|TCGA Ovarian(3;0.0088)																												yes	Rec	yes	Neurofibromatosis type 1	17	17q12	4763	neurofibromatosis type 1 gene		O	14	Whole gene deletion(8)|Substitution - Nonsense(3)|Unknown(3)	soft_tissue(8)|central_nervous_system(3)|autonomic_ganglia(2)|lung(1)	GRCh37	CM900173	NF1	M	rs137854552						131.0	119.0	123.0					17																	29661945		2203	4300	6503	SO:0001587	stop_gained	Familial Cancer Database	NF1, von Recklinghausen disease, incl.: Hereditary Spinal Neurofibromatosis, Neurofibromatosis-Noonan syndrome		CCDS11264.1, CCDS42292.1, CCDS45645.1	17q11.2	2014-09-17	2008-07-31		ENSG00000196712	ENSG00000196712	4763			7765	protein-coding gene	gene with protein product	"""neurofibromatosis"", ""von Recklinghausen disease"", ""Watson disease"""	613113				1715669	Standard	NM_000267	NM_000267		Approved		uc002hgg.3	P21359	OTTHUMG00000132871	ENST00000358273.4:c.5902C>T	chr17.hg19:g.29661945C>T	ENSP00000351015:p.Arg1968*		O00662|Q14284|Q14930|Q14931|Q9UMK3	True	hg19	CCDS42292.1	.	.	.	.	.	.	.	.	.	.	C	49	15.179225	0.99825	.	.	ENSG00000196712	ENST00000358273;ENST00000356175;ENST00000456735	.	.	.	5.48	4.42	0.53409	.	0.000000	0.85682	D	0.000000	.	.	.	.	.	.	0.80722	A	1	.	.	.	.	.	.	.	.	.	.	0.02654	T	1	.	14.975	0.71264	0.1858:0.8142:0.0:0.0	.	.	.	.	X	1968;1947;1613	.	ENSP00000348498:R1947X	R	+	1	2	NF1	26686071	1.000000	0.71417	1.000000	0.80357	0.997000	0.91878	2.867000	0.48428	1.079000	0.41038	0.557000	0.71058	CGA	NF1-001	KNOWN	basic|appris_candidate_longest|CCDS	protein_coding		protein_coding	OTTHUMT00000256351.2		100.0		+	ENST00000358273.4
NF1	4763	__UNKNOWN__	__UNKNOWN__	17	29701070	29701070	__UNKNOWN__	Missense_Mutation	SNP	G	G	T			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr17:29701070G>T	ENST00000358273.4	+	58	8800	c.8417G>T	c.(8416-8418)gGc>gTc	p.G2806V	NF1_ENST00000356175.3_Missense_Mutation_p.G2785V|NF1_ENST00000444181.2_Missense_Mutation_p.G599V	NM_001042492.2	NP_001035957.1	P21359	NF1_HUMAN	neurofibromin 1	2806					actin cytoskeleton organization (GO:0030036)|adrenal gland development (GO:0030325)|artery morphogenesis (GO:0048844)|brain development (GO:0007420)|camera-type eye morphogenesis (GO:0048593)|cell communication (GO:0007154)|cerebral cortex development (GO:0021987)|cognition (GO:0050890)|collagen fibril organization (GO:0030199)|extracellular matrix organization (GO:0030198)|extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625)|forebrain astrocyte development (GO:0021897)|forebrain morphogenesis (GO:0048853)|heart development (GO:0007507)|liver development (GO:0001889)|MAPK cascade (GO:0000165)|metanephros development (GO:0001656)|myelination in peripheral nervous system (GO:0022011)|negative regulation of angiogenesis (GO:0016525)|negative regulation of astrocyte differentiation (GO:0048712)|negative regulation of cell migration (GO:0030336)|negative regulation of cell-matrix adhesion (GO:0001953)|negative regulation of endothelial cell proliferation (GO:0001937)|negative regulation of fibroblast proliferation (GO:0048147)|negative regulation of MAP kinase activity (GO:0043407)|negative regulation of MAPK cascade (GO:0043409)|negative regulation of neuroblast proliferation (GO:0007406)|negative regulation of neurotransmitter secretion (GO:0046929)|negative regulation of oligodendrocyte differentiation (GO:0048715)|negative regulation of osteoclast differentiation (GO:0045671)|negative regulation of protein kinase activity (GO:0006469)|negative regulation of Rac protein signal transduction (GO:0035021)|negative regulation of Ras protein signal transduction (GO:0046580)|negative regulation of transcription factor import into nucleus (GO:0042992)|neural tube development (GO:0021915)|osteoblast differentiation (GO:0001649)|peripheral nervous system development (GO:0007422)|phosphatidylinositol 3-kinase signaling (GO:0014065)|pigmentation (GO:0043473)|positive regulation of adenylate cyclase activity (GO:0045762)|positive regulation of apoptotic process (GO:0043065)|positive regulation of endothelial cell proliferation (GO:0001938)|positive regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001241)|positive regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902043)|positive regulation of neuron apoptotic process (GO:0043525)|positive regulation of Ras GTPase activity (GO:0032320)|Ras protein signal transduction (GO:0007265)|regulation of angiogenesis (GO:0045765)|regulation of blood vessel endothelial cell migration (GO:0043535)|regulation of bone resorption (GO:0045124)|regulation of cell-matrix adhesion (GO:0001952)|regulation of glial cell differentiation (GO:0045685)|regulation of long-term neuronal synaptic plasticity (GO:0048169)|regulation of Ras GTPase activity (GO:0032318)|regulation of synaptic transmission, GABAergic (GO:0032228)|response to hypoxia (GO:0001666)|Schwann cell development (GO:0014044)|skeletal muscle tissue development (GO:0007519)|smooth muscle tissue development (GO:0048745)|spinal cord development (GO:0021510)|sympathetic nervous system development (GO:0048485)|visual learning (GO:0008542)|wound healing (GO:0042060)	axon (GO:0030424)|cytoplasm (GO:0005737)|dendrite (GO:0030425)|intrinsic component of the cytoplasmic side of the plasma membrane (GO:0031235)|membrane (GO:0016020)|nucleus (GO:0005634)	phosphatidylcholine binding (GO:0031210)|phosphatidylethanolamine binding (GO:0008429)|Ras GTPase activator activity (GO:0005099)	p.0?(8)|p.?(3)	NF1/ACCN1(2)	autonomic_ganglia(12)|breast(11)|central_nervous_system(72)|cervix(6)|endometrium(12)|haematopoietic_and_lymphoid_tissue(59)|kidney(9)|large_intestine(39)|liver(1)|lung(80)|ovary(20)|pancreas(2)|prostate(2)|skin(8)|soft_tissue(249)|stomach(2)|thyroid(1)|upper_aerodigestive_tract(5)|urinary_tract(9)	599		all_cancers(10;1.29e-12)|all_epithelial(10;0.00347)|all_hematologic(16;0.00556)|Acute lymphoblastic leukemia(14;0.00593)|Breast(31;0.014)|Myeloproliferative disorder(56;0.0255)|all_lung(9;0.0321)|Lung NSC(157;0.0659)		UCEC - Uterine corpus endometrioid carcinoma (4;4.38e-05)|all cancers(4;1.64e-26)|Epithelial(4;9.15e-23)|OV - Ovarian serous cystadenocarcinoma(4;3.58e-21)|GBM - Glioblastoma multiforme(4;0.00146)		CCTACCACTGGCCACTGTAAC	0.478			"""D, Mis, N, F, S, O"""		"""neurofibroma, glioma"""	"""neurofibroma, glioma"""			Neurofibromatosis, type 1	TCGA GBM(6;<1E-08)|TSP Lung(7;0.0071)|TCGA Ovarian(3;0.0088)																												yes	Rec	yes	Neurofibromatosis type 1	17	17q12	4763	neurofibromatosis type 1 gene		O	11	Whole gene deletion(8)|Unknown(3)	soft_tissue(7)|autonomic_ganglia(2)|lung(1)|central_nervous_system(1)											76.0	71.0	72.0					17																	29701070		2203	4300	6503	SO:0001583	missense	Familial Cancer Database	NF1, von Recklinghausen disease, incl.: Hereditary Spinal Neurofibromatosis, Neurofibromatosis-Noonan syndrome		CCDS11264.1, CCDS42292.1, CCDS45645.1	17q11.2	2014-09-17	2008-07-31		ENSG00000196712	ENSG00000196712	4763			7765	protein-coding gene	gene with protein product	"""neurofibromatosis"", ""von Recklinghausen disease"", ""Watson disease"""	613113				1715669	Standard	NM_000267	NM_000267		Approved		uc002hgg.3	P21359	OTTHUMG00000132871	ENST00000358273.4:c.8417G>T	chr17.hg19:g.29701070G>T	ENSP00000351015:p.Gly2806Val		O00662|Q14284|Q14930|Q14931|Q9UMK3	True	hg19	CCDS42292.1	.	.	.	.	.	.	.	.	.	.	G	13.29	2.194403	0.38806	.	.	ENSG00000196712	ENST00000358273;ENST00000356175;ENST00000456735;ENST00000444181	T;T;T;T	0.53423	3.07;3.2;2.88;0.62	5.5	5.5	0.81552	.	0.056153	0.64402	D	0.000001	T	0.38374	0.1038	N	0.19112	0.55	0.58432	D	0.999999	B;B	0.26809	0.16;0.099	B;B	0.31337	0.128;0.06	T	0.33085	-0.9882	10	0.72032	D	0.01	.	15.7282	0.77780	0.0:0.1366:0.8634:0.0	.	2785;2806	P21359-2;P21359	.;NF1_HUMAN	V	2806;2785;2469;599	ENSP00000351015:G2806V;ENSP00000348498:G2785V;ENSP00000389907:G2469V;ENSP00000396481:G599V	ENSP00000348498:G2785V	G	+	2	0	NF1	26725196	1.000000	0.71417	1.000000	0.80357	0.998000	0.95712	4.706000	0.61845	2.575000	0.86900	0.563000	0.77884	GGC	NF1-001	KNOWN	basic|appris_candidate_longest|CCDS	protein_coding		protein_coding	OTTHUMT00000256351.2		25.0		+	ENST00000358273.4
MAP2K2	5605	__UNKNOWN__	__UNKNOWN__	19	4123851	4123851	__UNKNOWN__	Missense_Mutation	SNP	C	C	T			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr19:4123851C>T	ENST00000262948.5	-	1	275	c.22G>A	c.(22-24)Gtg>Atg	p.V8M	MAP2K2_ENST00000394867.4_Intron|MAP2K2_ENST00000599345.1_5'UTR	NM_030662.3	NP_109587.1	P36507	MP2K2_HUMAN	mitogen-activated protein kinase kinase 2	8					activation of MAPK activity (GO:0000187)|activation of MAPKK activity (GO:0000186)|axon guidance (GO:0007411)|epidermal growth factor receptor signaling pathway (GO:0007173)|ERK1 and ERK2 cascade (GO:0070371)|Fc-epsilon receptor signaling pathway (GO:0038095)|fibroblast growth factor receptor signaling pathway (GO:0008543)|innate immune response (GO:0045087)|insulin receptor signaling pathway (GO:0008286)|MAPK cascade (GO:0000165)|MyD88-dependent toll-like receptor signaling pathway (GO:0002755)|MyD88-independent toll-like receptor signaling pathway (GO:0002756)|neurotrophin TRK receptor signaling pathway (GO:0048011)|peptidyl-serine autophosphorylation (GO:0036289)|positive regulation of cell motility (GO:2000147)|positive regulation of protein serine/threonine kinase activity (GO:0071902)|Ras protein signal transduction (GO:0007265)|regulation of early endosome to late endosome transport (GO:2000641)|regulation of Golgi inheritance (GO:0090170)|regulation of stress-activated MAPK cascade (GO:0032872)|small GTPase mediated signal transduction (GO:0007264)|stress-activated MAPK cascade (GO:0051403)|toll-like receptor 10 signaling pathway (GO:0034166)|toll-like receptor 2 signaling pathway (GO:0034134)|toll-like receptor 3 signaling pathway (GO:0034138)|toll-like receptor 4 signaling pathway (GO:0034142)|toll-like receptor 5 signaling pathway (GO:0034146)|toll-like receptor 9 signaling pathway (GO:0034162)|toll-like receptor signaling pathway (GO:0002224)|toll-like receptor TLR1:TLR2 signaling pathway (GO:0038123)|toll-like receptor TLR6:TLR2 signaling pathway (GO:0038124)|TRIF-dependent toll-like receptor signaling pathway (GO:0035666)	cell cortex (GO:0005938)|cell-cell junction (GO:0005911)|cytoplasm (GO:0005737)|cytoplasmic side of plasma membrane (GO:0009898)|cytosol (GO:0005829)|early endosome (GO:0005769)|endoplasmic reticulum (GO:0005783)|extracellular region (GO:0005576)|focal adhesion (GO:0005925)|Golgi apparatus (GO:0005794)|late endosome (GO:0005770)|microtubule (GO:0005874)|mitochondrion (GO:0005739)|nucleus (GO:0005634)|perinuclear region of cytoplasm (GO:0048471)|peroxisomal membrane (GO:0005778)	ATP binding (GO:0005524)|MAP kinase kinase activity (GO:0004708)|PDZ domain binding (GO:0030165)|protein serine/threonine kinase activator activity (GO:0043539)|protein serine/threonine kinase activity (GO:0004674)|protein serine/threonine/tyrosine kinase activity (GO:0004712)|protein tyrosine kinase activity (GO:0004713)|scaffold protein binding (GO:0097110)						Hepatocellular(1079;0.137)		UCEC - Uterine corpus endometrioid carcinoma (162;6.64e-05)|BRCA - Breast invasive adenocarcinoma(158;0.0149)|STAD - Stomach adenocarcinoma(1328;0.18)	Bosutinib(DB06616)|Trametinib(DB08911)	GCCGGCAGCACCGGCTTCCTC	0.766																																																0													6.0	7.0	6.0					19																	4123851		2091	4154	6245	SO:0001583	missense			L11285	CCDS12120.1	19p13.3	2014-09-17			ENSG00000126934	ENSG00000126934	5605	2.7.12.2	"""Mitogen-activated protein kinase cascade / Kinase kinases"""	6842	protein-coding gene	gene with protein product		601263		PRKMK2		8388392	Standard		NM_030662		Approved	MEK2	uc002lzk.3	P36507	OTTHUMG00000134286	ENST00000262948.5:c.22G>A	chr19.hg19:g.4123851C>T	ENSP00000262948:p.Val8Met			True	hg19	CCDS12120.1	.	.	.	.	.	.	.	.	.	.	c	14.86	2.662510	0.47572	.	.	ENSG00000126934	ENST00000262948	T	0.76709	-1.04	3.93	2.88	0.33553	.	0.241045	0.34200	U	0.004165	T	0.60379	0.2264	N	0.22421	0.69	0.80722	D	1	B	0.02656	0.0	B	0.04013	0.001	T	0.51593	-0.8686	10	0.34782	T	0.22	-8.5699	6.775	0.23615	0.0:0.7203:0.1783:0.1014	.	8	P36507	MP2K2_HUMAN	M	8	ENSP00000262948:V8M	ENSP00000262948:V8M	V	-	1	0	MAP2K2	4074851	0.998000	0.40836	1.000000	0.80357	0.991000	0.79684	1.049000	0.30392	0.760000	0.33108	0.450000	0.29827	GTG	MAP2K2-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000258957.2		22.0		-	ENST00000262948.5
MAP2K2	5605	__UNKNOWN__	__UNKNOWN__	19	4123874	4123874	__UNKNOWN__	5'UTR	SNP	G	G	C			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr19:4123874G>C	ENST00000262948.5	-	0	252				MAP2K2_ENST00000394867.4_Intron|MAP2K2_ENST00000599345.1_5'UTR	NM_030662.3	NP_109587.1	P36507	MP2K2_HUMAN	mitogen-activated protein kinase kinase 2						activation of MAPK activity (GO:0000187)|activation of MAPKK activity (GO:0000186)|axon guidance (GO:0007411)|epidermal growth factor receptor signaling pathway (GO:0007173)|ERK1 and ERK2 cascade (GO:0070371)|Fc-epsilon receptor signaling pathway (GO:0038095)|fibroblast growth factor receptor signaling pathway (GO:0008543)|innate immune response (GO:0045087)|insulin receptor signaling pathway (GO:0008286)|MAPK cascade (GO:0000165)|MyD88-dependent toll-like receptor signaling pathway (GO:0002755)|MyD88-independent toll-like receptor signaling pathway (GO:0002756)|neurotrophin TRK receptor signaling pathway (GO:0048011)|peptidyl-serine autophosphorylation (GO:0036289)|positive regulation of cell motility (GO:2000147)|positive regulation of protein serine/threonine kinase activity (GO:0071902)|Ras protein signal transduction (GO:0007265)|regulation of early endosome to late endosome transport (GO:2000641)|regulation of Golgi inheritance (GO:0090170)|regulation of stress-activated MAPK cascade (GO:0032872)|small GTPase mediated signal transduction (GO:0007264)|stress-activated MAPK cascade (GO:0051403)|toll-like receptor 10 signaling pathway (GO:0034166)|toll-like receptor 2 signaling pathway (GO:0034134)|toll-like receptor 3 signaling pathway (GO:0034138)|toll-like receptor 4 signaling pathway (GO:0034142)|toll-like receptor 5 signaling pathway (GO:0034146)|toll-like receptor 9 signaling pathway (GO:0034162)|toll-like receptor signaling pathway (GO:0002224)|toll-like receptor TLR1:TLR2 signaling pathway (GO:0038123)|toll-like receptor TLR6:TLR2 signaling pathway (GO:0038124)|TRIF-dependent toll-like receptor signaling pathway (GO:0035666)	cell cortex (GO:0005938)|cell-cell junction (GO:0005911)|cytoplasm (GO:0005737)|cytoplasmic side of plasma membrane (GO:0009898)|cytosol (GO:0005829)|early endosome (GO:0005769)|endoplasmic reticulum (GO:0005783)|extracellular region (GO:0005576)|focal adhesion (GO:0005925)|Golgi apparatus (GO:0005794)|late endosome (GO:0005770)|microtubule (GO:0005874)|mitochondrion (GO:0005739)|nucleus (GO:0005634)|perinuclear region of cytoplasm (GO:0048471)|peroxisomal membrane (GO:0005778)	ATP binding (GO:0005524)|MAP kinase kinase activity (GO:0004708)|PDZ domain binding (GO:0030165)|protein serine/threonine kinase activator activity (GO:0043539)|protein serine/threonine kinase activity (GO:0004674)|protein serine/threonine/tyrosine kinase activity (GO:0004712)|protein tyrosine kinase activity (GO:0004713)|scaffold protein binding (GO:0097110)						Hepatocellular(1079;0.137)		UCEC - Uterine corpus endometrioid carcinoma (162;6.64e-05)|BRCA - Breast invasive adenocarcinoma(158;0.0149)|STAD - Stomach adenocarcinoma(1328;0.18)	Bosutinib(DB06616)|Trametinib(DB08911)	GGCCAGCATCGGGGCTccgcg	0.786																																																0													3.0	4.0	4.0					19																	4123874		1851	3849	5700	SO:0001623	5_prime_UTR_variant			L11285	CCDS12120.1	19p13.3	2014-09-17			ENSG00000126934	ENSG00000126934	5605	2.7.12.2	"""Mitogen-activated protein kinase cascade / Kinase kinases"""	6842	protein-coding gene	gene with protein product		601263		PRKMK2		8388392	Standard		NM_030662		Approved	MEK2	uc002lzk.3	P36507	OTTHUMG00000134286	ENST00000262948.5:c.-2C>G	chr19.hg19:g.4123874G>C				True	hg19	CCDS12120.1																																																																																			MAP2K2-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000258957.2		28.0		-	ENST00000262948.5
SMARCA4	6597	__UNKNOWN__	__UNKNOWN__	19	11094963	11094963	__UNKNOWN__	Missense_Mutation	SNP	A	A	T			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr19:11094963A>T	ENST00000541122.2	+	3	421	c.136A>T	c.(136-138)Agc>Tgc	p.S46C	SMARCA4_ENST00000358026.2_Missense_Mutation_p.S46C|SMARCA4_ENST00000413806.3_Missense_Mutation_p.S46C|SMARCA4_ENST00000589677.1_Missense_Mutation_p.S46C|SMARCA4_ENST00000429416.3_Missense_Mutation_p.S46C|SMARCA4_ENST00000344626.4_Missense_Mutation_p.S46C|SMARCA4_ENST00000590574.1_Missense_Mutation_p.S46C|SMARCA4_ENST00000444061.3_Missense_Mutation_p.S46C|SMARCA4_ENST00000450717.3_Missense_Mutation_p.S46C			P51532	SMCA4_HUMAN	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4	46	Necessary for interaction with SS18L1/CREST. {ECO:0000250}.				aortic smooth muscle cell differentiation (GO:0035887)|ATP catabolic process (GO:0006200)|ATP-dependent chromatin remodeling (GO:0043044)|blastocyst growth (GO:0001832)|blastocyst hatching (GO:0001835)|cell morphogenesis (GO:0000902)|chromatin remodeling (GO:0006338)|definitive erythrocyte differentiation (GO:0060318)|DNA methylation on cytosine within a CG sequence (GO:0010424)|embryonic hindlimb morphogenesis (GO:0035116)|embryonic organ morphogenesis (GO:0048562)|epidermis morphogenesis (GO:0048730)|extracellular matrix organization (GO:0030198)|forebrain development (GO:0030900)|glial cell fate determination (GO:0007403)|heart trabecula formation (GO:0060347)|hindbrain development (GO:0030902)|histone H3 acetylation (GO:0043966)|keratinocyte differentiation (GO:0030216)|lens fiber cell development (GO:0070307)|liver development (GO:0001889)|methylation-dependent chromatin silencing (GO:0006346)|negative regulation of androgen receptor signaling pathway (GO:0060766)|negative regulation of cell growth (GO:0030308)|negative regulation of G1/S transition of mitotic cell cycle (GO:2000134)|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|negative regulation of transcription from RNA polymerase II promoter during mitosis (GO:0007070)|negative regulation of transcription, DNA-templated (GO:0045892)|neural retina development (GO:0003407)|nucleosome disassembly (GO:0006337)|positive regulation by host of viral transcription (GO:0043923)|positive regulation of DNA binding (GO:0043388)|positive regulation of sequence-specific DNA binding transcription factor activity (GO:0051091)|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|positive regulation of transcription, DNA-templated (GO:0045893)|regulation of transcription from RNA polymerase II promoter (GO:0006357)|stem cell maintenance (GO:0019827)|vasculogenesis (GO:0001570)	extracellular space (GO:0005615)|heterochromatin (GO:0000792)|membrane (GO:0016020)|nBAF complex (GO:0071565)|npBAF complex (GO:0071564)|nuclear chromatin (GO:0000790)|nuclear euchromatin (GO:0005719)|nucleolus (GO:0005730)|nucleus (GO:0005634)|perichromatin fibrils (GO:0005726)|protein complex (GO:0043234)|SWI/SNF complex (GO:0016514)	androgen receptor binding (GO:0050681)|ATP binding (GO:0005524)|chromatin binding (GO:0003682)|DNA-dependent ATPase activity (GO:0008094)|helicase activity (GO:0004386)|lysine-acetylated histone binding (GO:0070577)|p53 binding (GO:0002039)|protein N-terminus binding (GO:0047485)|RNA polymerase II regulatory region sequence-specific DNA binding (GO:0000977)|RNA polymerase II transcription coactivator activity (GO:0001105)|Tat protein binding (GO:0030957)|transcription coactivator activity (GO:0003713)|transcription corepressor activity (GO:0003714)	p.?(1)		adrenal_gland(1)|autonomic_ganglia(1)|breast(6)|central_nervous_system(23)|endometrium(10)|haematopoietic_and_lymphoid_tissue(1)|kidney(8)|large_intestine(16)|liver(4)|lung(60)|ovary(10)|pancreas(7)|prostate(3)|skin(8)|stomach(1)|upper_aerodigestive_tract(2)|urinary_tract(2)	163		all_lung(6;0.0512)|Lung NSC(9;0.0568)				GATGGGGCCCAGCCCAGGGCC	0.706			"""F, N, Mis"""		NSCLC																																		Rec	yes		19	19p13.2	6597	"""SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4"""		E	1	Unknown(1)	lung(1)											17.0	16.0	16.0					19																	11094963		2191	4295	6486	SO:0001583	missense			D26156	CCDS12253.1, CCDS45972.1, CCDS45973.1, CCDS54217.1, CCDS54218.1	19p13.3	2014-09-17	2006-11-09		ENSG00000127616	ENSG00000127616	6597			11100	protein-coding gene	gene with protein product	"""SNF2-like 4"", ""global transcription activator homologous sequence"", ""sucrose nonfermenting-like 4"", ""mitotic growth and transcription activator"", ""BRM/SWI2-related gene 1"", ""homeotic gene regulator"", ""nuclear protein GRB1"", ""brahma protein-like 1"", ""ATP-dependent helicase SMARCA4"""	603254		SNF2L4		8208605	Standard	NM_003072	NM_003072		Approved	hSNF2b, BRG1, BAF190, SNF2, SWI2, SNF2-BETA, SNF2LB, FLJ39786	uc010dxo.3	P51532	OTTHUMG00000169272	ENST00000541122.2:c.136A>T	chr19.hg19:g.11094963A>T	ENSP00000445036:p.Ser46Cys		B1A8Z4|B1A8Z5|B1A8Z6|B1A8Z7|E9PBR8|O95052|Q9HBD3	True	hg19	CCDS45972.1	.	.	.	.	.	.	.	.	.	.	A	19.30	3.801886	0.70682	.	.	ENSG00000127616	ENST00000429416;ENST00000358026;ENST00000421844;ENST00000344626;ENST00000541122;ENST00000444061;ENST00000450717;ENST00000413806	D;D;D;D;D;D;D	0.89343	-2.48;-2.5;-2.48;-2.35;-2.45;-2.45;-2.35	4.95	4.95	0.65309	.	0.000000	0.85682	D	0.000000	D	0.92309	0.7560	L	0.53249	1.67	0.52099	D	0.999948	D;D;D;D;D;D;D	0.69078	0.997;0.997;0.997;0.997;0.997;0.997;0.997	D;D;D;D;D;D;D	0.70935	0.971;0.971;0.971;0.971;0.971;0.971;0.971	D	0.93072	0.6483	10	0.87932	D	0	-41.5976	13.7487	0.62894	1.0:0.0:0.0:0.0	.	46;46;46;46;46;46;46	B1A8Z6;B1A8Z4;B1A8Z7;Q9HBD4;B1A8Z5;A7E2E1;P51532	.;.;.;.;.;.;SMCA4_HUMAN	C	46	ENSP00000395654:S46C;ENSP00000350720:S46C;ENSP00000343896:S46C;ENSP00000445036:S46C;ENSP00000392837:S46C;ENSP00000397783:S46C;ENSP00000414727:S46C	ENSP00000343896:S46C	S	+	1	0	SMARCA4	10955963	1.000000	0.71417	1.000000	0.80357	0.936000	0.57629	5.967000	0.70403	2.073000	0.62155	0.533000	0.62120	AGC	SMARCA4-005	KNOWN	non_canonical_conserved|basic|appris_candidate_longest|CCDS	protein_coding		protein_coding	OTTHUMT00000403237.2		55.0		+	ENST00000541122.2
SMARCA4	6597	__UNKNOWN__	__UNKNOWN__	19	11094966	11094966	__UNKNOWN__	Missense_Mutation	SNP	C	C	G			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr19:11094966C>G	ENST00000541122.2	+	3	424	c.139C>G	c.(139-141)Cca>Gca	p.P47A	SMARCA4_ENST00000358026.2_Missense_Mutation_p.P47A|SMARCA4_ENST00000413806.3_Missense_Mutation_p.P47A|SMARCA4_ENST00000589677.1_Missense_Mutation_p.P47A|SMARCA4_ENST00000429416.3_Missense_Mutation_p.P47A|SMARCA4_ENST00000344626.4_Missense_Mutation_p.P47A|SMARCA4_ENST00000590574.1_Missense_Mutation_p.P47A|SMARCA4_ENST00000444061.3_Missense_Mutation_p.P47A|SMARCA4_ENST00000450717.3_Missense_Mutation_p.P47A			P51532	SMCA4_HUMAN	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4	47	Necessary for interaction with SS18L1/CREST. {ECO:0000250}.				aortic smooth muscle cell differentiation (GO:0035887)|ATP catabolic process (GO:0006200)|ATP-dependent chromatin remodeling (GO:0043044)|blastocyst growth (GO:0001832)|blastocyst hatching (GO:0001835)|cell morphogenesis (GO:0000902)|chromatin remodeling (GO:0006338)|definitive erythrocyte differentiation (GO:0060318)|DNA methylation on cytosine within a CG sequence (GO:0010424)|embryonic hindlimb morphogenesis (GO:0035116)|embryonic organ morphogenesis (GO:0048562)|epidermis morphogenesis (GO:0048730)|extracellular matrix organization (GO:0030198)|forebrain development (GO:0030900)|glial cell fate determination (GO:0007403)|heart trabecula formation (GO:0060347)|hindbrain development (GO:0030902)|histone H3 acetylation (GO:0043966)|keratinocyte differentiation (GO:0030216)|lens fiber cell development (GO:0070307)|liver development (GO:0001889)|methylation-dependent chromatin silencing (GO:0006346)|negative regulation of androgen receptor signaling pathway (GO:0060766)|negative regulation of cell growth (GO:0030308)|negative regulation of G1/S transition of mitotic cell cycle (GO:2000134)|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|negative regulation of transcription from RNA polymerase II promoter during mitosis (GO:0007070)|negative regulation of transcription, DNA-templated (GO:0045892)|neural retina development (GO:0003407)|nucleosome disassembly (GO:0006337)|positive regulation by host of viral transcription (GO:0043923)|positive regulation of DNA binding (GO:0043388)|positive regulation of sequence-specific DNA binding transcription factor activity (GO:0051091)|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|positive regulation of transcription, DNA-templated (GO:0045893)|regulation of transcription from RNA polymerase II promoter (GO:0006357)|stem cell maintenance (GO:0019827)|vasculogenesis (GO:0001570)	extracellular space (GO:0005615)|heterochromatin (GO:0000792)|membrane (GO:0016020)|nBAF complex (GO:0071565)|npBAF complex (GO:0071564)|nuclear chromatin (GO:0000790)|nuclear euchromatin (GO:0005719)|nucleolus (GO:0005730)|nucleus (GO:0005634)|perichromatin fibrils (GO:0005726)|protein complex (GO:0043234)|SWI/SNF complex (GO:0016514)	androgen receptor binding (GO:0050681)|ATP binding (GO:0005524)|chromatin binding (GO:0003682)|DNA-dependent ATPase activity (GO:0008094)|helicase activity (GO:0004386)|lysine-acetylated histone binding (GO:0070577)|p53 binding (GO:0002039)|protein N-terminus binding (GO:0047485)|RNA polymerase II regulatory region sequence-specific DNA binding (GO:0000977)|RNA polymerase II transcription coactivator activity (GO:0001105)|Tat protein binding (GO:0030957)|transcription coactivator activity (GO:0003713)|transcription corepressor activity (GO:0003714)	p.?(1)		adrenal_gland(1)|autonomic_ganglia(1)|breast(6)|central_nervous_system(23)|endometrium(10)|haematopoietic_and_lymphoid_tissue(1)|kidney(8)|large_intestine(16)|liver(4)|lung(60)|ovary(10)|pancreas(7)|prostate(3)|skin(8)|stomach(1)|upper_aerodigestive_tract(2)|urinary_tract(2)	163		all_lung(6;0.0512)|Lung NSC(9;0.0568)				GGGGCCCAGCCCAGGGCCGCC	0.711			"""F, N, Mis"""		NSCLC																																		Rec	yes		19	19p13.2	6597	"""SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4"""		E	1	Unknown(1)	lung(1)											17.0	16.0	16.0					19																	11094966		2191	4295	6486	SO:0001583	missense			D26156	CCDS12253.1, CCDS45972.1, CCDS45973.1, CCDS54217.1, CCDS54218.1	19p13.3	2014-09-17	2006-11-09		ENSG00000127616	ENSG00000127616	6597			11100	protein-coding gene	gene with protein product	"""SNF2-like 4"", ""global transcription activator homologous sequence"", ""sucrose nonfermenting-like 4"", ""mitotic growth and transcription activator"", ""BRM/SWI2-related gene 1"", ""homeotic gene regulator"", ""nuclear protein GRB1"", ""brahma protein-like 1"", ""ATP-dependent helicase SMARCA4"""	603254		SNF2L4		8208605	Standard	NM_003072	NM_003072		Approved	hSNF2b, BRG1, BAF190, SNF2, SWI2, SNF2-BETA, SNF2LB, FLJ39786	uc010dxo.3	P51532	OTTHUMG00000169272	ENST00000541122.2:c.139C>G	chr19.hg19:g.11094966C>G	ENSP00000445036:p.Pro47Ala		B1A8Z4|B1A8Z5|B1A8Z6|B1A8Z7|E9PBR8|O95052|Q9HBD3	True	hg19	CCDS45972.1	.	.	.	.	.	.	.	.	.	.	C	17.59	3.428146	0.62844	.	.	ENSG00000127616	ENST00000429416;ENST00000358026;ENST00000421844;ENST00000344626;ENST00000541122;ENST00000444061;ENST00000450717;ENST00000413806	D;D;D;D;D;D;D	0.88896	-2.44;-2.43;-2.44;-2.25;-2.37;-2.38;-2.25	4.95	4.95	0.65309	.	0.000000	0.85682	D	0.000000	D	0.92548	0.7633	L	0.55481	1.735	0.58432	D	0.999993	D;D;D;D;D;D;D	0.63880	0.993;0.993;0.993;0.993;0.993;0.993;0.993	D;D;D;D;D;D;D	0.68192	0.956;0.956;0.956;0.956;0.956;0.956;0.956	D	0.92033	0.5635	10	0.44086	T	0.13	-21.3027	17.1334	0.86732	0.0:1.0:0.0:0.0	.	47;47;47;47;47;47;47	B1A8Z6;B1A8Z4;B1A8Z7;Q9HBD4;B1A8Z5;A7E2E1;P51532	.;.;.;.;.;.;SMCA4_HUMAN	A	47	ENSP00000395654:P47A;ENSP00000350720:P47A;ENSP00000343896:P47A;ENSP00000445036:P47A;ENSP00000392837:P47A;ENSP00000397783:P47A;ENSP00000414727:P47A	ENSP00000343896:P47A	P	+	1	0	SMARCA4	10955966	1.000000	0.71417	0.997000	0.53966	0.798000	0.45092	4.723000	0.61965	2.563000	0.86464	0.655000	0.94253	CCA	SMARCA4-005	KNOWN	non_canonical_conserved|basic|appris_candidate_longest|CCDS	protein_coding		protein_coding	OTTHUMT00000403237.2		53.0		+	ENST00000541122.2
SMARCA4	6597	__UNKNOWN__	__UNKNOWN__	19	11094968	11094968	__UNKNOWN__	Silent	SNP	A	A	T			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr19:11094968A>T	ENST00000541122.2	+	3	426	c.141A>T	c.(139-141)ccA>ccT	p.P47P	SMARCA4_ENST00000358026.2_Silent_p.P47P|SMARCA4_ENST00000413806.3_Silent_p.P47P|SMARCA4_ENST00000589677.1_Silent_p.P47P|SMARCA4_ENST00000429416.3_Silent_p.P47P|SMARCA4_ENST00000344626.4_Silent_p.P47P|SMARCA4_ENST00000590574.1_Silent_p.P47P|SMARCA4_ENST00000444061.3_Silent_p.P47P|SMARCA4_ENST00000450717.3_Silent_p.P47P			P51532	SMCA4_HUMAN	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4	47	Necessary for interaction with SS18L1/CREST. {ECO:0000250}.				aortic smooth muscle cell differentiation (GO:0035887)|ATP catabolic process (GO:0006200)|ATP-dependent chromatin remodeling (GO:0043044)|blastocyst growth (GO:0001832)|blastocyst hatching (GO:0001835)|cell morphogenesis (GO:0000902)|chromatin remodeling (GO:0006338)|definitive erythrocyte differentiation (GO:0060318)|DNA methylation on cytosine within a CG sequence (GO:0010424)|embryonic hindlimb morphogenesis (GO:0035116)|embryonic organ morphogenesis (GO:0048562)|epidermis morphogenesis (GO:0048730)|extracellular matrix organization (GO:0030198)|forebrain development (GO:0030900)|glial cell fate determination (GO:0007403)|heart trabecula formation (GO:0060347)|hindbrain development (GO:0030902)|histone H3 acetylation (GO:0043966)|keratinocyte differentiation (GO:0030216)|lens fiber cell development (GO:0070307)|liver development (GO:0001889)|methylation-dependent chromatin silencing (GO:0006346)|negative regulation of androgen receptor signaling pathway (GO:0060766)|negative regulation of cell growth (GO:0030308)|negative regulation of G1/S transition of mitotic cell cycle (GO:2000134)|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|negative regulation of transcription from RNA polymerase II promoter during mitosis (GO:0007070)|negative regulation of transcription, DNA-templated (GO:0045892)|neural retina development (GO:0003407)|nucleosome disassembly (GO:0006337)|positive regulation by host of viral transcription (GO:0043923)|positive regulation of DNA binding (GO:0043388)|positive regulation of sequence-specific DNA binding transcription factor activity (GO:0051091)|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|positive regulation of transcription, DNA-templated (GO:0045893)|regulation of transcription from RNA polymerase II promoter (GO:0006357)|stem cell maintenance (GO:0019827)|vasculogenesis (GO:0001570)	extracellular space (GO:0005615)|heterochromatin (GO:0000792)|membrane (GO:0016020)|nBAF complex (GO:0071565)|npBAF complex (GO:0071564)|nuclear chromatin (GO:0000790)|nuclear euchromatin (GO:0005719)|nucleolus (GO:0005730)|nucleus (GO:0005634)|perichromatin fibrils (GO:0005726)|protein complex (GO:0043234)|SWI/SNF complex (GO:0016514)	androgen receptor binding (GO:0050681)|ATP binding (GO:0005524)|chromatin binding (GO:0003682)|DNA-dependent ATPase activity (GO:0008094)|helicase activity (GO:0004386)|lysine-acetylated histone binding (GO:0070577)|p53 binding (GO:0002039)|protein N-terminus binding (GO:0047485)|RNA polymerase II regulatory region sequence-specific DNA binding (GO:0000977)|RNA polymerase II transcription coactivator activity (GO:0001105)|Tat protein binding (GO:0030957)|transcription coactivator activity (GO:0003713)|transcription corepressor activity (GO:0003714)	p.?(1)		adrenal_gland(1)|autonomic_ganglia(1)|breast(6)|central_nervous_system(23)|endometrium(10)|haematopoietic_and_lymphoid_tissue(1)|kidney(8)|large_intestine(16)|liver(4)|lung(60)|ovary(10)|pancreas(7)|prostate(3)|skin(8)|stomach(1)|upper_aerodigestive_tract(2)|urinary_tract(2)	163		all_lung(6;0.0512)|Lung NSC(9;0.0568)				GGCCCAGCCCAGGGCCGCCCT	0.711			"""F, N, Mis"""		NSCLC																																		Rec	yes		19	19p13.2	6597	"""SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4"""		E	1	Unknown(1)	lung(1)											17.0	17.0	17.0					19																	11094968		2190	4295	6485	SO:0001819	synonymous_variant			D26156	CCDS12253.1, CCDS45972.1, CCDS45973.1, CCDS54217.1, CCDS54218.1	19p13.3	2014-09-17	2006-11-09		ENSG00000127616	ENSG00000127616	6597			11100	protein-coding gene	gene with protein product	"""SNF2-like 4"", ""global transcription activator homologous sequence"", ""sucrose nonfermenting-like 4"", ""mitotic growth and transcription activator"", ""BRM/SWI2-related gene 1"", ""homeotic gene regulator"", ""nuclear protein GRB1"", ""brahma protein-like 1"", ""ATP-dependent helicase SMARCA4"""	603254		SNF2L4		8208605	Standard	NM_003072	NM_003072		Approved	hSNF2b, BRG1, BAF190, SNF2, SWI2, SNF2-BETA, SNF2LB, FLJ39786	uc010dxo.3	P51532	OTTHUMG00000169272	ENST00000541122.2:c.141A>T	chr19.hg19:g.11094968A>T			B1A8Z4|B1A8Z5|B1A8Z6|B1A8Z7|E9PBR8|O95052|Q9HBD3	True	hg19	CCDS45972.1																																																																																			SMARCA4-005	KNOWN	non_canonical_conserved|basic|appris_candidate_longest|CCDS	protein_coding		protein_coding	OTTHUMT00000403237.2		59.0		+	ENST00000541122.2
SMARCA4	6597	__UNKNOWN__	__UNKNOWN__	19	11096042	11096042	__UNKNOWN__	Missense_Mutation	SNP	A	A	C			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr19:11096042A>C	ENST00000541122.2	+	4	601	c.316A>C	c.(316-318)Atg>Ctg	p.M106L	SMARCA4_ENST00000358026.2_Missense_Mutation_p.M106L|SMARCA4_ENST00000413806.3_Missense_Mutation_p.M106L|SMARCA4_ENST00000589677.1_Missense_Mutation_p.M106L|SMARCA4_ENST00000429416.3_Missense_Mutation_p.M106L|SMARCA4_ENST00000344626.4_Missense_Mutation_p.M106L|SMARCA4_ENST00000590574.1_Missense_Mutation_p.M106L|SMARCA4_ENST00000444061.3_Missense_Mutation_p.M106L|SMARCA4_ENST00000450717.3_Missense_Mutation_p.M106L			P51532	SMCA4_HUMAN	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4	106	Necessary for interaction with SS18L1/CREST. {ECO:0000250}.				aortic smooth muscle cell differentiation (GO:0035887)|ATP catabolic process (GO:0006200)|ATP-dependent chromatin remodeling (GO:0043044)|blastocyst growth (GO:0001832)|blastocyst hatching (GO:0001835)|cell morphogenesis (GO:0000902)|chromatin remodeling (GO:0006338)|definitive erythrocyte differentiation (GO:0060318)|DNA methylation on cytosine within a CG sequence (GO:0010424)|embryonic hindlimb morphogenesis (GO:0035116)|embryonic organ morphogenesis (GO:0048562)|epidermis morphogenesis (GO:0048730)|extracellular matrix organization (GO:0030198)|forebrain development (GO:0030900)|glial cell fate determination (GO:0007403)|heart trabecula formation (GO:0060347)|hindbrain development (GO:0030902)|histone H3 acetylation (GO:0043966)|keratinocyte differentiation (GO:0030216)|lens fiber cell development (GO:0070307)|liver development (GO:0001889)|methylation-dependent chromatin silencing (GO:0006346)|negative regulation of androgen receptor signaling pathway (GO:0060766)|negative regulation of cell growth (GO:0030308)|negative regulation of G1/S transition of mitotic cell cycle (GO:2000134)|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|negative regulation of transcription from RNA polymerase II promoter during mitosis (GO:0007070)|negative regulation of transcription, DNA-templated (GO:0045892)|neural retina development (GO:0003407)|nucleosome disassembly (GO:0006337)|positive regulation by host of viral transcription (GO:0043923)|positive regulation of DNA binding (GO:0043388)|positive regulation of sequence-specific DNA binding transcription factor activity (GO:0051091)|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|positive regulation of transcription, DNA-templated (GO:0045893)|regulation of transcription from RNA polymerase II promoter (GO:0006357)|stem cell maintenance (GO:0019827)|vasculogenesis (GO:0001570)	extracellular space (GO:0005615)|heterochromatin (GO:0000792)|membrane (GO:0016020)|nBAF complex (GO:0071565)|npBAF complex (GO:0071564)|nuclear chromatin (GO:0000790)|nuclear euchromatin (GO:0005719)|nucleolus (GO:0005730)|nucleus (GO:0005634)|perichromatin fibrils (GO:0005726)|protein complex (GO:0043234)|SWI/SNF complex (GO:0016514)	androgen receptor binding (GO:0050681)|ATP binding (GO:0005524)|chromatin binding (GO:0003682)|DNA-dependent ATPase activity (GO:0008094)|helicase activity (GO:0004386)|lysine-acetylated histone binding (GO:0070577)|p53 binding (GO:0002039)|protein N-terminus binding (GO:0047485)|RNA polymerase II regulatory region sequence-specific DNA binding (GO:0000977)|RNA polymerase II transcription coactivator activity (GO:0001105)|Tat protein binding (GO:0030957)|transcription coactivator activity (GO:0003713)|transcription corepressor activity (GO:0003714)	p.?(1)		adrenal_gland(1)|autonomic_ganglia(1)|breast(6)|central_nervous_system(23)|endometrium(10)|haematopoietic_and_lymphoid_tissue(1)|kidney(8)|large_intestine(16)|liver(4)|lung(60)|ovary(10)|pancreas(7)|prostate(3)|skin(8)|stomach(1)|upper_aerodigestive_tract(2)|urinary_tract(2)	163		all_lung(6;0.0512)|Lung NSC(9;0.0568)				CCATGCTGGGATGGGGCCCCC	0.592			"""F, N, Mis"""		NSCLC																																		Rec	yes		19	19p13.2	6597	"""SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4"""		E	1	Unknown(1)	lung(1)											43.0	41.0	42.0					19																	11096042		2203	4300	6503	SO:0001583	missense			D26156	CCDS12253.1, CCDS45972.1, CCDS45973.1, CCDS54217.1, CCDS54218.1	19p13.3	2014-09-17	2006-11-09		ENSG00000127616	ENSG00000127616	6597			11100	protein-coding gene	gene with protein product	"""SNF2-like 4"", ""global transcription activator homologous sequence"", ""sucrose nonfermenting-like 4"", ""mitotic growth and transcription activator"", ""BRM/SWI2-related gene 1"", ""homeotic gene regulator"", ""nuclear protein GRB1"", ""brahma protein-like 1"", ""ATP-dependent helicase SMARCA4"""	603254		SNF2L4		8208605	Standard	NM_003072	NM_003072		Approved	hSNF2b, BRG1, BAF190, SNF2, SWI2, SNF2-BETA, SNF2LB, FLJ39786	uc010dxo.3	P51532	OTTHUMG00000169272	ENST00000541122.2:c.316A>C	chr19.hg19:g.11096042A>C	ENSP00000445036:p.Met106Leu		B1A8Z4|B1A8Z5|B1A8Z6|B1A8Z7|E9PBR8|O95052|Q9HBD3	True	hg19	CCDS45972.1	.	.	.	.	.	.	.	.	.	.	A	15.69	2.909186	0.52439	.	.	ENSG00000127616	ENST00000429416;ENST00000358026;ENST00000421844;ENST00000344626;ENST00000541122;ENST00000444061;ENST00000450717;ENST00000413806	D;D;D;D;D;D;D	0.86694	-2.15;-2.16;-2.15;-2.16;-2.13;-2.13;-2.16	4.66	4.66	0.58398	.	0.000000	0.85682	D	0.000000	D	0.84151	0.5409	L	0.55481	1.735	0.39071	D	0.960712	B;B;B;B;B;B;B	0.02656	0.0;0.0;0.0;0.0;0.0;0.0;0.0	B;B;B;B;B;B;B	0.01281	0.0;0.0;0.0;0.0;0.0;0.0;0.0	T	0.83265	-0.0046	10	0.72032	D	0.01	-43.4984	13.2148	0.59854	1.0:0.0:0.0:0.0	.	106;106;106;106;106;106;106	B1A8Z6;B1A8Z4;B1A8Z7;Q9HBD4;B1A8Z5;A7E2E1;P51532	.;.;.;.;.;.;SMCA4_HUMAN	L	106	ENSP00000395654:M106L;ENSP00000350720:M106L;ENSP00000343896:M106L;ENSP00000445036:M106L;ENSP00000392837:M106L;ENSP00000397783:M106L;ENSP00000414727:M106L	ENSP00000343896:M106L	M	+	1	0	SMARCA4	10957042	1.000000	0.71417	0.902000	0.35471	0.893000	0.52053	6.989000	0.76219	1.953000	0.56701	0.460000	0.39030	ATG	SMARCA4-005	KNOWN	non_canonical_conserved|basic|appris_candidate_longest|CCDS	protein_coding		protein_coding	OTTHUMT00000403237.2		24.0		+	ENST00000541122.2
SMARCA4	6597	__UNKNOWN__	__UNKNOWN__	19	11097222	11097222	__UNKNOWN__	Missense_Mutation	SNP	C	C	A	rs568390760	byFrequency	__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr19:11097222C>A	ENST00000541122.2	+	5	998	c.713C>A	c.(712-714)cCc>cAc	p.P238H	SMARCA4_ENST00000358026.2_Missense_Mutation_p.P238H|SMARCA4_ENST00000413806.3_Missense_Mutation_p.P238H|SMARCA4_ENST00000589677.1_Missense_Mutation_p.P238H|SMARCA4_ENST00000429416.3_Missense_Mutation_p.P238H|SMARCA4_ENST00000344626.4_Missense_Mutation_p.P238H|SMARCA4_ENST00000590574.1_Missense_Mutation_p.P238H|SMARCA4_ENST00000444061.3_Missense_Mutation_p.P238H|SMARCA4_ENST00000450717.3_Missense_Mutation_p.P238H			P51532	SMCA4_HUMAN	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4	238	Necessary for interaction with SS18L1/CREST. {ECO:0000250}.				aortic smooth muscle cell differentiation (GO:0035887)|ATP catabolic process (GO:0006200)|ATP-dependent chromatin remodeling (GO:0043044)|blastocyst growth (GO:0001832)|blastocyst hatching (GO:0001835)|cell morphogenesis (GO:0000902)|chromatin remodeling (GO:0006338)|definitive erythrocyte differentiation (GO:0060318)|DNA methylation on cytosine within a CG sequence (GO:0010424)|embryonic hindlimb morphogenesis (GO:0035116)|embryonic organ morphogenesis (GO:0048562)|epidermis morphogenesis (GO:0048730)|extracellular matrix organization (GO:0030198)|forebrain development (GO:0030900)|glial cell fate determination (GO:0007403)|heart trabecula formation (GO:0060347)|hindbrain development (GO:0030902)|histone H3 acetylation (GO:0043966)|keratinocyte differentiation (GO:0030216)|lens fiber cell development (GO:0070307)|liver development (GO:0001889)|methylation-dependent chromatin silencing (GO:0006346)|negative regulation of androgen receptor signaling pathway (GO:0060766)|negative regulation of cell growth (GO:0030308)|negative regulation of G1/S transition of mitotic cell cycle (GO:2000134)|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|negative regulation of transcription from RNA polymerase II promoter during mitosis (GO:0007070)|negative regulation of transcription, DNA-templated (GO:0045892)|neural retina development (GO:0003407)|nucleosome disassembly (GO:0006337)|positive regulation by host of viral transcription (GO:0043923)|positive regulation of DNA binding (GO:0043388)|positive regulation of sequence-specific DNA binding transcription factor activity (GO:0051091)|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|positive regulation of transcription, DNA-templated (GO:0045893)|regulation of transcription from RNA polymerase II promoter (GO:0006357)|stem cell maintenance (GO:0019827)|vasculogenesis (GO:0001570)	extracellular space (GO:0005615)|heterochromatin (GO:0000792)|membrane (GO:0016020)|nBAF complex (GO:0071565)|npBAF complex (GO:0071564)|nuclear chromatin (GO:0000790)|nuclear euchromatin (GO:0005719)|nucleolus (GO:0005730)|nucleus (GO:0005634)|perichromatin fibrils (GO:0005726)|protein complex (GO:0043234)|SWI/SNF complex (GO:0016514)	androgen receptor binding (GO:0050681)|ATP binding (GO:0005524)|chromatin binding (GO:0003682)|DNA-dependent ATPase activity (GO:0008094)|helicase activity (GO:0004386)|lysine-acetylated histone binding (GO:0070577)|p53 binding (GO:0002039)|protein N-terminus binding (GO:0047485)|RNA polymerase II regulatory region sequence-specific DNA binding (GO:0000977)|RNA polymerase II transcription coactivator activity (GO:0001105)|Tat protein binding (GO:0030957)|transcription coactivator activity (GO:0003713)|transcription corepressor activity (GO:0003714)	p.?(1)		adrenal_gland(1)|autonomic_ganglia(1)|breast(6)|central_nervous_system(23)|endometrium(10)|haematopoietic_and_lymphoid_tissue(1)|kidney(8)|large_intestine(16)|liver(4)|lung(60)|ovary(10)|pancreas(7)|prostate(3)|skin(8)|stomach(1)|upper_aerodigestive_tract(2)|urinary_tract(2)	163		all_lung(6;0.0512)|Lung NSC(9;0.0568)				ggccctggccccggcccgggt	0.697			"""F, N, Mis"""		NSCLC																																		Rec	yes		19	19p13.2	6597	"""SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4"""		E	1	Unknown(1)	lung(1)											3.0	3.0	3.0					19																	11097222		1777	3467	5244	SO:0001583	missense			D26156	CCDS12253.1, CCDS45972.1, CCDS45973.1, CCDS54217.1, CCDS54218.1	19p13.3	2014-09-17	2006-11-09		ENSG00000127616	ENSG00000127616	6597			11100	protein-coding gene	gene with protein product	"""SNF2-like 4"", ""global transcription activator homologous sequence"", ""sucrose nonfermenting-like 4"", ""mitotic growth and transcription activator"", ""BRM/SWI2-related gene 1"", ""homeotic gene regulator"", ""nuclear protein GRB1"", ""brahma protein-like 1"", ""ATP-dependent helicase SMARCA4"""	603254		SNF2L4		8208605	Standard	NM_003072	NM_003072		Approved	hSNF2b, BRG1, BAF190, SNF2, SWI2, SNF2-BETA, SNF2LB, FLJ39786	uc010dxo.3	P51532	OTTHUMG00000169272	ENST00000541122.2:c.713C>A	chr19.hg19:g.11097222C>A	ENSP00000445036:p.Pro238His		B1A8Z4|B1A8Z5|B1A8Z6|B1A8Z7|E9PBR8|O95052|Q9HBD3	True	hg19	CCDS45972.1	.	.	.	.	.	.	.	.	.	.	C	11.06	1.529015	0.27387	.	.	ENSG00000127616	ENST00000429416;ENST00000358026;ENST00000421844;ENST00000344626;ENST00000541122;ENST00000444061;ENST00000450717;ENST00000413806	D;D;D;D;D;D;D	0.87256	-2.22;-2.21;-2.22;-2.23;-2.22;-2.21;-2.23	4.76	4.76	0.60689	.	0.237554	0.33235	N	0.005123	T	0.81772	0.4893	L	0.29908	0.895	0.38511	D	0.948462	P;P;P;P;P;P;P	0.50943	0.859;0.859;0.859;0.94;0.859;0.859;0.859	B;B;B;B;B;B;B	0.43783	0.237;0.237;0.237;0.431;0.237;0.339;0.339	D	0.83650	0.0155	10	0.38643	T	0.18	-12.1117	14.6953	0.69118	0.0:1.0:0.0:0.0	.	238;238;238;238;238;238;238	B1A8Z6;B1A8Z4;B1A8Z7;Q9HBD4;B1A8Z5;A7E2E1;P51532	.;.;.;.;.;.;SMCA4_HUMAN	H	238	ENSP00000395654:P238H;ENSP00000350720:P238H;ENSP00000343896:P238H;ENSP00000445036:P238H;ENSP00000392837:P238H;ENSP00000397783:P238H;ENSP00000414727:P238H	ENSP00000343896:P238H	P	+	2	0	SMARCA4	10958222	1.000000	0.71417	0.909000	0.35828	0.230000	0.25150	3.941000	0.56607	2.195000	0.70347	0.462000	0.41574	CCC	SMARCA4-005	KNOWN	non_canonical_conserved|basic|appris_candidate_longest|CCDS	protein_coding		protein_coding	OTTHUMT00000403237.2		20.0		+	ENST00000541122.2
SMARCA4	6597	__UNKNOWN__	__UNKNOWN__	19	11097228	11097228	__UNKNOWN__	Missense_Mutation	SNP	C	C	A	rs201600949|rs568390760	byFrequency	__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr19:11097228C>A	ENST00000541122.2	+	5	1004	c.719C>A	c.(718-720)cCg>cAg	p.P240Q	SMARCA4_ENST00000358026.2_Missense_Mutation_p.P240Q|SMARCA4_ENST00000413806.3_Missense_Mutation_p.P240Q|SMARCA4_ENST00000589677.1_Missense_Mutation_p.P240Q|SMARCA4_ENST00000429416.3_Missense_Mutation_p.P240Q|SMARCA4_ENST00000344626.4_Missense_Mutation_p.P240Q|SMARCA4_ENST00000590574.1_Missense_Mutation_p.P240Q|SMARCA4_ENST00000444061.3_Missense_Mutation_p.P240Q|SMARCA4_ENST00000450717.3_Missense_Mutation_p.P240Q			P51532	SMCA4_HUMAN	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4	240	Necessary for interaction with SS18L1/CREST. {ECO:0000250}.				aortic smooth muscle cell differentiation (GO:0035887)|ATP catabolic process (GO:0006200)|ATP-dependent chromatin remodeling (GO:0043044)|blastocyst growth (GO:0001832)|blastocyst hatching (GO:0001835)|cell morphogenesis (GO:0000902)|chromatin remodeling (GO:0006338)|definitive erythrocyte differentiation (GO:0060318)|DNA methylation on cytosine within a CG sequence (GO:0010424)|embryonic hindlimb morphogenesis (GO:0035116)|embryonic organ morphogenesis (GO:0048562)|epidermis morphogenesis (GO:0048730)|extracellular matrix organization (GO:0030198)|forebrain development (GO:0030900)|glial cell fate determination (GO:0007403)|heart trabecula formation (GO:0060347)|hindbrain development (GO:0030902)|histone H3 acetylation (GO:0043966)|keratinocyte differentiation (GO:0030216)|lens fiber cell development (GO:0070307)|liver development (GO:0001889)|methylation-dependent chromatin silencing (GO:0006346)|negative regulation of androgen receptor signaling pathway (GO:0060766)|negative regulation of cell growth (GO:0030308)|negative regulation of G1/S transition of mitotic cell cycle (GO:2000134)|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|negative regulation of transcription from RNA polymerase II promoter during mitosis (GO:0007070)|negative regulation of transcription, DNA-templated (GO:0045892)|neural retina development (GO:0003407)|nucleosome disassembly (GO:0006337)|positive regulation by host of viral transcription (GO:0043923)|positive regulation of DNA binding (GO:0043388)|positive regulation of sequence-specific DNA binding transcription factor activity (GO:0051091)|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|positive regulation of transcription, DNA-templated (GO:0045893)|regulation of transcription from RNA polymerase II promoter (GO:0006357)|stem cell maintenance (GO:0019827)|vasculogenesis (GO:0001570)	extracellular space (GO:0005615)|heterochromatin (GO:0000792)|membrane (GO:0016020)|nBAF complex (GO:0071565)|npBAF complex (GO:0071564)|nuclear chromatin (GO:0000790)|nuclear euchromatin (GO:0005719)|nucleolus (GO:0005730)|nucleus (GO:0005634)|perichromatin fibrils (GO:0005726)|protein complex (GO:0043234)|SWI/SNF complex (GO:0016514)	androgen receptor binding (GO:0050681)|ATP binding (GO:0005524)|chromatin binding (GO:0003682)|DNA-dependent ATPase activity (GO:0008094)|helicase activity (GO:0004386)|lysine-acetylated histone binding (GO:0070577)|p53 binding (GO:0002039)|protein N-terminus binding (GO:0047485)|RNA polymerase II regulatory region sequence-specific DNA binding (GO:0000977)|RNA polymerase II transcription coactivator activity (GO:0001105)|Tat protein binding (GO:0030957)|transcription coactivator activity (GO:0003713)|transcription corepressor activity (GO:0003714)	p.?(1)		adrenal_gland(1)|autonomic_ganglia(1)|breast(6)|central_nervous_system(23)|endometrium(10)|haematopoietic_and_lymphoid_tissue(1)|kidney(8)|large_intestine(16)|liver(4)|lung(60)|ovary(10)|pancreas(7)|prostate(3)|skin(8)|stomach(1)|upper_aerodigestive_tract(2)|urinary_tract(2)	163		all_lung(6;0.0512)|Lung NSC(9;0.0568)				ggccccggcccgggtcccggc	0.697			"""F, N, Mis"""		NSCLC																																		Rec	yes		19	19p13.2	6597	"""SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4"""		E	1	Unknown(1)	lung(1)											2.0	3.0	2.0					19																	11097228		1699	3329	5028	SO:0001583	missense			D26156	CCDS12253.1, CCDS45972.1, CCDS45973.1, CCDS54217.1, CCDS54218.1	19p13.3	2014-09-17	2006-11-09		ENSG00000127616	ENSG00000127616	6597			11100	protein-coding gene	gene with protein product	"""SNF2-like 4"", ""global transcription activator homologous sequence"", ""sucrose nonfermenting-like 4"", ""mitotic growth and transcription activator"", ""BRM/SWI2-related gene 1"", ""homeotic gene regulator"", ""nuclear protein GRB1"", ""brahma protein-like 1"", ""ATP-dependent helicase SMARCA4"""	603254		SNF2L4		8208605	Standard	NM_003072	NM_003072		Approved	hSNF2b, BRG1, BAF190, SNF2, SWI2, SNF2-BETA, SNF2LB, FLJ39786	uc010dxo.3	P51532	OTTHUMG00000169272	ENST00000541122.2:c.719C>A	chr19.hg19:g.11097228C>A	ENSP00000445036:p.Pro240Gln		B1A8Z4|B1A8Z5|B1A8Z6|B1A8Z7|E9PBR8|O95052|Q9HBD3	True	hg19	CCDS45972.1	.	.	.	.	.	.	.	.	.	.	C	6.009	0.370067	0.11352	.	.	ENSG00000127616	ENST00000429416;ENST00000358026;ENST00000421844;ENST00000344626;ENST00000541122;ENST00000444061;ENST00000450717;ENST00000413806	D;D;D;D;D;D;D	0.86627	-2.13;-2.15;-2.13;-2.13;-2.12;-2.14;-2.13	4.48	3.36	0.38483	.	0.066518	0.64402	D	0.000010	T	0.69646	0.3134	N	0.11927	0.2	0.32955	D	0.520245	P;P;P;P;P;P;P	0.45240	0.574;0.574;0.574;0.854;0.574;0.574;0.574	B;B;B;B;B;B;B	0.40375	0.327;0.228;0.228;0.32;0.327;0.327;0.327	T	0.74150	-0.3758	10	0.02654	T	1	-13.3208	8.9525	0.35799	0.2213:0.7787:0.0:0.0	.	240;240;240;240;240;240;240	B1A8Z6;B1A8Z4;B1A8Z7;Q9HBD4;B1A8Z5;A7E2E1;P51532	.;.;.;.;.;.;SMCA4_HUMAN	Q	240	ENSP00000395654:P240Q;ENSP00000350720:P240Q;ENSP00000343896:P240Q;ENSP00000445036:P240Q;ENSP00000392837:P240Q;ENSP00000397783:P240Q;ENSP00000414727:P240Q	ENSP00000343896:P240Q	P	+	2	0	SMARCA4	10958228	0.629000	0.27146	0.170000	0.22879	0.185000	0.23345	2.247000	0.43151	2.073000	0.62155	0.456000	0.33151	CCG	SMARCA4-005	KNOWN	non_canonical_conserved|basic|appris_candidate_longest|CCDS	protein_coding		protein_coding	OTTHUMT00000403237.2		27.0		+	ENST00000541122.2
SMARCA4	6597	__UNKNOWN__	__UNKNOWN__	19	11097232	11097232	__UNKNOWN__	Silent	SNP	T	T	A	rs568390760	byFrequency	__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr19:11097232T>A	ENST00000541122.2	+	5	1008	c.723T>A	c.(721-723)ggT>ggA	p.G241G	SMARCA4_ENST00000358026.2_Silent_p.G241G|SMARCA4_ENST00000413806.3_Silent_p.G241G|SMARCA4_ENST00000589677.1_Silent_p.G241G|SMARCA4_ENST00000429416.3_Silent_p.G241G|SMARCA4_ENST00000344626.4_Silent_p.G241G|SMARCA4_ENST00000590574.1_Silent_p.G241G|SMARCA4_ENST00000444061.3_Silent_p.G241G|SMARCA4_ENST00000450717.3_Silent_p.G241G			P51532	SMCA4_HUMAN	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4	241	Necessary for interaction with SS18L1/CREST. {ECO:0000250}.				aortic smooth muscle cell differentiation (GO:0035887)|ATP catabolic process (GO:0006200)|ATP-dependent chromatin remodeling (GO:0043044)|blastocyst growth (GO:0001832)|blastocyst hatching (GO:0001835)|cell morphogenesis (GO:0000902)|chromatin remodeling (GO:0006338)|definitive erythrocyte differentiation (GO:0060318)|DNA methylation on cytosine within a CG sequence (GO:0010424)|embryonic hindlimb morphogenesis (GO:0035116)|embryonic organ morphogenesis (GO:0048562)|epidermis morphogenesis (GO:0048730)|extracellular matrix organization (GO:0030198)|forebrain development (GO:0030900)|glial cell fate determination (GO:0007403)|heart trabecula formation (GO:0060347)|hindbrain development (GO:0030902)|histone H3 acetylation (GO:0043966)|keratinocyte differentiation (GO:0030216)|lens fiber cell development (GO:0070307)|liver development (GO:0001889)|methylation-dependent chromatin silencing (GO:0006346)|negative regulation of androgen receptor signaling pathway (GO:0060766)|negative regulation of cell growth (GO:0030308)|negative regulation of G1/S transition of mitotic cell cycle (GO:2000134)|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|negative regulation of transcription from RNA polymerase II promoter during mitosis (GO:0007070)|negative regulation of transcription, DNA-templated (GO:0045892)|neural retina development (GO:0003407)|nucleosome disassembly (GO:0006337)|positive regulation by host of viral transcription (GO:0043923)|positive regulation of DNA binding (GO:0043388)|positive regulation of sequence-specific DNA binding transcription factor activity (GO:0051091)|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|positive regulation of transcription, DNA-templated (GO:0045893)|regulation of transcription from RNA polymerase II promoter (GO:0006357)|stem cell maintenance (GO:0019827)|vasculogenesis (GO:0001570)	extracellular space (GO:0005615)|heterochromatin (GO:0000792)|membrane (GO:0016020)|nBAF complex (GO:0071565)|npBAF complex (GO:0071564)|nuclear chromatin (GO:0000790)|nuclear euchromatin (GO:0005719)|nucleolus (GO:0005730)|nucleus (GO:0005634)|perichromatin fibrils (GO:0005726)|protein complex (GO:0043234)|SWI/SNF complex (GO:0016514)	androgen receptor binding (GO:0050681)|ATP binding (GO:0005524)|chromatin binding (GO:0003682)|DNA-dependent ATPase activity (GO:0008094)|helicase activity (GO:0004386)|lysine-acetylated histone binding (GO:0070577)|p53 binding (GO:0002039)|protein N-terminus binding (GO:0047485)|RNA polymerase II regulatory region sequence-specific DNA binding (GO:0000977)|RNA polymerase II transcription coactivator activity (GO:0001105)|Tat protein binding (GO:0030957)|transcription coactivator activity (GO:0003713)|transcription corepressor activity (GO:0003714)	p.?(1)		adrenal_gland(1)|autonomic_ganglia(1)|breast(6)|central_nervous_system(23)|endometrium(10)|haematopoietic_and_lymphoid_tissue(1)|kidney(8)|large_intestine(16)|liver(4)|lung(60)|ovary(10)|pancreas(7)|prostate(3)|skin(8)|stomach(1)|upper_aerodigestive_tract(2)|urinary_tract(2)	163		all_lung(6;0.0512)|Lung NSC(9;0.0568)				ccggcccgggtcccggcccGG	0.706			"""F, N, Mis"""		NSCLC																																		Rec	yes		19	19p13.2	6597	"""SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4"""		E	1	Unknown(1)	lung(1)											2.0	3.0	2.0					19																	11097232		1665	3277	4942	SO:0001819	synonymous_variant			D26156	CCDS12253.1, CCDS45972.1, CCDS45973.1, CCDS54217.1, CCDS54218.1	19p13.3	2014-09-17	2006-11-09		ENSG00000127616	ENSG00000127616	6597			11100	protein-coding gene	gene with protein product	"""SNF2-like 4"", ""global transcription activator homologous sequence"", ""sucrose nonfermenting-like 4"", ""mitotic growth and transcription activator"", ""BRM/SWI2-related gene 1"", ""homeotic gene regulator"", ""nuclear protein GRB1"", ""brahma protein-like 1"", ""ATP-dependent helicase SMARCA4"""	603254		SNF2L4		8208605	Standard	NM_003072	NM_003072		Approved	hSNF2b, BRG1, BAF190, SNF2, SWI2, SNF2-BETA, SNF2LB, FLJ39786	uc010dxo.3	P51532	OTTHUMG00000169272	ENST00000541122.2:c.723T>A	chr19.hg19:g.11097232T>A			B1A8Z4|B1A8Z5|B1A8Z6|B1A8Z7|E9PBR8|O95052|Q9HBD3	True	hg19	CCDS45972.1																																																																																			SMARCA4-005	KNOWN	non_canonical_conserved|basic|appris_candidate_longest|CCDS	protein_coding		protein_coding	OTTHUMT00000403237.2		23.0		+	ENST00000541122.2
SMARCA4	6597	__UNKNOWN__	__UNKNOWN__	19	11097238	11097238	__UNKNOWN__	Silent	SNP	C	C	G			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr19:11097238C>G	ENST00000541122.2	+	5	1014	c.729C>G	c.(727-729)ggC>ggG	p.G243G	SMARCA4_ENST00000358026.2_Silent_p.G243G|SMARCA4_ENST00000413806.3_Silent_p.G243G|SMARCA4_ENST00000589677.1_Silent_p.G243G|SMARCA4_ENST00000429416.3_Silent_p.G243G|SMARCA4_ENST00000344626.4_Silent_p.G243G|SMARCA4_ENST00000590574.1_Silent_p.G243G|SMARCA4_ENST00000444061.3_Silent_p.G243G|SMARCA4_ENST00000450717.3_Silent_p.G243G			P51532	SMCA4_HUMAN	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4	243	Necessary for interaction with SS18L1/CREST. {ECO:0000250}.				aortic smooth muscle cell differentiation (GO:0035887)|ATP catabolic process (GO:0006200)|ATP-dependent chromatin remodeling (GO:0043044)|blastocyst growth (GO:0001832)|blastocyst hatching (GO:0001835)|cell morphogenesis (GO:0000902)|chromatin remodeling (GO:0006338)|definitive erythrocyte differentiation (GO:0060318)|DNA methylation on cytosine within a CG sequence (GO:0010424)|embryonic hindlimb morphogenesis (GO:0035116)|embryonic organ morphogenesis (GO:0048562)|epidermis morphogenesis (GO:0048730)|extracellular matrix organization (GO:0030198)|forebrain development (GO:0030900)|glial cell fate determination (GO:0007403)|heart trabecula formation (GO:0060347)|hindbrain development (GO:0030902)|histone H3 acetylation (GO:0043966)|keratinocyte differentiation (GO:0030216)|lens fiber cell development (GO:0070307)|liver development (GO:0001889)|methylation-dependent chromatin silencing (GO:0006346)|negative regulation of androgen receptor signaling pathway (GO:0060766)|negative regulation of cell growth (GO:0030308)|negative regulation of G1/S transition of mitotic cell cycle (GO:2000134)|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|negative regulation of transcription from RNA polymerase II promoter during mitosis (GO:0007070)|negative regulation of transcription, DNA-templated (GO:0045892)|neural retina development (GO:0003407)|nucleosome disassembly (GO:0006337)|positive regulation by host of viral transcription (GO:0043923)|positive regulation of DNA binding (GO:0043388)|positive regulation of sequence-specific DNA binding transcription factor activity (GO:0051091)|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|positive regulation of transcription, DNA-templated (GO:0045893)|regulation of transcription from RNA polymerase II promoter (GO:0006357)|stem cell maintenance (GO:0019827)|vasculogenesis (GO:0001570)	extracellular space (GO:0005615)|heterochromatin (GO:0000792)|membrane (GO:0016020)|nBAF complex (GO:0071565)|npBAF complex (GO:0071564)|nuclear chromatin (GO:0000790)|nuclear euchromatin (GO:0005719)|nucleolus (GO:0005730)|nucleus (GO:0005634)|perichromatin fibrils (GO:0005726)|protein complex (GO:0043234)|SWI/SNF complex (GO:0016514)	androgen receptor binding (GO:0050681)|ATP binding (GO:0005524)|chromatin binding (GO:0003682)|DNA-dependent ATPase activity (GO:0008094)|helicase activity (GO:0004386)|lysine-acetylated histone binding (GO:0070577)|p53 binding (GO:0002039)|protein N-terminus binding (GO:0047485)|RNA polymerase II regulatory region sequence-specific DNA binding (GO:0000977)|RNA polymerase II transcription coactivator activity (GO:0001105)|Tat protein binding (GO:0030957)|transcription coactivator activity (GO:0003713)|transcription corepressor activity (GO:0003714)	p.P244fs*59(1)|p.?(1)		adrenal_gland(1)|autonomic_ganglia(1)|breast(6)|central_nervous_system(23)|endometrium(10)|haematopoietic_and_lymphoid_tissue(1)|kidney(8)|large_intestine(16)|liver(4)|lung(60)|ovary(10)|pancreas(7)|prostate(3)|skin(8)|stomach(1)|upper_aerodigestive_tract(2)|urinary_tract(2)	163		all_lung(6;0.0512)|Lung NSC(9;0.0568)				cgggtcccggcccGGCACCTC	0.701			"""F, N, Mis"""		NSCLC																																		Rec	yes		19	19p13.2	6597	"""SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4"""		E	2	Unknown(1)|Deletion - Frameshift(1)	lung(1)|pancreas(1)											2.0	2.0	2.0					19																	11097238		1616	3163	4779	SO:0001819	synonymous_variant			D26156	CCDS12253.1, CCDS45972.1, CCDS45973.1, CCDS54217.1, CCDS54218.1	19p13.3	2014-09-17	2006-11-09		ENSG00000127616	ENSG00000127616	6597			11100	protein-coding gene	gene with protein product	"""SNF2-like 4"", ""global transcription activator homologous sequence"", ""sucrose nonfermenting-like 4"", ""mitotic growth and transcription activator"", ""BRM/SWI2-related gene 1"", ""homeotic gene regulator"", ""nuclear protein GRB1"", ""brahma protein-like 1"", ""ATP-dependent helicase SMARCA4"""	603254		SNF2L4		8208605	Standard	NM_003072	NM_003072		Approved	hSNF2b, BRG1, BAF190, SNF2, SWI2, SNF2-BETA, SNF2LB, FLJ39786	uc010dxo.3	P51532	OTTHUMG00000169272	ENST00000541122.2:c.729C>G	chr19.hg19:g.11097238C>G			B1A8Z4|B1A8Z5|B1A8Z6|B1A8Z7|E9PBR8|O95052|Q9HBD3	True	hg19	CCDS45972.1																																																																																			SMARCA4-005	KNOWN	non_canonical_conserved|basic|appris_candidate_longest|CCDS	protein_coding		protein_coding	OTTHUMT00000403237.2		36.0		+	ENST00000541122.2
SMARCA4	6597	__UNKNOWN__	__UNKNOWN__	19	11097643	11097645	__UNKNOWN__	In_Frame_Del	DEL	CAG	CAG	-			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr19:11097643_11097645delCAG	ENST00000541122.2	+	6	1108_1110	c.823_825delCAG	c.(823-825)cagdel	p.Q275del	SMARCA4_ENST00000358026.2_In_Frame_Del_p.Q275del|SMARCA4_ENST00000413806.3_In_Frame_Del_p.Q275del|SMARCA4_ENST00000589677.1_In_Frame_Del_p.Q275del|SMARCA4_ENST00000429416.3_In_Frame_Del_p.Q275del|SMARCA4_ENST00000344626.4_In_Frame_Del_p.Q275del|SMARCA4_ENST00000590574.1_In_Frame_Del_p.Q275del|SMARCA4_ENST00000444061.3_In_Frame_Del_p.Q275del|SMARCA4_ENST00000450717.3_In_Frame_Del_p.Q275del			P51532	SMCA4_HUMAN	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4	275	Necessary for interaction with SS18L1/CREST. {ECO:0000250}.				aortic smooth muscle cell differentiation (GO:0035887)|ATP catabolic process (GO:0006200)|ATP-dependent chromatin remodeling (GO:0043044)|blastocyst growth (GO:0001832)|blastocyst hatching (GO:0001835)|cell morphogenesis (GO:0000902)|chromatin remodeling (GO:0006338)|definitive erythrocyte differentiation (GO:0060318)|DNA methylation on cytosine within a CG sequence (GO:0010424)|embryonic hindlimb morphogenesis (GO:0035116)|embryonic organ morphogenesis (GO:0048562)|epidermis morphogenesis (GO:0048730)|extracellular matrix organization (GO:0030198)|forebrain development (GO:0030900)|glial cell fate determination (GO:0007403)|heart trabecula formation (GO:0060347)|hindbrain development (GO:0030902)|histone H3 acetylation (GO:0043966)|keratinocyte differentiation (GO:0030216)|lens fiber cell development (GO:0070307)|liver development (GO:0001889)|methylation-dependent chromatin silencing (GO:0006346)|negative regulation of androgen receptor signaling pathway (GO:0060766)|negative regulation of cell growth (GO:0030308)|negative regulation of G1/S transition of mitotic cell cycle (GO:2000134)|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|negative regulation of transcription from RNA polymerase II promoter during mitosis (GO:0007070)|negative regulation of transcription, DNA-templated (GO:0045892)|neural retina development (GO:0003407)|nucleosome disassembly (GO:0006337)|positive regulation by host of viral transcription (GO:0043923)|positive regulation of DNA binding (GO:0043388)|positive regulation of sequence-specific DNA binding transcription factor activity (GO:0051091)|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|positive regulation of transcription, DNA-templated (GO:0045893)|regulation of transcription from RNA polymerase II promoter (GO:0006357)|stem cell maintenance (GO:0019827)|vasculogenesis (GO:0001570)	extracellular space (GO:0005615)|heterochromatin (GO:0000792)|membrane (GO:0016020)|nBAF complex (GO:0071565)|npBAF complex (GO:0071564)|nuclear chromatin (GO:0000790)|nuclear euchromatin (GO:0005719)|nucleolus (GO:0005730)|nucleus (GO:0005634)|perichromatin fibrils (GO:0005726)|protein complex (GO:0043234)|SWI/SNF complex (GO:0016514)	androgen receptor binding (GO:0050681)|ATP binding (GO:0005524)|chromatin binding (GO:0003682)|DNA-dependent ATPase activity (GO:0008094)|helicase activity (GO:0004386)|lysine-acetylated histone binding (GO:0070577)|p53 binding (GO:0002039)|protein N-terminus binding (GO:0047485)|RNA polymerase II regulatory region sequence-specific DNA binding (GO:0000977)|RNA polymerase II transcription coactivator activity (GO:0001105)|Tat protein binding (GO:0030957)|transcription coactivator activity (GO:0003713)|transcription corepressor activity (GO:0003714)	p.?(1)		adrenal_gland(1)|autonomic_ganglia(1)|breast(6)|central_nervous_system(23)|endometrium(10)|haematopoietic_and_lymphoid_tissue(1)|kidney(8)|large_intestine(16)|liver(4)|lung(60)|ovary(10)|pancreas(7)|prostate(3)|skin(8)|stomach(1)|upper_aerodigestive_tract(2)|urinary_tract(2)	163		all_lung(6;0.0512)|Lung NSC(9;0.0568)				GATGCCAGGCCAGCCTCCTGGAG	0.621			"""F, N, Mis"""		NSCLC																																		Rec	yes		19	19p13.2	6597	"""SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4"""		E	1	Unknown(1)	lung(1)																																								SO:0001651	inframe_deletion			D26156	CCDS12253.1, CCDS45972.1, CCDS45973.1, CCDS54217.1, CCDS54218.1	19p13.3	2014-09-17	2006-11-09		ENSG00000127616	ENSG00000127616	6597			11100	protein-coding gene	gene with protein product	"""SNF2-like 4"", ""global transcription activator homologous sequence"", ""sucrose nonfermenting-like 4"", ""mitotic growth and transcription activator"", ""BRM/SWI2-related gene 1"", ""homeotic gene regulator"", ""nuclear protein GRB1"", ""brahma protein-like 1"", ""ATP-dependent helicase SMARCA4"""	603254		SNF2L4		8208605	Standard	NM_003072	NM_003072		Approved	hSNF2b, BRG1, BAF190, SNF2, SWI2, SNF2-BETA, SNF2LB, FLJ39786	uc010dxo.3	P51532	OTTHUMG00000169272	ENST00000541122.2:c.823_825delCAG	chr19.hg19:g.11097643_11097645delCAG	ENSP00000445036:p.Gln275del		B1A8Z4|B1A8Z5|B1A8Z6|B1A8Z7|E9PBR8|O95052|Q9HBD3	True	hg19	CCDS45972.1																																																																																			SMARCA4-005	KNOWN	non_canonical_conserved|basic|appris_candidate_longest|CCDS	protein_coding		protein_coding	OTTHUMT00000403237.2		23.0		+	ENST00000541122.2
SMARCA4	6597	__UNKNOWN__	__UNKNOWN__	19	11097651	11097651	__UNKNOWN__	Silent	SNP	T	T	A			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr19:11097651T>A	ENST00000541122.2	+	6	1116	c.831T>A	c.(829-831)ccT>ccA	p.P277P	SMARCA4_ENST00000358026.2_Silent_p.P277P|SMARCA4_ENST00000413806.3_Silent_p.P277P|SMARCA4_ENST00000589677.1_Silent_p.P277P|SMARCA4_ENST00000429416.3_Silent_p.P277P|SMARCA4_ENST00000344626.4_Silent_p.P277P|SMARCA4_ENST00000590574.1_Silent_p.P277P|SMARCA4_ENST00000444061.3_Silent_p.P277P|SMARCA4_ENST00000450717.3_Silent_p.P277P			P51532	SMCA4_HUMAN	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4	277	Necessary for interaction with SS18L1/CREST. {ECO:0000250}.				aortic smooth muscle cell differentiation (GO:0035887)|ATP catabolic process (GO:0006200)|ATP-dependent chromatin remodeling (GO:0043044)|blastocyst growth (GO:0001832)|blastocyst hatching (GO:0001835)|cell morphogenesis (GO:0000902)|chromatin remodeling (GO:0006338)|definitive erythrocyte differentiation (GO:0060318)|DNA methylation on cytosine within a CG sequence (GO:0010424)|embryonic hindlimb morphogenesis (GO:0035116)|embryonic organ morphogenesis (GO:0048562)|epidermis morphogenesis (GO:0048730)|extracellular matrix organization (GO:0030198)|forebrain development (GO:0030900)|glial cell fate determination (GO:0007403)|heart trabecula formation (GO:0060347)|hindbrain development (GO:0030902)|histone H3 acetylation (GO:0043966)|keratinocyte differentiation (GO:0030216)|lens fiber cell development (GO:0070307)|liver development (GO:0001889)|methylation-dependent chromatin silencing (GO:0006346)|negative regulation of androgen receptor signaling pathway (GO:0060766)|negative regulation of cell growth (GO:0030308)|negative regulation of G1/S transition of mitotic cell cycle (GO:2000134)|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|negative regulation of transcription from RNA polymerase II promoter during mitosis (GO:0007070)|negative regulation of transcription, DNA-templated (GO:0045892)|neural retina development (GO:0003407)|nucleosome disassembly (GO:0006337)|positive regulation by host of viral transcription (GO:0043923)|positive regulation of DNA binding (GO:0043388)|positive regulation of sequence-specific DNA binding transcription factor activity (GO:0051091)|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|positive regulation of transcription, DNA-templated (GO:0045893)|regulation of transcription from RNA polymerase II promoter (GO:0006357)|stem cell maintenance (GO:0019827)|vasculogenesis (GO:0001570)	extracellular space (GO:0005615)|heterochromatin (GO:0000792)|membrane (GO:0016020)|nBAF complex (GO:0071565)|npBAF complex (GO:0071564)|nuclear chromatin (GO:0000790)|nuclear euchromatin (GO:0005719)|nucleolus (GO:0005730)|nucleus (GO:0005634)|perichromatin fibrils (GO:0005726)|protein complex (GO:0043234)|SWI/SNF complex (GO:0016514)	androgen receptor binding (GO:0050681)|ATP binding (GO:0005524)|chromatin binding (GO:0003682)|DNA-dependent ATPase activity (GO:0008094)|helicase activity (GO:0004386)|lysine-acetylated histone binding (GO:0070577)|p53 binding (GO:0002039)|protein N-terminus binding (GO:0047485)|RNA polymerase II regulatory region sequence-specific DNA binding (GO:0000977)|RNA polymerase II transcription coactivator activity (GO:0001105)|Tat protein binding (GO:0030957)|transcription coactivator activity (GO:0003713)|transcription corepressor activity (GO:0003714)	p.?(1)		adrenal_gland(1)|autonomic_ganglia(1)|breast(6)|central_nervous_system(23)|endometrium(10)|haematopoietic_and_lymphoid_tissue(1)|kidney(8)|large_intestine(16)|liver(4)|lung(60)|ovary(10)|pancreas(7)|prostate(3)|skin(8)|stomach(1)|upper_aerodigestive_tract(2)|urinary_tract(2)	163		all_lung(6;0.0512)|Lung NSC(9;0.0568)				GCCAGCCTCCTGGAGGGCCTC	0.617			"""F, N, Mis"""		NSCLC																																		Rec	yes		19	19p13.2	6597	"""SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4"""		E	1	Unknown(1)	lung(1)											35.0	39.0	37.0					19																	11097651		2202	4298	6500	SO:0001819	synonymous_variant			D26156	CCDS12253.1, CCDS45972.1, CCDS45973.1, CCDS54217.1, CCDS54218.1	19p13.3	2014-09-17	2006-11-09		ENSG00000127616	ENSG00000127616	6597			11100	protein-coding gene	gene with protein product	"""SNF2-like 4"", ""global transcription activator homologous sequence"", ""sucrose nonfermenting-like 4"", ""mitotic growth and transcription activator"", ""BRM/SWI2-related gene 1"", ""homeotic gene regulator"", ""nuclear protein GRB1"", ""brahma protein-like 1"", ""ATP-dependent helicase SMARCA4"""	603254		SNF2L4		8208605	Standard	NM_003072	NM_003072		Approved	hSNF2b, BRG1, BAF190, SNF2, SWI2, SNF2-BETA, SNF2LB, FLJ39786	uc010dxo.3	P51532	OTTHUMG00000169272	ENST00000541122.2:c.831T>A	chr19.hg19:g.11097651T>A			B1A8Z4|B1A8Z5|B1A8Z6|B1A8Z7|E9PBR8|O95052|Q9HBD3	True	hg19	CCDS45972.1																																																																																			SMARCA4-005	KNOWN	non_canonical_conserved|basic|appris_candidate_longest|CCDS	protein_coding		protein_coding	OTTHUMT00000403237.2		24.0		+	ENST00000541122.2
ERG	2078	__UNKNOWN__	__UNKNOWN__	21	39769384	39769384	__UNKNOWN__	Intron	SNP	A	A	G			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr21:39769384A>G	ENST00000417133.2	-	8	952				ERG_ENST00000442448.1_Intron|ERG_ENST00000398919.2_Intron|ERG_ENST00000398911.1_Intron|ERG_ENST00000453032.2_Intron|ERG_ENST00000398897.1_Intron|ERG_ENST00000429727.2_Intron|ERG_ENST00000398910.1_Intron|ERG_ENST00000288319.7_Intron|ERG_ENST00000398907.1_Intron|ERG_ENST00000398905.1_Intron	NM_001136154.1|NM_001243432.1	NP_001129626.1|NP_001230361.1	Q12809	KCNH2_HUMAN	v-ets avian erythroblastosis virus E26 oncogene homolog						cardiac muscle contraction (GO:0060048)|cellular response to drug (GO:0035690)|membrane depolarization during action potential (GO:0086010)|membrane repolarization during action potential (GO:0086011)|membrane repolarization during cardiac muscle cell action potential (GO:0086013)|negative regulation of potassium ion export (GO:1902303)|negative regulation of potassium ion transmembrane transport (GO:1901380)|positive regulation of potassium ion transmembrane transport (GO:1901381)|potassium ion export (GO:0071435)|potassium ion homeostasis (GO:0055075)|potassium ion transmembrane transport (GO:0071805)|regulation of heart rate by cardiac conduction (GO:0086091)|regulation of heart rate by hormone (GO:0003064)|regulation of membrane potential (GO:0042391)|regulation of membrane repolarization (GO:0060306)|regulation of potassium ion transmembrane transport (GO:1901379)|regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307)|synaptic transmission (GO:0007268)|ventricular cardiac muscle cell action potential (GO:0086005)	cell surface (GO:0009986)|cytoplasm (GO:0005737)|nuclear envelope (GO:0005635)|plasma membrane (GO:0005886)|voltage-gated potassium channel complex (GO:0008076)	delayed rectifier potassium channel activity (GO:0005251)|identical protein binding (GO:0042802)|inward rectifier potassium channel activity (GO:0005242)|phosphorelay sensor kinase activity (GO:0000155)|protein homodimerization activity (GO:0042803)|ubiquitin protein ligase binding (GO:0031625)|voltage-gated potassium channel activity (GO:0005249)|voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282)		EWSR1/ERG(178)|NDRG1/ERG(5)|TMPRSS2/ERG(3582)|FUS/ERG(167)|SLC45A3/ERG(50)	lung(2)|ovary(1)|skin(1)	4		Prostate(19;3.6e-06)			Alfuzosin(DB00346)|Amiodarone(DB01118)|Amsacrine(DB00276)|Astemizole(DB00637)|Carvedilol(DB01136)|Chlorpromazine(DB00477)|Cisapride(DB00604)|Dofetilide(DB00204)|Doxazosin(DB00590)|Doxepin(DB01142)|Dronedarone(DB04855)|Halofantrine(DB01218)|Ibutilide(DB00308)|Imipramine(DB00458)|Miconazole(DB01110)|Pimozide(DB01100)|Prazosin(DB00457)|Propafenone(DB01182)|Quinidine(DB00908)|Sertindole(DB06144)|Sotalol(DB00489)|Terazosin(DB01162)|Thioridazine(DB00679)|Verapamil(DB00661)	gctgggcatgatggcatgcgc	0.527			T	"""EWSR1, TMPRSS2, ELF4, FUS, HERPUD1, NDRG1"""	"""Ewing sarcoma, prostate, AML"""																																Esophageal Squamous(130;336 1700 3010 3083 40589)		Dom	yes		21	21q22.3	2078	v-ets erythroblastosis virus E26 oncogene like (avian)		"""M, E, L"""	0																																										SO:0001627	intron_variant				CCDS13657.1, CCDS13658.1, CCDS46648.1, CCDS46649.1, CCDS58789.1	21q22.3	2013-07-09	2013-07-09		ENSG00000157554	ENSG00000157554	2078			3446	protein-coding gene	gene with protein product	"""v-ets avian erythroblastosis virus E26 oncogene related"", ""transcriptional regulator ERG (transforming protein ERG)"", ""v-ets erythroblastosis virus E26 oncogene like"", ""TMPRSS2-ERG prostate cancer specific"""	165080	"""v-ets avian erythroblastosis virus E26 oncogene related"""			3274086	Standard	NM_182918	NM_001136154		Approved	erg-3, p55	uc002yxa.3	P11308	OTTHUMG00000090767	ENST00000417133.2:c.766+3111T>C	chr21.hg19:g.39769384A>G			A5H1P7|C4PFH9|D3DX04|O75418|O75680|Q708S9|Q9BT72|Q9BUT7|Q9H3P0	True	hg19	CCDS46648.1																																																																																			ERG-002	KNOWN	basic|appris_candidate_longest|CCDS	protein_coding		protein_coding	OTTHUMT00000207532.2		24.0		-	ENST00000417133.2
ERG	2078	__UNKNOWN__	__UNKNOWN__	21	39769401	39769401	__UNKNOWN__	Intron	SNP	C	C	T			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr21:39769401C>T	ENST00000417133.2	-	8	952				ERG_ENST00000442448.1_Intron|ERG_ENST00000398919.2_Intron|ERG_ENST00000398911.1_Intron|ERG_ENST00000453032.2_Intron|ERG_ENST00000398897.1_Intron|ERG_ENST00000429727.2_Intron|ERG_ENST00000398910.1_Intron|ERG_ENST00000288319.7_Intron|ERG_ENST00000398907.1_Intron|ERG_ENST00000398905.1_Intron	NM_001136154.1|NM_001243432.1	NP_001129626.1|NP_001230361.1	Q12809	KCNH2_HUMAN	v-ets avian erythroblastosis virus E26 oncogene homolog						cardiac muscle contraction (GO:0060048)|cellular response to drug (GO:0035690)|membrane depolarization during action potential (GO:0086010)|membrane repolarization during action potential (GO:0086011)|membrane repolarization during cardiac muscle cell action potential (GO:0086013)|negative regulation of potassium ion export (GO:1902303)|negative regulation of potassium ion transmembrane transport (GO:1901380)|positive regulation of potassium ion transmembrane transport (GO:1901381)|potassium ion export (GO:0071435)|potassium ion homeostasis (GO:0055075)|potassium ion transmembrane transport (GO:0071805)|regulation of heart rate by cardiac conduction (GO:0086091)|regulation of heart rate by hormone (GO:0003064)|regulation of membrane potential (GO:0042391)|regulation of membrane repolarization (GO:0060306)|regulation of potassium ion transmembrane transport (GO:1901379)|regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307)|synaptic transmission (GO:0007268)|ventricular cardiac muscle cell action potential (GO:0086005)	cell surface (GO:0009986)|cytoplasm (GO:0005737)|nuclear envelope (GO:0005635)|plasma membrane (GO:0005886)|voltage-gated potassium channel complex (GO:0008076)	delayed rectifier potassium channel activity (GO:0005251)|identical protein binding (GO:0042802)|inward rectifier potassium channel activity (GO:0005242)|phosphorelay sensor kinase activity (GO:0000155)|protein homodimerization activity (GO:0042803)|ubiquitin protein ligase binding (GO:0031625)|voltage-gated potassium channel activity (GO:0005249)|voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282)		EWSR1/ERG(178)|NDRG1/ERG(5)|TMPRSS2/ERG(3582)|FUS/ERG(167)|SLC45A3/ERG(50)	lung(2)|ovary(1)|skin(1)	4		Prostate(19;3.6e-06)			Alfuzosin(DB00346)|Amiodarone(DB01118)|Amsacrine(DB00276)|Astemizole(DB00637)|Carvedilol(DB01136)|Chlorpromazine(DB00477)|Cisapride(DB00604)|Dofetilide(DB00204)|Doxazosin(DB00590)|Doxepin(DB01142)|Dronedarone(DB04855)|Halofantrine(DB01218)|Ibutilide(DB00308)|Imipramine(DB00458)|Miconazole(DB01110)|Pimozide(DB01100)|Prazosin(DB00457)|Propafenone(DB01182)|Quinidine(DB00908)|Sertindole(DB06144)|Sotalol(DB00489)|Terazosin(DB01162)|Thioridazine(DB00679)|Verapamil(DB00661)	gcgcctgtagccccagctact	0.512			T	"""EWSR1, TMPRSS2, ELF4, FUS, HERPUD1, NDRG1"""	"""Ewing sarcoma, prostate, AML"""																																Esophageal Squamous(130;336 1700 3010 3083 40589)		Dom	yes		21	21q22.3	2078	v-ets erythroblastosis virus E26 oncogene like (avian)		"""M, E, L"""	0																																										SO:0001627	intron_variant				CCDS13657.1, CCDS13658.1, CCDS46648.1, CCDS46649.1, CCDS58789.1	21q22.3	2013-07-09	2013-07-09		ENSG00000157554	ENSG00000157554	2078			3446	protein-coding gene	gene with protein product	"""v-ets avian erythroblastosis virus E26 oncogene related"", ""transcriptional regulator ERG (transforming protein ERG)"", ""v-ets erythroblastosis virus E26 oncogene like"", ""TMPRSS2-ERG prostate cancer specific"""	165080	"""v-ets avian erythroblastosis virus E26 oncogene related"""			3274086	Standard	NM_182918	NM_001136154		Approved	erg-3, p55	uc002yxa.3	P11308	OTTHUMG00000090767	ENST00000417133.2:c.766+3094G>A	chr21.hg19:g.39769401C>T			A5H1P7|C4PFH9|D3DX04|O75418|O75680|Q708S9|Q9BT72|Q9BUT7|Q9H3P0	True	hg19	CCDS46648.1																																																																																			ERG-002	KNOWN	basic|appris_candidate_longest|CCDS	protein_coding		protein_coding	OTTHUMT00000207532.2		24.0		-	ENST00000417133.2
ERG	2078	__UNKNOWN__	__UNKNOWN__	21	39769519	39769519	__UNKNOWN__	Intron	DEL	A	A	-	rs71990489|rs61047146		__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr21:39769519delA	ENST00000417133.2	-	8	952				ERG_ENST00000442448.1_Intron|ERG_ENST00000398919.2_Intron|ERG_ENST00000398911.1_Intron|ERG_ENST00000453032.2_Intron|ERG_ENST00000398897.1_Intron|ERG_ENST00000429727.2_Intron|ERG_ENST00000398910.1_Intron|ERG_ENST00000288319.7_Intron|ERG_ENST00000398907.1_Intron|ERG_ENST00000398905.1_Intron	NM_001136154.1|NM_001243432.1	NP_001129626.1|NP_001230361.1	Q12809	KCNH2_HUMAN	v-ets avian erythroblastosis virus E26 oncogene homolog						cardiac muscle contraction (GO:0060048)|cellular response to drug (GO:0035690)|membrane depolarization during action potential (GO:0086010)|membrane repolarization during action potential (GO:0086011)|membrane repolarization during cardiac muscle cell action potential (GO:0086013)|negative regulation of potassium ion export (GO:1902303)|negative regulation of potassium ion transmembrane transport (GO:1901380)|positive regulation of potassium ion transmembrane transport (GO:1901381)|potassium ion export (GO:0071435)|potassium ion homeostasis (GO:0055075)|potassium ion transmembrane transport (GO:0071805)|regulation of heart rate by cardiac conduction (GO:0086091)|regulation of heart rate by hormone (GO:0003064)|regulation of membrane potential (GO:0042391)|regulation of membrane repolarization (GO:0060306)|regulation of potassium ion transmembrane transport (GO:1901379)|regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307)|synaptic transmission (GO:0007268)|ventricular cardiac muscle cell action potential (GO:0086005)	cell surface (GO:0009986)|cytoplasm (GO:0005737)|nuclear envelope (GO:0005635)|plasma membrane (GO:0005886)|voltage-gated potassium channel complex (GO:0008076)	delayed rectifier potassium channel activity (GO:0005251)|identical protein binding (GO:0042802)|inward rectifier potassium channel activity (GO:0005242)|phosphorelay sensor kinase activity (GO:0000155)|protein homodimerization activity (GO:0042803)|ubiquitin protein ligase binding (GO:0031625)|voltage-gated potassium channel activity (GO:0005249)|voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282)		EWSR1/ERG(178)|NDRG1/ERG(5)|TMPRSS2/ERG(3582)|FUS/ERG(167)|SLC45A3/ERG(50)	lung(2)|ovary(1)|skin(1)	4		Prostate(19;3.6e-06)			Alfuzosin(DB00346)|Amiodarone(DB01118)|Amsacrine(DB00276)|Astemizole(DB00637)|Carvedilol(DB01136)|Chlorpromazine(DB00477)|Cisapride(DB00604)|Dofetilide(DB00204)|Doxazosin(DB00590)|Doxepin(DB01142)|Dronedarone(DB04855)|Halofantrine(DB01218)|Ibutilide(DB00308)|Imipramine(DB00458)|Miconazole(DB01110)|Pimozide(DB01100)|Prazosin(DB00457)|Propafenone(DB01182)|Quinidine(DB00908)|Sertindole(DB06144)|Sotalol(DB00489)|Terazosin(DB01162)|Thioridazine(DB00679)|Verapamil(DB00661)	actccatctcaaaaaaaaaaa	0.458			T	"""EWSR1, TMPRSS2, ELF4, FUS, HERPUD1, NDRG1"""	"""Ewing sarcoma, prostate, AML"""																																Esophageal Squamous(130;336 1700 3010 3083 40589)		Dom	yes		21	21q22.3	2078	v-ets erythroblastosis virus E26 oncogene like (avian)		"""M, E, L"""	0																																										SO:0001627	intron_variant				CCDS13657.1, CCDS13658.1, CCDS46648.1, CCDS46649.1, CCDS58789.1	21q22.3	2013-07-09	2013-07-09		ENSG00000157554	ENSG00000157554	2078			3446	protein-coding gene	gene with protein product	"""v-ets avian erythroblastosis virus E26 oncogene related"", ""transcriptional regulator ERG (transforming protein ERG)"", ""v-ets erythroblastosis virus E26 oncogene like"", ""TMPRSS2-ERG prostate cancer specific"""	165080	"""v-ets avian erythroblastosis virus E26 oncogene related"""			3274086	Standard	NM_182918	NM_001136154		Approved	erg-3, p55	uc002yxa.3	P11308	OTTHUMG00000090767	ENST00000417133.2:c.766+2976T>-	chr21.hg19:g.39769519delA			A5H1P7|C4PFH9|D3DX04|O75418|O75680|Q708S9|Q9BT72|Q9BUT7|Q9H3P0	True	hg19	CCDS46648.1																																																																																			ERG-002	KNOWN	basic|appris_candidate_longest|CCDS	protein_coding		protein_coding	OTTHUMT00000207532.2		95.0		-	ENST00000417133.2
ERG	2078	__UNKNOWN__	__UNKNOWN__	21	39769518	39769519	__UNKNOWN__	Intron	INS	-	-	A	rs71990489|rs71184619|rs61047146|rs398036432		__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr21:39769518_39769519insA	ENST00000417133.2	-	8	952				ERG_ENST00000442448.1_Intron|ERG_ENST00000398919.2_Intron|ERG_ENST00000398911.1_Intron|ERG_ENST00000453032.2_Intron|ERG_ENST00000398897.1_Intron|ERG_ENST00000429727.2_Intron|ERG_ENST00000398910.1_Intron|ERG_ENST00000288319.7_Intron|ERG_ENST00000398907.1_Intron|ERG_ENST00000398905.1_Intron	NM_001136154.1|NM_001243432.1	NP_001129626.1|NP_001230361.1	Q12809	KCNH2_HUMAN	v-ets avian erythroblastosis virus E26 oncogene homolog						cardiac muscle contraction (GO:0060048)|cellular response to drug (GO:0035690)|membrane depolarization during action potential (GO:0086010)|membrane repolarization during action potential (GO:0086011)|membrane repolarization during cardiac muscle cell action potential (GO:0086013)|negative regulation of potassium ion export (GO:1902303)|negative regulation of potassium ion transmembrane transport (GO:1901380)|positive regulation of potassium ion transmembrane transport (GO:1901381)|potassium ion export (GO:0071435)|potassium ion homeostasis (GO:0055075)|potassium ion transmembrane transport (GO:0071805)|regulation of heart rate by cardiac conduction (GO:0086091)|regulation of heart rate by hormone (GO:0003064)|regulation of membrane potential (GO:0042391)|regulation of membrane repolarization (GO:0060306)|regulation of potassium ion transmembrane transport (GO:1901379)|regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307)|synaptic transmission (GO:0007268)|ventricular cardiac muscle cell action potential (GO:0086005)	cell surface (GO:0009986)|cytoplasm (GO:0005737)|nuclear envelope (GO:0005635)|plasma membrane (GO:0005886)|voltage-gated potassium channel complex (GO:0008076)	delayed rectifier potassium channel activity (GO:0005251)|identical protein binding (GO:0042802)|inward rectifier potassium channel activity (GO:0005242)|phosphorelay sensor kinase activity (GO:0000155)|protein homodimerization activity (GO:0042803)|ubiquitin protein ligase binding (GO:0031625)|voltage-gated potassium channel activity (GO:0005249)|voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282)		EWSR1/ERG(178)|NDRG1/ERG(5)|TMPRSS2/ERG(3582)|FUS/ERG(167)|SLC45A3/ERG(50)	lung(2)|ovary(1)|skin(1)	4		Prostate(19;3.6e-06)			Alfuzosin(DB00346)|Amiodarone(DB01118)|Amsacrine(DB00276)|Astemizole(DB00637)|Carvedilol(DB01136)|Chlorpromazine(DB00477)|Cisapride(DB00604)|Dofetilide(DB00204)|Doxazosin(DB00590)|Doxepin(DB01142)|Dronedarone(DB04855)|Halofantrine(DB01218)|Ibutilide(DB00308)|Imipramine(DB00458)|Miconazole(DB01110)|Pimozide(DB01100)|Prazosin(DB00457)|Propafenone(DB01182)|Quinidine(DB00908)|Sertindole(DB06144)|Sotalol(DB00489)|Terazosin(DB01162)|Thioridazine(DB00679)|Verapamil(DB00661)	gactccatctcaaaaaaaaaaa	0.460			T	"""EWSR1, TMPRSS2, ELF4, FUS, HERPUD1, NDRG1"""	"""Ewing sarcoma, prostate, AML"""																																Esophageal Squamous(130;336 1700 3010 3083 40589)		Dom	yes		21	21q22.3	2078	v-ets erythroblastosis virus E26 oncogene like (avian)		"""M, E, L"""	0																																										SO:0001627	intron_variant				CCDS13657.1, CCDS13658.1, CCDS46648.1, CCDS46649.1, CCDS58789.1	21q22.3	2013-07-09	2013-07-09		ENSG00000157554	ENSG00000157554	2078			3446	protein-coding gene	gene with protein product	"""v-ets avian erythroblastosis virus E26 oncogene related"", ""transcriptional regulator ERG (transforming protein ERG)"", ""v-ets erythroblastosis virus E26 oncogene like"", ""TMPRSS2-ERG prostate cancer specific"""	165080	"""v-ets avian erythroblastosis virus E26 oncogene related"""			3274086	Standard	NM_182918	NM_001136154		Approved	erg-3, p55	uc002yxa.3	P11308	OTTHUMG00000090767	ENST00000417133.2:c.766+2976->T	chr21.hg19:g.39769529_39769529dupA			A5H1P7|C4PFH9|D3DX04|O75418|O75680|Q708S9|Q9BT72|Q9BUT7|Q9H3P0	True	hg19	CCDS46648.1																																																																																			ERG-002	KNOWN	basic|appris_candidate_longest|CCDS	protein_coding		protein_coding	OTTHUMT00000207532.2		20.0		-	ENST00000417133.2
ERG	2078	__UNKNOWN__	__UNKNOWN__	21	39769519	39769519	__UNKNOWN__	Intron	SNP	A	A	C	rs71990489|rs61047146		__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr21:39769519A>C	ENST00000417133.2	-	8	952				ERG_ENST00000442448.1_Intron|ERG_ENST00000398919.2_Intron|ERG_ENST00000398911.1_Intron|ERG_ENST00000453032.2_Intron|ERG_ENST00000398897.1_Intron|ERG_ENST00000429727.2_Intron|ERG_ENST00000398910.1_Intron|ERG_ENST00000288319.7_Intron|ERG_ENST00000398907.1_Intron|ERG_ENST00000398905.1_Intron	NM_001136154.1|NM_001243432.1	NP_001129626.1|NP_001230361.1	Q12809	KCNH2_HUMAN	v-ets avian erythroblastosis virus E26 oncogene homolog						cardiac muscle contraction (GO:0060048)|cellular response to drug (GO:0035690)|membrane depolarization during action potential (GO:0086010)|membrane repolarization during action potential (GO:0086011)|membrane repolarization during cardiac muscle cell action potential (GO:0086013)|negative regulation of potassium ion export (GO:1902303)|negative regulation of potassium ion transmembrane transport (GO:1901380)|positive regulation of potassium ion transmembrane transport (GO:1901381)|potassium ion export (GO:0071435)|potassium ion homeostasis (GO:0055075)|potassium ion transmembrane transport (GO:0071805)|regulation of heart rate by cardiac conduction (GO:0086091)|regulation of heart rate by hormone (GO:0003064)|regulation of membrane potential (GO:0042391)|regulation of membrane repolarization (GO:0060306)|regulation of potassium ion transmembrane transport (GO:1901379)|regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307)|synaptic transmission (GO:0007268)|ventricular cardiac muscle cell action potential (GO:0086005)	cell surface (GO:0009986)|cytoplasm (GO:0005737)|nuclear envelope (GO:0005635)|plasma membrane (GO:0005886)|voltage-gated potassium channel complex (GO:0008076)	delayed rectifier potassium channel activity (GO:0005251)|identical protein binding (GO:0042802)|inward rectifier potassium channel activity (GO:0005242)|phosphorelay sensor kinase activity (GO:0000155)|protein homodimerization activity (GO:0042803)|ubiquitin protein ligase binding (GO:0031625)|voltage-gated potassium channel activity (GO:0005249)|voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282)		EWSR1/ERG(178)|NDRG1/ERG(5)|TMPRSS2/ERG(3582)|FUS/ERG(167)|SLC45A3/ERG(50)	lung(2)|ovary(1)|skin(1)	4		Prostate(19;3.6e-06)			Alfuzosin(DB00346)|Amiodarone(DB01118)|Amsacrine(DB00276)|Astemizole(DB00637)|Carvedilol(DB01136)|Chlorpromazine(DB00477)|Cisapride(DB00604)|Dofetilide(DB00204)|Doxazosin(DB00590)|Doxepin(DB01142)|Dronedarone(DB04855)|Halofantrine(DB01218)|Ibutilide(DB00308)|Imipramine(DB00458)|Miconazole(DB01110)|Pimozide(DB01100)|Prazosin(DB00457)|Propafenone(DB01182)|Quinidine(DB00908)|Sertindole(DB06144)|Sotalol(DB00489)|Terazosin(DB01162)|Thioridazine(DB00679)|Verapamil(DB00661)	actccatctcaaaaaaaaaaa	0.458			T	"""EWSR1, TMPRSS2, ELF4, FUS, HERPUD1, NDRG1"""	"""Ewing sarcoma, prostate, AML"""																																Esophageal Squamous(130;336 1700 3010 3083 40589)		Dom	yes		21	21q22.3	2078	v-ets erythroblastosis virus E26 oncogene like (avian)		"""M, E, L"""	0																																										SO:0001627	intron_variant				CCDS13657.1, CCDS13658.1, CCDS46648.1, CCDS46649.1, CCDS58789.1	21q22.3	2013-07-09	2013-07-09		ENSG00000157554	ENSG00000157554	2078			3446	protein-coding gene	gene with protein product	"""v-ets avian erythroblastosis virus E26 oncogene related"", ""transcriptional regulator ERG (transforming protein ERG)"", ""v-ets erythroblastosis virus E26 oncogene like"", ""TMPRSS2-ERG prostate cancer specific"""	165080	"""v-ets avian erythroblastosis virus E26 oncogene related"""			3274086	Standard	NM_182918	NM_001136154		Approved	erg-3, p55	uc002yxa.3	P11308	OTTHUMG00000090767	ENST00000417133.2:c.766+2976T>G	chr21.hg19:g.39769519A>C			A5H1P7|C4PFH9|D3DX04|O75418|O75680|Q708S9|Q9BT72|Q9BUT7|Q9H3P0	True	hg19	CCDS46648.1																																																																																			ERG-002	KNOWN	basic|appris_candidate_longest|CCDS	protein_coding		protein_coding	OTTHUMT00000207532.2		44.0		-	ENST00000417133.2
ERG	2078	__UNKNOWN__	__UNKNOWN__	21	39769519	39769519	__UNKNOWN__	Intron	SNP	A	A	T	rs71990489|rs61047146		__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr21:39769519A>T	ENST00000417133.2	-	8	952				ERG_ENST00000442448.1_Intron|ERG_ENST00000398919.2_Intron|ERG_ENST00000398911.1_Intron|ERG_ENST00000453032.2_Intron|ERG_ENST00000398897.1_Intron|ERG_ENST00000429727.2_Intron|ERG_ENST00000398910.1_Intron|ERG_ENST00000288319.7_Intron|ERG_ENST00000398907.1_Intron|ERG_ENST00000398905.1_Intron	NM_001136154.1|NM_001243432.1	NP_001129626.1|NP_001230361.1	Q12809	KCNH2_HUMAN	v-ets avian erythroblastosis virus E26 oncogene homolog						cardiac muscle contraction (GO:0060048)|cellular response to drug (GO:0035690)|membrane depolarization during action potential (GO:0086010)|membrane repolarization during action potential (GO:0086011)|membrane repolarization during cardiac muscle cell action potential (GO:0086013)|negative regulation of potassium ion export (GO:1902303)|negative regulation of potassium ion transmembrane transport (GO:1901380)|positive regulation of potassium ion transmembrane transport (GO:1901381)|potassium ion export (GO:0071435)|potassium ion homeostasis (GO:0055075)|potassium ion transmembrane transport (GO:0071805)|regulation of heart rate by cardiac conduction (GO:0086091)|regulation of heart rate by hormone (GO:0003064)|regulation of membrane potential (GO:0042391)|regulation of membrane repolarization (GO:0060306)|regulation of potassium ion transmembrane transport (GO:1901379)|regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307)|synaptic transmission (GO:0007268)|ventricular cardiac muscle cell action potential (GO:0086005)	cell surface (GO:0009986)|cytoplasm (GO:0005737)|nuclear envelope (GO:0005635)|plasma membrane (GO:0005886)|voltage-gated potassium channel complex (GO:0008076)	delayed rectifier potassium channel activity (GO:0005251)|identical protein binding (GO:0042802)|inward rectifier potassium channel activity (GO:0005242)|phosphorelay sensor kinase activity (GO:0000155)|protein homodimerization activity (GO:0042803)|ubiquitin protein ligase binding (GO:0031625)|voltage-gated potassium channel activity (GO:0005249)|voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282)		EWSR1/ERG(178)|NDRG1/ERG(5)|TMPRSS2/ERG(3582)|FUS/ERG(167)|SLC45A3/ERG(50)	lung(2)|ovary(1)|skin(1)	4		Prostate(19;3.6e-06)			Alfuzosin(DB00346)|Amiodarone(DB01118)|Amsacrine(DB00276)|Astemizole(DB00637)|Carvedilol(DB01136)|Chlorpromazine(DB00477)|Cisapride(DB00604)|Dofetilide(DB00204)|Doxazosin(DB00590)|Doxepin(DB01142)|Dronedarone(DB04855)|Halofantrine(DB01218)|Ibutilide(DB00308)|Imipramine(DB00458)|Miconazole(DB01110)|Pimozide(DB01100)|Prazosin(DB00457)|Propafenone(DB01182)|Quinidine(DB00908)|Sertindole(DB06144)|Sotalol(DB00489)|Terazosin(DB01162)|Thioridazine(DB00679)|Verapamil(DB00661)	actccatctcaaaaaaaaaaa	0.458			T	"""EWSR1, TMPRSS2, ELF4, FUS, HERPUD1, NDRG1"""	"""Ewing sarcoma, prostate, AML"""																																Esophageal Squamous(130;336 1700 3010 3083 40589)		Dom	yes		21	21q22.3	2078	v-ets erythroblastosis virus E26 oncogene like (avian)		"""M, E, L"""	0																																										SO:0001627	intron_variant				CCDS13657.1, CCDS13658.1, CCDS46648.1, CCDS46649.1, CCDS58789.1	21q22.3	2013-07-09	2013-07-09		ENSG00000157554	ENSG00000157554	2078			3446	protein-coding gene	gene with protein product	"""v-ets avian erythroblastosis virus E26 oncogene related"", ""transcriptional regulator ERG (transforming protein ERG)"", ""v-ets erythroblastosis virus E26 oncogene like"", ""TMPRSS2-ERG prostate cancer specific"""	165080	"""v-ets avian erythroblastosis virus E26 oncogene related"""			3274086	Standard	NM_182918	NM_001136154		Approved	erg-3, p55	uc002yxa.3	P11308	OTTHUMG00000090767	ENST00000417133.2:c.766+2976T>A	chr21.hg19:g.39769519A>T			A5H1P7|C4PFH9|D3DX04|O75418|O75680|Q708S9|Q9BT72|Q9BUT7|Q9H3P0	True	hg19	CCDS46648.1																																																																																			ERG-002	KNOWN	basic|appris_candidate_longest|CCDS	protein_coding		protein_coding	OTTHUMT00000207532.2		21.0		-	ENST00000417133.2
ERG	2078	__UNKNOWN__	__UNKNOWN__	21	39769521	39769521	__UNKNOWN__	Intron	SNP	A	A	C			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr21:39769521A>C	ENST00000417133.2	-	8	952				ERG_ENST00000442448.1_Intron|ERG_ENST00000398919.2_Intron|ERG_ENST00000398911.1_Intron|ERG_ENST00000453032.2_Intron|ERG_ENST00000398897.1_Intron|ERG_ENST00000429727.2_Intron|ERG_ENST00000398910.1_Intron|ERG_ENST00000288319.7_Intron|ERG_ENST00000398907.1_Intron|ERG_ENST00000398905.1_Intron	NM_001136154.1|NM_001243432.1	NP_001129626.1|NP_001230361.1	Q12809	KCNH2_HUMAN	v-ets avian erythroblastosis virus E26 oncogene homolog						cardiac muscle contraction (GO:0060048)|cellular response to drug (GO:0035690)|membrane depolarization during action potential (GO:0086010)|membrane repolarization during action potential (GO:0086011)|membrane repolarization during cardiac muscle cell action potential (GO:0086013)|negative regulation of potassium ion export (GO:1902303)|negative regulation of potassium ion transmembrane transport (GO:1901380)|positive regulation of potassium ion transmembrane transport (GO:1901381)|potassium ion export (GO:0071435)|potassium ion homeostasis (GO:0055075)|potassium ion transmembrane transport (GO:0071805)|regulation of heart rate by cardiac conduction (GO:0086091)|regulation of heart rate by hormone (GO:0003064)|regulation of membrane potential (GO:0042391)|regulation of membrane repolarization (GO:0060306)|regulation of potassium ion transmembrane transport (GO:1901379)|regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307)|synaptic transmission (GO:0007268)|ventricular cardiac muscle cell action potential (GO:0086005)	cell surface (GO:0009986)|cytoplasm (GO:0005737)|nuclear envelope (GO:0005635)|plasma membrane (GO:0005886)|voltage-gated potassium channel complex (GO:0008076)	delayed rectifier potassium channel activity (GO:0005251)|identical protein binding (GO:0042802)|inward rectifier potassium channel activity (GO:0005242)|phosphorelay sensor kinase activity (GO:0000155)|protein homodimerization activity (GO:0042803)|ubiquitin protein ligase binding (GO:0031625)|voltage-gated potassium channel activity (GO:0005249)|voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282)		EWSR1/ERG(178)|NDRG1/ERG(5)|TMPRSS2/ERG(3582)|FUS/ERG(167)|SLC45A3/ERG(50)	lung(2)|ovary(1)|skin(1)	4		Prostate(19;3.6e-06)			Alfuzosin(DB00346)|Amiodarone(DB01118)|Amsacrine(DB00276)|Astemizole(DB00637)|Carvedilol(DB01136)|Chlorpromazine(DB00477)|Cisapride(DB00604)|Dofetilide(DB00204)|Doxazosin(DB00590)|Doxepin(DB01142)|Dronedarone(DB04855)|Halofantrine(DB01218)|Ibutilide(DB00308)|Imipramine(DB00458)|Miconazole(DB01110)|Pimozide(DB01100)|Prazosin(DB00457)|Propafenone(DB01182)|Quinidine(DB00908)|Sertindole(DB06144)|Sotalol(DB00489)|Terazosin(DB01162)|Thioridazine(DB00679)|Verapamil(DB00661)	tccatctcaaaaaaaaaaaaa	0.453			T	"""EWSR1, TMPRSS2, ELF4, FUS, HERPUD1, NDRG1"""	"""Ewing sarcoma, prostate, AML"""																																Esophageal Squamous(130;336 1700 3010 3083 40589)		Dom	yes		21	21q22.3	2078	v-ets erythroblastosis virus E26 oncogene like (avian)		"""M, E, L"""	0																																										SO:0001627	intron_variant				CCDS13657.1, CCDS13658.1, CCDS46648.1, CCDS46649.1, CCDS58789.1	21q22.3	2013-07-09	2013-07-09		ENSG00000157554	ENSG00000157554	2078			3446	protein-coding gene	gene with protein product	"""v-ets avian erythroblastosis virus E26 oncogene related"", ""transcriptional regulator ERG (transforming protein ERG)"", ""v-ets erythroblastosis virus E26 oncogene like"", ""TMPRSS2-ERG prostate cancer specific"""	165080	"""v-ets avian erythroblastosis virus E26 oncogene related"""			3274086	Standard	NM_182918	NM_001136154		Approved	erg-3, p55	uc002yxa.3	P11308	OTTHUMG00000090767	ENST00000417133.2:c.766+2974T>G	chr21.hg19:g.39769521A>C			A5H1P7|C4PFH9|D3DX04|O75418|O75680|Q708S9|Q9BT72|Q9BUT7|Q9H3P0	True	hg19	CCDS46648.1																																																																																			ERG-002	KNOWN	basic|appris_candidate_longest|CCDS	protein_coding		protein_coding	OTTHUMT00000207532.2		27.0		-	ENST00000417133.2
ERG	2078	__UNKNOWN__	__UNKNOWN__	21	39774603	39774603	__UNKNOWN__	Intron	SNP	G	G	A	rs552146814	byFrequency	__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr21:39774603G>A	ENST00000417133.2	-	7	799				ERG_ENST00000442448.1_Intron|ERG_ENST00000398919.2_Intron|ERG_ENST00000398911.1_Intron|ERG_ENST00000453032.2_Intron|ERG_ENST00000398897.1_Intron|ERG_ENST00000429727.2_Intron|ERG_ENST00000398910.1_Intron|ERG_ENST00000288319.7_Intron|ERG_ENST00000398907.1_Intron|ERG_ENST00000398905.1_Intron	NM_001136154.1|NM_001243432.1	NP_001129626.1|NP_001230361.1	Q12809	KCNH2_HUMAN	v-ets avian erythroblastosis virus E26 oncogene homolog						cardiac muscle contraction (GO:0060048)|cellular response to drug (GO:0035690)|membrane depolarization during action potential (GO:0086010)|membrane repolarization during action potential (GO:0086011)|membrane repolarization during cardiac muscle cell action potential (GO:0086013)|negative regulation of potassium ion export (GO:1902303)|negative regulation of potassium ion transmembrane transport (GO:1901380)|positive regulation of potassium ion transmembrane transport (GO:1901381)|potassium ion export (GO:0071435)|potassium ion homeostasis (GO:0055075)|potassium ion transmembrane transport (GO:0071805)|regulation of heart rate by cardiac conduction (GO:0086091)|regulation of heart rate by hormone (GO:0003064)|regulation of membrane potential (GO:0042391)|regulation of membrane repolarization (GO:0060306)|regulation of potassium ion transmembrane transport (GO:1901379)|regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307)|synaptic transmission (GO:0007268)|ventricular cardiac muscle cell action potential (GO:0086005)	cell surface (GO:0009986)|cytoplasm (GO:0005737)|nuclear envelope (GO:0005635)|plasma membrane (GO:0005886)|voltage-gated potassium channel complex (GO:0008076)	delayed rectifier potassium channel activity (GO:0005251)|identical protein binding (GO:0042802)|inward rectifier potassium channel activity (GO:0005242)|phosphorelay sensor kinase activity (GO:0000155)|protein homodimerization activity (GO:0042803)|ubiquitin protein ligase binding (GO:0031625)|voltage-gated potassium channel activity (GO:0005249)|voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282)		EWSR1/ERG(178)|NDRG1/ERG(5)|TMPRSS2/ERG(3582)|FUS/ERG(167)|SLC45A3/ERG(50)	lung(2)|ovary(1)|skin(1)	4		Prostate(19;3.6e-06)			Alfuzosin(DB00346)|Amiodarone(DB01118)|Amsacrine(DB00276)|Astemizole(DB00637)|Carvedilol(DB01136)|Chlorpromazine(DB00477)|Cisapride(DB00604)|Dofetilide(DB00204)|Doxazosin(DB00590)|Doxepin(DB01142)|Dronedarone(DB04855)|Halofantrine(DB01218)|Ibutilide(DB00308)|Imipramine(DB00458)|Miconazole(DB01110)|Pimozide(DB01100)|Prazosin(DB00457)|Propafenone(DB01182)|Quinidine(DB00908)|Sertindole(DB06144)|Sotalol(DB00489)|Terazosin(DB01162)|Thioridazine(DB00679)|Verapamil(DB00661)	AAAAAAAAAAGAGAGAGAGAG	0.328			T	"""EWSR1, TMPRSS2, ELF4, FUS, HERPUD1, NDRG1"""	"""Ewing sarcoma, prostate, AML"""																																Esophageal Squamous(130;336 1700 3010 3083 40589)		Dom	yes		21	21q22.3	2078	v-ets erythroblastosis virus E26 oncogene like (avian)		"""M, E, L"""	0													23.0	23.0	23.0					21																	39774603		2202	4298	6500	SO:0001627	intron_variant				CCDS13657.1, CCDS13658.1, CCDS46648.1, CCDS46649.1, CCDS58789.1	21q22.3	2013-07-09	2013-07-09		ENSG00000157554	ENSG00000157554	2078			3446	protein-coding gene	gene with protein product	"""v-ets avian erythroblastosis virus E26 oncogene related"", ""transcriptional regulator ERG (transforming protein ERG)"", ""v-ets erythroblastosis virus E26 oncogene like"", ""TMPRSS2-ERG prostate cancer specific"""	165080	"""v-ets avian erythroblastosis virus E26 oncogene related"""			3274086	Standard	NM_182918	NM_001136154		Approved	erg-3, p55	uc002yxa.3	P11308	OTTHUMG00000090767	ENST00000417133.2:c.614-44C>T	chr21.hg19:g.39774603G>A			A5H1P7|C4PFH9|D3DX04|O75418|O75680|Q708S9|Q9BT72|Q9BUT7|Q9H3P0	True	hg19	CCDS46648.1																																																																																			ERG-002	KNOWN	basic|appris_candidate_longest|CCDS	protein_coding		protein_coding	OTTHUMT00000207532.2		30.0		-	ENST00000417133.2
ERG	2078	__UNKNOWN__	__UNKNOWN__	21	39774629	39774629	__UNKNOWN__	Intron	SNP	T	T	A			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr21:39774629T>A	ENST00000417133.2	-	7	799				ERG_ENST00000442448.1_Intron|ERG_ENST00000398919.2_Intron|ERG_ENST00000398911.1_Intron|ERG_ENST00000453032.2_Intron|ERG_ENST00000398897.1_Intron|ERG_ENST00000429727.2_Intron|ERG_ENST00000398910.1_Intron|ERG_ENST00000288319.7_Intron|ERG_ENST00000398907.1_Intron|ERG_ENST00000398905.1_Intron	NM_001136154.1|NM_001243432.1	NP_001129626.1|NP_001230361.1	Q12809	KCNH2_HUMAN	v-ets avian erythroblastosis virus E26 oncogene homolog						cardiac muscle contraction (GO:0060048)|cellular response to drug (GO:0035690)|membrane depolarization during action potential (GO:0086010)|membrane repolarization during action potential (GO:0086011)|membrane repolarization during cardiac muscle cell action potential (GO:0086013)|negative regulation of potassium ion export (GO:1902303)|negative regulation of potassium ion transmembrane transport (GO:1901380)|positive regulation of potassium ion transmembrane transport (GO:1901381)|potassium ion export (GO:0071435)|potassium ion homeostasis (GO:0055075)|potassium ion transmembrane transport (GO:0071805)|regulation of heart rate by cardiac conduction (GO:0086091)|regulation of heart rate by hormone (GO:0003064)|regulation of membrane potential (GO:0042391)|regulation of membrane repolarization (GO:0060306)|regulation of potassium ion transmembrane transport (GO:1901379)|regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307)|synaptic transmission (GO:0007268)|ventricular cardiac muscle cell action potential (GO:0086005)	cell surface (GO:0009986)|cytoplasm (GO:0005737)|nuclear envelope (GO:0005635)|plasma membrane (GO:0005886)|voltage-gated potassium channel complex (GO:0008076)	delayed rectifier potassium channel activity (GO:0005251)|identical protein binding (GO:0042802)|inward rectifier potassium channel activity (GO:0005242)|phosphorelay sensor kinase activity (GO:0000155)|protein homodimerization activity (GO:0042803)|ubiquitin protein ligase binding (GO:0031625)|voltage-gated potassium channel activity (GO:0005249)|voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282)		EWSR1/ERG(178)|NDRG1/ERG(5)|TMPRSS2/ERG(3582)|FUS/ERG(167)|SLC45A3/ERG(50)	lung(2)|ovary(1)|skin(1)	4		Prostate(19;3.6e-06)			Alfuzosin(DB00346)|Amiodarone(DB01118)|Amsacrine(DB00276)|Astemizole(DB00637)|Carvedilol(DB01136)|Chlorpromazine(DB00477)|Cisapride(DB00604)|Dofetilide(DB00204)|Doxazosin(DB00590)|Doxepin(DB01142)|Dronedarone(DB04855)|Halofantrine(DB01218)|Ibutilide(DB00308)|Imipramine(DB00458)|Miconazole(DB01110)|Pimozide(DB01100)|Prazosin(DB00457)|Propafenone(DB01182)|Quinidine(DB00908)|Sertindole(DB06144)|Sotalol(DB00489)|Terazosin(DB01162)|Thioridazine(DB00679)|Verapamil(DB00661)	GAATTACCTTTCTTACaaaaa	0.328			T	"""EWSR1, TMPRSS2, ELF4, FUS, HERPUD1, NDRG1"""	"""Ewing sarcoma, prostate, AML"""																																Esophageal Squamous(130;336 1700 3010 3083 40589)		Dom	yes		21	21q22.3	2078	v-ets erythroblastosis virus E26 oncogene like (avian)		"""M, E, L"""	0																																										SO:0001627	intron_variant				CCDS13657.1, CCDS13658.1, CCDS46648.1, CCDS46649.1, CCDS58789.1	21q22.3	2013-07-09	2013-07-09		ENSG00000157554	ENSG00000157554	2078			3446	protein-coding gene	gene with protein product	"""v-ets avian erythroblastosis virus E26 oncogene related"", ""transcriptional regulator ERG (transforming protein ERG)"", ""v-ets erythroblastosis virus E26 oncogene like"", ""TMPRSS2-ERG prostate cancer specific"""	165080	"""v-ets avian erythroblastosis virus E26 oncogene related"""			3274086	Standard	NM_182918	NM_001136154		Approved	erg-3, p55	uc002yxa.3	P11308	OTTHUMG00000090767	ENST00000417133.2:c.614-70A>T	chr21.hg19:g.39774629T>A			A5H1P7|C4PFH9|D3DX04|O75418|O75680|Q708S9|Q9BT72|Q9BUT7|Q9H3P0	True	hg19	CCDS46648.1																																																																																			ERG-002	KNOWN	basic|appris_candidate_longest|CCDS	protein_coding		protein_coding	OTTHUMT00000207532.2		20.0		-	ENST00000417133.2
ERG	2078	__UNKNOWN__	__UNKNOWN__	21	39778082	39778082	__UNKNOWN__	Intron	SNP	A	A	C			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr21:39778082A>C	ENST00000417133.2	-	6	595				ERG_ENST00000442448.1_Intron|ERG_ENST00000398919.2_Intron|ERG_ENST00000398911.1_Intron|ERG_ENST00000453032.2_Intron|ERG_ENST00000398897.1_Intron|ERG_ENST00000429727.2_Intron|ERG_ENST00000398910.1_Intron|ERG_ENST00000288319.7_Intron|ERG_ENST00000398907.1_Intron|ERG_ENST00000398905.1_Intron	NM_001136154.1|NM_001243432.1	NP_001129626.1|NP_001230361.1	Q12809	KCNH2_HUMAN	v-ets avian erythroblastosis virus E26 oncogene homolog						cardiac muscle contraction (GO:0060048)|cellular response to drug (GO:0035690)|membrane depolarization during action potential (GO:0086010)|membrane repolarization during action potential (GO:0086011)|membrane repolarization during cardiac muscle cell action potential (GO:0086013)|negative regulation of potassium ion export (GO:1902303)|negative regulation of potassium ion transmembrane transport (GO:1901380)|positive regulation of potassium ion transmembrane transport (GO:1901381)|potassium ion export (GO:0071435)|potassium ion homeostasis (GO:0055075)|potassium ion transmembrane transport (GO:0071805)|regulation of heart rate by cardiac conduction (GO:0086091)|regulation of heart rate by hormone (GO:0003064)|regulation of membrane potential (GO:0042391)|regulation of membrane repolarization (GO:0060306)|regulation of potassium ion transmembrane transport (GO:1901379)|regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307)|synaptic transmission (GO:0007268)|ventricular cardiac muscle cell action potential (GO:0086005)	cell surface (GO:0009986)|cytoplasm (GO:0005737)|nuclear envelope (GO:0005635)|plasma membrane (GO:0005886)|voltage-gated potassium channel complex (GO:0008076)	delayed rectifier potassium channel activity (GO:0005251)|identical protein binding (GO:0042802)|inward rectifier potassium channel activity (GO:0005242)|phosphorelay sensor kinase activity (GO:0000155)|protein homodimerization activity (GO:0042803)|ubiquitin protein ligase binding (GO:0031625)|voltage-gated potassium channel activity (GO:0005249)|voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282)		EWSR1/ERG(178)|NDRG1/ERG(5)|TMPRSS2/ERG(3582)|FUS/ERG(167)|SLC45A3/ERG(50)	lung(2)|ovary(1)|skin(1)	4		Prostate(19;3.6e-06)			Alfuzosin(DB00346)|Amiodarone(DB01118)|Amsacrine(DB00276)|Astemizole(DB00637)|Carvedilol(DB01136)|Chlorpromazine(DB00477)|Cisapride(DB00604)|Dofetilide(DB00204)|Doxazosin(DB00590)|Doxepin(DB01142)|Dronedarone(DB04855)|Halofantrine(DB01218)|Ibutilide(DB00308)|Imipramine(DB00458)|Miconazole(DB01110)|Pimozide(DB01100)|Prazosin(DB00457)|Propafenone(DB01182)|Quinidine(DB00908)|Sertindole(DB06144)|Sotalol(DB00489)|Terazosin(DB01162)|Thioridazine(DB00679)|Verapamil(DB00661)	atctcaaaaaaaaaaaaaaaa	0.458			T	"""EWSR1, TMPRSS2, ELF4, FUS, HERPUD1, NDRG1"""	"""Ewing sarcoma, prostate, AML"""																																Esophageal Squamous(130;336 1700 3010 3083 40589)		Dom	yes		21	21q22.3	2078	v-ets erythroblastosis virus E26 oncogene like (avian)		"""M, E, L"""	0																																										SO:0001627	intron_variant				CCDS13657.1, CCDS13658.1, CCDS46648.1, CCDS46649.1, CCDS58789.1	21q22.3	2013-07-09	2013-07-09		ENSG00000157554	ENSG00000157554	2078			3446	protein-coding gene	gene with protein product	"""v-ets avian erythroblastosis virus E26 oncogene related"", ""transcriptional regulator ERG (transforming protein ERG)"", ""v-ets erythroblastosis virus E26 oncogene like"", ""TMPRSS2-ERG prostate cancer specific"""	165080	"""v-ets avian erythroblastosis virus E26 oncogene related"""			3274086	Standard	NM_182918	NM_001136154		Approved	erg-3, p55	uc002yxa.3	P11308	OTTHUMG00000090767	ENST00000417133.2:c.410-2451T>G	chr21.hg19:g.39778082A>C			A5H1P7|C4PFH9|D3DX04|O75418|O75680|Q708S9|Q9BT72|Q9BUT7|Q9H3P0	True	hg19	CCDS46648.1																																																																																			ERG-002	KNOWN	basic|appris_candidate_longest|CCDS	protein_coding		protein_coding	OTTHUMT00000207532.2		21.0		-	ENST00000417133.2
ERG	2078	__UNKNOWN__	__UNKNOWN__	21	39779650	39779650	__UNKNOWN__	Intron	SNP	A	A	T			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr21:39779650A>T	ENST00000417133.2	-	6	595				ERG_ENST00000442448.1_Intron|ERG_ENST00000398919.2_Intron|ERG_ENST00000398911.1_Intron|ERG_ENST00000453032.2_Intron|ERG_ENST00000398897.1_Intron|ERG_ENST00000429727.2_Intron|ERG_ENST00000398910.1_Intron|ERG_ENST00000288319.7_Intron|ERG_ENST00000398907.1_Intron|ERG_ENST00000398905.1_Intron	NM_001136154.1|NM_001243432.1	NP_001129626.1|NP_001230361.1	Q12809	KCNH2_HUMAN	v-ets avian erythroblastosis virus E26 oncogene homolog						cardiac muscle contraction (GO:0060048)|cellular response to drug (GO:0035690)|membrane depolarization during action potential (GO:0086010)|membrane repolarization during action potential (GO:0086011)|membrane repolarization during cardiac muscle cell action potential (GO:0086013)|negative regulation of potassium ion export (GO:1902303)|negative regulation of potassium ion transmembrane transport (GO:1901380)|positive regulation of potassium ion transmembrane transport (GO:1901381)|potassium ion export (GO:0071435)|potassium ion homeostasis (GO:0055075)|potassium ion transmembrane transport (GO:0071805)|regulation of heart rate by cardiac conduction (GO:0086091)|regulation of heart rate by hormone (GO:0003064)|regulation of membrane potential (GO:0042391)|regulation of membrane repolarization (GO:0060306)|regulation of potassium ion transmembrane transport (GO:1901379)|regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307)|synaptic transmission (GO:0007268)|ventricular cardiac muscle cell action potential (GO:0086005)	cell surface (GO:0009986)|cytoplasm (GO:0005737)|nuclear envelope (GO:0005635)|plasma membrane (GO:0005886)|voltage-gated potassium channel complex (GO:0008076)	delayed rectifier potassium channel activity (GO:0005251)|identical protein binding (GO:0042802)|inward rectifier potassium channel activity (GO:0005242)|phosphorelay sensor kinase activity (GO:0000155)|protein homodimerization activity (GO:0042803)|ubiquitin protein ligase binding (GO:0031625)|voltage-gated potassium channel activity (GO:0005249)|voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282)		EWSR1/ERG(178)|NDRG1/ERG(5)|TMPRSS2/ERG(3582)|FUS/ERG(167)|SLC45A3/ERG(50)	lung(2)|ovary(1)|skin(1)	4		Prostate(19;3.6e-06)			Alfuzosin(DB00346)|Amiodarone(DB01118)|Amsacrine(DB00276)|Astemizole(DB00637)|Carvedilol(DB01136)|Chlorpromazine(DB00477)|Cisapride(DB00604)|Dofetilide(DB00204)|Doxazosin(DB00590)|Doxepin(DB01142)|Dronedarone(DB04855)|Halofantrine(DB01218)|Ibutilide(DB00308)|Imipramine(DB00458)|Miconazole(DB01110)|Pimozide(DB01100)|Prazosin(DB00457)|Propafenone(DB01182)|Quinidine(DB00908)|Sertindole(DB06144)|Sotalol(DB00489)|Terazosin(DB01162)|Thioridazine(DB00679)|Verapamil(DB00661)	TAAATACTTTATAAAAAGTAT	0.134			T	"""EWSR1, TMPRSS2, ELF4, FUS, HERPUD1, NDRG1"""	"""Ewing sarcoma, prostate, AML"""																																Esophageal Squamous(130;336 1700 3010 3083 40589)		Dom	yes		21	21q22.3	2078	v-ets erythroblastosis virus E26 oncogene like (avian)		"""M, E, L"""	0																																										SO:0001627	intron_variant				CCDS13657.1, CCDS13658.1, CCDS46648.1, CCDS46649.1, CCDS58789.1	21q22.3	2013-07-09	2013-07-09		ENSG00000157554	ENSG00000157554	2078			3446	protein-coding gene	gene with protein product	"""v-ets avian erythroblastosis virus E26 oncogene related"", ""transcriptional regulator ERG (transforming protein ERG)"", ""v-ets erythroblastosis virus E26 oncogene like"", ""TMPRSS2-ERG prostate cancer specific"""	165080	"""v-ets avian erythroblastosis virus E26 oncogene related"""			3274086	Standard	NM_182918	NM_001136154		Approved	erg-3, p55	uc002yxa.3	P11308	OTTHUMG00000090767	ENST00000417133.2:c.410-4019T>A	chr21.hg19:g.39779650A>T			A5H1P7|C4PFH9|D3DX04|O75418|O75680|Q708S9|Q9BT72|Q9BUT7|Q9H3P0	True	hg19	CCDS46648.1																																																																																			ERG-002	KNOWN	basic|appris_candidate_longest|CCDS	protein_coding		protein_coding	OTTHUMT00000207532.2		28.0		-	ENST00000417133.2
ERG	2078	__UNKNOWN__	__UNKNOWN__	21	39779663	39779666	__UNKNOWN__	Intron	DEL	TTTA	TTTA	-			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr21:39779663_39779666delTTTA	ENST00000417133.2	-	6	595				ERG_ENST00000442448.1_Intron|ERG_ENST00000398919.2_Intron|ERG_ENST00000398911.1_Intron|ERG_ENST00000453032.2_Intron|ERG_ENST00000398897.1_Intron|ERG_ENST00000429727.2_Intron|ERG_ENST00000398910.1_Intron|ERG_ENST00000288319.7_Intron|ERG_ENST00000398907.1_Intron|ERG_ENST00000398905.1_Intron	NM_001136154.1|NM_001243432.1	NP_001129626.1|NP_001230361.1	Q12809	KCNH2_HUMAN	v-ets avian erythroblastosis virus E26 oncogene homolog						cardiac muscle contraction (GO:0060048)|cellular response to drug (GO:0035690)|membrane depolarization during action potential (GO:0086010)|membrane repolarization during action potential (GO:0086011)|membrane repolarization during cardiac muscle cell action potential (GO:0086013)|negative regulation of potassium ion export (GO:1902303)|negative regulation of potassium ion transmembrane transport (GO:1901380)|positive regulation of potassium ion transmembrane transport (GO:1901381)|potassium ion export (GO:0071435)|potassium ion homeostasis (GO:0055075)|potassium ion transmembrane transport (GO:0071805)|regulation of heart rate by cardiac conduction (GO:0086091)|regulation of heart rate by hormone (GO:0003064)|regulation of membrane potential (GO:0042391)|regulation of membrane repolarization (GO:0060306)|regulation of potassium ion transmembrane transport (GO:1901379)|regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307)|synaptic transmission (GO:0007268)|ventricular cardiac muscle cell action potential (GO:0086005)	cell surface (GO:0009986)|cytoplasm (GO:0005737)|nuclear envelope (GO:0005635)|plasma membrane (GO:0005886)|voltage-gated potassium channel complex (GO:0008076)	delayed rectifier potassium channel activity (GO:0005251)|identical protein binding (GO:0042802)|inward rectifier potassium channel activity (GO:0005242)|phosphorelay sensor kinase activity (GO:0000155)|protein homodimerization activity (GO:0042803)|ubiquitin protein ligase binding (GO:0031625)|voltage-gated potassium channel activity (GO:0005249)|voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282)		EWSR1/ERG(178)|NDRG1/ERG(5)|TMPRSS2/ERG(3582)|FUS/ERG(167)|SLC45A3/ERG(50)	lung(2)|ovary(1)|skin(1)	4		Prostate(19;3.6e-06)			Alfuzosin(DB00346)|Amiodarone(DB01118)|Amsacrine(DB00276)|Astemizole(DB00637)|Carvedilol(DB01136)|Chlorpromazine(DB00477)|Cisapride(DB00604)|Dofetilide(DB00204)|Doxazosin(DB00590)|Doxepin(DB01142)|Dronedarone(DB04855)|Halofantrine(DB01218)|Ibutilide(DB00308)|Imipramine(DB00458)|Miconazole(DB01110)|Pimozide(DB01100)|Prazosin(DB00457)|Propafenone(DB01182)|Quinidine(DB00908)|Sertindole(DB06144)|Sotalol(DB00489)|Terazosin(DB01162)|Thioridazine(DB00679)|Verapamil(DB00661)	AAAAGTATTTTTTaaaagtataaa	0.127			T	"""EWSR1, TMPRSS2, ELF4, FUS, HERPUD1, NDRG1"""	"""Ewing sarcoma, prostate, AML"""																																Esophageal Squamous(130;336 1700 3010 3083 40589)		Dom	yes		21	21q22.3	2078	v-ets erythroblastosis virus E26 oncogene like (avian)		"""M, E, L"""	0																																										SO:0001627	intron_variant				CCDS13657.1, CCDS13658.1, CCDS46648.1, CCDS46649.1, CCDS58789.1	21q22.3	2013-07-09	2013-07-09		ENSG00000157554	ENSG00000157554	2078			3446	protein-coding gene	gene with protein product	"""v-ets avian erythroblastosis virus E26 oncogene related"", ""transcriptional regulator ERG (transforming protein ERG)"", ""v-ets erythroblastosis virus E26 oncogene like"", ""TMPRSS2-ERG prostate cancer specific"""	165080	"""v-ets avian erythroblastosis virus E26 oncogene related"""			3274086	Standard	NM_182918	NM_001136154		Approved	erg-3, p55	uc002yxa.3	P11308	OTTHUMG00000090767	ENST00000417133.2:c.410-4032TAAA>-	chr21.hg19:g.39779663_39779666delTTTA			A5H1P7|C4PFH9|D3DX04|O75418|O75680|Q708S9|Q9BT72|Q9BUT7|Q9H3P0	True	hg19	CCDS46648.1																																																																																			ERG-002	KNOWN	basic|appris_candidate_longest|CCDS	protein_coding		protein_coding	OTTHUMT00000207532.2		32.0		-	ENST00000417133.2
ERG	2078	__UNKNOWN__	__UNKNOWN__	21	39779825	39779825	__UNKNOWN__	Intron	SNP	C	C	G			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr21:39779825C>G	ENST00000417133.2	-	6	595				ERG_ENST00000442448.1_Intron|ERG_ENST00000398919.2_Intron|ERG_ENST00000398911.1_Intron|ERG_ENST00000453032.2_Intron|ERG_ENST00000398897.1_Intron|ERG_ENST00000429727.2_Intron|ERG_ENST00000398910.1_Intron|ERG_ENST00000288319.7_Intron|ERG_ENST00000398907.1_Intron|ERG_ENST00000398905.1_Intron	NM_001136154.1|NM_001243432.1	NP_001129626.1|NP_001230361.1	Q12809	KCNH2_HUMAN	v-ets avian erythroblastosis virus E26 oncogene homolog						cardiac muscle contraction (GO:0060048)|cellular response to drug (GO:0035690)|membrane depolarization during action potential (GO:0086010)|membrane repolarization during action potential (GO:0086011)|membrane repolarization during cardiac muscle cell action potential (GO:0086013)|negative regulation of potassium ion export (GO:1902303)|negative regulation of potassium ion transmembrane transport (GO:1901380)|positive regulation of potassium ion transmembrane transport (GO:1901381)|potassium ion export (GO:0071435)|potassium ion homeostasis (GO:0055075)|potassium ion transmembrane transport (GO:0071805)|regulation of heart rate by cardiac conduction (GO:0086091)|regulation of heart rate by hormone (GO:0003064)|regulation of membrane potential (GO:0042391)|regulation of membrane repolarization (GO:0060306)|regulation of potassium ion transmembrane transport (GO:1901379)|regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307)|synaptic transmission (GO:0007268)|ventricular cardiac muscle cell action potential (GO:0086005)	cell surface (GO:0009986)|cytoplasm (GO:0005737)|nuclear envelope (GO:0005635)|plasma membrane (GO:0005886)|voltage-gated potassium channel complex (GO:0008076)	delayed rectifier potassium channel activity (GO:0005251)|identical protein binding (GO:0042802)|inward rectifier potassium channel activity (GO:0005242)|phosphorelay sensor kinase activity (GO:0000155)|protein homodimerization activity (GO:0042803)|ubiquitin protein ligase binding (GO:0031625)|voltage-gated potassium channel activity (GO:0005249)|voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282)		EWSR1/ERG(178)|NDRG1/ERG(5)|TMPRSS2/ERG(3582)|FUS/ERG(167)|SLC45A3/ERG(50)	lung(2)|ovary(1)|skin(1)	4		Prostate(19;3.6e-06)			Alfuzosin(DB00346)|Amiodarone(DB01118)|Amsacrine(DB00276)|Astemizole(DB00637)|Carvedilol(DB01136)|Chlorpromazine(DB00477)|Cisapride(DB00604)|Dofetilide(DB00204)|Doxazosin(DB00590)|Doxepin(DB01142)|Dronedarone(DB04855)|Halofantrine(DB01218)|Ibutilide(DB00308)|Imipramine(DB00458)|Miconazole(DB01110)|Pimozide(DB01100)|Prazosin(DB00457)|Propafenone(DB01182)|Quinidine(DB00908)|Sertindole(DB06144)|Sotalol(DB00489)|Terazosin(DB01162)|Thioridazine(DB00679)|Verapamil(DB00661)	agaatatatacttacatatat	0.149			T	"""EWSR1, TMPRSS2, ELF4, FUS, HERPUD1, NDRG1"""	"""Ewing sarcoma, prostate, AML"""																																Esophageal Squamous(130;336 1700 3010 3083 40589)		Dom	yes		21	21q22.3	2078	v-ets erythroblastosis virus E26 oncogene like (avian)		"""M, E, L"""	0																																										SO:0001627	intron_variant				CCDS13657.1, CCDS13658.1, CCDS46648.1, CCDS46649.1, CCDS58789.1	21q22.3	2013-07-09	2013-07-09		ENSG00000157554	ENSG00000157554	2078			3446	protein-coding gene	gene with protein product	"""v-ets avian erythroblastosis virus E26 oncogene related"", ""transcriptional regulator ERG (transforming protein ERG)"", ""v-ets erythroblastosis virus E26 oncogene like"", ""TMPRSS2-ERG prostate cancer specific"""	165080	"""v-ets avian erythroblastosis virus E26 oncogene related"""			3274086	Standard	NM_182918	NM_001136154		Approved	erg-3, p55	uc002yxa.3	P11308	OTTHUMG00000090767	ENST00000417133.2:c.410-4194G>C	chr21.hg19:g.39779825C>G			A5H1P7|C4PFH9|D3DX04|O75418|O75680|Q708S9|Q9BT72|Q9BUT7|Q9H3P0	True	hg19	CCDS46648.1																																																																																			ERG-002	KNOWN	basic|appris_candidate_longest|CCDS	protein_coding		protein_coding	OTTHUMT00000207532.2		25.0		-	ENST00000417133.2
ERG	2078	__UNKNOWN__	__UNKNOWN__	21	39783308	39783308	__UNKNOWN__	Intron	SNP	G	G	C			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr21:39783308G>C	ENST00000417133.2	-	6	595				ERG_ENST00000442448.1_Intron|ERG_ENST00000398919.2_Intron|ERG_ENST00000398911.1_Intron|ERG_ENST00000453032.2_Intron|ERG_ENST00000398897.1_Intron|ERG_ENST00000429727.2_Intron|ERG_ENST00000398910.1_Intron|ERG_ENST00000288319.7_Intron|ERG_ENST00000398907.1_Intron|ERG_ENST00000398905.1_Intron	NM_001136154.1|NM_001243432.1	NP_001129626.1|NP_001230361.1	Q12809	KCNH2_HUMAN	v-ets avian erythroblastosis virus E26 oncogene homolog						cardiac muscle contraction (GO:0060048)|cellular response to drug (GO:0035690)|membrane depolarization during action potential (GO:0086010)|membrane repolarization during action potential (GO:0086011)|membrane repolarization during cardiac muscle cell action potential (GO:0086013)|negative regulation of potassium ion export (GO:1902303)|negative regulation of potassium ion transmembrane transport (GO:1901380)|positive regulation of potassium ion transmembrane transport (GO:1901381)|potassium ion export (GO:0071435)|potassium ion homeostasis (GO:0055075)|potassium ion transmembrane transport (GO:0071805)|regulation of heart rate by cardiac conduction (GO:0086091)|regulation of heart rate by hormone (GO:0003064)|regulation of membrane potential (GO:0042391)|regulation of membrane repolarization (GO:0060306)|regulation of potassium ion transmembrane transport (GO:1901379)|regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307)|synaptic transmission (GO:0007268)|ventricular cardiac muscle cell action potential (GO:0086005)	cell surface (GO:0009986)|cytoplasm (GO:0005737)|nuclear envelope (GO:0005635)|plasma membrane (GO:0005886)|voltage-gated potassium channel complex (GO:0008076)	delayed rectifier potassium channel activity (GO:0005251)|identical protein binding (GO:0042802)|inward rectifier potassium channel activity (GO:0005242)|phosphorelay sensor kinase activity (GO:0000155)|protein homodimerization activity (GO:0042803)|ubiquitin protein ligase binding (GO:0031625)|voltage-gated potassium channel activity (GO:0005249)|voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282)		EWSR1/ERG(178)|NDRG1/ERG(5)|TMPRSS2/ERG(3582)|FUS/ERG(167)|SLC45A3/ERG(50)	lung(2)|ovary(1)|skin(1)	4		Prostate(19;3.6e-06)			Alfuzosin(DB00346)|Amiodarone(DB01118)|Amsacrine(DB00276)|Astemizole(DB00637)|Carvedilol(DB01136)|Chlorpromazine(DB00477)|Cisapride(DB00604)|Dofetilide(DB00204)|Doxazosin(DB00590)|Doxepin(DB01142)|Dronedarone(DB04855)|Halofantrine(DB01218)|Ibutilide(DB00308)|Imipramine(DB00458)|Miconazole(DB01110)|Pimozide(DB01100)|Prazosin(DB00457)|Propafenone(DB01182)|Quinidine(DB00908)|Sertindole(DB06144)|Sotalol(DB00489)|Terazosin(DB01162)|Thioridazine(DB00679)|Verapamil(DB00661)	ggcatgatctgggctcactgc	0.443			T	"""EWSR1, TMPRSS2, ELF4, FUS, HERPUD1, NDRG1"""	"""Ewing sarcoma, prostate, AML"""																																Esophageal Squamous(130;336 1700 3010 3083 40589)		Dom	yes		21	21q22.3	2078	v-ets erythroblastosis virus E26 oncogene like (avian)		"""M, E, L"""	0																																										SO:0001627	intron_variant				CCDS13657.1, CCDS13658.1, CCDS46648.1, CCDS46649.1, CCDS58789.1	21q22.3	2013-07-09	2013-07-09		ENSG00000157554	ENSG00000157554	2078			3446	protein-coding gene	gene with protein product	"""v-ets avian erythroblastosis virus E26 oncogene related"", ""transcriptional regulator ERG (transforming protein ERG)"", ""v-ets erythroblastosis virus E26 oncogene like"", ""TMPRSS2-ERG prostate cancer specific"""	165080	"""v-ets avian erythroblastosis virus E26 oncogene related"""			3274086	Standard	NM_182918	NM_001136154		Approved	erg-3, p55	uc002yxa.3	P11308	OTTHUMG00000090767	ENST00000417133.2:c.410-7677C>G	chr21.hg19:g.39783308G>C			A5H1P7|C4PFH9|D3DX04|O75418|O75680|Q708S9|Q9BT72|Q9BUT7|Q9H3P0	True	hg19	CCDS46648.1																																																																																			ERG-002	KNOWN	basic|appris_candidate_longest|CCDS	protein_coding		protein_coding	OTTHUMT00000207532.2		24.0		-	ENST00000417133.2
ERG	2078	__UNKNOWN__	__UNKNOWN__	21	39783325	39783325	__UNKNOWN__	Intron	SNP	T	T	C	rs527836459		__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr21:39783325T>C	ENST00000417133.2	-	6	595				ERG_ENST00000442448.1_Intron|ERG_ENST00000398919.2_Intron|ERG_ENST00000398911.1_Intron|ERG_ENST00000453032.2_Intron|ERG_ENST00000398897.1_Intron|ERG_ENST00000429727.2_Intron|ERG_ENST00000398910.1_Intron|ERG_ENST00000288319.7_Intron|ERG_ENST00000398907.1_Intron|ERG_ENST00000398905.1_Intron	NM_001136154.1|NM_001243432.1	NP_001129626.1|NP_001230361.1	Q12809	KCNH2_HUMAN	v-ets avian erythroblastosis virus E26 oncogene homolog						cardiac muscle contraction (GO:0060048)|cellular response to drug (GO:0035690)|membrane depolarization during action potential (GO:0086010)|membrane repolarization during action potential (GO:0086011)|membrane repolarization during cardiac muscle cell action potential (GO:0086013)|negative regulation of potassium ion export (GO:1902303)|negative regulation of potassium ion transmembrane transport (GO:1901380)|positive regulation of potassium ion transmembrane transport (GO:1901381)|potassium ion export (GO:0071435)|potassium ion homeostasis (GO:0055075)|potassium ion transmembrane transport (GO:0071805)|regulation of heart rate by cardiac conduction (GO:0086091)|regulation of heart rate by hormone (GO:0003064)|regulation of membrane potential (GO:0042391)|regulation of membrane repolarization (GO:0060306)|regulation of potassium ion transmembrane transport (GO:1901379)|regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307)|synaptic transmission (GO:0007268)|ventricular cardiac muscle cell action potential (GO:0086005)	cell surface (GO:0009986)|cytoplasm (GO:0005737)|nuclear envelope (GO:0005635)|plasma membrane (GO:0005886)|voltage-gated potassium channel complex (GO:0008076)	delayed rectifier potassium channel activity (GO:0005251)|identical protein binding (GO:0042802)|inward rectifier potassium channel activity (GO:0005242)|phosphorelay sensor kinase activity (GO:0000155)|protein homodimerization activity (GO:0042803)|ubiquitin protein ligase binding (GO:0031625)|voltage-gated potassium channel activity (GO:0005249)|voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282)		EWSR1/ERG(178)|NDRG1/ERG(5)|TMPRSS2/ERG(3582)|FUS/ERG(167)|SLC45A3/ERG(50)	lung(2)|ovary(1)|skin(1)	4		Prostate(19;3.6e-06)			Alfuzosin(DB00346)|Amiodarone(DB01118)|Amsacrine(DB00276)|Astemizole(DB00637)|Carvedilol(DB01136)|Chlorpromazine(DB00477)|Cisapride(DB00604)|Dofetilide(DB00204)|Doxazosin(DB00590)|Doxepin(DB01142)|Dronedarone(DB04855)|Halofantrine(DB01218)|Ibutilide(DB00308)|Imipramine(DB00458)|Miconazole(DB01110)|Pimozide(DB01100)|Prazosin(DB00457)|Propafenone(DB01182)|Quinidine(DB00908)|Sertindole(DB06144)|Sotalol(DB00489)|Terazosin(DB01162)|Thioridazine(DB00679)|Verapamil(DB00661)	ctgcaacctctgcctcccagg	0.443			T	"""EWSR1, TMPRSS2, ELF4, FUS, HERPUD1, NDRG1"""	"""Ewing sarcoma, prostate, AML"""																																Esophageal Squamous(130;336 1700 3010 3083 40589)		Dom	yes		21	21q22.3	2078	v-ets erythroblastosis virus E26 oncogene like (avian)		"""M, E, L"""	0																																										SO:0001627	intron_variant				CCDS13657.1, CCDS13658.1, CCDS46648.1, CCDS46649.1, CCDS58789.1	21q22.3	2013-07-09	2013-07-09		ENSG00000157554	ENSG00000157554	2078			3446	protein-coding gene	gene with protein product	"""v-ets avian erythroblastosis virus E26 oncogene related"", ""transcriptional regulator ERG (transforming protein ERG)"", ""v-ets erythroblastosis virus E26 oncogene like"", ""TMPRSS2-ERG prostate cancer specific"""	165080	"""v-ets avian erythroblastosis virus E26 oncogene related"""			3274086	Standard	NM_182918	NM_001136154		Approved	erg-3, p55	uc002yxa.3	P11308	OTTHUMG00000090767	ENST00000417133.2:c.410-7694A>G	chr21.hg19:g.39783325T>C			A5H1P7|C4PFH9|D3DX04|O75418|O75680|Q708S9|Q9BT72|Q9BUT7|Q9H3P0	True	hg19	CCDS46648.1																																																																																			ERG-002	KNOWN	basic|appris_candidate_longest|CCDS	protein_coding		protein_coding	OTTHUMT00000207532.2		30.0		-	ENST00000417133.2
ERG	2078	__UNKNOWN__	__UNKNOWN__	21	39783328	39783328	__UNKNOWN__	Intron	SNP	C	C	T	rs2032093	byFrequency	__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr21:39783328C>T	ENST00000417133.2	-	6	595				ERG_ENST00000442448.1_Intron|ERG_ENST00000398919.2_Intron|ERG_ENST00000398911.1_Intron|ERG_ENST00000453032.2_Intron|ERG_ENST00000398897.1_Intron|ERG_ENST00000429727.2_Intron|ERG_ENST00000398910.1_Intron|ERG_ENST00000288319.7_Intron|ERG_ENST00000398907.1_Intron|ERG_ENST00000398905.1_Intron	NM_001136154.1|NM_001243432.1	NP_001129626.1|NP_001230361.1	Q12809	KCNH2_HUMAN	v-ets avian erythroblastosis virus E26 oncogene homolog						cardiac muscle contraction (GO:0060048)|cellular response to drug (GO:0035690)|membrane depolarization during action potential (GO:0086010)|membrane repolarization during action potential (GO:0086011)|membrane repolarization during cardiac muscle cell action potential (GO:0086013)|negative regulation of potassium ion export (GO:1902303)|negative regulation of potassium ion transmembrane transport (GO:1901380)|positive regulation of potassium ion transmembrane transport (GO:1901381)|potassium ion export (GO:0071435)|potassium ion homeostasis (GO:0055075)|potassium ion transmembrane transport (GO:0071805)|regulation of heart rate by cardiac conduction (GO:0086091)|regulation of heart rate by hormone (GO:0003064)|regulation of membrane potential (GO:0042391)|regulation of membrane repolarization (GO:0060306)|regulation of potassium ion transmembrane transport (GO:1901379)|regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307)|synaptic transmission (GO:0007268)|ventricular cardiac muscle cell action potential (GO:0086005)	cell surface (GO:0009986)|cytoplasm (GO:0005737)|nuclear envelope (GO:0005635)|plasma membrane (GO:0005886)|voltage-gated potassium channel complex (GO:0008076)	delayed rectifier potassium channel activity (GO:0005251)|identical protein binding (GO:0042802)|inward rectifier potassium channel activity (GO:0005242)|phosphorelay sensor kinase activity (GO:0000155)|protein homodimerization activity (GO:0042803)|ubiquitin protein ligase binding (GO:0031625)|voltage-gated potassium channel activity (GO:0005249)|voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282)		EWSR1/ERG(178)|NDRG1/ERG(5)|TMPRSS2/ERG(3582)|FUS/ERG(167)|SLC45A3/ERG(50)	lung(2)|ovary(1)|skin(1)	4		Prostate(19;3.6e-06)			Alfuzosin(DB00346)|Amiodarone(DB01118)|Amsacrine(DB00276)|Astemizole(DB00637)|Carvedilol(DB01136)|Chlorpromazine(DB00477)|Cisapride(DB00604)|Dofetilide(DB00204)|Doxazosin(DB00590)|Doxepin(DB01142)|Dronedarone(DB04855)|Halofantrine(DB01218)|Ibutilide(DB00308)|Imipramine(DB00458)|Miconazole(DB01110)|Pimozide(DB01100)|Prazosin(DB00457)|Propafenone(DB01182)|Quinidine(DB00908)|Sertindole(DB06144)|Sotalol(DB00489)|Terazosin(DB01162)|Thioridazine(DB00679)|Verapamil(DB00661)	caacctctgcctcccaggttc	0.448			T	"""EWSR1, TMPRSS2, ELF4, FUS, HERPUD1, NDRG1"""	"""Ewing sarcoma, prostate, AML"""								C|||	1644	0.328275	0.1316	0.317	5008	,	,		15229	0.4018		0.4901	False		,,,				2504	0.3599				Esophageal Squamous(130;336 1700 3010 3083 40589)		Dom	yes		21	21q22.3	2078	v-ets erythroblastosis virus E26 oncogene like (avian)		"""M, E, L"""	0																																										SO:0001627	intron_variant				CCDS13657.1, CCDS13658.1, CCDS46648.1, CCDS46649.1, CCDS58789.1	21q22.3	2013-07-09	2013-07-09		ENSG00000157554	ENSG00000157554	2078			3446	protein-coding gene	gene with protein product	"""v-ets avian erythroblastosis virus E26 oncogene related"", ""transcriptional regulator ERG (transforming protein ERG)"", ""v-ets erythroblastosis virus E26 oncogene like"", ""TMPRSS2-ERG prostate cancer specific"""	165080	"""v-ets avian erythroblastosis virus E26 oncogene related"""			3274086	Standard	NM_182918	NM_001136154		Approved	erg-3, p55	uc002yxa.3	P11308	OTTHUMG00000090767	ENST00000417133.2:c.410-7697G>A	chr21.hg19:g.39783328C>T			A5H1P7|C4PFH9|D3DX04|O75418|O75680|Q708S9|Q9BT72|Q9BUT7|Q9H3P0	True	hg19	CCDS46648.1																																																																																			ERG-002	KNOWN	basic|appris_candidate_longest|CCDS	protein_coding		protein_coding	OTTHUMT00000207532.2	rs2032093	100.0		-	ENST00000417133.2
ERG	2078	__UNKNOWN__	__UNKNOWN__	21	39790205	39790206	__UNKNOWN__	Intron	INS	-	-	TGTC			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr21:39790205_39790206insTGTC	ENST00000417133.2	-	5	595				ERG_ENST00000442448.1_Intron|ERG_ENST00000398919.2_Intron|ERG_ENST00000398911.1_Intron|ERG_ENST00000453032.2_Intron|ERG_ENST00000398897.1_Intron|ERG_ENST00000429727.2_Intron|ERG_ENST00000398910.1_Intron|ERG_ENST00000288319.7_Intron|ERG_ENST00000398907.1_Intron|ERG_ENST00000398905.1_Intron	NM_001136154.1|NM_001243432.1	NP_001129626.1|NP_001230361.1	Q12809	KCNH2_HUMAN	v-ets avian erythroblastosis virus E26 oncogene homolog						cardiac muscle contraction (GO:0060048)|cellular response to drug (GO:0035690)|membrane depolarization during action potential (GO:0086010)|membrane repolarization during action potential (GO:0086011)|membrane repolarization during cardiac muscle cell action potential (GO:0086013)|negative regulation of potassium ion export (GO:1902303)|negative regulation of potassium ion transmembrane transport (GO:1901380)|positive regulation of potassium ion transmembrane transport (GO:1901381)|potassium ion export (GO:0071435)|potassium ion homeostasis (GO:0055075)|potassium ion transmembrane transport (GO:0071805)|regulation of heart rate by cardiac conduction (GO:0086091)|regulation of heart rate by hormone (GO:0003064)|regulation of membrane potential (GO:0042391)|regulation of membrane repolarization (GO:0060306)|regulation of potassium ion transmembrane transport (GO:1901379)|regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307)|synaptic transmission (GO:0007268)|ventricular cardiac muscle cell action potential (GO:0086005)	cell surface (GO:0009986)|cytoplasm (GO:0005737)|nuclear envelope (GO:0005635)|plasma membrane (GO:0005886)|voltage-gated potassium channel complex (GO:0008076)	delayed rectifier potassium channel activity (GO:0005251)|identical protein binding (GO:0042802)|inward rectifier potassium channel activity (GO:0005242)|phosphorelay sensor kinase activity (GO:0000155)|protein homodimerization activity (GO:0042803)|ubiquitin protein ligase binding (GO:0031625)|voltage-gated potassium channel activity (GO:0005249)|voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282)		EWSR1/ERG(178)|NDRG1/ERG(5)|TMPRSS2/ERG(3582)|FUS/ERG(167)|SLC45A3/ERG(50)	lung(2)|ovary(1)|skin(1)	4		Prostate(19;3.6e-06)			Alfuzosin(DB00346)|Amiodarone(DB01118)|Amsacrine(DB00276)|Astemizole(DB00637)|Carvedilol(DB01136)|Chlorpromazine(DB00477)|Cisapride(DB00604)|Dofetilide(DB00204)|Doxazosin(DB00590)|Doxepin(DB01142)|Dronedarone(DB04855)|Halofantrine(DB01218)|Ibutilide(DB00308)|Imipramine(DB00458)|Miconazole(DB01110)|Pimozide(DB01100)|Prazosin(DB00457)|Propafenone(DB01182)|Quinidine(DB00908)|Sertindole(DB06144)|Sotalol(DB00489)|Terazosin(DB01162)|Thioridazine(DB00679)|Verapamil(DB00661)	gtgtgtgtgtgtgtgtgtgtgt	0.446			T	"""EWSR1, TMPRSS2, ELF4, FUS, HERPUD1, NDRG1"""	"""Ewing sarcoma, prostate, AML"""																																Esophageal Squamous(130;336 1700 3010 3083 40589)		Dom	yes		21	21q22.3	2078	v-ets erythroblastosis virus E26 oncogene like (avian)		"""M, E, L"""	0																																										SO:0001627	intron_variant				CCDS13657.1, CCDS13658.1, CCDS46648.1, CCDS46649.1, CCDS58789.1	21q22.3	2013-07-09	2013-07-09		ENSG00000157554	ENSG00000157554	2078			3446	protein-coding gene	gene with protein product	"""v-ets avian erythroblastosis virus E26 oncogene related"", ""transcriptional regulator ERG (transforming protein ERG)"", ""v-ets erythroblastosis virus E26 oncogene like"", ""TMPRSS2-ERG prostate cancer specific"""	165080	"""v-ets avian erythroblastosis virus E26 oncogene related"""			3274086	Standard	NM_182918	NM_001136154		Approved	erg-3, p55	uc002yxa.3	P11308	OTTHUMG00000090767	ENST00000417133.2:c.409+5125->GACA	chr21.hg19:g.39790205_39790206insTGTC			A5H1P7|C4PFH9|D3DX04|O75418|O75680|Q708S9|Q9BT72|Q9BUT7|Q9H3P0	True	hg19	CCDS46648.1																																																																																			ERG-002	KNOWN	basic|appris_candidate_longest|CCDS	protein_coding		protein_coding	OTTHUMT00000207532.2		20.0		-	ENST00000417133.2
ERG	2078	__UNKNOWN__	__UNKNOWN__	21	39790207	39790207	__UNKNOWN__	Intron	SNP	G	G	C			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr21:39790207G>C	ENST00000417133.2	-	5	595				ERG_ENST00000442448.1_Intron|ERG_ENST00000398919.2_Intron|ERG_ENST00000398911.1_Intron|ERG_ENST00000453032.2_Intron|ERG_ENST00000398897.1_Intron|ERG_ENST00000429727.2_Intron|ERG_ENST00000398910.1_Intron|ERG_ENST00000288319.7_Intron|ERG_ENST00000398907.1_Intron|ERG_ENST00000398905.1_Intron	NM_001136154.1|NM_001243432.1	NP_001129626.1|NP_001230361.1	Q12809	KCNH2_HUMAN	v-ets avian erythroblastosis virus E26 oncogene homolog						cardiac muscle contraction (GO:0060048)|cellular response to drug (GO:0035690)|membrane depolarization during action potential (GO:0086010)|membrane repolarization during action potential (GO:0086011)|membrane repolarization during cardiac muscle cell action potential (GO:0086013)|negative regulation of potassium ion export (GO:1902303)|negative regulation of potassium ion transmembrane transport (GO:1901380)|positive regulation of potassium ion transmembrane transport (GO:1901381)|potassium ion export (GO:0071435)|potassium ion homeostasis (GO:0055075)|potassium ion transmembrane transport (GO:0071805)|regulation of heart rate by cardiac conduction (GO:0086091)|regulation of heart rate by hormone (GO:0003064)|regulation of membrane potential (GO:0042391)|regulation of membrane repolarization (GO:0060306)|regulation of potassium ion transmembrane transport (GO:1901379)|regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307)|synaptic transmission (GO:0007268)|ventricular cardiac muscle cell action potential (GO:0086005)	cell surface (GO:0009986)|cytoplasm (GO:0005737)|nuclear envelope (GO:0005635)|plasma membrane (GO:0005886)|voltage-gated potassium channel complex (GO:0008076)	delayed rectifier potassium channel activity (GO:0005251)|identical protein binding (GO:0042802)|inward rectifier potassium channel activity (GO:0005242)|phosphorelay sensor kinase activity (GO:0000155)|protein homodimerization activity (GO:0042803)|ubiquitin protein ligase binding (GO:0031625)|voltage-gated potassium channel activity (GO:0005249)|voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282)		EWSR1/ERG(178)|NDRG1/ERG(5)|TMPRSS2/ERG(3582)|FUS/ERG(167)|SLC45A3/ERG(50)	lung(2)|ovary(1)|skin(1)	4		Prostate(19;3.6e-06)			Alfuzosin(DB00346)|Amiodarone(DB01118)|Amsacrine(DB00276)|Astemizole(DB00637)|Carvedilol(DB01136)|Chlorpromazine(DB00477)|Cisapride(DB00604)|Dofetilide(DB00204)|Doxazosin(DB00590)|Doxepin(DB01142)|Dronedarone(DB04855)|Halofantrine(DB01218)|Ibutilide(DB00308)|Imipramine(DB00458)|Miconazole(DB01110)|Pimozide(DB01100)|Prazosin(DB00457)|Propafenone(DB01182)|Quinidine(DB00908)|Sertindole(DB06144)|Sotalol(DB00489)|Terazosin(DB01162)|Thioridazine(DB00679)|Verapamil(DB00661)	gtgtgtgtgtgtgtgtgtgtg	0.443			T	"""EWSR1, TMPRSS2, ELF4, FUS, HERPUD1, NDRG1"""	"""Ewing sarcoma, prostate, AML"""																																Esophageal Squamous(130;336 1700 3010 3083 40589)		Dom	yes		21	21q22.3	2078	v-ets erythroblastosis virus E26 oncogene like (avian)		"""M, E, L"""	0																																										SO:0001627	intron_variant				CCDS13657.1, CCDS13658.1, CCDS46648.1, CCDS46649.1, CCDS58789.1	21q22.3	2013-07-09	2013-07-09		ENSG00000157554	ENSG00000157554	2078			3446	protein-coding gene	gene with protein product	"""v-ets avian erythroblastosis virus E26 oncogene related"", ""transcriptional regulator ERG (transforming protein ERG)"", ""v-ets erythroblastosis virus E26 oncogene like"", ""TMPRSS2-ERG prostate cancer specific"""	165080	"""v-ets avian erythroblastosis virus E26 oncogene related"""			3274086	Standard	NM_182918	NM_001136154		Approved	erg-3, p55	uc002yxa.3	P11308	OTTHUMG00000090767	ENST00000417133.2:c.409+5124C>G	chr21.hg19:g.39790207G>C			A5H1P7|C4PFH9|D3DX04|O75418|O75680|Q708S9|Q9BT72|Q9BUT7|Q9H3P0	True	hg19	CCDS46648.1																																																																																			ERG-002	KNOWN	basic|appris_candidate_longest|CCDS	protein_coding		protein_coding	OTTHUMT00000207532.2		100.0		-	ENST00000417133.2
ERG	2078	__UNKNOWN__	__UNKNOWN__	21	39790436	39790436	__UNKNOWN__	Intron	SNP	T	T	C			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr21:39790436T>C	ENST00000417133.2	-	5	595				ERG_ENST00000442448.1_Intron|ERG_ENST00000398919.2_Intron|ERG_ENST00000398911.1_Intron|ERG_ENST00000453032.2_Intron|ERG_ENST00000398897.1_Intron|ERG_ENST00000429727.2_Intron|ERG_ENST00000398910.1_Intron|ERG_ENST00000288319.7_Intron|ERG_ENST00000398907.1_Intron|ERG_ENST00000398905.1_Intron	NM_001136154.1|NM_001243432.1	NP_001129626.1|NP_001230361.1	Q12809	KCNH2_HUMAN	v-ets avian erythroblastosis virus E26 oncogene homolog						cardiac muscle contraction (GO:0060048)|cellular response to drug (GO:0035690)|membrane depolarization during action potential (GO:0086010)|membrane repolarization during action potential (GO:0086011)|membrane repolarization during cardiac muscle cell action potential (GO:0086013)|negative regulation of potassium ion export (GO:1902303)|negative regulation of potassium ion transmembrane transport (GO:1901380)|positive regulation of potassium ion transmembrane transport (GO:1901381)|potassium ion export (GO:0071435)|potassium ion homeostasis (GO:0055075)|potassium ion transmembrane transport (GO:0071805)|regulation of heart rate by cardiac conduction (GO:0086091)|regulation of heart rate by hormone (GO:0003064)|regulation of membrane potential (GO:0042391)|regulation of membrane repolarization (GO:0060306)|regulation of potassium ion transmembrane transport (GO:1901379)|regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307)|synaptic transmission (GO:0007268)|ventricular cardiac muscle cell action potential (GO:0086005)	cell surface (GO:0009986)|cytoplasm (GO:0005737)|nuclear envelope (GO:0005635)|plasma membrane (GO:0005886)|voltage-gated potassium channel complex (GO:0008076)	delayed rectifier potassium channel activity (GO:0005251)|identical protein binding (GO:0042802)|inward rectifier potassium channel activity (GO:0005242)|phosphorelay sensor kinase activity (GO:0000155)|protein homodimerization activity (GO:0042803)|ubiquitin protein ligase binding (GO:0031625)|voltage-gated potassium channel activity (GO:0005249)|voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282)		EWSR1/ERG(178)|NDRG1/ERG(5)|TMPRSS2/ERG(3582)|FUS/ERG(167)|SLC45A3/ERG(50)	lung(2)|ovary(1)|skin(1)	4		Prostate(19;3.6e-06)			Alfuzosin(DB00346)|Amiodarone(DB01118)|Amsacrine(DB00276)|Astemizole(DB00637)|Carvedilol(DB01136)|Chlorpromazine(DB00477)|Cisapride(DB00604)|Dofetilide(DB00204)|Doxazosin(DB00590)|Doxepin(DB01142)|Dronedarone(DB04855)|Halofantrine(DB01218)|Ibutilide(DB00308)|Imipramine(DB00458)|Miconazole(DB01110)|Pimozide(DB01100)|Prazosin(DB00457)|Propafenone(DB01182)|Quinidine(DB00908)|Sertindole(DB06144)|Sotalol(DB00489)|Terazosin(DB01162)|Thioridazine(DB00679)|Verapamil(DB00661)	ttgaactccttggcctcccaa	0.438			T	"""EWSR1, TMPRSS2, ELF4, FUS, HERPUD1, NDRG1"""	"""Ewing sarcoma, prostate, AML"""																																Esophageal Squamous(130;336 1700 3010 3083 40589)		Dom	yes		21	21q22.3	2078	v-ets erythroblastosis virus E26 oncogene like (avian)		"""M, E, L"""	0																																										SO:0001627	intron_variant				CCDS13657.1, CCDS13658.1, CCDS46648.1, CCDS46649.1, CCDS58789.1	21q22.3	2013-07-09	2013-07-09		ENSG00000157554	ENSG00000157554	2078			3446	protein-coding gene	gene with protein product	"""v-ets avian erythroblastosis virus E26 oncogene related"", ""transcriptional regulator ERG (transforming protein ERG)"", ""v-ets erythroblastosis virus E26 oncogene like"", ""TMPRSS2-ERG prostate cancer specific"""	165080	"""v-ets avian erythroblastosis virus E26 oncogene related"""			3274086	Standard	NM_182918	NM_001136154		Approved	erg-3, p55	uc002yxa.3	P11308	OTTHUMG00000090767	ENST00000417133.2:c.409+4895A>G	chr21.hg19:g.39790436T>C			A5H1P7|C4PFH9|D3DX04|O75418|O75680|Q708S9|Q9BT72|Q9BUT7|Q9H3P0	True	hg19	CCDS46648.1																																																																																			ERG-002	KNOWN	basic|appris_candidate_longest|CCDS	protein_coding		protein_coding	OTTHUMT00000207532.2		30.0		-	ENST00000417133.2
ERG	2078	__UNKNOWN__	__UNKNOWN__	21	39790764	39790764	__UNKNOWN__	Intron	SNP	A	A	G			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr21:39790764A>G	ENST00000417133.2	-	5	595				ERG_ENST00000442448.1_Intron|ERG_ENST00000398919.2_Intron|ERG_ENST00000398911.1_Intron|ERG_ENST00000453032.2_Intron|ERG_ENST00000398897.1_Intron|ERG_ENST00000429727.2_Intron|ERG_ENST00000398910.1_Intron|ERG_ENST00000288319.7_Intron|ERG_ENST00000398907.1_Intron|ERG_ENST00000398905.1_Intron	NM_001136154.1|NM_001243432.1	NP_001129626.1|NP_001230361.1	Q12809	KCNH2_HUMAN	v-ets avian erythroblastosis virus E26 oncogene homolog						cardiac muscle contraction (GO:0060048)|cellular response to drug (GO:0035690)|membrane depolarization during action potential (GO:0086010)|membrane repolarization during action potential (GO:0086011)|membrane repolarization during cardiac muscle cell action potential (GO:0086013)|negative regulation of potassium ion export (GO:1902303)|negative regulation of potassium ion transmembrane transport (GO:1901380)|positive regulation of potassium ion transmembrane transport (GO:1901381)|potassium ion export (GO:0071435)|potassium ion homeostasis (GO:0055075)|potassium ion transmembrane transport (GO:0071805)|regulation of heart rate by cardiac conduction (GO:0086091)|regulation of heart rate by hormone (GO:0003064)|regulation of membrane potential (GO:0042391)|regulation of membrane repolarization (GO:0060306)|regulation of potassium ion transmembrane transport (GO:1901379)|regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307)|synaptic transmission (GO:0007268)|ventricular cardiac muscle cell action potential (GO:0086005)	cell surface (GO:0009986)|cytoplasm (GO:0005737)|nuclear envelope (GO:0005635)|plasma membrane (GO:0005886)|voltage-gated potassium channel complex (GO:0008076)	delayed rectifier potassium channel activity (GO:0005251)|identical protein binding (GO:0042802)|inward rectifier potassium channel activity (GO:0005242)|phosphorelay sensor kinase activity (GO:0000155)|protein homodimerization activity (GO:0042803)|ubiquitin protein ligase binding (GO:0031625)|voltage-gated potassium channel activity (GO:0005249)|voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282)		EWSR1/ERG(178)|NDRG1/ERG(5)|TMPRSS2/ERG(3582)|FUS/ERG(167)|SLC45A3/ERG(50)	lung(2)|ovary(1)|skin(1)	4		Prostate(19;3.6e-06)			Alfuzosin(DB00346)|Amiodarone(DB01118)|Amsacrine(DB00276)|Astemizole(DB00637)|Carvedilol(DB01136)|Chlorpromazine(DB00477)|Cisapride(DB00604)|Dofetilide(DB00204)|Doxazosin(DB00590)|Doxepin(DB01142)|Dronedarone(DB04855)|Halofantrine(DB01218)|Ibutilide(DB00308)|Imipramine(DB00458)|Miconazole(DB01110)|Pimozide(DB01100)|Prazosin(DB00457)|Propafenone(DB01182)|Quinidine(DB00908)|Sertindole(DB06144)|Sotalol(DB00489)|Terazosin(DB01162)|Thioridazine(DB00679)|Verapamil(DB00661)	caggagaatcacttgaacctg	0.488			T	"""EWSR1, TMPRSS2, ELF4, FUS, HERPUD1, NDRG1"""	"""Ewing sarcoma, prostate, AML"""																																Esophageal Squamous(130;336 1700 3010 3083 40589)		Dom	yes		21	21q22.3	2078	v-ets erythroblastosis virus E26 oncogene like (avian)		"""M, E, L"""	0																																										SO:0001627	intron_variant				CCDS13657.1, CCDS13658.1, CCDS46648.1, CCDS46649.1, CCDS58789.1	21q22.3	2013-07-09	2013-07-09		ENSG00000157554	ENSG00000157554	2078			3446	protein-coding gene	gene with protein product	"""v-ets avian erythroblastosis virus E26 oncogene related"", ""transcriptional regulator ERG (transforming protein ERG)"", ""v-ets erythroblastosis virus E26 oncogene like"", ""TMPRSS2-ERG prostate cancer specific"""	165080	"""v-ets avian erythroblastosis virus E26 oncogene related"""			3274086	Standard	NM_182918	NM_001136154		Approved	erg-3, p55	uc002yxa.3	P11308	OTTHUMG00000090767	ENST00000417133.2:c.409+4567T>C	chr21.hg19:g.39790764A>G			A5H1P7|C4PFH9|D3DX04|O75418|O75680|Q708S9|Q9BT72|Q9BUT7|Q9H3P0	True	hg19	CCDS46648.1																																																																																			ERG-002	KNOWN	basic|appris_candidate_longest|CCDS	protein_coding		protein_coding	OTTHUMT00000207532.2		20.0		-	ENST00000417133.2
ERG	2078	__UNKNOWN__	__UNKNOWN__	21	39790773	39790773	__UNKNOWN__	Intron	SNP	T	T	C			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr21:39790773T>C	ENST00000417133.2	-	5	595				ERG_ENST00000442448.1_Intron|ERG_ENST00000398919.2_Intron|ERG_ENST00000398911.1_Intron|ERG_ENST00000453032.2_Intron|ERG_ENST00000398897.1_Intron|ERG_ENST00000429727.2_Intron|ERG_ENST00000398910.1_Intron|ERG_ENST00000288319.7_Intron|ERG_ENST00000398907.1_Intron|ERG_ENST00000398905.1_Intron	NM_001136154.1|NM_001243432.1	NP_001129626.1|NP_001230361.1	Q12809	KCNH2_HUMAN	v-ets avian erythroblastosis virus E26 oncogene homolog						cardiac muscle contraction (GO:0060048)|cellular response to drug (GO:0035690)|membrane depolarization during action potential (GO:0086010)|membrane repolarization during action potential (GO:0086011)|membrane repolarization during cardiac muscle cell action potential (GO:0086013)|negative regulation of potassium ion export (GO:1902303)|negative regulation of potassium ion transmembrane transport (GO:1901380)|positive regulation of potassium ion transmembrane transport (GO:1901381)|potassium ion export (GO:0071435)|potassium ion homeostasis (GO:0055075)|potassium ion transmembrane transport (GO:0071805)|regulation of heart rate by cardiac conduction (GO:0086091)|regulation of heart rate by hormone (GO:0003064)|regulation of membrane potential (GO:0042391)|regulation of membrane repolarization (GO:0060306)|regulation of potassium ion transmembrane transport (GO:1901379)|regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307)|synaptic transmission (GO:0007268)|ventricular cardiac muscle cell action potential (GO:0086005)	cell surface (GO:0009986)|cytoplasm (GO:0005737)|nuclear envelope (GO:0005635)|plasma membrane (GO:0005886)|voltage-gated potassium channel complex (GO:0008076)	delayed rectifier potassium channel activity (GO:0005251)|identical protein binding (GO:0042802)|inward rectifier potassium channel activity (GO:0005242)|phosphorelay sensor kinase activity (GO:0000155)|protein homodimerization activity (GO:0042803)|ubiquitin protein ligase binding (GO:0031625)|voltage-gated potassium channel activity (GO:0005249)|voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282)		EWSR1/ERG(178)|NDRG1/ERG(5)|TMPRSS2/ERG(3582)|FUS/ERG(167)|SLC45A3/ERG(50)	lung(2)|ovary(1)|skin(1)	4		Prostate(19;3.6e-06)			Alfuzosin(DB00346)|Amiodarone(DB01118)|Amsacrine(DB00276)|Astemizole(DB00637)|Carvedilol(DB01136)|Chlorpromazine(DB00477)|Cisapride(DB00604)|Dofetilide(DB00204)|Doxazosin(DB00590)|Doxepin(DB01142)|Dronedarone(DB04855)|Halofantrine(DB01218)|Ibutilide(DB00308)|Imipramine(DB00458)|Miconazole(DB01110)|Pimozide(DB01100)|Prazosin(DB00457)|Propafenone(DB01182)|Quinidine(DB00908)|Sertindole(DB06144)|Sotalol(DB00489)|Terazosin(DB01162)|Thioridazine(DB00679)|Verapamil(DB00661)	cacttgaacctgggaggcaga	0.468			T	"""EWSR1, TMPRSS2, ELF4, FUS, HERPUD1, NDRG1"""	"""Ewing sarcoma, prostate, AML"""																																Esophageal Squamous(130;336 1700 3010 3083 40589)		Dom	yes		21	21q22.3	2078	v-ets erythroblastosis virus E26 oncogene like (avian)		"""M, E, L"""	0																																										SO:0001627	intron_variant				CCDS13657.1, CCDS13658.1, CCDS46648.1, CCDS46649.1, CCDS58789.1	21q22.3	2013-07-09	2013-07-09		ENSG00000157554	ENSG00000157554	2078			3446	protein-coding gene	gene with protein product	"""v-ets avian erythroblastosis virus E26 oncogene related"", ""transcriptional regulator ERG (transforming protein ERG)"", ""v-ets erythroblastosis virus E26 oncogene like"", ""TMPRSS2-ERG prostate cancer specific"""	165080	"""v-ets avian erythroblastosis virus E26 oncogene related"""			3274086	Standard	NM_182918	NM_001136154		Approved	erg-3, p55	uc002yxa.3	P11308	OTTHUMG00000090767	ENST00000417133.2:c.409+4558A>G	chr21.hg19:g.39790773T>C			A5H1P7|C4PFH9|D3DX04|O75418|O75680|Q708S9|Q9BT72|Q9BUT7|Q9H3P0	True	hg19	CCDS46648.1																																																																																			ERG-002	KNOWN	basic|appris_candidate_longest|CCDS	protein_coding		protein_coding	OTTHUMT00000207532.2		20.0		-	ENST00000417133.2
ERG	2078	__UNKNOWN__	__UNKNOWN__	21	39790843	39790843	__UNKNOWN__	Intron	SNP	T	T	A			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr21:39790843T>A	ENST00000417133.2	-	5	595				ERG_ENST00000442448.1_Intron|ERG_ENST00000398919.2_Intron|ERG_ENST00000398911.1_Intron|ERG_ENST00000453032.2_Intron|ERG_ENST00000398897.1_Intron|ERG_ENST00000429727.2_Intron|ERG_ENST00000398910.1_Intron|ERG_ENST00000288319.7_Intron|ERG_ENST00000398907.1_Intron|ERG_ENST00000398905.1_Intron	NM_001136154.1|NM_001243432.1	NP_001129626.1|NP_001230361.1	Q12809	KCNH2_HUMAN	v-ets avian erythroblastosis virus E26 oncogene homolog						cardiac muscle contraction (GO:0060048)|cellular response to drug (GO:0035690)|membrane depolarization during action potential (GO:0086010)|membrane repolarization during action potential (GO:0086011)|membrane repolarization during cardiac muscle cell action potential (GO:0086013)|negative regulation of potassium ion export (GO:1902303)|negative regulation of potassium ion transmembrane transport (GO:1901380)|positive regulation of potassium ion transmembrane transport (GO:1901381)|potassium ion export (GO:0071435)|potassium ion homeostasis (GO:0055075)|potassium ion transmembrane transport (GO:0071805)|regulation of heart rate by cardiac conduction (GO:0086091)|regulation of heart rate by hormone (GO:0003064)|regulation of membrane potential (GO:0042391)|regulation of membrane repolarization (GO:0060306)|regulation of potassium ion transmembrane transport (GO:1901379)|regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307)|synaptic transmission (GO:0007268)|ventricular cardiac muscle cell action potential (GO:0086005)	cell surface (GO:0009986)|cytoplasm (GO:0005737)|nuclear envelope (GO:0005635)|plasma membrane (GO:0005886)|voltage-gated potassium channel complex (GO:0008076)	delayed rectifier potassium channel activity (GO:0005251)|identical protein binding (GO:0042802)|inward rectifier potassium channel activity (GO:0005242)|phosphorelay sensor kinase activity (GO:0000155)|protein homodimerization activity (GO:0042803)|ubiquitin protein ligase binding (GO:0031625)|voltage-gated potassium channel activity (GO:0005249)|voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282)		EWSR1/ERG(178)|NDRG1/ERG(5)|TMPRSS2/ERG(3582)|FUS/ERG(167)|SLC45A3/ERG(50)	lung(2)|ovary(1)|skin(1)	4		Prostate(19;3.6e-06)			Alfuzosin(DB00346)|Amiodarone(DB01118)|Amsacrine(DB00276)|Astemizole(DB00637)|Carvedilol(DB01136)|Chlorpromazine(DB00477)|Cisapride(DB00604)|Dofetilide(DB00204)|Doxazosin(DB00590)|Doxepin(DB01142)|Dronedarone(DB04855)|Halofantrine(DB01218)|Ibutilide(DB00308)|Imipramine(DB00458)|Miconazole(DB01110)|Pimozide(DB01100)|Prazosin(DB00457)|Propafenone(DB01182)|Quinidine(DB00908)|Sertindole(DB06144)|Sotalol(DB00489)|Terazosin(DB01162)|Thioridazine(DB00679)|Verapamil(DB00661)	gagcgagactttgtctcaaaa	0.413			T	"""EWSR1, TMPRSS2, ELF4, FUS, HERPUD1, NDRG1"""	"""Ewing sarcoma, prostate, AML"""																																Esophageal Squamous(130;336 1700 3010 3083 40589)		Dom	yes		21	21q22.3	2078	v-ets erythroblastosis virus E26 oncogene like (avian)		"""M, E, L"""	0																																										SO:0001627	intron_variant				CCDS13657.1, CCDS13658.1, CCDS46648.1, CCDS46649.1, CCDS58789.1	21q22.3	2013-07-09	2013-07-09		ENSG00000157554	ENSG00000157554	2078			3446	protein-coding gene	gene with protein product	"""v-ets avian erythroblastosis virus E26 oncogene related"", ""transcriptional regulator ERG (transforming protein ERG)"", ""v-ets erythroblastosis virus E26 oncogene like"", ""TMPRSS2-ERG prostate cancer specific"""	165080	"""v-ets avian erythroblastosis virus E26 oncogene related"""			3274086	Standard	NM_182918	NM_001136154		Approved	erg-3, p55	uc002yxa.3	P11308	OTTHUMG00000090767	ENST00000417133.2:c.409+4488A>T	chr21.hg19:g.39790843T>A			A5H1P7|C4PFH9|D3DX04|O75418|O75680|Q708S9|Q9BT72|Q9BUT7|Q9H3P0	True	hg19	CCDS46648.1																																																																																			ERG-002	KNOWN	basic|appris_candidate_longest|CCDS	protein_coding		protein_coding	OTTHUMT00000207532.2		36.0		-	ENST00000417133.2
ERG	2078	__UNKNOWN__	__UNKNOWN__	21	39790853	39790853	__UNKNOWN__	Intron	SNP	A	A	C			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr21:39790853A>C	ENST00000417133.2	-	5	595				ERG_ENST00000442448.1_Intron|ERG_ENST00000398919.2_Intron|ERG_ENST00000398911.1_Intron|ERG_ENST00000453032.2_Intron|ERG_ENST00000398897.1_Intron|ERG_ENST00000429727.2_Intron|ERG_ENST00000398910.1_Intron|ERG_ENST00000288319.7_Intron|ERG_ENST00000398907.1_Intron|ERG_ENST00000398905.1_Intron	NM_001136154.1|NM_001243432.1	NP_001129626.1|NP_001230361.1	Q12809	KCNH2_HUMAN	v-ets avian erythroblastosis virus E26 oncogene homolog						cardiac muscle contraction (GO:0060048)|cellular response to drug (GO:0035690)|membrane depolarization during action potential (GO:0086010)|membrane repolarization during action potential (GO:0086011)|membrane repolarization during cardiac muscle cell action potential (GO:0086013)|negative regulation of potassium ion export (GO:1902303)|negative regulation of potassium ion transmembrane transport (GO:1901380)|positive regulation of potassium ion transmembrane transport (GO:1901381)|potassium ion export (GO:0071435)|potassium ion homeostasis (GO:0055075)|potassium ion transmembrane transport (GO:0071805)|regulation of heart rate by cardiac conduction (GO:0086091)|regulation of heart rate by hormone (GO:0003064)|regulation of membrane potential (GO:0042391)|regulation of membrane repolarization (GO:0060306)|regulation of potassium ion transmembrane transport (GO:1901379)|regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307)|synaptic transmission (GO:0007268)|ventricular cardiac muscle cell action potential (GO:0086005)	cell surface (GO:0009986)|cytoplasm (GO:0005737)|nuclear envelope (GO:0005635)|plasma membrane (GO:0005886)|voltage-gated potassium channel complex (GO:0008076)	delayed rectifier potassium channel activity (GO:0005251)|identical protein binding (GO:0042802)|inward rectifier potassium channel activity (GO:0005242)|phosphorelay sensor kinase activity (GO:0000155)|protein homodimerization activity (GO:0042803)|ubiquitin protein ligase binding (GO:0031625)|voltage-gated potassium channel activity (GO:0005249)|voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282)		EWSR1/ERG(178)|NDRG1/ERG(5)|TMPRSS2/ERG(3582)|FUS/ERG(167)|SLC45A3/ERG(50)	lung(2)|ovary(1)|skin(1)	4		Prostate(19;3.6e-06)			Alfuzosin(DB00346)|Amiodarone(DB01118)|Amsacrine(DB00276)|Astemizole(DB00637)|Carvedilol(DB01136)|Chlorpromazine(DB00477)|Cisapride(DB00604)|Dofetilide(DB00204)|Doxazosin(DB00590)|Doxepin(DB01142)|Dronedarone(DB04855)|Halofantrine(DB01218)|Ibutilide(DB00308)|Imipramine(DB00458)|Miconazole(DB01110)|Pimozide(DB01100)|Prazosin(DB00457)|Propafenone(DB01182)|Quinidine(DB00908)|Sertindole(DB06144)|Sotalol(DB00489)|Terazosin(DB01162)|Thioridazine(DB00679)|Verapamil(DB00661)	ttgtctcaaaaaaaaaaaaaa	0.413			T	"""EWSR1, TMPRSS2, ELF4, FUS, HERPUD1, NDRG1"""	"""Ewing sarcoma, prostate, AML"""																																Esophageal Squamous(130;336 1700 3010 3083 40589)		Dom	yes		21	21q22.3	2078	v-ets erythroblastosis virus E26 oncogene like (avian)		"""M, E, L"""	0																																										SO:0001627	intron_variant				CCDS13657.1, CCDS13658.1, CCDS46648.1, CCDS46649.1, CCDS58789.1	21q22.3	2013-07-09	2013-07-09		ENSG00000157554	ENSG00000157554	2078			3446	protein-coding gene	gene with protein product	"""v-ets avian erythroblastosis virus E26 oncogene related"", ""transcriptional regulator ERG (transforming protein ERG)"", ""v-ets erythroblastosis virus E26 oncogene like"", ""TMPRSS2-ERG prostate cancer specific"""	165080	"""v-ets avian erythroblastosis virus E26 oncogene related"""			3274086	Standard	NM_182918	NM_001136154		Approved	erg-3, p55	uc002yxa.3	P11308	OTTHUMG00000090767	ENST00000417133.2:c.409+4478T>G	chr21.hg19:g.39790853A>C			A5H1P7|C4PFH9|D3DX04|O75418|O75680|Q708S9|Q9BT72|Q9BUT7|Q9H3P0	True	hg19	CCDS46648.1																																																																																			ERG-002	KNOWN	basic|appris_candidate_longest|CCDS	protein_coding		protein_coding	OTTHUMT00000207532.2		44.0		-	ENST00000417133.2
ERG	2078	__UNKNOWN__	__UNKNOWN__	21	39791430	39791430	__UNKNOWN__	Intron	SNP	A	A	T			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr21:39791430A>T	ENST00000417133.2	-	5	595				ERG_ENST00000442448.1_Intron|ERG_ENST00000398919.2_Intron|ERG_ENST00000398911.1_Intron|ERG_ENST00000453032.2_Intron|ERG_ENST00000398897.1_Intron|ERG_ENST00000429727.2_Intron|ERG_ENST00000398910.1_Intron|ERG_ENST00000288319.7_Intron|ERG_ENST00000398907.1_Intron|ERG_ENST00000398905.1_Intron	NM_001136154.1|NM_001243432.1	NP_001129626.1|NP_001230361.1	Q12809	KCNH2_HUMAN	v-ets avian erythroblastosis virus E26 oncogene homolog						cardiac muscle contraction (GO:0060048)|cellular response to drug (GO:0035690)|membrane depolarization during action potential (GO:0086010)|membrane repolarization during action potential (GO:0086011)|membrane repolarization during cardiac muscle cell action potential (GO:0086013)|negative regulation of potassium ion export (GO:1902303)|negative regulation of potassium ion transmembrane transport (GO:1901380)|positive regulation of potassium ion transmembrane transport (GO:1901381)|potassium ion export (GO:0071435)|potassium ion homeostasis (GO:0055075)|potassium ion transmembrane transport (GO:0071805)|regulation of heart rate by cardiac conduction (GO:0086091)|regulation of heart rate by hormone (GO:0003064)|regulation of membrane potential (GO:0042391)|regulation of membrane repolarization (GO:0060306)|regulation of potassium ion transmembrane transport (GO:1901379)|regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307)|synaptic transmission (GO:0007268)|ventricular cardiac muscle cell action potential (GO:0086005)	cell surface (GO:0009986)|cytoplasm (GO:0005737)|nuclear envelope (GO:0005635)|plasma membrane (GO:0005886)|voltage-gated potassium channel complex (GO:0008076)	delayed rectifier potassium channel activity (GO:0005251)|identical protein binding (GO:0042802)|inward rectifier potassium channel activity (GO:0005242)|phosphorelay sensor kinase activity (GO:0000155)|protein homodimerization activity (GO:0042803)|ubiquitin protein ligase binding (GO:0031625)|voltage-gated potassium channel activity (GO:0005249)|voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282)		EWSR1/ERG(178)|NDRG1/ERG(5)|TMPRSS2/ERG(3582)|FUS/ERG(167)|SLC45A3/ERG(50)	lung(2)|ovary(1)|skin(1)	4		Prostate(19;3.6e-06)			Alfuzosin(DB00346)|Amiodarone(DB01118)|Amsacrine(DB00276)|Astemizole(DB00637)|Carvedilol(DB01136)|Chlorpromazine(DB00477)|Cisapride(DB00604)|Dofetilide(DB00204)|Doxazosin(DB00590)|Doxepin(DB01142)|Dronedarone(DB04855)|Halofantrine(DB01218)|Ibutilide(DB00308)|Imipramine(DB00458)|Miconazole(DB01110)|Pimozide(DB01100)|Prazosin(DB00457)|Propafenone(DB01182)|Quinidine(DB00908)|Sertindole(DB06144)|Sotalol(DB00489)|Terazosin(DB01162)|Thioridazine(DB00679)|Verapamil(DB00661)	TGCAATTAAAAATACACATAC	0.368			T	"""EWSR1, TMPRSS2, ELF4, FUS, HERPUD1, NDRG1"""	"""Ewing sarcoma, prostate, AML"""																																Esophageal Squamous(130;336 1700 3010 3083 40589)		Dom	yes		21	21q22.3	2078	v-ets erythroblastosis virus E26 oncogene like (avian)		"""M, E, L"""	0																																										SO:0001627	intron_variant				CCDS13657.1, CCDS13658.1, CCDS46648.1, CCDS46649.1, CCDS58789.1	21q22.3	2013-07-09	2013-07-09		ENSG00000157554	ENSG00000157554	2078			3446	protein-coding gene	gene with protein product	"""v-ets avian erythroblastosis virus E26 oncogene related"", ""transcriptional regulator ERG (transforming protein ERG)"", ""v-ets erythroblastosis virus E26 oncogene like"", ""TMPRSS2-ERG prostate cancer specific"""	165080	"""v-ets avian erythroblastosis virus E26 oncogene related"""			3274086	Standard	NM_182918	NM_001136154		Approved	erg-3, p55	uc002yxa.3	P11308	OTTHUMG00000090767	ENST00000417133.2:c.409+3901T>A	chr21.hg19:g.39791430A>T			A5H1P7|C4PFH9|D3DX04|O75418|O75680|Q708S9|Q9BT72|Q9BUT7|Q9H3P0	True	hg19	CCDS46648.1																																																																																			ERG-002	KNOWN	basic|appris_candidate_longest|CCDS	protein_coding		protein_coding	OTTHUMT00000207532.2		35.0		-	ENST00000417133.2
ERG	2078	__UNKNOWN__	__UNKNOWN__	21	39791432	39791432	__UNKNOWN__	Intron	SNP	T	T	C			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr21:39791432T>C	ENST00000417133.2	-	5	595				ERG_ENST00000442448.1_Intron|ERG_ENST00000398919.2_Intron|ERG_ENST00000398911.1_Intron|ERG_ENST00000453032.2_Intron|ERG_ENST00000398897.1_Intron|ERG_ENST00000429727.2_Intron|ERG_ENST00000398910.1_Intron|ERG_ENST00000288319.7_Intron|ERG_ENST00000398907.1_Intron|ERG_ENST00000398905.1_Intron	NM_001136154.1|NM_001243432.1	NP_001129626.1|NP_001230361.1	Q12809	KCNH2_HUMAN	v-ets avian erythroblastosis virus E26 oncogene homolog						cardiac muscle contraction (GO:0060048)|cellular response to drug (GO:0035690)|membrane depolarization during action potential (GO:0086010)|membrane repolarization during action potential (GO:0086011)|membrane repolarization during cardiac muscle cell action potential (GO:0086013)|negative regulation of potassium ion export (GO:1902303)|negative regulation of potassium ion transmembrane transport (GO:1901380)|positive regulation of potassium ion transmembrane transport (GO:1901381)|potassium ion export (GO:0071435)|potassium ion homeostasis (GO:0055075)|potassium ion transmembrane transport (GO:0071805)|regulation of heart rate by cardiac conduction (GO:0086091)|regulation of heart rate by hormone (GO:0003064)|regulation of membrane potential (GO:0042391)|regulation of membrane repolarization (GO:0060306)|regulation of potassium ion transmembrane transport (GO:1901379)|regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307)|synaptic transmission (GO:0007268)|ventricular cardiac muscle cell action potential (GO:0086005)	cell surface (GO:0009986)|cytoplasm (GO:0005737)|nuclear envelope (GO:0005635)|plasma membrane (GO:0005886)|voltage-gated potassium channel complex (GO:0008076)	delayed rectifier potassium channel activity (GO:0005251)|identical protein binding (GO:0042802)|inward rectifier potassium channel activity (GO:0005242)|phosphorelay sensor kinase activity (GO:0000155)|protein homodimerization activity (GO:0042803)|ubiquitin protein ligase binding (GO:0031625)|voltage-gated potassium channel activity (GO:0005249)|voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282)		EWSR1/ERG(178)|NDRG1/ERG(5)|TMPRSS2/ERG(3582)|FUS/ERG(167)|SLC45A3/ERG(50)	lung(2)|ovary(1)|skin(1)	4		Prostate(19;3.6e-06)			Alfuzosin(DB00346)|Amiodarone(DB01118)|Amsacrine(DB00276)|Astemizole(DB00637)|Carvedilol(DB01136)|Chlorpromazine(DB00477)|Cisapride(DB00604)|Dofetilide(DB00204)|Doxazosin(DB00590)|Doxepin(DB01142)|Dronedarone(DB04855)|Halofantrine(DB01218)|Ibutilide(DB00308)|Imipramine(DB00458)|Miconazole(DB01110)|Pimozide(DB01100)|Prazosin(DB00457)|Propafenone(DB01182)|Quinidine(DB00908)|Sertindole(DB06144)|Sotalol(DB00489)|Terazosin(DB01162)|Thioridazine(DB00679)|Verapamil(DB00661)	CAATTAAAAATACACATACAC	0.363			T	"""EWSR1, TMPRSS2, ELF4, FUS, HERPUD1, NDRG1"""	"""Ewing sarcoma, prostate, AML"""																																Esophageal Squamous(130;336 1700 3010 3083 40589)		Dom	yes		21	21q22.3	2078	v-ets erythroblastosis virus E26 oncogene like (avian)		"""M, E, L"""	0																																										SO:0001627	intron_variant				CCDS13657.1, CCDS13658.1, CCDS46648.1, CCDS46649.1, CCDS58789.1	21q22.3	2013-07-09	2013-07-09		ENSG00000157554	ENSG00000157554	2078			3446	protein-coding gene	gene with protein product	"""v-ets avian erythroblastosis virus E26 oncogene related"", ""transcriptional regulator ERG (transforming protein ERG)"", ""v-ets erythroblastosis virus E26 oncogene like"", ""TMPRSS2-ERG prostate cancer specific"""	165080	"""v-ets avian erythroblastosis virus E26 oncogene related"""			3274086	Standard	NM_182918	NM_001136154		Approved	erg-3, p55	uc002yxa.3	P11308	OTTHUMG00000090767	ENST00000417133.2:c.409+3899A>G	chr21.hg19:g.39791432T>C			A5H1P7|C4PFH9|D3DX04|O75418|O75680|Q708S9|Q9BT72|Q9BUT7|Q9H3P0	True	hg19	CCDS46648.1																																																																																			ERG-002	KNOWN	basic|appris_candidate_longest|CCDS	protein_coding		protein_coding	OTTHUMT00000207532.2		67.0		-	ENST00000417133.2
ERG	2078	__UNKNOWN__	__UNKNOWN__	21	39791436	39791436	__UNKNOWN__	Intron	SNP	C	C	T			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr21:39791436C>T	ENST00000417133.2	-	5	595				ERG_ENST00000442448.1_Intron|ERG_ENST00000398919.2_Intron|ERG_ENST00000398911.1_Intron|ERG_ENST00000453032.2_Intron|ERG_ENST00000398897.1_Intron|ERG_ENST00000429727.2_Intron|ERG_ENST00000398910.1_Intron|ERG_ENST00000288319.7_Intron|ERG_ENST00000398907.1_Intron|ERG_ENST00000398905.1_Intron	NM_001136154.1|NM_001243432.1	NP_001129626.1|NP_001230361.1	Q12809	KCNH2_HUMAN	v-ets avian erythroblastosis virus E26 oncogene homolog						cardiac muscle contraction (GO:0060048)|cellular response to drug (GO:0035690)|membrane depolarization during action potential (GO:0086010)|membrane repolarization during action potential (GO:0086011)|membrane repolarization during cardiac muscle cell action potential (GO:0086013)|negative regulation of potassium ion export (GO:1902303)|negative regulation of potassium ion transmembrane transport (GO:1901380)|positive regulation of potassium ion transmembrane transport (GO:1901381)|potassium ion export (GO:0071435)|potassium ion homeostasis (GO:0055075)|potassium ion transmembrane transport (GO:0071805)|regulation of heart rate by cardiac conduction (GO:0086091)|regulation of heart rate by hormone (GO:0003064)|regulation of membrane potential (GO:0042391)|regulation of membrane repolarization (GO:0060306)|regulation of potassium ion transmembrane transport (GO:1901379)|regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307)|synaptic transmission (GO:0007268)|ventricular cardiac muscle cell action potential (GO:0086005)	cell surface (GO:0009986)|cytoplasm (GO:0005737)|nuclear envelope (GO:0005635)|plasma membrane (GO:0005886)|voltage-gated potassium channel complex (GO:0008076)	delayed rectifier potassium channel activity (GO:0005251)|identical protein binding (GO:0042802)|inward rectifier potassium channel activity (GO:0005242)|phosphorelay sensor kinase activity (GO:0000155)|protein homodimerization activity (GO:0042803)|ubiquitin protein ligase binding (GO:0031625)|voltage-gated potassium channel activity (GO:0005249)|voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282)		EWSR1/ERG(178)|NDRG1/ERG(5)|TMPRSS2/ERG(3582)|FUS/ERG(167)|SLC45A3/ERG(50)	lung(2)|ovary(1)|skin(1)	4		Prostate(19;3.6e-06)			Alfuzosin(DB00346)|Amiodarone(DB01118)|Amsacrine(DB00276)|Astemizole(DB00637)|Carvedilol(DB01136)|Chlorpromazine(DB00477)|Cisapride(DB00604)|Dofetilide(DB00204)|Doxazosin(DB00590)|Doxepin(DB01142)|Dronedarone(DB04855)|Halofantrine(DB01218)|Ibutilide(DB00308)|Imipramine(DB00458)|Miconazole(DB01110)|Pimozide(DB01100)|Prazosin(DB00457)|Propafenone(DB01182)|Quinidine(DB00908)|Sertindole(DB06144)|Sotalol(DB00489)|Terazosin(DB01162)|Thioridazine(DB00679)|Verapamil(DB00661)	TAAAAATACACATACACACAC	0.348			T	"""EWSR1, TMPRSS2, ELF4, FUS, HERPUD1, NDRG1"""	"""Ewing sarcoma, prostate, AML"""																																Esophageal Squamous(130;336 1700 3010 3083 40589)		Dom	yes		21	21q22.3	2078	v-ets erythroblastosis virus E26 oncogene like (avian)		"""M, E, L"""	0																																										SO:0001627	intron_variant				CCDS13657.1, CCDS13658.1, CCDS46648.1, CCDS46649.1, CCDS58789.1	21q22.3	2013-07-09	2013-07-09		ENSG00000157554	ENSG00000157554	2078			3446	protein-coding gene	gene with protein product	"""v-ets avian erythroblastosis virus E26 oncogene related"", ""transcriptional regulator ERG (transforming protein ERG)"", ""v-ets erythroblastosis virus E26 oncogene like"", ""TMPRSS2-ERG prostate cancer specific"""	165080	"""v-ets avian erythroblastosis virus E26 oncogene related"""			3274086	Standard	NM_182918	NM_001136154		Approved	erg-3, p55	uc002yxa.3	P11308	OTTHUMG00000090767	ENST00000417133.2:c.409+3895G>A	chr21.hg19:g.39791436C>T			A5H1P7|C4PFH9|D3DX04|O75418|O75680|Q708S9|Q9BT72|Q9BUT7|Q9H3P0	True	hg19	CCDS46648.1																																																																																			ERG-002	KNOWN	basic|appris_candidate_longest|CCDS	protein_coding		protein_coding	OTTHUMT00000207532.2	rs74852785	100.0		-	ENST00000417133.2
ERG	2078	__UNKNOWN__	__UNKNOWN__	21	39791453	39791453	__UNKNOWN__	Intron	SNP	G	G	A			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr21:39791453G>A	ENST00000417133.2	-	5	595				ERG_ENST00000442448.1_Intron|ERG_ENST00000398919.2_Intron|ERG_ENST00000398911.1_Intron|ERG_ENST00000453032.2_Intron|ERG_ENST00000398897.1_Intron|ERG_ENST00000429727.2_Intron|ERG_ENST00000398910.1_Intron|ERG_ENST00000288319.7_Intron|ERG_ENST00000398907.1_Intron|ERG_ENST00000398905.1_Intron	NM_001136154.1|NM_001243432.1	NP_001129626.1|NP_001230361.1	Q12809	KCNH2_HUMAN	v-ets avian erythroblastosis virus E26 oncogene homolog						cardiac muscle contraction (GO:0060048)|cellular response to drug (GO:0035690)|membrane depolarization during action potential (GO:0086010)|membrane repolarization during action potential (GO:0086011)|membrane repolarization during cardiac muscle cell action potential (GO:0086013)|negative regulation of potassium ion export (GO:1902303)|negative regulation of potassium ion transmembrane transport (GO:1901380)|positive regulation of potassium ion transmembrane transport (GO:1901381)|potassium ion export (GO:0071435)|potassium ion homeostasis (GO:0055075)|potassium ion transmembrane transport (GO:0071805)|regulation of heart rate by cardiac conduction (GO:0086091)|regulation of heart rate by hormone (GO:0003064)|regulation of membrane potential (GO:0042391)|regulation of membrane repolarization (GO:0060306)|regulation of potassium ion transmembrane transport (GO:1901379)|regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307)|synaptic transmission (GO:0007268)|ventricular cardiac muscle cell action potential (GO:0086005)	cell surface (GO:0009986)|cytoplasm (GO:0005737)|nuclear envelope (GO:0005635)|plasma membrane (GO:0005886)|voltage-gated potassium channel complex (GO:0008076)	delayed rectifier potassium channel activity (GO:0005251)|identical protein binding (GO:0042802)|inward rectifier potassium channel activity (GO:0005242)|phosphorelay sensor kinase activity (GO:0000155)|protein homodimerization activity (GO:0042803)|ubiquitin protein ligase binding (GO:0031625)|voltage-gated potassium channel activity (GO:0005249)|voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282)		EWSR1/ERG(178)|NDRG1/ERG(5)|TMPRSS2/ERG(3582)|FUS/ERG(167)|SLC45A3/ERG(50)	lung(2)|ovary(1)|skin(1)	4		Prostate(19;3.6e-06)			Alfuzosin(DB00346)|Amiodarone(DB01118)|Amsacrine(DB00276)|Astemizole(DB00637)|Carvedilol(DB01136)|Chlorpromazine(DB00477)|Cisapride(DB00604)|Dofetilide(DB00204)|Doxazosin(DB00590)|Doxepin(DB01142)|Dronedarone(DB04855)|Halofantrine(DB01218)|Ibutilide(DB00308)|Imipramine(DB00458)|Miconazole(DB01110)|Pimozide(DB01100)|Prazosin(DB00457)|Propafenone(DB01182)|Quinidine(DB00908)|Sertindole(DB06144)|Sotalol(DB00489)|Terazosin(DB01162)|Thioridazine(DB00679)|Verapamil(DB00661)	ACACACACACGTGCGTGTAAA	0.363			T	"""EWSR1, TMPRSS2, ELF4, FUS, HERPUD1, NDRG1"""	"""Ewing sarcoma, prostate, AML"""																																Esophageal Squamous(130;336 1700 3010 3083 40589)		Dom	yes		21	21q22.3	2078	v-ets erythroblastosis virus E26 oncogene like (avian)		"""M, E, L"""	0																																										SO:0001627	intron_variant				CCDS13657.1, CCDS13658.1, CCDS46648.1, CCDS46649.1, CCDS58789.1	21q22.3	2013-07-09	2013-07-09		ENSG00000157554	ENSG00000157554	2078			3446	protein-coding gene	gene with protein product	"""v-ets avian erythroblastosis virus E26 oncogene related"", ""transcriptional regulator ERG (transforming protein ERG)"", ""v-ets erythroblastosis virus E26 oncogene like"", ""TMPRSS2-ERG prostate cancer specific"""	165080	"""v-ets avian erythroblastosis virus E26 oncogene related"""			3274086	Standard	NM_182918	NM_001136154		Approved	erg-3, p55	uc002yxa.3	P11308	OTTHUMG00000090767	ENST00000417133.2:c.409+3878C>T	chr21.hg19:g.39791453G>A			A5H1P7|C4PFH9|D3DX04|O75418|O75680|Q708S9|Q9BT72|Q9BUT7|Q9H3P0	True	hg19	CCDS46648.1																																																																																			ERG-002	KNOWN	basic|appris_candidate_longest|CCDS	protein_coding		protein_coding	OTTHUMT00000207532.2	rs78010563	35.0		-	ENST00000417133.2
ERG	2078	__UNKNOWN__	__UNKNOWN__	21	39791454	39791454	__UNKNOWN__	Intron	SNP	T	T	C			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr21:39791454T>C	ENST00000417133.2	-	5	595				ERG_ENST00000442448.1_Intron|ERG_ENST00000398919.2_Intron|ERG_ENST00000398911.1_Intron|ERG_ENST00000453032.2_Intron|ERG_ENST00000398897.1_Intron|ERG_ENST00000429727.2_Intron|ERG_ENST00000398910.1_Intron|ERG_ENST00000288319.7_Intron|ERG_ENST00000398907.1_Intron|ERG_ENST00000398905.1_Intron	NM_001136154.1|NM_001243432.1	NP_001129626.1|NP_001230361.1	Q12809	KCNH2_HUMAN	v-ets avian erythroblastosis virus E26 oncogene homolog						cardiac muscle contraction (GO:0060048)|cellular response to drug (GO:0035690)|membrane depolarization during action potential (GO:0086010)|membrane repolarization during action potential (GO:0086011)|membrane repolarization during cardiac muscle cell action potential (GO:0086013)|negative regulation of potassium ion export (GO:1902303)|negative regulation of potassium ion transmembrane transport (GO:1901380)|positive regulation of potassium ion transmembrane transport (GO:1901381)|potassium ion export (GO:0071435)|potassium ion homeostasis (GO:0055075)|potassium ion transmembrane transport (GO:0071805)|regulation of heart rate by cardiac conduction (GO:0086091)|regulation of heart rate by hormone (GO:0003064)|regulation of membrane potential (GO:0042391)|regulation of membrane repolarization (GO:0060306)|regulation of potassium ion transmembrane transport (GO:1901379)|regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307)|synaptic transmission (GO:0007268)|ventricular cardiac muscle cell action potential (GO:0086005)	cell surface (GO:0009986)|cytoplasm (GO:0005737)|nuclear envelope (GO:0005635)|plasma membrane (GO:0005886)|voltage-gated potassium channel complex (GO:0008076)	delayed rectifier potassium channel activity (GO:0005251)|identical protein binding (GO:0042802)|inward rectifier potassium channel activity (GO:0005242)|phosphorelay sensor kinase activity (GO:0000155)|protein homodimerization activity (GO:0042803)|ubiquitin protein ligase binding (GO:0031625)|voltage-gated potassium channel activity (GO:0005249)|voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282)		EWSR1/ERG(178)|NDRG1/ERG(5)|TMPRSS2/ERG(3582)|FUS/ERG(167)|SLC45A3/ERG(50)	lung(2)|ovary(1)|skin(1)	4		Prostate(19;3.6e-06)			Alfuzosin(DB00346)|Amiodarone(DB01118)|Amsacrine(DB00276)|Astemizole(DB00637)|Carvedilol(DB01136)|Chlorpromazine(DB00477)|Cisapride(DB00604)|Dofetilide(DB00204)|Doxazosin(DB00590)|Doxepin(DB01142)|Dronedarone(DB04855)|Halofantrine(DB01218)|Ibutilide(DB00308)|Imipramine(DB00458)|Miconazole(DB01110)|Pimozide(DB01100)|Prazosin(DB00457)|Propafenone(DB01182)|Quinidine(DB00908)|Sertindole(DB06144)|Sotalol(DB00489)|Terazosin(DB01162)|Thioridazine(DB00679)|Verapamil(DB00661)	CACACACACGTGCGTGTAAAC	0.363			T	"""EWSR1, TMPRSS2, ELF4, FUS, HERPUD1, NDRG1"""	"""Ewing sarcoma, prostate, AML"""																																Esophageal Squamous(130;336 1700 3010 3083 40589)		Dom	yes		21	21q22.3	2078	v-ets erythroblastosis virus E26 oncogene like (avian)		"""M, E, L"""	0																																										SO:0001627	intron_variant				CCDS13657.1, CCDS13658.1, CCDS46648.1, CCDS46649.1, CCDS58789.1	21q22.3	2013-07-09	2013-07-09		ENSG00000157554	ENSG00000157554	2078			3446	protein-coding gene	gene with protein product	"""v-ets avian erythroblastosis virus E26 oncogene related"", ""transcriptional regulator ERG (transforming protein ERG)"", ""v-ets erythroblastosis virus E26 oncogene like"", ""TMPRSS2-ERG prostate cancer specific"""	165080	"""v-ets avian erythroblastosis virus E26 oncogene related"""			3274086	Standard	NM_182918	NM_001136154		Approved	erg-3, p55	uc002yxa.3	P11308	OTTHUMG00000090767	ENST00000417133.2:c.409+3877A>G	chr21.hg19:g.39791454T>C			A5H1P7|C4PFH9|D3DX04|O75418|O75680|Q708S9|Q9BT72|Q9BUT7|Q9H3P0	True	hg19	CCDS46648.1																																																																																			ERG-002	KNOWN	basic|appris_candidate_longest|CCDS	protein_coding		protein_coding	OTTHUMT00000207532.2		39.0		-	ENST00000417133.2
ERG	2078	__UNKNOWN__	__UNKNOWN__	21	39791687	39791687	__UNKNOWN__	Intron	SNP	T	T	G			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr21:39791687T>G	ENST00000417133.2	-	5	595				ERG_ENST00000442448.1_Intron|ERG_ENST00000398919.2_Intron|ERG_ENST00000398911.1_Intron|ERG_ENST00000453032.2_Intron|ERG_ENST00000398897.1_Intron|ERG_ENST00000429727.2_Intron|ERG_ENST00000398910.1_Intron|ERG_ENST00000288319.7_Intron|ERG_ENST00000398907.1_Intron|ERG_ENST00000398905.1_Intron	NM_001136154.1|NM_001243432.1	NP_001129626.1|NP_001230361.1	Q12809	KCNH2_HUMAN	v-ets avian erythroblastosis virus E26 oncogene homolog						cardiac muscle contraction (GO:0060048)|cellular response to drug (GO:0035690)|membrane depolarization during action potential (GO:0086010)|membrane repolarization during action potential (GO:0086011)|membrane repolarization during cardiac muscle cell action potential (GO:0086013)|negative regulation of potassium ion export (GO:1902303)|negative regulation of potassium ion transmembrane transport (GO:1901380)|positive regulation of potassium ion transmembrane transport (GO:1901381)|potassium ion export (GO:0071435)|potassium ion homeostasis (GO:0055075)|potassium ion transmembrane transport (GO:0071805)|regulation of heart rate by cardiac conduction (GO:0086091)|regulation of heart rate by hormone (GO:0003064)|regulation of membrane potential (GO:0042391)|regulation of membrane repolarization (GO:0060306)|regulation of potassium ion transmembrane transport (GO:1901379)|regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307)|synaptic transmission (GO:0007268)|ventricular cardiac muscle cell action potential (GO:0086005)	cell surface (GO:0009986)|cytoplasm (GO:0005737)|nuclear envelope (GO:0005635)|plasma membrane (GO:0005886)|voltage-gated potassium channel complex (GO:0008076)	delayed rectifier potassium channel activity (GO:0005251)|identical protein binding (GO:0042802)|inward rectifier potassium channel activity (GO:0005242)|phosphorelay sensor kinase activity (GO:0000155)|protein homodimerization activity (GO:0042803)|ubiquitin protein ligase binding (GO:0031625)|voltage-gated potassium channel activity (GO:0005249)|voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282)		EWSR1/ERG(178)|NDRG1/ERG(5)|TMPRSS2/ERG(3582)|FUS/ERG(167)|SLC45A3/ERG(50)	lung(2)|ovary(1)|skin(1)	4		Prostate(19;3.6e-06)			Alfuzosin(DB00346)|Amiodarone(DB01118)|Amsacrine(DB00276)|Astemizole(DB00637)|Carvedilol(DB01136)|Chlorpromazine(DB00477)|Cisapride(DB00604)|Dofetilide(DB00204)|Doxazosin(DB00590)|Doxepin(DB01142)|Dronedarone(DB04855)|Halofantrine(DB01218)|Ibutilide(DB00308)|Imipramine(DB00458)|Miconazole(DB01110)|Pimozide(DB01100)|Prazosin(DB00457)|Propafenone(DB01182)|Quinidine(DB00908)|Sertindole(DB06144)|Sotalol(DB00489)|Terazosin(DB01162)|Thioridazine(DB00679)|Verapamil(DB00661)	GGCTTTTTTTTGACACTTTTT	0.378			T	"""EWSR1, TMPRSS2, ELF4, FUS, HERPUD1, NDRG1"""	"""Ewing sarcoma, prostate, AML"""																																Esophageal Squamous(130;336 1700 3010 3083 40589)		Dom	yes		21	21q22.3	2078	v-ets erythroblastosis virus E26 oncogene like (avian)		"""M, E, L"""	0																																										SO:0001627	intron_variant				CCDS13657.1, CCDS13658.1, CCDS46648.1, CCDS46649.1, CCDS58789.1	21q22.3	2013-07-09	2013-07-09		ENSG00000157554	ENSG00000157554	2078			3446	protein-coding gene	gene with protein product	"""v-ets avian erythroblastosis virus E26 oncogene related"", ""transcriptional regulator ERG (transforming protein ERG)"", ""v-ets erythroblastosis virus E26 oncogene like"", ""TMPRSS2-ERG prostate cancer specific"""	165080	"""v-ets avian erythroblastosis virus E26 oncogene related"""			3274086	Standard	NM_182918	NM_001136154		Approved	erg-3, p55	uc002yxa.3	P11308	OTTHUMG00000090767	ENST00000417133.2:c.409+3644A>C	chr21.hg19:g.39791687T>G			A5H1P7|C4PFH9|D3DX04|O75418|O75680|Q708S9|Q9BT72|Q9BUT7|Q9H3P0	True	hg19	CCDS46648.1																																																																																			ERG-002	KNOWN	basic|appris_candidate_longest|CCDS	protein_coding		protein_coding	OTTHUMT00000207532.2		100.0		-	ENST00000417133.2
ERG	2078	__UNKNOWN__	__UNKNOWN__	21	39792035	39792035	__UNKNOWN__	Intron	SNP	C	C	T			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr21:39792035C>T	ENST00000417133.2	-	5	595				ERG_ENST00000442448.1_Intron|ERG_ENST00000398919.2_Intron|ERG_ENST00000398911.1_Intron|ERG_ENST00000453032.2_Intron|ERG_ENST00000398897.1_Intron|ERG_ENST00000429727.2_Intron|ERG_ENST00000398910.1_Intron|ERG_ENST00000288319.7_Intron|ERG_ENST00000398907.1_Intron|ERG_ENST00000398905.1_Intron	NM_001136154.1|NM_001243432.1	NP_001129626.1|NP_001230361.1	Q12809	KCNH2_HUMAN	v-ets avian erythroblastosis virus E26 oncogene homolog						cardiac muscle contraction (GO:0060048)|cellular response to drug (GO:0035690)|membrane depolarization during action potential (GO:0086010)|membrane repolarization during action potential (GO:0086011)|membrane repolarization during cardiac muscle cell action potential (GO:0086013)|negative regulation of potassium ion export (GO:1902303)|negative regulation of potassium ion transmembrane transport (GO:1901380)|positive regulation of potassium ion transmembrane transport (GO:1901381)|potassium ion export (GO:0071435)|potassium ion homeostasis (GO:0055075)|potassium ion transmembrane transport (GO:0071805)|regulation of heart rate by cardiac conduction (GO:0086091)|regulation of heart rate by hormone (GO:0003064)|regulation of membrane potential (GO:0042391)|regulation of membrane repolarization (GO:0060306)|regulation of potassium ion transmembrane transport (GO:1901379)|regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307)|synaptic transmission (GO:0007268)|ventricular cardiac muscle cell action potential (GO:0086005)	cell surface (GO:0009986)|cytoplasm (GO:0005737)|nuclear envelope (GO:0005635)|plasma membrane (GO:0005886)|voltage-gated potassium channel complex (GO:0008076)	delayed rectifier potassium channel activity (GO:0005251)|identical protein binding (GO:0042802)|inward rectifier potassium channel activity (GO:0005242)|phosphorelay sensor kinase activity (GO:0000155)|protein homodimerization activity (GO:0042803)|ubiquitin protein ligase binding (GO:0031625)|voltage-gated potassium channel activity (GO:0005249)|voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282)		EWSR1/ERG(178)|NDRG1/ERG(5)|TMPRSS2/ERG(3582)|FUS/ERG(167)|SLC45A3/ERG(50)	lung(2)|ovary(1)|skin(1)	4		Prostate(19;3.6e-06)			Alfuzosin(DB00346)|Amiodarone(DB01118)|Amsacrine(DB00276)|Astemizole(DB00637)|Carvedilol(DB01136)|Chlorpromazine(DB00477)|Cisapride(DB00604)|Dofetilide(DB00204)|Doxazosin(DB00590)|Doxepin(DB01142)|Dronedarone(DB04855)|Halofantrine(DB01218)|Ibutilide(DB00308)|Imipramine(DB00458)|Miconazole(DB01110)|Pimozide(DB01100)|Prazosin(DB00457)|Propafenone(DB01182)|Quinidine(DB00908)|Sertindole(DB06144)|Sotalol(DB00489)|Terazosin(DB01162)|Thioridazine(DB00679)|Verapamil(DB00661)	CTATGTGAACCACTCAGGACC	0.443			T	"""EWSR1, TMPRSS2, ELF4, FUS, HERPUD1, NDRG1"""	"""Ewing sarcoma, prostate, AML"""																																Esophageal Squamous(130;336 1700 3010 3083 40589)		Dom	yes		21	21q22.3	2078	v-ets erythroblastosis virus E26 oncogene like (avian)		"""M, E, L"""	0																																										SO:0001627	intron_variant				CCDS13657.1, CCDS13658.1, CCDS46648.1, CCDS46649.1, CCDS58789.1	21q22.3	2013-07-09	2013-07-09		ENSG00000157554	ENSG00000157554	2078			3446	protein-coding gene	gene with protein product	"""v-ets avian erythroblastosis virus E26 oncogene related"", ""transcriptional regulator ERG (transforming protein ERG)"", ""v-ets erythroblastosis virus E26 oncogene like"", ""TMPRSS2-ERG prostate cancer specific"""	165080	"""v-ets avian erythroblastosis virus E26 oncogene related"""			3274086	Standard	NM_182918	NM_001136154		Approved	erg-3, p55	uc002yxa.3	P11308	OTTHUMG00000090767	ENST00000417133.2:c.409+3296G>A	chr21.hg19:g.39792035C>T			A5H1P7|C4PFH9|D3DX04|O75418|O75680|Q708S9|Q9BT72|Q9BUT7|Q9H3P0	True	hg19	CCDS46648.1																																																																																			ERG-002	KNOWN	basic|appris_candidate_longest|CCDS	protein_coding		protein_coding	OTTHUMT00000207532.2		100.0		-	ENST00000417133.2
ERG	2078	__UNKNOWN__	__UNKNOWN__	21	39795047	39795047	__UNKNOWN__	Intron	SNP	A	A	G			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr21:39795047A>G	ENST00000417133.2	-	5	595				ERG_ENST00000442448.1_Intron|ERG_ENST00000398919.2_Intron|ERG_ENST00000398911.1_Intron|ERG_ENST00000453032.2_Intron|ERG_ENST00000398897.1_Intron|ERG_ENST00000429727.2_Intron|ERG_ENST00000398910.1_Intron|ERG_ENST00000288319.7_Intron|ERG_ENST00000398907.1_Intron|ERG_ENST00000398905.1_Intron	NM_001136154.1|NM_001243432.1	NP_001129626.1|NP_001230361.1	Q12809	KCNH2_HUMAN	v-ets avian erythroblastosis virus E26 oncogene homolog						cardiac muscle contraction (GO:0060048)|cellular response to drug (GO:0035690)|membrane depolarization during action potential (GO:0086010)|membrane repolarization during action potential (GO:0086011)|membrane repolarization during cardiac muscle cell action potential (GO:0086013)|negative regulation of potassium ion export (GO:1902303)|negative regulation of potassium ion transmembrane transport (GO:1901380)|positive regulation of potassium ion transmembrane transport (GO:1901381)|potassium ion export (GO:0071435)|potassium ion homeostasis (GO:0055075)|potassium ion transmembrane transport (GO:0071805)|regulation of heart rate by cardiac conduction (GO:0086091)|regulation of heart rate by hormone (GO:0003064)|regulation of membrane potential (GO:0042391)|regulation of membrane repolarization (GO:0060306)|regulation of potassium ion transmembrane transport (GO:1901379)|regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307)|synaptic transmission (GO:0007268)|ventricular cardiac muscle cell action potential (GO:0086005)	cell surface (GO:0009986)|cytoplasm (GO:0005737)|nuclear envelope (GO:0005635)|plasma membrane (GO:0005886)|voltage-gated potassium channel complex (GO:0008076)	delayed rectifier potassium channel activity (GO:0005251)|identical protein binding (GO:0042802)|inward rectifier potassium channel activity (GO:0005242)|phosphorelay sensor kinase activity (GO:0000155)|protein homodimerization activity (GO:0042803)|ubiquitin protein ligase binding (GO:0031625)|voltage-gated potassium channel activity (GO:0005249)|voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282)		EWSR1/ERG(178)|NDRG1/ERG(5)|TMPRSS2/ERG(3582)|FUS/ERG(167)|SLC45A3/ERG(50)	lung(2)|ovary(1)|skin(1)	4		Prostate(19;3.6e-06)			Alfuzosin(DB00346)|Amiodarone(DB01118)|Amsacrine(DB00276)|Astemizole(DB00637)|Carvedilol(DB01136)|Chlorpromazine(DB00477)|Cisapride(DB00604)|Dofetilide(DB00204)|Doxazosin(DB00590)|Doxepin(DB01142)|Dronedarone(DB04855)|Halofantrine(DB01218)|Ibutilide(DB00308)|Imipramine(DB00458)|Miconazole(DB01110)|Pimozide(DB01100)|Prazosin(DB00457)|Propafenone(DB01182)|Quinidine(DB00908)|Sertindole(DB06144)|Sotalol(DB00489)|Terazosin(DB01162)|Thioridazine(DB00679)|Verapamil(DB00661)	gtgtgtgtgtATTTTTCTCTA	0.393			T	"""EWSR1, TMPRSS2, ELF4, FUS, HERPUD1, NDRG1"""	"""Ewing sarcoma, prostate, AML"""																																Esophageal Squamous(130;336 1700 3010 3083 40589)		Dom	yes		21	21q22.3	2078	v-ets erythroblastosis virus E26 oncogene like (avian)		"""M, E, L"""	0																																										SO:0001627	intron_variant				CCDS13657.1, CCDS13658.1, CCDS46648.1, CCDS46649.1, CCDS58789.1	21q22.3	2013-07-09	2013-07-09		ENSG00000157554	ENSG00000157554	2078			3446	protein-coding gene	gene with protein product	"""v-ets avian erythroblastosis virus E26 oncogene related"", ""transcriptional regulator ERG (transforming protein ERG)"", ""v-ets erythroblastosis virus E26 oncogene like"", ""TMPRSS2-ERG prostate cancer specific"""	165080	"""v-ets avian erythroblastosis virus E26 oncogene related"""			3274086	Standard	NM_182918	NM_001136154		Approved	erg-3, p55	uc002yxa.3	P11308	OTTHUMG00000090767	ENST00000417133.2:c.409+284T>C	chr21.hg19:g.39795047A>G			A5H1P7|C4PFH9|D3DX04|O75418|O75680|Q708S9|Q9BT72|Q9BUT7|Q9H3P0	True	hg19	CCDS46648.1																																																																																			ERG-002	KNOWN	basic|appris_candidate_longest|CCDS	protein_coding		protein_coding	OTTHUMT00000207532.2		20.0		-	ENST00000417133.2
ERG	2078	__UNKNOWN__	__UNKNOWN__	21	39795047	39795047	__UNKNOWN__	Intron	SNP	A	A	T			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr21:39795047A>T	ENST00000417133.2	-	5	595				ERG_ENST00000442448.1_Intron|ERG_ENST00000398919.2_Intron|ERG_ENST00000398911.1_Intron|ERG_ENST00000453032.2_Intron|ERG_ENST00000398897.1_Intron|ERG_ENST00000429727.2_Intron|ERG_ENST00000398910.1_Intron|ERG_ENST00000288319.7_Intron|ERG_ENST00000398907.1_Intron|ERG_ENST00000398905.1_Intron	NM_001136154.1|NM_001243432.1	NP_001129626.1|NP_001230361.1	Q12809	KCNH2_HUMAN	v-ets avian erythroblastosis virus E26 oncogene homolog						cardiac muscle contraction (GO:0060048)|cellular response to drug (GO:0035690)|membrane depolarization during action potential (GO:0086010)|membrane repolarization during action potential (GO:0086011)|membrane repolarization during cardiac muscle cell action potential (GO:0086013)|negative regulation of potassium ion export (GO:1902303)|negative regulation of potassium ion transmembrane transport (GO:1901380)|positive regulation of potassium ion transmembrane transport (GO:1901381)|potassium ion export (GO:0071435)|potassium ion homeostasis (GO:0055075)|potassium ion transmembrane transport (GO:0071805)|regulation of heart rate by cardiac conduction (GO:0086091)|regulation of heart rate by hormone (GO:0003064)|regulation of membrane potential (GO:0042391)|regulation of membrane repolarization (GO:0060306)|regulation of potassium ion transmembrane transport (GO:1901379)|regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307)|synaptic transmission (GO:0007268)|ventricular cardiac muscle cell action potential (GO:0086005)	cell surface (GO:0009986)|cytoplasm (GO:0005737)|nuclear envelope (GO:0005635)|plasma membrane (GO:0005886)|voltage-gated potassium channel complex (GO:0008076)	delayed rectifier potassium channel activity (GO:0005251)|identical protein binding (GO:0042802)|inward rectifier potassium channel activity (GO:0005242)|phosphorelay sensor kinase activity (GO:0000155)|protein homodimerization activity (GO:0042803)|ubiquitin protein ligase binding (GO:0031625)|voltage-gated potassium channel activity (GO:0005249)|voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282)		EWSR1/ERG(178)|NDRG1/ERG(5)|TMPRSS2/ERG(3582)|FUS/ERG(167)|SLC45A3/ERG(50)	lung(2)|ovary(1)|skin(1)	4		Prostate(19;3.6e-06)			Alfuzosin(DB00346)|Amiodarone(DB01118)|Amsacrine(DB00276)|Astemizole(DB00637)|Carvedilol(DB01136)|Chlorpromazine(DB00477)|Cisapride(DB00604)|Dofetilide(DB00204)|Doxazosin(DB00590)|Doxepin(DB01142)|Dronedarone(DB04855)|Halofantrine(DB01218)|Ibutilide(DB00308)|Imipramine(DB00458)|Miconazole(DB01110)|Pimozide(DB01100)|Prazosin(DB00457)|Propafenone(DB01182)|Quinidine(DB00908)|Sertindole(DB06144)|Sotalol(DB00489)|Terazosin(DB01162)|Thioridazine(DB00679)|Verapamil(DB00661)	gtgtgtgtgtATTTTTCTCTA	0.393			T	"""EWSR1, TMPRSS2, ELF4, FUS, HERPUD1, NDRG1"""	"""Ewing sarcoma, prostate, AML"""																																Esophageal Squamous(130;336 1700 3010 3083 40589)		Dom	yes		21	21q22.3	2078	v-ets erythroblastosis virus E26 oncogene like (avian)		"""M, E, L"""	0																																										SO:0001627	intron_variant				CCDS13657.1, CCDS13658.1, CCDS46648.1, CCDS46649.1, CCDS58789.1	21q22.3	2013-07-09	2013-07-09		ENSG00000157554	ENSG00000157554	2078			3446	protein-coding gene	gene with protein product	"""v-ets avian erythroblastosis virus E26 oncogene related"", ""transcriptional regulator ERG (transforming protein ERG)"", ""v-ets erythroblastosis virus E26 oncogene like"", ""TMPRSS2-ERG prostate cancer specific"""	165080	"""v-ets avian erythroblastosis virus E26 oncogene related"""			3274086	Standard	NM_182918	NM_001136154		Approved	erg-3, p55	uc002yxa.3	P11308	OTTHUMG00000090767	ENST00000417133.2:c.409+284T>A	chr21.hg19:g.39795047A>T			A5H1P7|C4PFH9|D3DX04|O75418|O75680|Q708S9|Q9BT72|Q9BUT7|Q9H3P0	True	hg19	CCDS46648.1																																																																																			ERG-002	KNOWN	basic|appris_candidate_longest|CCDS	protein_coding		protein_coding	OTTHUMT00000207532.2		20.0		-	ENST00000417133.2
EWSR1	2130	__UNKNOWN__	__UNKNOWN__	22	29678999	29678999	__UNKNOWN__	Intron	SNP	T	T	C			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr22:29678999T>C	ENST00000414183.2	+	7	620				EWSR1_ENST00000397938.2_Intron|EWSR1_ENST00000332035.6_Intron|EWSR1_ENST00000333395.6_Intron|EWSR1_ENST00000331029.7_Intron|EWSR1_ENST00000332050.6_Intron|EWSR1_ENST00000406548.1_Intron			Q01844	EWS_HUMAN	EWS RNA-binding protein 1						regulation of transcription, DNA-templated (GO:0006355)|transcription, DNA-templated (GO:0006351)	cytoplasm (GO:0005737)|nucleus (GO:0005634)|plasma membrane (GO:0005886)	identical protein binding (GO:0042802)|nucleotide binding (GO:0000166)|poly(A) RNA binding (GO:0044822)|RNA binding (GO:0003723)|zinc ion binding (GO:0008270)		EWSR1/ATF1(347)|EWSR1/POU5F1(10)|EWSR1/PBX1(3)|EWSR1/DDIT3(45)|EWSR1/FEV(11)|EWSR1/CREB1(44)|EWSR1/SMARCA5(2)|EWSR1/ETV4(6)|EWSR1/ERG(178)|EWSR1/ZNF384(4)|EWSR1/ETV1(7)|EWSR1/FLI1(2569)|EWSR1/NR4A3(146)|EWSR1/SP3(3)|EWSR1/PATZ1(2)|EWSR1/WT1(234)|EWSR1/NFATC2(9)	breast(2)|central_nervous_system(1)|endometrium(6)|haematopoietic_and_lymphoid_tissue(1)|kidney(2)|large_intestine(1)|liver(1)|lung(6)|ovary(2)|skin(2)|upper_aerodigestive_tract(1)|urinary_tract(1)	26						gatccacccatctcggcctcc	0.488			T	"""FLI1, ERG, ZNF278, NR4A3, FEV, ATF1, ETV1, ETV4, WT1, ZNF384, CREB1, POU5F1,  PBX1"""	"""Ewing sarcoma,  desmoplastic small round cell tumor , ALL, clear cell sarcoma, sarcoma, myoepithelioma"""																																		Dom	yes		22	22q12	2130	Ewing sarcoma breakpoint region 1 (EWS)		"""L, M"""	0																																										SO:0001627	intron_variant				CCDS13851.1, CCDS13852.1, CCDS13852.2, CCDS54512.1, CCDS54513.1, CCDS54514.1	22q12.2	2013-05-24	2013-05-24		ENSG00000182944	ENSG00000182944	2130		"""RNA binding motif (RRM) containing"""	3508	protein-coding gene	gene with protein product		133450	"""Ewing sarcoma breakpoint region 1"""			1522903	Standard	NM_005243	NM_005243		Approved	EWS	uc003aev.3	Q01844	OTTHUMG00000151107	ENST00000414183.2:c.599+453T>C	chr22.hg19:g.29678999T>C			B0QYK1|Q5THL0|Q92635|Q96FE8|Q96MN4|Q96MX4|Q9BWA2	True	hg19	CCDS13852.2																																																																																			EWSR1-021	KNOWN	basic|appris_candidate_longest|CCDS	protein_coding		protein_coding	OTTHUMT00000358290.1		33.0		+	ENST00000414183.2
EWSR1	2130	__UNKNOWN__	__UNKNOWN__	22	29679012	29679012	__UNKNOWN__	Intron	SNP	C	C	A			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr22:29679012C>A	ENST00000414183.2	+	7	620				EWSR1_ENST00000397938.2_Intron|EWSR1_ENST00000332035.6_Intron|EWSR1_ENST00000333395.6_Intron|EWSR1_ENST00000331029.7_Intron|EWSR1_ENST00000332050.6_Intron|EWSR1_ENST00000406548.1_Intron			Q01844	EWS_HUMAN	EWS RNA-binding protein 1						regulation of transcription, DNA-templated (GO:0006355)|transcription, DNA-templated (GO:0006351)	cytoplasm (GO:0005737)|nucleus (GO:0005634)|plasma membrane (GO:0005886)	identical protein binding (GO:0042802)|nucleotide binding (GO:0000166)|poly(A) RNA binding (GO:0044822)|RNA binding (GO:0003723)|zinc ion binding (GO:0008270)		EWSR1/ATF1(347)|EWSR1/POU5F1(10)|EWSR1/PBX1(3)|EWSR1/DDIT3(45)|EWSR1/FEV(11)|EWSR1/CREB1(44)|EWSR1/SMARCA5(2)|EWSR1/ETV4(6)|EWSR1/ERG(178)|EWSR1/ZNF384(4)|EWSR1/ETV1(7)|EWSR1/FLI1(2569)|EWSR1/NR4A3(146)|EWSR1/SP3(3)|EWSR1/PATZ1(2)|EWSR1/WT1(234)|EWSR1/NFATC2(9)	breast(2)|central_nervous_system(1)|endometrium(6)|haematopoietic_and_lymphoid_tissue(1)|kidney(2)|large_intestine(1)|liver(1)|lung(6)|ovary(2)|skin(2)|upper_aerodigestive_tract(1)|urinary_tract(1)	26						cggcctcccacagtgctggga	0.448			T	"""FLI1, ERG, ZNF278, NR4A3, FEV, ATF1, ETV1, ETV4, WT1, ZNF384, CREB1, POU5F1,  PBX1"""	"""Ewing sarcoma,  desmoplastic small round cell tumor , ALL, clear cell sarcoma, sarcoma, myoepithelioma"""																																		Dom	yes		22	22q12	2130	Ewing sarcoma breakpoint region 1 (EWS)		"""L, M"""	0																																										SO:0001627	intron_variant				CCDS13851.1, CCDS13852.1, CCDS13852.2, CCDS54512.1, CCDS54513.1, CCDS54514.1	22q12.2	2013-05-24	2013-05-24		ENSG00000182944	ENSG00000182944	2130		"""RNA binding motif (RRM) containing"""	3508	protein-coding gene	gene with protein product		133450	"""Ewing sarcoma breakpoint region 1"""			1522903	Standard	NM_005243	NM_005243		Approved	EWS	uc003aev.3	Q01844	OTTHUMG00000151107	ENST00000414183.2:c.599+466C>A	chr22.hg19:g.29679012C>A			B0QYK1|Q5THL0|Q92635|Q96FE8|Q96MN4|Q96MX4|Q9BWA2	True	hg19	CCDS13852.2																																																																																			EWSR1-021	KNOWN	basic|appris_candidate_longest|CCDS	protein_coding		protein_coding	OTTHUMT00000358290.1		41.0		+	ENST00000414183.2
EWSR1	2130	__UNKNOWN__	__UNKNOWN__	22	29679516	29679516	__UNKNOWN__	Intron	SNP	G	G	A			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr22:29679516G>A	ENST00000414183.2	+	7	620				EWSR1_ENST00000397938.2_Intron|EWSR1_ENST00000332035.6_Intron|EWSR1_ENST00000333395.6_Intron|EWSR1_ENST00000331029.7_Intron|EWSR1_ENST00000332050.6_Intron|EWSR1_ENST00000406548.1_Intron			Q01844	EWS_HUMAN	EWS RNA-binding protein 1						regulation of transcription, DNA-templated (GO:0006355)|transcription, DNA-templated (GO:0006351)	cytoplasm (GO:0005737)|nucleus (GO:0005634)|plasma membrane (GO:0005886)	identical protein binding (GO:0042802)|nucleotide binding (GO:0000166)|poly(A) RNA binding (GO:0044822)|RNA binding (GO:0003723)|zinc ion binding (GO:0008270)		EWSR1/ATF1(347)|EWSR1/POU5F1(10)|EWSR1/PBX1(3)|EWSR1/DDIT3(45)|EWSR1/FEV(11)|EWSR1/CREB1(44)|EWSR1/SMARCA5(2)|EWSR1/ETV4(6)|EWSR1/ERG(178)|EWSR1/ZNF384(4)|EWSR1/ETV1(7)|EWSR1/FLI1(2569)|EWSR1/NR4A3(146)|EWSR1/SP3(3)|EWSR1/PATZ1(2)|EWSR1/WT1(234)|EWSR1/NFATC2(9)	breast(2)|central_nervous_system(1)|endometrium(6)|haematopoietic_and_lymphoid_tissue(1)|kidney(2)|large_intestine(1)|liver(1)|lung(6)|ovary(2)|skin(2)|upper_aerodigestive_tract(1)|urinary_tract(1)	26						ttttctttttgttttattgtt	0.507			T	"""FLI1, ERG, ZNF278, NR4A3, FEV, ATF1, ETV1, ETV4, WT1, ZNF384, CREB1, POU5F1,  PBX1"""	"""Ewing sarcoma,  desmoplastic small round cell tumor , ALL, clear cell sarcoma, sarcoma, myoepithelioma"""																																		Dom	yes		22	22q12	2130	Ewing sarcoma breakpoint region 1 (EWS)		"""L, M"""	0																																										SO:0001627	intron_variant				CCDS13851.1, CCDS13852.1, CCDS13852.2, CCDS54512.1, CCDS54513.1, CCDS54514.1	22q12.2	2013-05-24	2013-05-24		ENSG00000182944	ENSG00000182944	2130		"""RNA binding motif (RRM) containing"""	3508	protein-coding gene	gene with protein product		133450	"""Ewing sarcoma breakpoint region 1"""			1522903	Standard	NM_005243	NM_005243		Approved	EWS	uc003aev.3	Q01844	OTTHUMG00000151107	ENST00000414183.2:c.599+970G>A	chr22.hg19:g.29679516G>A			B0QYK1|Q5THL0|Q92635|Q96FE8|Q96MN4|Q96MX4|Q9BWA2	True	hg19	CCDS13852.2																																																																																			EWSR1-021	KNOWN	basic|appris_candidate_longest|CCDS	protein_coding		protein_coding	OTTHUMT00000358290.1		29.0		+	ENST00000414183.2
EWSR1	2130	__UNKNOWN__	__UNKNOWN__	22	29679524	29679524	__UNKNOWN__	Intron	SNP	G	G	T			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr22:29679524G>T	ENST00000414183.2	+	7	620				EWSR1_ENST00000397938.2_Intron|EWSR1_ENST00000332035.6_Intron|EWSR1_ENST00000333395.6_Intron|EWSR1_ENST00000331029.7_Intron|EWSR1_ENST00000332050.6_Intron|EWSR1_ENST00000406548.1_Intron			Q01844	EWS_HUMAN	EWS RNA-binding protein 1						regulation of transcription, DNA-templated (GO:0006355)|transcription, DNA-templated (GO:0006351)	cytoplasm (GO:0005737)|nucleus (GO:0005634)|plasma membrane (GO:0005886)	identical protein binding (GO:0042802)|nucleotide binding (GO:0000166)|poly(A) RNA binding (GO:0044822)|RNA binding (GO:0003723)|zinc ion binding (GO:0008270)		EWSR1/ATF1(347)|EWSR1/POU5F1(10)|EWSR1/PBX1(3)|EWSR1/DDIT3(45)|EWSR1/FEV(11)|EWSR1/CREB1(44)|EWSR1/SMARCA5(2)|EWSR1/ETV4(6)|EWSR1/ERG(178)|EWSR1/ZNF384(4)|EWSR1/ETV1(7)|EWSR1/FLI1(2569)|EWSR1/NR4A3(146)|EWSR1/SP3(3)|EWSR1/PATZ1(2)|EWSR1/WT1(234)|EWSR1/NFATC2(9)	breast(2)|central_nervous_system(1)|endometrium(6)|haematopoietic_and_lymphoid_tissue(1)|kidney(2)|large_intestine(1)|liver(1)|lung(6)|ovary(2)|skin(2)|upper_aerodigestive_tract(1)|urinary_tract(1)	26						ttgttttattgttgttttgag	0.498			T	"""FLI1, ERG, ZNF278, NR4A3, FEV, ATF1, ETV1, ETV4, WT1, ZNF384, CREB1, POU5F1,  PBX1"""	"""Ewing sarcoma,  desmoplastic small round cell tumor , ALL, clear cell sarcoma, sarcoma, myoepithelioma"""																																		Dom	yes		22	22q12	2130	Ewing sarcoma breakpoint region 1 (EWS)		"""L, M"""	0																																										SO:0001627	intron_variant				CCDS13851.1, CCDS13852.1, CCDS13852.2, CCDS54512.1, CCDS54513.1, CCDS54514.1	22q12.2	2013-05-24	2013-05-24		ENSG00000182944	ENSG00000182944	2130		"""RNA binding motif (RRM) containing"""	3508	protein-coding gene	gene with protein product		133450	"""Ewing sarcoma breakpoint region 1"""			1522903	Standard	NM_005243	NM_005243		Approved	EWS	uc003aev.3	Q01844	OTTHUMG00000151107	ENST00000414183.2:c.599+978G>T	chr22.hg19:g.29679524G>T			B0QYK1|Q5THL0|Q92635|Q96FE8|Q96MN4|Q96MX4|Q9BWA2	True	hg19	CCDS13852.2																																																																																			EWSR1-021	KNOWN	basic|appris_candidate_longest|CCDS	protein_coding		protein_coding	OTTHUMT00000358290.1		29.0		+	ENST00000414183.2
EWSR1	2130	__UNKNOWN__	__UNKNOWN__	22	29679527	29679527	__UNKNOWN__	Intron	SNP	G	G	A			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr22:29679527G>A	ENST00000414183.2	+	7	620				EWSR1_ENST00000397938.2_Intron|EWSR1_ENST00000332035.6_Intron|EWSR1_ENST00000333395.6_Intron|EWSR1_ENST00000331029.7_Intron|EWSR1_ENST00000332050.6_Intron|EWSR1_ENST00000406548.1_Intron			Q01844	EWS_HUMAN	EWS RNA-binding protein 1						regulation of transcription, DNA-templated (GO:0006355)|transcription, DNA-templated (GO:0006351)	cytoplasm (GO:0005737)|nucleus (GO:0005634)|plasma membrane (GO:0005886)	identical protein binding (GO:0042802)|nucleotide binding (GO:0000166)|poly(A) RNA binding (GO:0044822)|RNA binding (GO:0003723)|zinc ion binding (GO:0008270)		EWSR1/ATF1(347)|EWSR1/POU5F1(10)|EWSR1/PBX1(3)|EWSR1/DDIT3(45)|EWSR1/FEV(11)|EWSR1/CREB1(44)|EWSR1/SMARCA5(2)|EWSR1/ETV4(6)|EWSR1/ERG(178)|EWSR1/ZNF384(4)|EWSR1/ETV1(7)|EWSR1/FLI1(2569)|EWSR1/NR4A3(146)|EWSR1/SP3(3)|EWSR1/PATZ1(2)|EWSR1/WT1(234)|EWSR1/NFATC2(9)	breast(2)|central_nervous_system(1)|endometrium(6)|haematopoietic_and_lymphoid_tissue(1)|kidney(2)|large_intestine(1)|liver(1)|lung(6)|ovary(2)|skin(2)|upper_aerodigestive_tract(1)|urinary_tract(1)	26						ttttattgttgttttgagatg	0.502			T	"""FLI1, ERG, ZNF278, NR4A3, FEV, ATF1, ETV1, ETV4, WT1, ZNF384, CREB1, POU5F1,  PBX1"""	"""Ewing sarcoma,  desmoplastic small round cell tumor , ALL, clear cell sarcoma, sarcoma, myoepithelioma"""																																		Dom	yes		22	22q12	2130	Ewing sarcoma breakpoint region 1 (EWS)		"""L, M"""	0																																										SO:0001627	intron_variant				CCDS13851.1, CCDS13852.1, CCDS13852.2, CCDS54512.1, CCDS54513.1, CCDS54514.1	22q12.2	2013-05-24	2013-05-24		ENSG00000182944	ENSG00000182944	2130		"""RNA binding motif (RRM) containing"""	3508	protein-coding gene	gene with protein product		133450	"""Ewing sarcoma breakpoint region 1"""			1522903	Standard	NM_005243	NM_005243		Approved	EWS	uc003aev.3	Q01844	OTTHUMG00000151107	ENST00000414183.2:c.599+981G>A	chr22.hg19:g.29679527G>A			B0QYK1|Q5THL0|Q92635|Q96FE8|Q96MN4|Q96MX4|Q9BWA2	True	hg19	CCDS13852.2																																																																																			EWSR1-021	KNOWN	basic|appris_candidate_longest|CCDS	protein_coding		protein_coding	OTTHUMT00000358290.1		29.0		+	ENST00000414183.2
EWSR1	2130	__UNKNOWN__	__UNKNOWN__	22	29680188	29680188	__UNKNOWN__	Intron	SNP	G	G	A			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr22:29680188G>A	ENST00000414183.2	+	7	620				EWSR1_ENST00000397938.2_Intron|EWSR1_ENST00000332035.6_Intron|EWSR1_ENST00000333395.6_Intron|EWSR1_ENST00000331029.7_Intron|EWSR1_ENST00000332050.6_Intron|EWSR1_ENST00000406548.1_Intron			Q01844	EWS_HUMAN	EWS RNA-binding protein 1						regulation of transcription, DNA-templated (GO:0006355)|transcription, DNA-templated (GO:0006351)	cytoplasm (GO:0005737)|nucleus (GO:0005634)|plasma membrane (GO:0005886)	identical protein binding (GO:0042802)|nucleotide binding (GO:0000166)|poly(A) RNA binding (GO:0044822)|RNA binding (GO:0003723)|zinc ion binding (GO:0008270)		EWSR1/ATF1(347)|EWSR1/POU5F1(10)|EWSR1/PBX1(3)|EWSR1/DDIT3(45)|EWSR1/FEV(11)|EWSR1/CREB1(44)|EWSR1/SMARCA5(2)|EWSR1/ETV4(6)|EWSR1/ERG(178)|EWSR1/ZNF384(4)|EWSR1/ETV1(7)|EWSR1/FLI1(2569)|EWSR1/NR4A3(146)|EWSR1/SP3(3)|EWSR1/PATZ1(2)|EWSR1/WT1(234)|EWSR1/NFATC2(9)	breast(2)|central_nervous_system(1)|endometrium(6)|haematopoietic_and_lymphoid_tissue(1)|kidney(2)|large_intestine(1)|liver(1)|lung(6)|ovary(2)|skin(2)|upper_aerodigestive_tract(1)|urinary_tract(1)	26						tgaactcctggcctcaagtga	0.522			T	"""FLI1, ERG, ZNF278, NR4A3, FEV, ATF1, ETV1, ETV4, WT1, ZNF384, CREB1, POU5F1,  PBX1"""	"""Ewing sarcoma,  desmoplastic small round cell tumor , ALL, clear cell sarcoma, sarcoma, myoepithelioma"""																																		Dom	yes		22	22q12	2130	Ewing sarcoma breakpoint region 1 (EWS)		"""L, M"""	0																																										SO:0001627	intron_variant				CCDS13851.1, CCDS13852.1, CCDS13852.2, CCDS54512.1, CCDS54513.1, CCDS54514.1	22q12.2	2013-05-24	2013-05-24		ENSG00000182944	ENSG00000182944	2130		"""RNA binding motif (RRM) containing"""	3508	protein-coding gene	gene with protein product		133450	"""Ewing sarcoma breakpoint region 1"""			1522903	Standard	NM_005243	NM_005243		Approved	EWS	uc003aev.3	Q01844	OTTHUMG00000151107	ENST00000414183.2:c.599+1642G>A	chr22.hg19:g.29680188G>A			B0QYK1|Q5THL0|Q92635|Q96FE8|Q96MN4|Q96MX4|Q9BWA2	True	hg19	CCDS13852.2																																																																																			EWSR1-021	KNOWN	basic|appris_candidate_longest|CCDS	protein_coding		protein_coding	OTTHUMT00000358290.1		20.0		+	ENST00000414183.2
EWSR1	2130	__UNKNOWN__	__UNKNOWN__	22	29680863	29680863	__UNKNOWN__	Intron	SNP	C	C	A			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr22:29680863C>A	ENST00000414183.2	+	8	620				EWSR1_ENST00000397938.2_Intron|EWSR1_ENST00000332035.6_Intron|EWSR1_ENST00000333395.6_Intron|EWSR1_ENST00000331029.7_Intron|EWSR1_ENST00000332050.6_Intron|EWSR1_ENST00000406548.1_Intron			Q01844	EWS_HUMAN	EWS RNA-binding protein 1						regulation of transcription, DNA-templated (GO:0006355)|transcription, DNA-templated (GO:0006351)	cytoplasm (GO:0005737)|nucleus (GO:0005634)|plasma membrane (GO:0005886)	identical protein binding (GO:0042802)|nucleotide binding (GO:0000166)|poly(A) RNA binding (GO:0044822)|RNA binding (GO:0003723)|zinc ion binding (GO:0008270)		EWSR1/ATF1(347)|EWSR1/POU5F1(10)|EWSR1/PBX1(3)|EWSR1/DDIT3(45)|EWSR1/FEV(11)|EWSR1/CREB1(44)|EWSR1/SMARCA5(2)|EWSR1/ETV4(6)|EWSR1/ERG(178)|EWSR1/ZNF384(4)|EWSR1/ETV1(7)|EWSR1/FLI1(2569)|EWSR1/NR4A3(146)|EWSR1/SP3(3)|EWSR1/PATZ1(2)|EWSR1/WT1(234)|EWSR1/NFATC2(9)	breast(2)|central_nervous_system(1)|endometrium(6)|haematopoietic_and_lymphoid_tissue(1)|kidney(2)|large_intestine(1)|liver(1)|lung(6)|ovary(2)|skin(2)|upper_aerodigestive_tract(1)|urinary_tract(1)	26						ggctggagtgcaatggtgcga	0.458			T	"""FLI1, ERG, ZNF278, NR4A3, FEV, ATF1, ETV1, ETV4, WT1, ZNF384, CREB1, POU5F1,  PBX1"""	"""Ewing sarcoma,  desmoplastic small round cell tumor , ALL, clear cell sarcoma, sarcoma, myoepithelioma"""																																		Dom	yes		22	22q12	2130	Ewing sarcoma breakpoint region 1 (EWS)		"""L, M"""	0																																										SO:0001627	intron_variant				CCDS13851.1, CCDS13852.1, CCDS13852.2, CCDS54512.1, CCDS54513.1, CCDS54514.1	22q12.2	2013-05-24	2013-05-24		ENSG00000182944	ENSG00000182944	2130		"""RNA binding motif (RRM) containing"""	3508	protein-coding gene	gene with protein product		133450	"""Ewing sarcoma breakpoint region 1"""			1522903	Standard	NM_005243	NM_005243		Approved	EWS	uc003aev.3	Q01844	OTTHUMG00000151107	ENST00000414183.2:c.600-2049C>A	chr22.hg19:g.29680863C>A			B0QYK1|Q5THL0|Q92635|Q96FE8|Q96MN4|Q96MX4|Q9BWA2	True	hg19	CCDS13852.2																																																																																			EWSR1-021	KNOWN	basic|appris_candidate_longest|CCDS	protein_coding		protein_coding	OTTHUMT00000358290.1		32.0		+	ENST00000414183.2
EWSR1	2130	__UNKNOWN__	__UNKNOWN__	22	29682258	29682258	__UNKNOWN__	Intron	SNP	A	A	G			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr22:29682258A>G	ENST00000414183.2	+	8	620				EWSR1_ENST00000397938.2_Intron|EWSR1_ENST00000332035.6_Intron|EWSR1_ENST00000333395.6_Intron|EWSR1_ENST00000331029.7_Intron|EWSR1_ENST00000332050.6_Intron|EWSR1_ENST00000406548.1_Intron			Q01844	EWS_HUMAN	EWS RNA-binding protein 1						regulation of transcription, DNA-templated (GO:0006355)|transcription, DNA-templated (GO:0006351)	cytoplasm (GO:0005737)|nucleus (GO:0005634)|plasma membrane (GO:0005886)	identical protein binding (GO:0042802)|nucleotide binding (GO:0000166)|poly(A) RNA binding (GO:0044822)|RNA binding (GO:0003723)|zinc ion binding (GO:0008270)		EWSR1/ATF1(347)|EWSR1/POU5F1(10)|EWSR1/PBX1(3)|EWSR1/DDIT3(45)|EWSR1/FEV(11)|EWSR1/CREB1(44)|EWSR1/SMARCA5(2)|EWSR1/ETV4(6)|EWSR1/ERG(178)|EWSR1/ZNF384(4)|EWSR1/ETV1(7)|EWSR1/FLI1(2569)|EWSR1/NR4A3(146)|EWSR1/SP3(3)|EWSR1/PATZ1(2)|EWSR1/WT1(234)|EWSR1/NFATC2(9)	breast(2)|central_nervous_system(1)|endometrium(6)|haematopoietic_and_lymphoid_tissue(1)|kidney(2)|large_intestine(1)|liver(1)|lung(6)|ovary(2)|skin(2)|upper_aerodigestive_tract(1)|urinary_tract(1)	26						ccccagcctcagccttccaaa	0.517			T	"""FLI1, ERG, ZNF278, NR4A3, FEV, ATF1, ETV1, ETV4, WT1, ZNF384, CREB1, POU5F1,  PBX1"""	"""Ewing sarcoma,  desmoplastic small round cell tumor , ALL, clear cell sarcoma, sarcoma, myoepithelioma"""																																		Dom	yes		22	22q12	2130	Ewing sarcoma breakpoint region 1 (EWS)		"""L, M"""	0																																										SO:0001627	intron_variant				CCDS13851.1, CCDS13852.1, CCDS13852.2, CCDS54512.1, CCDS54513.1, CCDS54514.1	22q12.2	2013-05-24	2013-05-24		ENSG00000182944	ENSG00000182944	2130		"""RNA binding motif (RRM) containing"""	3508	protein-coding gene	gene with protein product		133450	"""Ewing sarcoma breakpoint region 1"""			1522903	Standard	NM_005243	NM_005243		Approved	EWS	uc003aev.3	Q01844	OTTHUMG00000151107	ENST00000414183.2:c.600-654A>G	chr22.hg19:g.29682258A>G			B0QYK1|Q5THL0|Q92635|Q96FE8|Q96MN4|Q96MX4|Q9BWA2	True	hg19	CCDS13852.2																																																																																			EWSR1-021	KNOWN	basic|appris_candidate_longest|CCDS	protein_coding		protein_coding	OTTHUMT00000358290.1		21.0		+	ENST00000414183.2
EWSR1	2130	__UNKNOWN__	__UNKNOWN__	22	29682438	29682438	__UNKNOWN__	Intron	SNP	G	G	A			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr22:29682438G>A	ENST00000414183.2	+	8	620				EWSR1_ENST00000397938.2_Intron|EWSR1_ENST00000332035.6_Intron|EWSR1_ENST00000333395.6_Intron|EWSR1_ENST00000331029.7_Intron|EWSR1_ENST00000332050.6_Intron|EWSR1_ENST00000406548.1_Intron			Q01844	EWS_HUMAN	EWS RNA-binding protein 1						regulation of transcription, DNA-templated (GO:0006355)|transcription, DNA-templated (GO:0006351)	cytoplasm (GO:0005737)|nucleus (GO:0005634)|plasma membrane (GO:0005886)	identical protein binding (GO:0042802)|nucleotide binding (GO:0000166)|poly(A) RNA binding (GO:0044822)|RNA binding (GO:0003723)|zinc ion binding (GO:0008270)		EWSR1/ATF1(347)|EWSR1/POU5F1(10)|EWSR1/PBX1(3)|EWSR1/DDIT3(45)|EWSR1/FEV(11)|EWSR1/CREB1(44)|EWSR1/SMARCA5(2)|EWSR1/ETV4(6)|EWSR1/ERG(178)|EWSR1/ZNF384(4)|EWSR1/ETV1(7)|EWSR1/FLI1(2569)|EWSR1/NR4A3(146)|EWSR1/SP3(3)|EWSR1/PATZ1(2)|EWSR1/WT1(234)|EWSR1/NFATC2(9)	breast(2)|central_nervous_system(1)|endometrium(6)|haematopoietic_and_lymphoid_tissue(1)|kidney(2)|large_intestine(1)|liver(1)|lung(6)|ovary(2)|skin(2)|upper_aerodigestive_tract(1)|urinary_tract(1)	26						agcactttgggaggccgaggt	0.478			T	"""FLI1, ERG, ZNF278, NR4A3, FEV, ATF1, ETV1, ETV4, WT1, ZNF384, CREB1, POU5F1,  PBX1"""	"""Ewing sarcoma,  desmoplastic small round cell tumor , ALL, clear cell sarcoma, sarcoma, myoepithelioma"""																																		Dom	yes		22	22q12	2130	Ewing sarcoma breakpoint region 1 (EWS)		"""L, M"""	0																																										SO:0001627	intron_variant				CCDS13851.1, CCDS13852.1, CCDS13852.2, CCDS54512.1, CCDS54513.1, CCDS54514.1	22q12.2	2013-05-24	2013-05-24		ENSG00000182944	ENSG00000182944	2130		"""RNA binding motif (RRM) containing"""	3508	protein-coding gene	gene with protein product		133450	"""Ewing sarcoma breakpoint region 1"""			1522903	Standard	NM_005243	NM_005243		Approved	EWS	uc003aev.3	Q01844	OTTHUMG00000151107	ENST00000414183.2:c.600-474G>A	chr22.hg19:g.29682438G>A			B0QYK1|Q5THL0|Q92635|Q96FE8|Q96MN4|Q96MX4|Q9BWA2	True	hg19	CCDS13852.2																																																																																			EWSR1-021	KNOWN	basic|appris_candidate_longest|CCDS	protein_coding		protein_coding	OTTHUMT00000358290.1		41.0		+	ENST00000414183.2
EWSR1	2130	__UNKNOWN__	__UNKNOWN__	22	29682590	29682590	__UNKNOWN__	Intron	SNP	G	G	T			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr22:29682590G>T	ENST00000414183.2	+	8	620				EWSR1_ENST00000397938.2_Intron|EWSR1_ENST00000332035.6_Intron|EWSR1_ENST00000333395.6_Intron|EWSR1_ENST00000331029.7_Intron|EWSR1_ENST00000332050.6_Intron|EWSR1_ENST00000406548.1_Intron			Q01844	EWS_HUMAN	EWS RNA-binding protein 1						regulation of transcription, DNA-templated (GO:0006355)|transcription, DNA-templated (GO:0006351)	cytoplasm (GO:0005737)|nucleus (GO:0005634)|plasma membrane (GO:0005886)	identical protein binding (GO:0042802)|nucleotide binding (GO:0000166)|poly(A) RNA binding (GO:0044822)|RNA binding (GO:0003723)|zinc ion binding (GO:0008270)		EWSR1/ATF1(347)|EWSR1/POU5F1(10)|EWSR1/PBX1(3)|EWSR1/DDIT3(45)|EWSR1/FEV(11)|EWSR1/CREB1(44)|EWSR1/SMARCA5(2)|EWSR1/ETV4(6)|EWSR1/ERG(178)|EWSR1/ZNF384(4)|EWSR1/ETV1(7)|EWSR1/FLI1(2569)|EWSR1/NR4A3(146)|EWSR1/SP3(3)|EWSR1/PATZ1(2)|EWSR1/WT1(234)|EWSR1/NFATC2(9)	breast(2)|central_nervous_system(1)|endometrium(6)|haematopoietic_and_lymphoid_tissue(1)|kidney(2)|large_intestine(1)|liver(1)|lung(6)|ovary(2)|skin(2)|upper_aerodigestive_tract(1)|urinary_tract(1)	26						gcaggagaatggcatgaaccc	0.512			T	"""FLI1, ERG, ZNF278, NR4A3, FEV, ATF1, ETV1, ETV4, WT1, ZNF384, CREB1, POU5F1,  PBX1"""	"""Ewing sarcoma,  desmoplastic small round cell tumor , ALL, clear cell sarcoma, sarcoma, myoepithelioma"""																																		Dom	yes		22	22q12	2130	Ewing sarcoma breakpoint region 1 (EWS)		"""L, M"""	0																																										SO:0001627	intron_variant				CCDS13851.1, CCDS13852.1, CCDS13852.2, CCDS54512.1, CCDS54513.1, CCDS54514.1	22q12.2	2013-05-24	2013-05-24		ENSG00000182944	ENSG00000182944	2130		"""RNA binding motif (RRM) containing"""	3508	protein-coding gene	gene with protein product		133450	"""Ewing sarcoma breakpoint region 1"""			1522903	Standard	NM_005243	NM_005243		Approved	EWS	uc003aev.3	Q01844	OTTHUMG00000151107	ENST00000414183.2:c.600-322G>T	chr22.hg19:g.29682590G>T			B0QYK1|Q5THL0|Q92635|Q96FE8|Q96MN4|Q96MX4|Q9BWA2	True	hg19	CCDS13852.2																																																																																			EWSR1-021	KNOWN	basic|appris_candidate_longest|CCDS	protein_coding		protein_coding	OTTHUMT00000358290.1		24.0		+	ENST00000414183.2
EWSR1	2130	__UNKNOWN__	__UNKNOWN__	22	29682593	29682593	__UNKNOWN__	Intron	SNP	A	A	T			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr22:29682593A>T	ENST00000414183.2	+	8	620				EWSR1_ENST00000397938.2_Intron|EWSR1_ENST00000332035.6_Intron|EWSR1_ENST00000333395.6_Intron|EWSR1_ENST00000331029.7_Intron|EWSR1_ENST00000332050.6_Intron|EWSR1_ENST00000406548.1_Intron			Q01844	EWS_HUMAN	EWS RNA-binding protein 1						regulation of transcription, DNA-templated (GO:0006355)|transcription, DNA-templated (GO:0006351)	cytoplasm (GO:0005737)|nucleus (GO:0005634)|plasma membrane (GO:0005886)	identical protein binding (GO:0042802)|nucleotide binding (GO:0000166)|poly(A) RNA binding (GO:0044822)|RNA binding (GO:0003723)|zinc ion binding (GO:0008270)		EWSR1/ATF1(347)|EWSR1/POU5F1(10)|EWSR1/PBX1(3)|EWSR1/DDIT3(45)|EWSR1/FEV(11)|EWSR1/CREB1(44)|EWSR1/SMARCA5(2)|EWSR1/ETV4(6)|EWSR1/ERG(178)|EWSR1/ZNF384(4)|EWSR1/ETV1(7)|EWSR1/FLI1(2569)|EWSR1/NR4A3(146)|EWSR1/SP3(3)|EWSR1/PATZ1(2)|EWSR1/WT1(234)|EWSR1/NFATC2(9)	breast(2)|central_nervous_system(1)|endometrium(6)|haematopoietic_and_lymphoid_tissue(1)|kidney(2)|large_intestine(1)|liver(1)|lung(6)|ovary(2)|skin(2)|upper_aerodigestive_tract(1)|urinary_tract(1)	26						ggagaatggcatgaacccggg	0.507			T	"""FLI1, ERG, ZNF278, NR4A3, FEV, ATF1, ETV1, ETV4, WT1, ZNF384, CREB1, POU5F1,  PBX1"""	"""Ewing sarcoma,  desmoplastic small round cell tumor , ALL, clear cell sarcoma, sarcoma, myoepithelioma"""																																		Dom	yes		22	22q12	2130	Ewing sarcoma breakpoint region 1 (EWS)		"""L, M"""	0																																										SO:0001627	intron_variant				CCDS13851.1, CCDS13852.1, CCDS13852.2, CCDS54512.1, CCDS54513.1, CCDS54514.1	22q12.2	2013-05-24	2013-05-24		ENSG00000182944	ENSG00000182944	2130		"""RNA binding motif (RRM) containing"""	3508	protein-coding gene	gene with protein product		133450	"""Ewing sarcoma breakpoint region 1"""			1522903	Standard	NM_005243	NM_005243		Approved	EWS	uc003aev.3	Q01844	OTTHUMG00000151107	ENST00000414183.2:c.600-319A>T	chr22.hg19:g.29682593A>T			B0QYK1|Q5THL0|Q92635|Q96FE8|Q96MN4|Q96MX4|Q9BWA2	True	hg19	CCDS13852.2																																																																																			EWSR1-021	KNOWN	basic|appris_candidate_longest|CCDS	protein_coding		protein_coding	OTTHUMT00000358290.1		21.0		+	ENST00000414183.2
EWSR1	2130	__UNKNOWN__	__UNKNOWN__	22	29683377	29683377	__UNKNOWN__	Intron	SNP	C	C	G			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr22:29683377C>G	ENST00000414183.2	+	8	832				EWSR1_ENST00000397938.2_Intron|EWSR1_ENST00000332035.6_Intron|EWSR1_ENST00000333395.6_Intron|EWSR1_ENST00000331029.7_Intron|EWSR1_ENST00000332050.6_Intron|EWSR1_ENST00000406548.1_Intron			Q01844	EWS_HUMAN	EWS RNA-binding protein 1						regulation of transcription, DNA-templated (GO:0006355)|transcription, DNA-templated (GO:0006351)	cytoplasm (GO:0005737)|nucleus (GO:0005634)|plasma membrane (GO:0005886)	identical protein binding (GO:0042802)|nucleotide binding (GO:0000166)|poly(A) RNA binding (GO:0044822)|RNA binding (GO:0003723)|zinc ion binding (GO:0008270)		EWSR1/ATF1(347)|EWSR1/POU5F1(10)|EWSR1/PBX1(3)|EWSR1/DDIT3(45)|EWSR1/FEV(11)|EWSR1/CREB1(44)|EWSR1/SMARCA5(2)|EWSR1/ETV4(6)|EWSR1/ERG(178)|EWSR1/ZNF384(4)|EWSR1/ETV1(7)|EWSR1/FLI1(2569)|EWSR1/NR4A3(146)|EWSR1/SP3(3)|EWSR1/PATZ1(2)|EWSR1/WT1(234)|EWSR1/NFATC2(9)	breast(2)|central_nervous_system(1)|endometrium(6)|haematopoietic_and_lymphoid_tissue(1)|kidney(2)|large_intestine(1)|liver(1)|lung(6)|ovary(2)|skin(2)|upper_aerodigestive_tract(1)|urinary_tract(1)	26						ttgtatttttcgtagagacgg	0.552			T	"""FLI1, ERG, ZNF278, NR4A3, FEV, ATF1, ETV1, ETV4, WT1, ZNF384, CREB1, POU5F1,  PBX1"""	"""Ewing sarcoma,  desmoplastic small round cell tumor , ALL, clear cell sarcoma, sarcoma, myoepithelioma"""																																		Dom	yes		22	22q12	2130	Ewing sarcoma breakpoint region 1 (EWS)		"""L, M"""	0																																										SO:0001627	intron_variant				CCDS13851.1, CCDS13852.1, CCDS13852.2, CCDS54512.1, CCDS54513.1, CCDS54514.1	22q12.2	2013-05-24	2013-05-24		ENSG00000182944	ENSG00000182944	2130		"""RNA binding motif (RRM) containing"""	3508	protein-coding gene	gene with protein product		133450	"""Ewing sarcoma breakpoint region 1"""			1522903	Standard	NM_005243	NM_005243		Approved	EWS	uc003aev.3	Q01844	OTTHUMG00000151107	ENST00000414183.2:c.811+254C>G	chr22.hg19:g.29683377C>G			B0QYK1|Q5THL0|Q92635|Q96FE8|Q96MN4|Q96MX4|Q9BWA2	True	hg19	CCDS13852.2																																																																																			EWSR1-021	KNOWN	basic|appris_candidate_longest|CCDS	protein_coding		protein_coding	OTTHUMT00000358290.1		27.0		+	ENST00000414183.2
EWSR1	2130	__UNKNOWN__	__UNKNOWN__	22	29683379	29683379	__UNKNOWN__	Intron	SNP	T	T	C			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr22:29683379T>C	ENST00000414183.2	+	8	832				EWSR1_ENST00000397938.2_Intron|EWSR1_ENST00000332035.6_Intron|EWSR1_ENST00000333395.6_Intron|EWSR1_ENST00000331029.7_Intron|EWSR1_ENST00000332050.6_Intron|EWSR1_ENST00000406548.1_Intron			Q01844	EWS_HUMAN	EWS RNA-binding protein 1						regulation of transcription, DNA-templated (GO:0006355)|transcription, DNA-templated (GO:0006351)	cytoplasm (GO:0005737)|nucleus (GO:0005634)|plasma membrane (GO:0005886)	identical protein binding (GO:0042802)|nucleotide binding (GO:0000166)|poly(A) RNA binding (GO:0044822)|RNA binding (GO:0003723)|zinc ion binding (GO:0008270)		EWSR1/ATF1(347)|EWSR1/POU5F1(10)|EWSR1/PBX1(3)|EWSR1/DDIT3(45)|EWSR1/FEV(11)|EWSR1/CREB1(44)|EWSR1/SMARCA5(2)|EWSR1/ETV4(6)|EWSR1/ERG(178)|EWSR1/ZNF384(4)|EWSR1/ETV1(7)|EWSR1/FLI1(2569)|EWSR1/NR4A3(146)|EWSR1/SP3(3)|EWSR1/PATZ1(2)|EWSR1/WT1(234)|EWSR1/NFATC2(9)	breast(2)|central_nervous_system(1)|endometrium(6)|haematopoietic_and_lymphoid_tissue(1)|kidney(2)|large_intestine(1)|liver(1)|lung(6)|ovary(2)|skin(2)|upper_aerodigestive_tract(1)|urinary_tract(1)	26						gtatttttcgtagagacgggg	0.552			T	"""FLI1, ERG, ZNF278, NR4A3, FEV, ATF1, ETV1, ETV4, WT1, ZNF384, CREB1, POU5F1,  PBX1"""	"""Ewing sarcoma,  desmoplastic small round cell tumor , ALL, clear cell sarcoma, sarcoma, myoepithelioma"""																																		Dom	yes		22	22q12	2130	Ewing sarcoma breakpoint region 1 (EWS)		"""L, M"""	0																																										SO:0001627	intron_variant				CCDS13851.1, CCDS13852.1, CCDS13852.2, CCDS54512.1, CCDS54513.1, CCDS54514.1	22q12.2	2013-05-24	2013-05-24		ENSG00000182944	ENSG00000182944	2130		"""RNA binding motif (RRM) containing"""	3508	protein-coding gene	gene with protein product		133450	"""Ewing sarcoma breakpoint region 1"""			1522903	Standard	NM_005243	NM_005243		Approved	EWS	uc003aev.3	Q01844	OTTHUMG00000151107	ENST00000414183.2:c.811+256T>C	chr22.hg19:g.29683379T>C			B0QYK1|Q5THL0|Q92635|Q96FE8|Q96MN4|Q96MX4|Q9BWA2	True	hg19	CCDS13852.2																																																																																			EWSR1-021	KNOWN	basic|appris_candidate_longest|CCDS	protein_coding		protein_coding	OTTHUMT00000358290.1		35.0		+	ENST00000414183.2
EWSR1	2130	__UNKNOWN__	__UNKNOWN__	22	29683380	29683380	__UNKNOWN__	Intron	SNP	A	A	T			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr22:29683380A>T	ENST00000414183.2	+	8	832				EWSR1_ENST00000397938.2_Intron|EWSR1_ENST00000332035.6_Intron|EWSR1_ENST00000333395.6_Intron|EWSR1_ENST00000331029.7_Intron|EWSR1_ENST00000332050.6_Intron|EWSR1_ENST00000406548.1_Intron			Q01844	EWS_HUMAN	EWS RNA-binding protein 1						regulation of transcription, DNA-templated (GO:0006355)|transcription, DNA-templated (GO:0006351)	cytoplasm (GO:0005737)|nucleus (GO:0005634)|plasma membrane (GO:0005886)	identical protein binding (GO:0042802)|nucleotide binding (GO:0000166)|poly(A) RNA binding (GO:0044822)|RNA binding (GO:0003723)|zinc ion binding (GO:0008270)		EWSR1/ATF1(347)|EWSR1/POU5F1(10)|EWSR1/PBX1(3)|EWSR1/DDIT3(45)|EWSR1/FEV(11)|EWSR1/CREB1(44)|EWSR1/SMARCA5(2)|EWSR1/ETV4(6)|EWSR1/ERG(178)|EWSR1/ZNF384(4)|EWSR1/ETV1(7)|EWSR1/FLI1(2569)|EWSR1/NR4A3(146)|EWSR1/SP3(3)|EWSR1/PATZ1(2)|EWSR1/WT1(234)|EWSR1/NFATC2(9)	breast(2)|central_nervous_system(1)|endometrium(6)|haematopoietic_and_lymphoid_tissue(1)|kidney(2)|large_intestine(1)|liver(1)|lung(6)|ovary(2)|skin(2)|upper_aerodigestive_tract(1)|urinary_tract(1)	26						tatttttcgtagagacggggt	0.547			T	"""FLI1, ERG, ZNF278, NR4A3, FEV, ATF1, ETV1, ETV4, WT1, ZNF384, CREB1, POU5F1,  PBX1"""	"""Ewing sarcoma,  desmoplastic small round cell tumor , ALL, clear cell sarcoma, sarcoma, myoepithelioma"""																																		Dom	yes		22	22q12	2130	Ewing sarcoma breakpoint region 1 (EWS)		"""L, M"""	0																																										SO:0001627	intron_variant				CCDS13851.1, CCDS13852.1, CCDS13852.2, CCDS54512.1, CCDS54513.1, CCDS54514.1	22q12.2	2013-05-24	2013-05-24		ENSG00000182944	ENSG00000182944	2130		"""RNA binding motif (RRM) containing"""	3508	protein-coding gene	gene with protein product		133450	"""Ewing sarcoma breakpoint region 1"""			1522903	Standard	NM_005243	NM_005243		Approved	EWS	uc003aev.3	Q01844	OTTHUMG00000151107	ENST00000414183.2:c.811+257A>T	chr22.hg19:g.29683380A>T			B0QYK1|Q5THL0|Q92635|Q96FE8|Q96MN4|Q96MX4|Q9BWA2	True	hg19	CCDS13852.2																																																																																			EWSR1-021	KNOWN	basic|appris_candidate_longest|CCDS	protein_coding		protein_coding	OTTHUMT00000358290.1		25.0		+	ENST00000414183.2
EWSR1	2130	__UNKNOWN__	__UNKNOWN__	22	29683922	29683923	__UNKNOWN__	Intron	DEL	GG	GG	-			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr22:29683922_29683923delGG	ENST00000414183.2	+	9	832				EWSR1_ENST00000397938.2_Intron|EWSR1_ENST00000332035.6_Intron|EWSR1_ENST00000333395.6_Intron|EWSR1_ENST00000331029.7_Intron|EWSR1_ENST00000332050.6_Intron|EWSR1_ENST00000406548.1_Intron			Q01844	EWS_HUMAN	EWS RNA-binding protein 1						regulation of transcription, DNA-templated (GO:0006355)|transcription, DNA-templated (GO:0006351)	cytoplasm (GO:0005737)|nucleus (GO:0005634)|plasma membrane (GO:0005886)	identical protein binding (GO:0042802)|nucleotide binding (GO:0000166)|poly(A) RNA binding (GO:0044822)|RNA binding (GO:0003723)|zinc ion binding (GO:0008270)		EWSR1/ATF1(347)|EWSR1/POU5F1(10)|EWSR1/PBX1(3)|EWSR1/DDIT3(45)|EWSR1/FEV(11)|EWSR1/CREB1(44)|EWSR1/SMARCA5(2)|EWSR1/ETV4(6)|EWSR1/ERG(178)|EWSR1/ZNF384(4)|EWSR1/ETV1(7)|EWSR1/FLI1(2569)|EWSR1/NR4A3(146)|EWSR1/SP3(3)|EWSR1/PATZ1(2)|EWSR1/WT1(234)|EWSR1/NFATC2(9)	breast(2)|central_nervous_system(1)|endometrium(6)|haematopoietic_and_lymphoid_tissue(1)|kidney(2)|large_intestine(1)|liver(1)|lung(6)|ovary(2)|skin(2)|upper_aerodigestive_tract(1)|urinary_tract(1)	26						ccagcactttgggggaggccaa	0.436			T	"""FLI1, ERG, ZNF278, NR4A3, FEV, ATF1, ETV1, ETV4, WT1, ZNF384, CREB1, POU5F1,  PBX1"""	"""Ewing sarcoma,  desmoplastic small round cell tumor , ALL, clear cell sarcoma, sarcoma, myoepithelioma"""																																		Dom	yes		22	22q12	2130	Ewing sarcoma breakpoint region 1 (EWS)		"""L, M"""	0																																										SO:0001627	intron_variant				CCDS13851.1, CCDS13852.1, CCDS13852.2, CCDS54512.1, CCDS54513.1, CCDS54514.1	22q12.2	2013-05-24	2013-05-24		ENSG00000182944	ENSG00000182944	2130		"""RNA binding motif (RRM) containing"""	3508	protein-coding gene	gene with protein product		133450	"""Ewing sarcoma breakpoint region 1"""			1522903	Standard	NM_005243	NM_005243		Approved	EWS	uc003aev.3	Q01844	OTTHUMG00000151107	ENST00000414183.2:c.812-672GG>-	chr22.hg19:g.29683924_29683925delGG			B0QYK1|Q5THL0|Q92635|Q96FE8|Q96MN4|Q96MX4|Q9BWA2	True	hg19	CCDS13852.2																																																																																			EWSR1-021	KNOWN	basic|appris_candidate_longest|CCDS	protein_coding		protein_coding	OTTHUMT00000358290.1		45.0		+	ENST00000414183.2
EWSR1	2130	__UNKNOWN__	__UNKNOWN__	22	29683932	29683932	__UNKNOWN__	Intron	SNP	A	A	G			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr22:29683932A>G	ENST00000414183.2	+	9	832				EWSR1_ENST00000397938.2_Intron|EWSR1_ENST00000332035.6_Intron|EWSR1_ENST00000333395.6_Intron|EWSR1_ENST00000331029.7_Intron|EWSR1_ENST00000332050.6_Intron|EWSR1_ENST00000406548.1_Intron			Q01844	EWS_HUMAN	EWS RNA-binding protein 1						regulation of transcription, DNA-templated (GO:0006355)|transcription, DNA-templated (GO:0006351)	cytoplasm (GO:0005737)|nucleus (GO:0005634)|plasma membrane (GO:0005886)	identical protein binding (GO:0042802)|nucleotide binding (GO:0000166)|poly(A) RNA binding (GO:0044822)|RNA binding (GO:0003723)|zinc ion binding (GO:0008270)		EWSR1/ATF1(347)|EWSR1/POU5F1(10)|EWSR1/PBX1(3)|EWSR1/DDIT3(45)|EWSR1/FEV(11)|EWSR1/CREB1(44)|EWSR1/SMARCA5(2)|EWSR1/ETV4(6)|EWSR1/ERG(178)|EWSR1/ZNF384(4)|EWSR1/ETV1(7)|EWSR1/FLI1(2569)|EWSR1/NR4A3(146)|EWSR1/SP3(3)|EWSR1/PATZ1(2)|EWSR1/WT1(234)|EWSR1/NFATC2(9)	breast(2)|central_nervous_system(1)|endometrium(6)|haematopoietic_and_lymphoid_tissue(1)|kidney(2)|large_intestine(1)|liver(1)|lung(6)|ovary(2)|skin(2)|upper_aerodigestive_tract(1)|urinary_tract(1)	26						gggggaggccaaggcaggagg	0.428			T	"""FLI1, ERG, ZNF278, NR4A3, FEV, ATF1, ETV1, ETV4, WT1, ZNF384, CREB1, POU5F1,  PBX1"""	"""Ewing sarcoma,  desmoplastic small round cell tumor , ALL, clear cell sarcoma, sarcoma, myoepithelioma"""																																		Dom	yes		22	22q12	2130	Ewing sarcoma breakpoint region 1 (EWS)		"""L, M"""	0																																										SO:0001627	intron_variant				CCDS13851.1, CCDS13852.1, CCDS13852.2, CCDS54512.1, CCDS54513.1, CCDS54514.1	22q12.2	2013-05-24	2013-05-24		ENSG00000182944	ENSG00000182944	2130		"""RNA binding motif (RRM) containing"""	3508	protein-coding gene	gene with protein product		133450	"""Ewing sarcoma breakpoint region 1"""			1522903	Standard	NM_005243	NM_005243		Approved	EWS	uc003aev.3	Q01844	OTTHUMG00000151107	ENST00000414183.2:c.812-663A>G	chr22.hg19:g.29683932A>G			B0QYK1|Q5THL0|Q92635|Q96FE8|Q96MN4|Q96MX4|Q9BWA2	True	hg19	CCDS13852.2																																																																																			EWSR1-021	KNOWN	basic|appris_candidate_longest|CCDS	protein_coding		protein_coding	OTTHUMT00000358290.1		40.0		+	ENST00000414183.2
EWSR1	2130	__UNKNOWN__	__UNKNOWN__	22	29683971	29683971	__UNKNOWN__	Intron	SNP	C	C	G			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chr22:29683971C>G	ENST00000414183.2	+	9	832				EWSR1_ENST00000397938.2_Intron|EWSR1_ENST00000332035.6_Intron|EWSR1_ENST00000333395.6_Intron|EWSR1_ENST00000331029.7_Intron|EWSR1_ENST00000332050.6_Intron|EWSR1_ENST00000406548.1_Intron			Q01844	EWS_HUMAN	EWS RNA-binding protein 1						regulation of transcription, DNA-templated (GO:0006355)|transcription, DNA-templated (GO:0006351)	cytoplasm (GO:0005737)|nucleus (GO:0005634)|plasma membrane (GO:0005886)	identical protein binding (GO:0042802)|nucleotide binding (GO:0000166)|poly(A) RNA binding (GO:0044822)|RNA binding (GO:0003723)|zinc ion binding (GO:0008270)		EWSR1/ATF1(347)|EWSR1/POU5F1(10)|EWSR1/PBX1(3)|EWSR1/DDIT3(45)|EWSR1/FEV(11)|EWSR1/CREB1(44)|EWSR1/SMARCA5(2)|EWSR1/ETV4(6)|EWSR1/ERG(178)|EWSR1/ZNF384(4)|EWSR1/ETV1(7)|EWSR1/FLI1(2569)|EWSR1/NR4A3(146)|EWSR1/SP3(3)|EWSR1/PATZ1(2)|EWSR1/WT1(234)|EWSR1/NFATC2(9)	breast(2)|central_nervous_system(1)|endometrium(6)|haematopoietic_and_lymphoid_tissue(1)|kidney(2)|large_intestine(1)|liver(1)|lung(6)|ovary(2)|skin(2)|upper_aerodigestive_tract(1)|urinary_tract(1)	26						tttgagaccaccctgggcaac	0.453			T	"""FLI1, ERG, ZNF278, NR4A3, FEV, ATF1, ETV1, ETV4, WT1, ZNF384, CREB1, POU5F1,  PBX1"""	"""Ewing sarcoma,  desmoplastic small round cell tumor , ALL, clear cell sarcoma, sarcoma, myoepithelioma"""																																		Dom	yes		22	22q12	2130	Ewing sarcoma breakpoint region 1 (EWS)		"""L, M"""	0																																										SO:0001627	intron_variant				CCDS13851.1, CCDS13852.1, CCDS13852.2, CCDS54512.1, CCDS54513.1, CCDS54514.1	22q12.2	2013-05-24	2013-05-24		ENSG00000182944	ENSG00000182944	2130		"""RNA binding motif (RRM) containing"""	3508	protein-coding gene	gene with protein product		133450	"""Ewing sarcoma breakpoint region 1"""			1522903	Standard	NM_005243	NM_005243		Approved	EWS	uc003aev.3	Q01844	OTTHUMG00000151107	ENST00000414183.2:c.812-624C>G	chr22.hg19:g.29683971C>G			B0QYK1|Q5THL0|Q92635|Q96FE8|Q96MN4|Q96MX4|Q9BWA2	True	hg19	CCDS13852.2																																																																																			EWSR1-021	KNOWN	basic|appris_candidate_longest|CCDS	protein_coding		protein_coding	OTTHUMT00000358290.1		20.0		+	ENST00000414183.2
BCOR	54880	__UNKNOWN__	__UNKNOWN__	X	39911836	39911836	__UNKNOWN__	Intron	SNP	G	G	T			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chrX:39911836G>T	ENST00000378444.4	-	15	5205				BCOR_ENST00000397354.3_Intron|BCOR_ENST00000378463.1_Intron|BCOR_ENST00000378455.4_Intron|BCOR_ENST00000342274.4_Intron	NM_001123385.1	NP_001116857.1	Q6W2J9	BCOR_HUMAN	BCL6 corepressor						heart development (GO:0007507)|histone H2A monoubiquitination (GO:0035518)|negative regulation of bone mineralization (GO:0030502)|negative regulation of histone H3-K36 methylation (GO:0000415)|negative regulation of histone H3-K4 methylation (GO:0051572)|negative regulation of tooth mineralization (GO:0070171)|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|negative regulation of transcription, DNA-templated (GO:0045892)|odontogenesis (GO:0042476)|palate development (GO:0060021)|specification of axis polarity (GO:0065001)|transcription, DNA-templated (GO:0006351)	nucleus (GO:0005634)	heat shock protein binding (GO:0031072)|histone deacetylase binding (GO:0042826)|transcription corepressor activity (GO:0003714)|transcription factor binding (GO:0008134)|transcription regulatory region DNA binding (GO:0044212)			breast(4)|central_nervous_system(11)|cervix(1)|endometrium(24)|eye(6)|haematopoietic_and_lymphoid_tissue(33)|kidney(2)|large_intestine(11)|lung(22)|ovary(2)|pancreas(1)|prostate(2)|skin(2)|upper_aerodigestive_tract(3)|urinary_tract(2)	126						tttttttttggagacggaatc	0.502			"""F, N, S, T"""	RARA	"""retinoblastoma, AML, APL(translocation)"""		oculo-facio-cardio-dental genetic																																Rec	yes		X	Xp11.4	54880	BCL6 corepressor	yes		0																																										SO:0001627	intron_variant			AF317391	CCDS14250.1, CCDS48092.1, CCDS48093.1	Xp11.4	2014-09-17	2010-06-10		ENSG00000183337	ENSG00000183337	54880		"""Ankyrin repeat domain containing"""	20893	protein-coding gene	gene with protein product		300485	"""BCL6 co-repressor"""			10898795	Standard	NM_017745	NM_017745		Approved	FLJ20285, KIAA1575	uc004den.4	Q6W2J9	OTTHUMG00000024100	ENST00000378444.4:c.4977-183C>A	chrX.hg19:g.39911836G>T			D3DWB3|D3DWB4|Q29RF6|Q6P4B6|Q7Z2K7|Q8TEB4|Q96DB3|Q9H232|Q9H233|Q9HCJ7|Q9NXF2	True	hg19	CCDS48093.1																																																																																			BCOR-003	KNOWN	basic|appris_candidate_longest|CCDS	protein_coding		protein_coding	OTTHUMT00000060666.2		73.0		-	ENST00000378444.4
ATRX	546	__UNKNOWN__	__UNKNOWN__	X	76890138	76890180	__UNKNOWN__	Frame_Shift_Del	DEL	GAGATTTCTTTGTTTTTTTCACAGACTCACAGCAGCAATCCCA	GAGATTTCTTTGTTTTTTTCACAGACTCACAGCAGCAATCCCA	-			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chrX:76890138_76890180delGAGATTTCTTTGTTTTTTTCACAGACTCACAGCAGCAATCCCA	ENST00000373344.5	-	17	4928_4970	c.4714_4756delTGGGATTGCTGCTGTGAGTCTGTGAAAAAAACAAAGAAATCTC	c.(4714-4758)tgggattgctgctgtgagtctgtgaaaaaaacaaagaaatctccafs	p.WDCCCESVKKTKKSP1572fs	ATRX_ENST00000480283.1_5'UTR|ATRX_ENST00000395603.3_Frame_Shift_Del_p.WDCCCESVKKTKKSP1534fs	NM_000489.3	NP_000480.3	P46100	ATRX_HUMAN	alpha thalassemia/mental retardation syndrome X-linked	1572					ATP catabolic process (GO:0006200)|cellular response to hydroxyurea (GO:0072711)|chromatin remodeling (GO:0006338)|DNA damage response, signal transduction by p53 class mediator (GO:0030330)|DNA duplex unwinding (GO:0032508)|DNA methylation (GO:0006306)|DNA recombination (GO:0006310)|DNA repair (GO:0006281)|DNA replication-independent nucleosome assembly (GO:0006336)|forebrain development (GO:0030900)|negative regulation of telomeric RNA transcription from RNA pol II promoter (GO:1901581)|nucleosome assembly (GO:0006334)|positive regulation of nuclear cell cycle DNA replication (GO:0010571)|positive regulation of telomere maintenance (GO:0032206)|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|regulation of transcription, DNA-templated (GO:0006355)|replication fork processing (GO:0031297)|seminiferous tubule development (GO:0072520)|Sertoli cell development (GO:0060009)|spermatogenesis (GO:0007283)|transcription, DNA-templated (GO:0006351)	cytoplasm (GO:0005737)|mitochondrion (GO:0005739)|nuclear heterochromatin (GO:0005720)|nucleolus (GO:0005730)|nucleus (GO:0005634)|SWI/SNF superfamily-type complex (GO:0070603)|telomeric heterochromatin (GO:0031933)	ATP binding (GO:0005524)|chromatin binding (GO:0003682)|chromo shadow domain binding (GO:0070087)|DNA binding (GO:0003677)|DNA helicase activity (GO:0003678)|DNA translocase activity (GO:0015616)|helicase activity (GO:0004386)|histone binding (GO:0042393)|methylated histone binding (GO:0035064)|zinc ion binding (GO:0008270)	p.K1584fs*17(2)|p.S1585F(2)|p.W1572*(2)|p.K1583N(1)|p.?(1)		bone(1)|breast(6)|central_nervous_system(31)|cervix(2)|endometrium(7)|haematopoietic_and_lymphoid_tissue(15)|kidney(14)|large_intestine(1)|liver(1)|lung(40)|ovary(2)|pancreas(13)|prostate(5)|skin(2)|upper_aerodigestive_tract(3)|urinary_tract(2)	145						CCTGAACCTGGAGATTTCTTTGTTTTTTTCACAGACTCACAGCAGCAATCCCACATAAACTGA	0.350			"""Mis, F, N"""		"""Pancreatic neuroendocrine tumors, paediatric GBM"""		ATR-X (alpha thalassemia/mental retardation) syndrome																																Rec	yes		X	Xq21.1	546	alpha thalassemia/mental retardation syndrome X-linked	yes	E	8	Substitution - Missense(3)|Insertion - Frameshift(2)|Substitution - Nonsense(2)|Unknown(1)	lung(4)|central_nervous_system(2)|large_intestine(1)|bone(1)																																								SO:0001589	frameshift_variant			U72937	CCDS14434.1, CCDS14435.1	Xq21.1	2014-06-17	2010-06-24		ENSG00000085224	ENSG00000085224	546			886	protein-coding gene	gene with protein product	"""RAD54 homolog (S. cerevisiae)"""	300032	"""alpha thalassemia/mental retardation syndrome X-linked (RAD54 (S. cerevisiae) homolog)"", ""Juberg-Marsidi syndrome"""	RAD54, JMS		7874112, 1415255, 8503439, 8630485	Standard	NM_000489	NM_000489		Approved	XH2, XNP	uc004ecp.4	P46100	OTTHUMG00000022686	ENST00000373344.5:c.4714_4756delTGGGATTGCTGCTGTGAGTCTGTGAAAAAAACAAAGAAATCTC	chrX.hg19:g.76890138_76890180delGAGATTTCTTTGTTTTTTTCACAGACTCACAGCAGCAATCCCA	ENSP00000362441:p.Trp1572fs		D3DTE2|P51068|Q15886|Q59FB5|Q59H31|Q5H9A2|Q5JWI4|Q7Z2J1|Q9H0Z1|Q9NTS3	True	hg19	CCDS14434.1																																																																																			ATRX-001	KNOWN	basic|appris_candidate_longest|CCDS	protein_coding		protein_coding	OTTHUMT00000058860.2		100.0		-	ENST00000373344.5
ATRX	546	__UNKNOWN__	__UNKNOWN__	X	76907796	76907796	__UNKNOWN__	Silent	SNP	C	C	T			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chrX:76907796C>T	ENST00000373344.5	-	15	4579	c.4365G>A	c.(4363-4365)gaG>gaA	p.E1455E	ATRX_ENST00000480283.1_5'UTR|ATRX_ENST00000395603.3_Silent_p.E1417E	NM_000489.3	NP_000480.3	P46100	ATRX_HUMAN	alpha thalassemia/mental retardation syndrome X-linked	1455	Poly-Glu.				ATP catabolic process (GO:0006200)|cellular response to hydroxyurea (GO:0072711)|chromatin remodeling (GO:0006338)|DNA damage response, signal transduction by p53 class mediator (GO:0030330)|DNA duplex unwinding (GO:0032508)|DNA methylation (GO:0006306)|DNA recombination (GO:0006310)|DNA repair (GO:0006281)|DNA replication-independent nucleosome assembly (GO:0006336)|forebrain development (GO:0030900)|negative regulation of telomeric RNA transcription from RNA pol II promoter (GO:1901581)|nucleosome assembly (GO:0006334)|positive regulation of nuclear cell cycle DNA replication (GO:0010571)|positive regulation of telomere maintenance (GO:0032206)|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|regulation of transcription, DNA-templated (GO:0006355)|replication fork processing (GO:0031297)|seminiferous tubule development (GO:0072520)|Sertoli cell development (GO:0060009)|spermatogenesis (GO:0007283)|transcription, DNA-templated (GO:0006351)	cytoplasm (GO:0005737)|mitochondrion (GO:0005739)|nuclear heterochromatin (GO:0005720)|nucleolus (GO:0005730)|nucleus (GO:0005634)|SWI/SNF superfamily-type complex (GO:0070603)|telomeric heterochromatin (GO:0031933)	ATP binding (GO:0005524)|chromatin binding (GO:0003682)|chromo shadow domain binding (GO:0070087)|DNA binding (GO:0003677)|DNA helicase activity (GO:0003678)|DNA translocase activity (GO:0015616)|helicase activity (GO:0004386)|histone binding (GO:0042393)|methylated histone binding (GO:0035064)|zinc ion binding (GO:0008270)	p.?(1)		bone(1)|breast(6)|central_nervous_system(31)|cervix(2)|endometrium(7)|haematopoietic_and_lymphoid_tissue(15)|kidney(14)|large_intestine(1)|liver(1)|lung(40)|ovary(2)|pancreas(13)|prostate(5)|skin(2)|upper_aerodigestive_tract(3)|urinary_tract(2)	145						cctcctcctcctcttcctcct	0.378			"""Mis, F, N"""		"""Pancreatic neuroendocrine tumors, paediatric GBM"""		ATR-X (alpha thalassemia/mental retardation) syndrome																																Rec	yes		X	Xq21.1	546	alpha thalassemia/mental retardation syndrome X-linked	yes	E	1	Unknown(1)	bone(1)											120.0	110.0	114.0					X																	76907796		2203	4300	6503	SO:0001819	synonymous_variant			U72937	CCDS14434.1, CCDS14435.1	Xq21.1	2014-06-17	2010-06-24		ENSG00000085224	ENSG00000085224	546			886	protein-coding gene	gene with protein product	"""RAD54 homolog (S. cerevisiae)"""	300032	"""alpha thalassemia/mental retardation syndrome X-linked (RAD54 (S. cerevisiae) homolog)"", ""Juberg-Marsidi syndrome"""	RAD54, JMS		7874112, 1415255, 8503439, 8630485	Standard	NM_000489	NM_000489		Approved	XH2, XNP	uc004ecp.4	P46100	OTTHUMG00000022686	ENST00000373344.5:c.4365G>A	chrX.hg19:g.76907796C>T			D3DTE2|P51068|Q15886|Q59FB5|Q59H31|Q5H9A2|Q5JWI4|Q7Z2J1|Q9H0Z1|Q9NTS3	True	hg19	CCDS14434.1																																																																																			ATRX-001	KNOWN	basic|appris_candidate_longest|CCDS	protein_coding		protein_coding	OTTHUMT00000058860.2		54.0		-	ENST00000373344.5
ATRX	546	__UNKNOWN__	__UNKNOWN__	X	76907799	76907799	__UNKNOWN__	Silent	SNP	T	T	C			__UNKNOWN__	16/10115z	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	__UNKNOWN__	16/10115z	g.chrX:76907799T>C	ENST00000373344.5	-	15	4576	c.4362A>G	c.(4360-4362)gaA>gaG	p.E1454E	ATRX_ENST00000480283.1_5'UTR|ATRX_ENST00000395603.3_Silent_p.E1416E	NM_000489.3	NP_000480.3	P46100	ATRX_HUMAN	alpha thalassemia/mental retardation syndrome X-linked	1454	Poly-Glu.				ATP catabolic process (GO:0006200)|cellular response to hydroxyurea (GO:0072711)|chromatin remodeling (GO:0006338)|DNA damage response, signal transduction by p53 class mediator (GO:0030330)|DNA duplex unwinding (GO:0032508)|DNA methylation (GO:0006306)|DNA recombination (GO:0006310)|DNA repair (GO:0006281)|DNA replication-independent nucleosome assembly (GO:0006336)|forebrain development (GO:0030900)|negative regulation of telomeric RNA transcription from RNA pol II promoter (GO:1901581)|nucleosome assembly (GO:0006334)|positive regulation of nuclear cell cycle DNA replication (GO:0010571)|positive regulation of telomere maintenance (GO:0032206)|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|regulation of transcription, DNA-templated (GO:0006355)|replication fork processing (GO:0031297)|seminiferous tubule development (GO:0072520)|Sertoli cell development (GO:0060009)|spermatogenesis (GO:0007283)|transcription, DNA-templated (GO:0006351)	cytoplasm (GO:0005737)|mitochondrion (GO:0005739)|nuclear heterochromatin (GO:0005720)|nucleolus (GO:0005730)|nucleus (GO:0005634)|SWI/SNF superfamily-type complex (GO:0070603)|telomeric heterochromatin (GO:0031933)	ATP binding (GO:0005524)|chromatin binding (GO:0003682)|chromo shadow domain binding (GO:0070087)|DNA binding (GO:0003677)|DNA helicase activity (GO:0003678)|DNA translocase activity (GO:0015616)|helicase activity (GO:0004386)|histone binding (GO:0042393)|methylated histone binding (GO:0035064)|zinc ion binding (GO:0008270)	p.?(1)		bone(1)|breast(6)|central_nervous_system(31)|cervix(2)|endometrium(7)|haematopoietic_and_lymphoid_tissue(15)|kidney(14)|large_intestine(1)|liver(1)|lung(40)|ovary(2)|pancreas(13)|prostate(5)|skin(2)|upper_aerodigestive_tract(3)|urinary_tract(2)	145						cctcctcctcttcctcctcct	0.373			"""Mis, F, N"""		"""Pancreatic neuroendocrine tumors, paediatric GBM"""		ATR-X (alpha thalassemia/mental retardation) syndrome																																Rec	yes		X	Xq21.1	546	alpha thalassemia/mental retardation syndrome X-linked	yes	E	1	Unknown(1)	bone(1)											113.0	103.0	107.0					X																	76907799		2203	4300	6503	SO:0001819	synonymous_variant			U72937	CCDS14434.1, CCDS14435.1	Xq21.1	2014-06-17	2010-06-24		ENSG00000085224	ENSG00000085224	546			886	protein-coding gene	gene with protein product	"""RAD54 homolog (S. cerevisiae)"""	300032	"""alpha thalassemia/mental retardation syndrome X-linked (RAD54 (S. cerevisiae) homolog)"", ""Juberg-Marsidi syndrome"""	RAD54, JMS		7874112, 1415255, 8503439, 8630485	Standard	NM_000489	NM_000489		Approved	XH2, XNP	uc004ecp.4	P46100	OTTHUMG00000022686	ENST00000373344.5:c.4362A>G	chrX.hg19:g.76907799T>C			D3DTE2|P51068|Q15886|Q59FB5|Q59H31|Q5H9A2|Q5JWI4|Q7Z2J1|Q9H0Z1|Q9NTS3	True	hg19	CCDS14434.1																																																																																			ATRX-001	KNOWN	basic|appris_candidate_longest|CCDS	protein_coding		protein_coding	OTTHUMT00000058860.2		54.0		-	ENST00000373344.5
